Enrichment analysis report,,,,,,,,,,,,
Enrichment by Pathway Maps,,,,,untransformed_FC,,,,rna_untransformed_FC,,,
#,Maps,Total,min(pValue),Min FDR,p-value,FDR,In Data,"Network Objects from
Active Data",p-value,FDR,In Data,"Network Objects from
Active Data"
1,Cell adhesion_ECM remodeling,55,2.37E-18,3.44E-15,2.37E-18,3.44E-15,31,"Laminin 5, MMP-13, CD44, SERPINE2, Caveolin-2, PLAT (TPA), MSN (moesin), IL-8, EGFR, MMP-14, MMP-2, Versican, MMP-12, Matrilysin (MMP-7), PLAUR (uPAR), alpha-5/beta-1 integrin, Actin cytoskeletal, alpha-1/beta-1 integrin, Collagen II, Collagen IV, IBP4, IL8RA, Fibronectin, Kallikrein 1, Nidogen, Osteonectin, LAMA4, MMP-9, PLAU (UPA), Kallikrein 3 (PSA), Collagen III",1.12E-17,1.61E-14,30,"Laminin 5, MMP-13, CD44, SERPINE2, Caveolin-2, PLAT (TPA), MSN (moesin), IL-8, EGFR, MMP-14, MMP-2, Versican, MMP-12, Matrilysin (MMP-7), PLAUR (uPAR), alpha-5/beta-1 integrin, alpha-1/beta-1 integrin, Collagen II, Collagen IV, IBP4, IL8RA, Fibronectin, Kallikrein 1, Nidogen, Osteonectin, LAMA4, MMP-9, PLAU (UPA), Kallikrein 3 (PSA), Collagen III"
2,Protein folding and maturation_POMC processing,30,2.59E-17,1.85E-14,5.41E-17,3.93E-14,22,"PAM, proACTH, POMC, NAT-1, N-POMC, beta-Endorphin extracellular region, gamma-LPH, ACTH 1-17, Joining peptide (JP), DA-alphaMSH, PC1, gamma-MSH, beta-LPH, gamma2-MSH, beta-MSH, N-POC, gamma3-MSH, ACTH, PC2, alpha-MSH, Carboxypeptidase H, CLIP",2.59E-17,1.85E-14,22,"PAM, proACTH, POMC, NAT-1, N-POMC, beta-Endorphin extracellular region, gamma-LPH, ACTH 1-17, Joining peptide (JP), DA-alphaMSH, PC1, gamma-MSH, beta-LPH, gamma2-MSH, beta-MSH, N-POC, gamma3-MSH, ACTH, PC2, alpha-MSH, Carboxypeptidase H, CLIP"
3,Development_Regulation of epithelial-to-mesenchymal transition (EMT),64,6.71E-15,2.49E-12,6.71E-15,2.49E-12,30,"HGF, IL-1 beta, N-cadherin, TGF-beta 2, RelA (p65 NF-kB subunit), TGF-beta 3, WNT, TGF-beta receptor type II, SLUG, EGFR, Bcl-2, SIP1 (ZFHX1B), MMP-2, NOTCH4, Caldesmon, ACTA2, FGF2, SNAIL1, PDGF-R-alpha, HGF receptor (Met), Fibronectin, Jagged1, Vimentin, TCF8, Claudin-1, MMP-9, Frizzled, EDNRA, ACTB, PDGF-R-beta",1.97E-13,9.40E-11,28,"HGF, IL-1 beta, N-cadherin, TGF-beta 2, RelA (p65 NF-kB subunit), TGF-beta 3, WNT, TGF-beta receptor type II, SLUG, EGFR, Bcl-2, SIP1 (ZFHX1B), MMP-2, NOTCH4, ACTA2, Caldesmon, FGF2, PDGF-R-alpha, HGF receptor (Met), Fibronectin, Jagged1, Vimentin, TCF8, Claudin-1, MMP-9, Frizzled, EDNRA, PDGF-R-beta"
4,Role of stellate cells in progression of pancreatic cancer,60,6.85E-15,2.49E-12,6.85E-15,2.49E-12,29,"GRO-2, NGF, PI3K cat class IA, RECK, RelA (p65 NF-kB subunit), MMP-13, CCL2, IL-8, TGF-beta receptor type II, EGFR, ERK1/2, MMP-2, IL-6, Galectin-1, ACTA2, alpha-5/beta-1 integrin, FGF2, SOS, SMAD3, CTGF, PDGF-R-alpha, AKT(PKB), PDGF receptor, OSF-2, PDK (PDPK1), Fibronectin, PDGF-R-beta, NF-kB p65/p65, Collagen III",1.89E-12,6.75E-10,26,"GRO-2, NGF, PI3K cat class IA, RECK, RelA (p65 NF-kB subunit), MMP-13, CCL2, IL-8, TGF-beta receptor type II, EGFR, MMP-2, IL-6, Galectin-1, ACTA2, alpha-5/beta-1 integrin, FGF2, SOS, CTGF, PDGF-R-alpha, AKT(PKB), PDGF receptor, OSF-2, Fibronectin, PDGF-R-beta, NF-kB p65/p65, Collagen III"
5,Signal transduction_PDGF signaling via PI3K/AKT and NFkB pathways,70,4.32E-11,1.01E-08,4.32E-11,1.01E-08,27,"PDK1, RelA (p65 NF-kB subunit), MYH11, PTEN, CCL2, ETS1, ERK1/2, MMP-2, PDGF-C, Transgelin, Beta-catenin, YB-1, ACTA2, SGK1, PDGFR-ab, NF-kB, MKL1, PDGF-R-alpha, AKT(PKB), SOS1, PDGF receptor, p53, PDK (PDPK1), p27KIP1, MMP-9, Phox1 (PRRX1), PDGF-R-beta",3.50E-05,5.81E-04,18,"RelA (p65 NF-kB subunit), CCL2, ETS1, MMP-2, PDGF-C, Transgelin, ACTA2, SGK1, PDGFR-ab, NF-kB, MKL1, PDGF-R-alpha, AKT(PKB), SOS1, PDGF receptor, MMP-9, Phox1 (PRRX1), PDGF-R-beta"
6,Beta-catenin-dependent transcription regulation in colorectal cancer,36,4.48E-11,1.01E-08,4.48E-11,1.01E-08,19,"COX-2 (PTGS2), LAMC2, LAMC2 (80kDa), CD44, Mucin 2, IL-8, CDX2, CD44 soluble, TCF7L2 (TCF4), Fascin, MMP-14, CD44 (EXT), Beta-catenin, PLAUR (uPAR), LAMC2 (100kDa), Claudin-1, NRCAM, PLAU (UPA), MDR1",2.68E-10,7.66E-08,18,"COX-2 (PTGS2), LAMC2, LAMC2 (80kDa), CD44, Mucin 2, IL-8, CDX2, CD44 soluble, TCF7L2 (TCF4), Fascin, MMP-14, CD44 (EXT), PLAUR (uPAR), LAMC2 (100kDa), Claudin-1, NRCAM, PLAU (UPA), MDR1"
7,Stimulation of TGF-beta signaling in lung cancer,48,4.84E-11,1.01E-08,4.84E-11,1.01E-08,22,"COX-2 (PTGS2), IL-1 beta, N-cadherin, TGF-beta 2, ITGB1, RelA (p65 NF-kB subunit), TGF-beta 3, TGF-beta receptor type II, SLUG, IRAKM, MMP-2, ACTA2, TGF-beta, Fyn, SNAIL1, SMAD3, AKT(PKB), MMP-28, Fibronectin, Vimentin, MMP-9, Tropomyosin-2",1.61E-09,2.56E-07,20,"COX-2 (PTGS2), IL-1 beta, N-cadherin, TGF-beta 2, ITGB1, RelA (p65 NF-kB subunit), TGF-beta 3, TGF-beta receptor type II, SLUG, IRAKM, MMP-2, ACTA2, TGF-beta, Fyn, AKT(PKB), MMP-28, Fibronectin, Vimentin, MMP-9, Tropomyosin-2"
8,Regulation of IGF family activity in colorectal cancer,30,1.06E-10,1.79E-08,1.06E-10,1.79E-08,17,"COX-2 (PTGS2), IL-1 beta, IBP2, Cystatin SN, IL-6, CEACAM5, Matrilysin (MMP-7), PLAUR (uPAR), PCSK5, IBP4, IBP6, IBP5, p53, MMP-9, IBP, PLAU (UPA), IBP3",7.71E-10,1.73E-07,16,"COX-2 (PTGS2), IL-1 beta, IBP2, Cystatin SN, IL-6, CEACAM5, Matrilysin (MMP-7), PLAUR (uPAR), PCSK5, IBP4, IBP6, IBP5, MMP-9, IBP, PLAU (UPA), IBP3"
9,ERBB family and HGF signaling in gastric cancer,54,1.11E-10,1.79E-08,1.11E-10,1.79E-08,23,"BAD, STAT3, HGF, COX-2 (PTGS2), PI3K cat class IA, Amphiregulin, Neuregulin 1, IL-8, Epiregulin, EGFR, TCF7L2 (TCF4), Neuropilin-1, ERK1/2, ErbB3, Beta-catenin, TGF-alpha, SOS, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), HGF receptor (Met), p27KIP1, ERK1 (MAPK3)",2.32E-04,2.46E-03,14,"HGF, COX-2 (PTGS2), PI3K cat class IA, Amphiregulin, Neuregulin 1, IL-8, Epiregulin, EGFR, TCF7L2 (TCF4), Neuropilin-1, TGF-alpha, SOS, AKT(PKB), HGF receptor (Met)"
10,Stromal-epithelial interaction in Prostate Cancer,42,1.56E-10,2.26E-08,1.56E-10,2.26E-08,20,"HGF, Keratin 17, Androgen receptor, TGF-beta 2, TGF-beta 3, TGF-beta receptor type II, MMP-2, Versican, IL-6, ACTA2, FGF2, SNAIL1, SMAD3, PDGF-R-alpha, HIC5, HGF receptor (Met), Fibronectin, Vimentin, MMP-9, PDGF-R-beta",6.16E-09,8.82E-07,18,"HGF, Keratin 17, Androgen receptor, TGF-beta 2, TGF-beta 3, TGF-beta receptor type II, MMP-2, Versican, IL-6, ACTA2, FGF2, PDGF-R-alpha, HIC5, HGF receptor (Met), Fibronectin, Vimentin, MMP-9, PDGF-R-beta"
11,TGF-beta signaling via SMADs in breast cancer,47,2.42E-10,3.12E-08,2.42E-10,3.12E-08,21,"TGF-beta 2, MMP-13, RUNX2, CD44, TGF-beta 3, IL-8, ETS1, TGF-beta receptor type II, SLUG, CD44 soluble, Fascin, MMP-14, PTHrP, HMGA2, SNAIL1, SMAD3, CTGF, p53, FOXQ1 (HFH1), MMP-9, GLI-2",5.13E-08,3.67E-06,18,"TGF-beta 2, MMP-13, RUNX2, CD44, TGF-beta 3, IL-8, ETS1, TGF-beta receptor type II, SLUG, CD44 soluble, Fascin, MMP-14, PTHrP, HMGA2, CTGF, FOXQ1 (HFH1), MMP-9, GLI-2"
12,Development_TGF-beta-dependent induction of EMT via SMADs ,35,2.58E-10,3.12E-08,2.58E-10,3.12E-08,18,"N-cadherin, TGF-beta 2, TGF-beta 3, ETS1, TGF-beta receptor type II, SLUG, SIP1 (ZFHX1B), MMP-2, TGF-beta, HMGA2, SNAIL1, SMAD3, MKL1, Fibronectin, Jagged1, Vimentin, TCF8, Claudin-1",1.39E-08,1.66E-06,16,"N-cadherin, TGF-beta 2, TGF-beta 3, ETS1, TGF-beta receptor type II, SLUG, SIP1 (ZFHX1B), MMP-2, TGF-beta, HMGA2, MKL1, Fibronectin, Jagged1, Vimentin, TCF8, Claudin-1"
13,G protein-coupled receptors signaling in lung cancer,76,3.88E-10,4.34E-08,3.88E-10,4.34E-08,27,"STAT3, PGE2R4, GRP-R, Amphiregulin, RelA (p65 NF-kB subunit), EDNRB, LPAR1, CD44, IL-8, EGFR, NT, G-protein alpha-i family, ERK1/2, MMP-2, VIP receptor 1, Galpha(i)-specific peptide GPCRs, BDKRB2, TGF-alpha, CCR5, VIP receptor 2, Galpha(q)-specific peptide GPCRs, AKT(PKB), G-protein alpha-q/11, IL8RA, PDK (PDPK1), PGE2R3, EDNRA",2.65E-08,2.41E-06,24,"PGE2R4, GRP-R, Amphiregulin, RelA (p65 NF-kB subunit), EDNRB, LPAR1, CD44, IL-8, EGFR, NT, G-protein alpha-i family, MMP-2, VIP receptor 1, Galpha(i)-specific peptide GPCRs, BDKRB2, TGF-alpha, CCR5, VIP receptor 2, Galpha(q)-specific peptide GPCRs, AKT(PKB), G-protein alpha-q/11, IL8RA, PGE2R3, EDNRA"
14,Inflammatory mechanisms of pancreatic cancerogenesis,67,5.21E-10,5.41E-08,5.21E-10,5.41E-08,25,"STAT3, COX-2 (PTGS2), IL-1 beta, TNF-R2, CCL20, RelA (p65 NF-kB subunit), GRO-1, iNOS, ICAM1, CCL2, IL-8, EGFR, G-protein alpha-i family, TLR4, Bcl-2, ENA-78, MMP-2, IL-32 (NK4), C/EBP, IL-6, TGF-alpha, NF-kB, IL8RA, MMP-9, PLAU (UPA)",1.52E-09,2.56E-07,24,"COX-2 (PTGS2), IL-1 beta, TNF-R2, CCL20, RelA (p65 NF-kB subunit), GRO-1, iNOS, ICAM1, CCL2, IL-8, EGFR, G-protein alpha-i family, TLR4, Bcl-2, ENA-78, MMP-2, IL-32 (NK4), C/EBP, IL-6, TGF-alpha, NF-kB, IL8RA, MMP-9, PLAU (UPA)"
15,Putative roles of SETDB1 and PLU-1 in melanoma,23,8.46E-10,1.14E-07,1.33E-09,1.14E-07,14,"HOXA6, HOXA4, p14ARF, HOXA10, HOXA2, LMO2, HOXA9, HOXA7, HOXA3, HOXA5, p16INK4, Jagged1, HOXA11, CDK6",8.46E-10,1.73E-07,14,"HOXA6, HOXA4, p14ARF, HOXA10, HOXA2, LMO2, HOXA9, HOXA7, HOXA3, HOXA5, p16INK4, Jagged1, HOXA11, CDK6"
16,"Development_TGF-beta-dependent induction of EMT via RhoA,  PI3K and ILK",46,1.18E-09,1.14E-07,1.18E-09,1.14E-07,20,"TGF-beta 2, PI3K cat class IA, RelA (p65 NF-kB subunit), TGF-beta 3, TGF-beta receptor type II, SLUG, Beta-catenin, Caldesmon, ACTA2, SNAIL1, SMAD3, MKL1, AKT(PKB), HIC5, PDK (PDPK1), Fibronectin, Vimentin, Claudin-1, Actin, ACTB",6.98E-06,1.89E-04,15,"TGF-beta 2, PI3K cat class IA, RelA (p65 NF-kB subunit), TGF-beta 3, TGF-beta receptor type II, SLUG, ACTA2, Caldesmon, MKL1, AKT(PKB), HIC5, Fibronectin, Vimentin, Claudin-1, Actin"
17,Development_WNT/Beta-catenin signaling in organogenesis,30,1.28E-09,1.14E-07,1.28E-09,1.14E-07,16,"FoxN1, MEPE, Oct-3/4, PROP1, Tcf(Lef), IL-8, WNT, TCF7L2 (TCF4), Neuropilin-1, FOXC2, LBH, Beta-catenin, PLA2G7, En1, BMP2, Frizzled",8.48E-09,1.10E-06,15,"FoxN1, MEPE, Oct-3/4, PROP1, Tcf(Lef), IL-8, WNT, TCF7L2 (TCF4), Neuropilin-1, FOXC2, LBH, PLA2G7, En1, BMP2, Frizzled"
18,Stellate cells activation and liver fibrosis,70,1.53E-09,1.23E-07,1.53E-09,1.23E-07,25,"GRO-2, IL-1 beta, Biglycan, TNF-R2, PI3K cat class IA, PTCH1, ICAM1, CCL2, Tcf(Lef), TGF-beta receptor type II, MMP-2, Beta-catenin, ACTA2, SOS, GLI-1, SMAD3, PDGF-R-alpha, ERK2 (MAPK1), AKT(PKB), PDGF receptor, Dsh, ERK1 (MAPK3), Frizzled, TLR2, PDGF-R-beta",2.25E-06,7.86E-05,20,"GRO-2, IL-1 beta, Biglycan, TNF-R2, PI3K cat class IA, PTCH1, ICAM1, CCL2, Tcf(Lef), TGF-beta receptor type II, MMP-2, ACTA2, SOS, GLI-1, PDGF-R-alpha, AKT(PKB), PDGF receptor, Frizzled, TLR2, PDGF-R-beta"
19,Glomerular injury in Lupus Nephritis,92,2.22E-09,1.69E-07,2.22E-09,1.69E-07,29,"GRO-2, IL-1 beta, RelA (p65 NF-kB subunit), GRO-1, iNOS, IP10, ICAM1, CCL2, PKC-alpha, IL-8, NGAL, LIN-28, Bcl-2, ERK1/2, IL-6, TGF-beta, NF-kB, AKT(PKB), CSF1, PDK (PDPK1), TLR3, Fibronectin, C3a, GRO-3, A20, IFN-beta, MMP-9, IFI56, PDGF-R-beta",2.10E-08,2.32E-06,27,"GRO-2, IL-1 beta, RelA (p65 NF-kB subunit), GRO-1, iNOS, IP10, ICAM1, CCL2, PKC-alpha, IL-8, NGAL, LIN-28, Bcl-2, IL-6, TGF-beta, NF-kB, AKT(PKB), CSF1, TLR3, Fibronectin, C3a, GRO-3, A20, IFN-beta, MMP-9, IFI56, PDGF-R-beta"
20,Breast cancer (general schema),41,6.64E-09,4.83E-07,6.64E-09,4.83E-07,18,"Androgen receptor, ESR1 (nuclear), PTCH1, Neuregulin 1, TGF-beta receptor type II, EGFR, ErbB3, PTHR1, ESR1 (membrane), IL-6, NOTCH4, TGF-beta, PTHrP, Jagged1, PR (membrane), GHR, Prolactin receptor, PR (nuclear)",2.98E-08,2.51E-06,17,"Androgen receptor, ESR1 (nuclear), PTCH1, Neuregulin 1, TGF-beta receptor type II, EGFR, PTHR1, ESR1 (membrane), IL-6, NOTCH4, TGF-beta, PTHrP, Jagged1, PR (membrane), GHR, Prolactin receptor, PR (nuclear)"
21,Role of Tissue factor-induced Thrombin signaling in cancerogenesis,65,8.47E-09,5.86E-07,8.47E-09,5.86E-07,23,"PAR3, RelA (p65 NF-kB subunit), GRO-1, MMP-13, PKC-alpha, IL-8, EGFR, G-protein alpha-i family, MRLC, ERK1/2, MMP-2, Angiopoietin 1, Actin cytoskeletal, ERK2 (MAPK1), AKT(PKB), G-protein alpha-q/11, Tissue factor, MELC, PDK (PDPK1), Coagulation factor VII, ERK1 (MAPK3), MLCK, IP3 receptor",1.16E-05,2.73E-04,18,"PAR3, RelA (p65 NF-kB subunit), GRO-1, MMP-13, PKC-alpha, IL-8, EGFR, G-protein alpha-i family, MRLC, MMP-2, Angiopoietin 1, AKT(PKB), G-protein alpha-q/11, Tissue factor, MELC, Coagulation factor VII, MLCK, IP3 receptor"
22,Cell adhesion_Tight junctions,38,1.24E-08,8.07E-07,1.24E-08,8.07E-07,17,"ITGB1, Claudin-18, Claudin-11, Actomyosin, F-Actin, Tcf(Lef), CDX2, Claudin-16, Myosin II, SNAIL1, WNK4, Caveolin-1, Claudin-8, Claudin-3, Claudin-1, Actin, CDX1",1.59E-05,3.56E-04,13,"ITGB1, Claudin-18, Claudin-11, Tcf(Lef), CDX2, Claudin-16, WNK4, Caveolin-1, Claudin-8, Claudin-3, Claudin-1, Actin, CDX1"
23,Immune response_IL-1 signaling pathway,82,1.30E-08,8.07E-07,1.30E-08,8.07E-07,26,"COX-2 (PTGS2), IL-1 beta, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), GRO-1, MMP-13, iNOS, RUNX2, IP10, ICAM1, CD44, CCL2, IL-8, ERK1/2, IL-6, FGF2, Collagen II, NF-kB, AKT(PKB), PDK (PDPK1), MYLK1, IFN-beta, MMP-9, PLAU (UPA), CCL7",1.35E-07,8.78E-06,24,"COX-2 (PTGS2), IL-1 beta, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), GRO-1, MMP-13, iNOS, RUNX2, IP10, ICAM1, CD44, CCL2, IL-8, IL-6, FGF2, Collagen II, NF-kB, AKT(PKB), MYLK1, IFN-beta, MMP-9, PLAU (UPA), CCL7"
24,Inhibition of remyelination in multiple sclerosis: role of cell-cell and ECM-cell interactions,47,1.33E-08,8.07E-07,1.33E-08,8.07E-07,19,"NGF, ITGB1, Myelin basic protein, Claudin-11, NGFR(TNFRSF16), Caspr1, Tetraspanin-2, NCAM1, PKC, CD44, Connexin 26, Connexin 32, Connexin 30, Actin cytoskeletal, Fyn, Connexin 45, Fibronectin, MMP-9, TLR2",5.13E-08,3.67E-06,18,"NGF, ITGB1, Myelin basic protein, Claudin-11, NGFR(TNFRSF16), Caspr1, Tetraspanin-2, NCAM1, PKC, CD44, Connexin 26, Connexin 32, Connexin 30, Fyn, Connexin 45, Fibronectin, MMP-9, TLR2"
25,ErbB2-induced breast cancer cell invasion,67,1.65E-08,9.32E-07,1.65E-08,9.32E-07,23,"PI3K cat class IA, MMP-13, ITGA4, PKC-alpha, Neuregulin 1, PDCD4, ETS1, NGAL, EGFR, ERK1/2, MMP-14, MMP-2, ErbB3, PLAUR (uPAR), Actin cytoskeletal, SOS, NF-kB, AKT(PKB), PDK (PDPK1), ER81, MMP-9, PLAU (UPA), IP3 receptor",4.54E-06,1.33E-04,19,"PI3K cat class IA, MMP-13, ITGA4, PKC-alpha, Neuregulin 1, PDCD4, ETS1, NGAL, EGFR, MMP-14, MMP-2, PLAUR (uPAR), SOS, NF-kB, AKT(PKB), ER81, MMP-9, PLAU (UPA), IP3 receptor"
26,Development_WNT/Beta-catenin signaling in embryogenesis,43,1.67E-08,9.32E-07,1.67E-08,9.32E-07,18,"p14ARF, LHX8, Oct-3/4, SOX2, Tcf(Lef), WNT, CDX2, TCF7L2 (TCF4), LBH, p15, Mixl1, Beta-catenin, SNAIL1, p16INK4, En1, TCF7 (TCF1), CDX1, Frizzled",4.53E-07,2.49E-05,16,"p14ARF, LHX8, Oct-3/4, SOX2, Tcf(Lef), WNT, CDX2, TCF7L2 (TCF4), LBH, p15, Mixl1, p16INK4, En1, TCF7 (TCF1), CDX1, Frizzled"
27,Main genetic and epigenetic alterations in lung cancer,48,2.02E-08,1.08E-06,2.02E-08,1.08E-06,19,"GSTP1, HGF, Neuropilin-2, p14ARF, RECK, PTEN, TGF-beta receptor type II, EGFR, Neuropilin-1, Bcl-2, MMP-2, TGF-alpha, IBP4, Caspase-8, p53, HGF receptor (Met), p16INK4, IBP, IBP3",2.49E-06,8.30E-05,16,"GSTP1, HGF, Neuropilin-2, p14ARF, RECK, TGF-beta receptor type II, EGFR, Neuropilin-1, Bcl-2, MMP-2, TGF-alpha, IBP4, HGF receptor (Met), p16INK4, IBP, IBP3"
28,Transcription_HIF-1 targets,95,2.20E-08,1.13E-06,2.20E-08,1.13E-06,28,"PDK1, TGF-beta 2, Ceruloplasmin, Carbonic anhydrase XII, iNOS, Lysyl oxidase, Transferrin, ROR-alpha, PLGF, Oct-3/4, SOX2, TGF-beta 3, CX3CR1, LOXL2, MMP-2, Galectin-1, NOXA, PLAUR (uPAR), 5'-NTD, FGF2, CTGF, Alpha-1B adrenergic receptor, p53, HGF receptor (Met), MMP-9, Carbonic anhydrase IX, MDR1, IBP3",1.81E-07,1.08E-05,26,"TGF-beta 2, Ceruloplasmin, Carbonic anhydrase XII, iNOS, Lysyl oxidase, Transferrin, ROR-alpha, PLGF, Oct-3/4, SOX2, TGF-beta 3, CX3CR1, LOXL2, MMP-2, Galectin-1, NOXA, PLAUR (uPAR), 5'-NTD, FGF2, CTGF, Alpha-1B adrenergic receptor, HGF receptor (Met), MMP-9, Carbonic anhydrase IX, MDR1, IBP3"
29,EGFR signaling pathway in lung cancer,53,2.25E-08,1.13E-06,2.25E-08,1.13E-06,20,"STAT3, HGF, COX-2 (PTGS2), PI3K cat class IA, Amphiregulin, PTEN, Neuregulin 1, EGFR, Bcl-2, ERK1/2, ErbB3, IL-6, TGF-alpha, SOS, NF-kB, AKT(PKB), PDK (PDPK1), HGF receptor (Met), MMP-9, Carbonic anhydrase IX",4.66E-05,6.74E-04,15,"HGF, COX-2 (PTGS2), PI3K cat class IA, Amphiregulin, Neuregulin 1, EGFR, Bcl-2, IL-6, TGF-alpha, SOS, NF-kB, AKT(PKB), HGF receptor (Met), MMP-9, Carbonic anhydrase IX"
30,SHH signaling in colorectal cancer,31,2.40E-08,1.16E-06,2.40E-08,1.16E-06,15,"PTCH1, WNT, IMP1(ZBP1), TCF7L2 (TCF4), Bcl-2, SIP1 (ZFHX1B), FOXC2, Beta-catenin, SNAIL1, GLI-1, PDGF-R-alpha, p53, Vimentin, Frizzled, GLI-2",7.81E-06,2.00E-04,12,"PTCH1, WNT, IMP1(ZBP1), TCF7L2 (TCF4), Bcl-2, SIP1 (ZFHX1B), FOXC2, GLI-1, PDGF-R-alpha, Vimentin, Frizzled, GLI-2"
31,Rheumatoid arthritis (general schema),50,2.54E-08,1.83E-06,4.42E-08,1.83E-06,19,"IL-15, IL-1 beta, TNF-R2, HLA-DRB1, MHC class II, alpha-4/beta-1 integrin, ICAM1, HLA-DRB, TLR4, IL-6, TGF-beta, FGF2, Collagen II, MMP-8, PTPN22, CSF1, MHC class II beta chain, MMP-9, TLR2",2.54E-08,2.41E-06,19,"IL-15, IL-1 beta, TNF-R2, HLA-DRB1, MHC class II, alpha-4/beta-1 integrin, ICAM1, HLA-DRB, TLR4, IL-6, TGF-beta, FGF2, Collagen II, MMP-8, PTPN22, CSF1, MHC class II beta chain, MMP-9, TLR2"
32,TGF-beta 1-mediated induction of EMT in normal and asthmatic airway epithelium,44,2.58E-08,1.21E-06,2.58E-08,1.21E-06,18,"IL-1 beta, N-cadherin, CD44, ITGB3, ETS1, TGF-beta receptor type II, BMP4, SLUG, MMP-2, ACTA2, HMGA2, SNAIL1, SMAD3, CTGF, Fibronectin, Jagged1, Vimentin, MMP-9",6.52E-07,3.22E-05,16,"IL-1 beta, N-cadherin, CD44, ITGB3, ETS1, TGF-beta receptor type II, BMP4, SLUG, MMP-2, ACTA2, HMGA2, CTGF, Fibronectin, Jagged1, Vimentin, MMP-9"
33,Release of pro-inflammatory mediators and elastolytic enzymes by alveolar macrophages in COPD,28,2.69E-08,1.78E-06,4.17E-08,1.78E-06,14,"CHI3L1, IL-1 beta, RelA (p65 NF-kB subunit), IP10, CCL2, IL-8, TLR4, MMP-2, MMP-12, IL-6, Matrilysin (MMP-7), Cathepsin S, MMP-9, TLR2",2.69E-08,2.41E-06,14,"CHI3L1, IL-1 beta, RelA (p65 NF-kB subunit), IP10, CCL2, IL-8, TLR4, MMP-2, MMP-12, IL-6, Matrilysin (MMP-7), Cathepsin S, MMP-9, TLR2"
34,Immune response_CCL2 signaling,54,3.26E-08,1.48E-06,3.26E-08,1.48E-06,20,"IL-1 beta, iNOS, alpha-4/beta-1 integrin, ICAM1, CCL2, PKC-alpha, ITGB3, ETS1, G-protein alpha-i family, ERK1/2, MMP-14, MMP-2, IL-6, alpha-5/beta-1 integrin, Actin cytoskeletal, NF-kB, Caveolin-1, p53, CDH19, PI3K cat class IA (p110-delta)",2.98E-06,9.08E-05,17,"IL-1 beta, iNOS, alpha-4/beta-1 integrin, ICAM1, CCL2, PKC-alpha, ITGB3, ETS1, G-protein alpha-i family, MMP-14, MMP-2, IL-6, alpha-5/beta-1 integrin, NF-kB, Caveolin-1, CDH19, PI3K cat class IA (p110-delta)"
35,Th17 cytokines in COPD,36,3.74E-08,1.65E-06,3.74E-08,1.65E-06,16,"STAT3, IL-1 beta, MHC class II, CCL20, GRO-1, IP10, ROR-alpha, CCL2, IL-8, ROR-gamma, Mucin 5AC, MMP-12, Mucin 5B, IL-6, NF-kB, MMP-9",1.81E-07,1.08E-05,15,"IL-1 beta, MHC class II, CCL20, GRO-1, IP10, ROR-alpha, CCL2, IL-8, ROR-gamma, Mucin 5AC, MMP-12, Mucin 5B, IL-6, NF-kB, MMP-9"
36,Ovarian cancer (main signaling cascades),65,4.52E-08,1.83E-06,4.52E-08,1.83E-06,22,"HGF, Androgen receptor, PI3K cat class IA, ESR1 (nuclear), LPAR1, PTEN, Tcf(Lef), EGFR, G-protein alpha-i family, ERK1/2, MMP-2, IL-6, Beta-catenin, SNAIL1, SOS, NF-kB, AKT(PKB), HGF receptor (Met), PI3K reg class IB (p101), MMP-9, PLAU (UPA), EDNRA",1.16E-05,2.73E-04,18,"HGF, Androgen receptor, PI3K cat class IA, ESR1 (nuclear), LPAR1, Tcf(Lef), EGFR, G-protein alpha-i family, MMP-2, IL-6, SOS, NF-kB, AKT(PKB), HGF receptor (Met), PI3K reg class IB (p101), MMP-9, PLAU (UPA), EDNRA"
37,Hedgehog signaling in gastric cancer,29,4.77E-08,2.68E-06,7.37E-08,2.68E-06,14,"N-cadherin, MSX-2, PTCH1, CDX2, BMP4, SLUG, SIP1 (ZFHX1B), MEF2C, GLI-1, SFRP1, EDNRA, TWIST2, GLI-2, PDGF-R-beta",4.77E-08,3.67E-06,14,"N-cadherin, MSX-2, PTCH1, CDX2, BMP4, SLUG, SIP1 (ZFHX1B), MEF2C, GLI-1, SFRP1, EDNRA, TWIST2, GLI-2, PDGF-R-beta"
38,EGFR signaling in Prostate Cancer,46,5.88E-08,2.31E-06,5.88E-08,2.31E-06,18,"STAT3, Androgen receptor, Tuberin, PI3K cat class IA, RelA (p65 NF-kB subunit), Neuregulin 1, EGFR, N-Ras, ERK1/2, ErbB3, TGF-alpha, SOS, ERK2 (MAPK1), AKT(PKB), Caveolin-1, PDK (PDPK1), p27KIP1, ERK1 (MAPK3)",2.03E-02,6.35E-02,9,"Androgen receptor, PI3K cat class IA, RelA (p65 NF-kB subunit), Neuregulin 1, EGFR, TGF-alpha, SOS, AKT(PKB), Caveolin-1"
39,Airway smooth muscle contraction in asthma,56,6.63E-08,2.54E-06,6.63E-08,2.54E-06,20,"PGE2R2, Histamine H1 receptor, TRPC3, PKC-alpha, G-protein alpha-i family, Adenylate cyclase, MRLC, Telokin, PGF2aR, Myosin II, BDKRB2, Beta-2 adrenergic receptor, TRPC6, CPI-17, G-protein alpha-q/11, MELC, MyHC, MLCK, IP3 receptor, ACM3",1.09E-06,4.44E-05,18,"PGE2R2, Histamine H1 receptor, TRPC3, PKC-alpha, G-protein alpha-i family, Adenylate cyclase, MRLC, Telokin, PGF2aR, BDKRB2, Beta-2 adrenergic receptor, TRPC6, CPI-17, G-protein alpha-q/11, MELC, MLCK, IP3 receptor, ACM3"
40,Development_EGF-induced proliferation of Type C cells in SVZ of adult brain,33,6.92E-08,2.58E-06,6.92E-08,2.58E-06,15,"PI3K cat class IA, PTCH1, SOX2, EGFR, ERK1/2, Fyn, TGF-alpha, DLX2, SOS, GLI-1, AKT(PKB), PDK (PDPK1), p27KIP1, GLI-2, Prolactin receptor",1.66E-05,3.59E-04,12,"PI3K cat class IA, PTCH1, SOX2, EGFR, Fyn, TGF-alpha, DLX2, SOS, GLI-1, AKT(PKB), GLI-2, Prolactin receptor"
41,Signal transduction_WNT/Beta-catenin signaling in tissue homeostasis,42,7.61E-08,2.70E-06,7.61E-08,2.70E-06,17,"COX-2 (PTGS2), iNOS, Tcf(Lef), IL-8, ROR-gamma, WNT, SLUG, TCF7L2 (TCF4), MMP-2, Versican, Beta-catenin, SNAIL1, ACADL, MMP-9, TCF7 (TCF1), CDX1, Frizzled",1.90E-06,6.99E-05,15,"COX-2 (PTGS2), iNOS, Tcf(Lef), IL-8, ROR-gamma, WNT, SLUG, TCF7L2 (TCF4), MMP-2, Versican, ACADL, MMP-9, TCF7 (TCF1), CDX1, Frizzled"
42,Neutrophil chemotaxis in asthma,38,9.50E-08,3.29E-06,9.50E-08,3.29E-06,16,"GRO-2, GRO-1, CCL2, PLGF, IL-8, G-protein alpha-i family, Tissue kallikreins, ERK1/2, ENA-78, BDKRB1, NF-kB, IL8RA, PI3K reg class IB (p101), GRO-3, TLR2, CCL7",4.22E-07,2.42E-05,15,"GRO-2, GRO-1, CCL2, PLGF, IL-8, G-protein alpha-i family, Tissue kallikreins, ENA-78, BDKRB1, NF-kB, IL8RA, PI3K reg class IB (p101), GRO-3, TLR2, CCL7"
43,Development_Extraembryonic differentiation of embryonic stem cells,35,1.15E-07,5.70E-06,1.81E-07,5.70E-06,15,"GATA-3, MSX-2, NCAM1, HNF4, Transferrin, SOX2, Gremlin, CGB3, BMP4, MAP2, Nestin, ID4, HNF3-alpha, BMP2, PAX6",1.15E-07,7.84E-06,15,"GATA-3, MSX-2, NCAM1, HNF4, Transferrin, SOX2, Gremlin, CGB3, BMP4, MAP2, Nestin, ID4, HNF3-alpha, BMP2, PAX6"
44,Neuroendocrine transdifferentiation in Prostate Cancer,48,1.27E-07,4.30E-06,1.27E-07,4.30E-06,18,"STAT3, Tuberin, Chromogranin A, BMX, Oct-3/4, Tcf(Lef), IL-8, EGFR, NT, TCF7L2 (TCF4), IL-6, Beta-catenin, PTHrP, SOS, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",9.11E-04,6.31E-03,12,"Chromogranin A, BMX, Oct-3/4, Tcf(Lef), IL-8, EGFR, NT, TCF7L2 (TCF4), IL-6, PTHrP, SOS, AKT(PKB)"
45,Chemotaxis_Inhibitory action of lipoxins on IL-8- and Leukotriene B4-induced neutrophil migration,53,1.32E-07,4.35E-06,1.32E-07,4.35E-06,19,"Actomyosin, ITGB2, ICAM1, IL-8, G-protein alpha-i family, MRLC, ERK1/2, Myosin II, Actin cytoskeletal, Rac2, AKT(PKB), MELC, IL8RA, PDK (PDPK1), MYLK1, PI3K reg class IB (p101), Actin, MLCK, PREX1",1.87E-04,2.08E-03,14,"ITGB2, ICAM1, IL-8, G-protein alpha-i family, MRLC, Rac2, AKT(PKB), MELC, IL8RA, MYLK1, PI3K reg class IB (p101), Actin, MLCK, PREX1"
46,Role of IL-8 in colorectal cancer,19,1.72E-07,5.54E-06,1.72E-07,5.54E-06,11,"HGF, IL-1 beta, PI3K cat class IA, ICAM1, CD44, IL-8, EGFR, ERK1/2, MMP-2, IL8RA, HGF receptor (Met)",1.52E-06,6.03E-05,10,"HGF, IL-1 beta, PI3K cat class IA, ICAM1, CD44, IL-8, EGFR, MMP-2, IL8RA, HGF receptor (Met)"
47,Androgen receptor activation and downstream signaling in Prostate cancer,110,1.84E-07,5.70E-06,1.84E-07,5.70E-06,29,"STAT3, Androgen receptor, N-cadherin, PTEN, STEAP1, IL-8, EGFR, N-Ras, FOLH1 (GCP2), Versican, Clusterin, IL-6, Matrilysin (MMP-7), SGK1, FGF2, SOS, ERK2 (MAPK1), PSCA, AKT(PKB), Caveolin-1, SPRY2, p53, PDK (PDPK1), HNF3-alpha, ER81, ERK1 (MAPK3), TLR2, IBP3, Kallikrein 3 (PSA)",2.93E-04,2.90E-03,22,"Androgen receptor, N-cadherin, STEAP1, IL-8, EGFR, FOLH1 (GCP2), Versican, Clusterin, IL-6, Matrilysin (MMP-7), SGK1, FGF2, SOS, PSCA, AKT(PKB), Caveolin-1, SPRY2, HNF3-alpha, ER81, TLR2, IBP3, Kallikrein 3 (PSA)"
48,Hypertrophy of  asthmatic airway smooth muscle cells ,70,2.02E-07,6.13E-06,2.02E-07,6.13E-06,22,"STAT3, Smooth muscle myosin, IL-1 beta, TGF-beta 2, Tuberin, EDNRB, MYH11, TGF-beta 3, TGF-beta receptor type II, EGFR, LIN-28, Transgelin, ACTA2, SMAD3, PDGF-R-alpha, AKT(PKB), IFN-beta, MLCK, EDNRA, Actin muscle, C/EBPalpha, PDGF-R-beta",1.24E-04,1.52E-03,17,"IL-1 beta, TGF-beta 2, EDNRB, TGF-beta 3, TGF-beta receptor type II, EGFR, LIN-28, Transgelin, ACTA2, PDGF-R-alpha, AKT(PKB), IFN-beta, MLCK, EDNRA, Actin muscle, C/EBPalpha, PDGF-R-beta"
49,WNT signaling in HCC,40,2.24E-07,6.46E-06,2.24E-07,6.46E-06,16,"Prickle-1, p14ARF, DVL-3, Tcf(Lef), WNT, EGFR, TCF7L2 (TCF4), WNT3, Beta-catenin, LGR5, SFRP1, p53, FZD7, Dsh, Frizzled, DACT1",1.44E-04,1.69E-03,12,"Prickle-1, p14ARF, Tcf(Lef), WNT, EGFR, TCF7L2 (TCF4), WNT3, LGR5, SFRP1, FZD7, Frizzled, DACT1"
50,TNF-alpha and IL-1 beta-mediated regulation of contraction and secretion of inflammatory factors in normal and asthmatic airway smooth muscle,65,2.26E-07,6.46E-06,2.26E-07,6.46E-06,21,"COX-2 (PTGS2), GRO-2, IL-1 beta, RelA (p65 NF-kB subunit), GRO-1, TRPC3, CCL2, PKC-alpha, CD38, IL-8, EGFR, ERK1/2, IL-6, PA24A, NF-kB, AKT(PKB), PLA2, GRO-3, MMP-9, PDGF-R-beta, CCL7",6.11E-07,3.12E-05,20,"COX-2 (PTGS2), GRO-2, IL-1 beta, RelA (p65 NF-kB subunit), GRO-1, TRPC3, CCL2, PKC-alpha, CD38, IL-8, EGFR, IL-6, PA24A, NF-kB, AKT(PKB), PLA2, GRO-3, MMP-9, PDGF-R-beta, CCL7"
51,Pancreatic cancer cell resistance to Tarceva (erlotinib),27,2.27E-07,6.46E-06,2.27E-07,6.46E-06,13,"Tuberin, PI3K cat class IA, PTEN, Neuregulin 1, EGFR, ErbB3, Beta-catenin, TGF-alpha, SNAIL1, AKT(PKB), PDK (PDPK1), Vimentin, TCF8",8.57E-03,3.45E-02,7,"PI3K cat class IA, Neuregulin 1, EGFR, TGF-alpha, AKT(PKB), Vimentin, TCF8"
52,Signal transduction_MIF signaling pathway,60,2.46E-07,6.56E-06,2.46E-07,6.56E-06,20,"BAD, Syk, COX-2 (PTGS2), PI3K cat class IA, RelA (p65 NF-kB subunit), ICAM1, CD44, IL-8, cPLA2, Lyn, G-protein alpha-i family, TLR4, Bcl-2, ERK1/2, NF-kB, AKT(PKB), p53, PDK (PDPK1), SFK, PI3K reg class IB (p101)",5.85E-05,8.21E-04,16,"Syk, COX-2 (PTGS2), PI3K cat class IA, RelA (p65 NF-kB subunit), ICAM1, CD44, IL-8, cPLA2, Lyn, G-protein alpha-i family, TLR4, Bcl-2, NF-kB, AKT(PKB), SFK, PI3K reg class IB (p101)"
53,Immune response_IL-17 signaling pathways,60,2.46E-07,6.56E-06,2.46E-07,6.56E-06,20,"COX-2 (PTGS2), IL-1 beta, PI3K cat class IA, CCL20, GRO-1, iNOS, GCP2, ICAM1, CCL2, IL-8, NGAL, Mucin 5AC, ERK1/2, ENA-78, Mucin 5B, IL-6, NF-kB, AKT(PKB), MMP-9, CCL7",7.09E-07,3.28E-05,19,"COX-2 (PTGS2), IL-1 beta, PI3K cat class IA, CCL20, GRO-1, iNOS, GCP2, ICAM1, CCL2, IL-8, NGAL, Mucin 5AC, ENA-78, Mucin 5B, IL-6, NF-kB, AKT(PKB), MMP-9, CCL7"
54,LKB1 signaling pathway in lung cancer cells,45,2.51E-07,6.56E-06,2.51E-07,6.56E-06,17,"STAT3, COX-2 (PTGS2), N-cadherin, TGF-beta 2, ITGB1, Tuberin, Lysyl oxidase, PTEN, ERK1/2, Beta-catenin, NF-kB, Collagen IV, p53, p16INK4, Fibronectin, Vimentin, TCF8",1.80E-03,1.06E-02,11,"COX-2 (PTGS2), N-cadherin, TGF-beta 2, ITGB1, Lysyl oxidase, NF-kB, Collagen IV, p16INK4, Fibronectin, Vimentin, TCF8"
55,Mechanisms of resistance to EGFR inhibitors in lung cancer,45,2.51E-07,6.56E-06,2.51E-07,6.56E-06,17,"HGF, PI3K cat class IA, PTEN, EGFR, ErbB3, CIN85, Beta-catenin, SNAIL1, SOS, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), HGF receptor (Met), Fibronectin, Vimentin, TCF8, ERK1 (MAPK3)",5.97E-03,2.61E-02,10,"HGF, PI3K cat class IA, EGFR, CIN85, SOS, AKT(PKB), HGF receptor (Met), Fibronectin, Vimentin, TCF8"
56,TGF-beta 1-induced transactivation of membrane receptors signaling in HCC,50,2.62E-07,6.56E-06,2.62E-07,6.56E-06,18,"ITGB1, Laminin 5, PI3K cat class IA, PTEN, Cyclin E, TGF-beta receptor type II, SLUG, Beta-catenin, alpha-5/beta-1 integrin, TGF-beta, SNAIL1, PDGF-R-alpha, AKT(PKB), PDGF receptor, ITGA5, Fibronectin, Actin, PDGF-R-beta",2.17E-05,4.45E-04,15,"ITGB1, Laminin 5, PI3K cat class IA, Cyclin E, TGF-beta receptor type II, SLUG, alpha-5/beta-1 integrin, TGF-beta, PDGF-R-alpha, AKT(PKB), PDGF receptor, ITGA5, Fibronectin, Actin, PDGF-R-beta"
57,VEGF signaling in multiple myeloma,50,2.62E-07,6.56E-06,2.62E-07,6.56E-06,18,"STAT3, ITGB1, PI3K cat class IA, alpha-4/beta-1 integrin, ICAM1, PKC-alpha, Semaphorin 3A, Neuropilin-1, IL-6, alpha-5/beta-1 integrin, SOS, ERK2 (MAPK1), Caveolin-1, PDK (PDPK1), Fibronectin, ERK1 (MAPK3), MDR1, IP3 receptor",9.44E-05,1.19E-03,14,"ITGB1, PI3K cat class IA, alpha-4/beta-1 integrin, ICAM1, PKC-alpha, Semaphorin 3A, Neuropilin-1, IL-6, alpha-5/beta-1 integrin, SOS, Caveolin-1, Fibronectin, MDR1, IP3 receptor"
58,Survival pathways in Prostate Cancer,50,2.62E-07,6.56E-06,2.62E-07,6.56E-06,18,"BAD, STAT3, TRUNDD(TNFRSF10D), Androgen receptor, Tuberin, PI3K cat class IA, Caspase-10, PTEN, CCL2, Bcl-2, IL-6, NF-kB, ERK2 (MAPK1), AKT(PKB), Caspase-8, p53, PDK (PDPK1), ERK1 (MAPK3)",3.34E-02,9.29E-02,9,"TRUNDD(TNFRSF10D), Androgen receptor, PI3K cat class IA, Caspase-10, CCL2, Bcl-2, IL-6, NF-kB, AKT(PKB)"
59,Role of IL-8 in melanoma,36,2.84E-07,6.96E-06,2.84E-07,6.96E-06,15,"IL-1 beta, RelA (p65 NF-kB subunit), ITGB2, ICAM1, IL-8, G-protein alpha-i family, ERK1/2, MMP-2, IL-6, Beta-catenin, SNAIL1, Beta-2 adrenergic receptor, NF-kB, AKT(PKB), IL8RA",4.52E-05,6.74E-04,12,"IL-1 beta, RelA (p65 NF-kB subunit), ITGB2, ICAM1, IL-8, G-protein alpha-i family, MMP-2, IL-6, Beta-2 adrenergic receptor, NF-kB, AKT(PKB), IL8RA"
60,Macrophage and dendritic cell phenotype shift in cancer,100,2.88E-07,6.96E-06,2.88E-07,6.96E-06,27,"STAT3, COX-2 (PTGS2), PGE2R2, MFGE8, IL-1 beta, HPRG, PGE2R4, IDO1, MHC class II, RelA (p65 NF-kB subunit), iNOS, IP10, ESR1 (nuclear), Activin A, PLGF, MSR1, XBP1, TLR4, IL-6, CD137 ligand(TNFSF9), TLR7, NF-kB, CSF1, OSF-2, Jagged1, IFN-beta, TLR2",5.45E-07,2.89E-05,26,"COX-2 (PTGS2), PGE2R2, MFGE8, IL-1 beta, HPRG, PGE2R4, IDO1, MHC class II, RelA (p65 NF-kB subunit), iNOS, IP10, ESR1 (nuclear), Activin A, PLGF, MSR1, XBP1, TLR4, IL-6, CD137 ligand(TNFSF9), TLR7, NF-kB, CSF1, OSF-2, Jagged1, IFN-beta, TLR2"
61,Fibroblast/ myofibroblast proliferation in asthmatic airways,41,3.36E-07,8.00E-06,3.36E-07,8.00E-06,16,"Histamine H1 receptor, IL-1 beta, PI3K cat class IA, EDNRB, PKC, ITGB3, TGF-beta receptor type II, ERK1/2, BDKRB1, NF-kB, SMAD3, CTGF, PDGF-R-alpha, Tryptase, Tissue factor, EDNRA",7.69E-06,2.00E-04,14,"Histamine H1 receptor, IL-1 beta, PI3K cat class IA, EDNRB, PKC, ITGB3, TGF-beta receptor type II, BDKRB1, NF-kB, CTGF, PDGF-R-alpha, Tryptase, Tissue factor, EDNRA"
62,Transcription_Androgen Receptor nuclear signaling,46,3.64E-07,8.53E-06,3.64E-07,8.53E-06,17,"STAT3, Androgen receptor, WNT, TGF-beta receptor type II, EGFR, MMP-2, IL-6, Beta-catenin, SOS, SMAD3, ERK2 (MAPK1), PAK6, AKT(PKB), HIC5, Dsh, Frizzled, Kallikrein 3 (PSA)",6.02E-04,4.74E-03,12,"Androgen receptor, WNT, TGF-beta receptor type II, EGFR, MMP-2, IL-6, SOS, PAK6, AKT(PKB), HIC5, Frizzled, Kallikrein 3 (PSA)"
63,FAK1 signaling in melanoma,42,4.96E-07,1.13E-05,4.96E-07,1.13E-05,16,"ITGB1, RelA (p65 NF-kB subunit), PKC-alpha, ITGB3, N-Ras, ERK1/2, MMP-14, MMP-2, alpha-5/beta-1 integrin, Actin cytoskeletal, SOS, NF-kB, Caveolin-1, ITGA5, Fibronectin, PLAU (UPA)",5.31E-05,7.61E-04,13,"ITGB1, RelA (p65 NF-kB subunit), PKC-alpha, ITGB3, MMP-14, MMP-2, alpha-5/beta-1 integrin, SOS, NF-kB, Caveolin-1, ITGA5, Fibronectin, PLAU (UPA)"
64,IL-1 signaling in melanoma,42,4.96E-07,1.13E-05,4.96E-07,1.13E-05,16,"COX-2 (PTGS2), GRO-2, IL-1 beta, PD-L2, GRO-1, iNOS, alpha-4/beta-1 integrin, ICAM1, CCL2, IL-8, IL-6, NF-kB, p53, GRO-3, MMP-9, PD-L1",1.90E-06,6.99E-05,15,"COX-2 (PTGS2), GRO-2, IL-1 beta, PD-L2, GRO-1, iNOS, alpha-4/beta-1 integrin, ICAM1, CCL2, IL-8, IL-6, NF-kB, GRO-3, MMP-9, PD-L1"
65,Role of metalloproteases and heparanase in progression of pancreatic cancer,33,5.44E-07,1.22E-05,5.44E-07,1.22E-05,14,"Heparanase 1, CD44, Alpha 1-antitrypsin, EGFR, CD44 soluble, MMP-14, MMP-2, CD44 (EXT), Matrilysin (MMP-7), SOS, Collagen IV, ERK1 (MAPK3), MMP-9, CD147",2.58E-06,8.40E-05,13,"Heparanase 1, CD44, Alpha 1-antitrypsin, EGFR, CD44 soluble, MMP-14, MMP-2, CD44 (EXT), Matrilysin (MMP-7), SOS, Collagen IV, MMP-9, CD147"
66,Vascular endothelial cell damage in SLE,63,6.02E-07,1.33E-05,6.02E-07,1.33E-05,20,"HGF, IL-1 beta, PD-L2, RelA (p65 NF-kB subunit), iNOS, alpha-4/beta-1 integrin, ICAM1, CCL2, MSR1, IL-8, ERK1/2, IL-6, alpha-5/beta-1 integrin, NF-kB, CSF1, Tissue factor, Caspase-1, Fibronectin, C3a, PD-L1",1.64E-06,6.33E-05,19,"HGF, IL-1 beta, PD-L2, RelA (p65 NF-kB subunit), iNOS, alpha-4/beta-1 integrin, ICAM1, CCL2, MSR1, IL-8, IL-6, alpha-5/beta-1 integrin, NF-kB, CSF1, Tissue factor, Caspase-1, Fibronectin, C3a, PD-L1"
67,Main pathways of Schwann cells transformation in neurofibromatosis type 1 ,80,6.45E-07,1.40E-05,6.45E-07,1.40E-05,23,"BAD, ITGB1, Tuberin, Myelin basic protein, PI3K cat class IA, Amphiregulin, PTEN, Neuregulin 1, EGFR, N-Ras, Bcl-2, ERK1/2, ErbB3, IL-6, Beta-catenin, Rac2, TGF-alpha, B-FABP, AKT(PKB), PDGF receptor, PDK (PDPK1), IP3 receptor, PDGF-R-beta",4.91E-03,2.27E-02,15,"ITGB1, Myelin basic protein, PI3K cat class IA, Amphiregulin, Neuregulin 1, EGFR, Bcl-2, IL-6, Rac2, TGF-alpha, B-FABP, AKT(PKB), PDGF receptor, IP3 receptor, PDGF-R-beta"
68,TGF-beta signaling via kinase cascades in breast cancer,58,6.66E-07,1.41E-05,6.66E-07,1.41E-05,19,"COX-2 (PTGS2), TGF-beta 2, ITGB1, Amphiregulin, RelA (p65 NF-kB subunit), MMP-13, ADAM12, Neuregulin 1, ITGB3, IL-8, TGF-beta receptor type II, EGFR, ERK1/2, MMP-2, ErbB3, TGF-alpha, AKT(PKB), SOS1, MMP-9",8.81E-06,2.21E-04,17,"COX-2 (PTGS2), TGF-beta 2, ITGB1, Amphiregulin, RelA (p65 NF-kB subunit), MMP-13, ADAM12, Neuregulin 1, ITGB3, IL-8, TGF-beta receptor type II, EGFR, MMP-2, TGF-alpha, AKT(PKB), SOS1, MMP-9"
69,Development_Role of HGF in hematopoietic stem cell mobilization,21,6.71E-07,1.41E-05,6.71E-07,1.41E-05,11,"HGF, Tuberin, PI3K cat class IA, RECK, MMP-14, MMP-2, SGK1, AKT(PKB), PDK (PDPK1), HGF receptor (Met), MMP-9",4.22E-05,6.56E-04,9,"HGF, PI3K cat class IA, RECK, MMP-14, MMP-2, SGK1, AKT(PKB), HGF receptor (Met), MMP-9"
70,Immune response_TLR2 and TLR4 signaling pathways,69,6.97E-07,1.45E-05,6.97E-07,1.45E-05,21,"COX-2 (PTGS2), IL-1 beta, TLR1, PI3K cat class IA, Pellino 1, iNOS, CD14, Pellino 2, TLR10, IL-8, TLR6, Lyn, TLR4, ERK1/2, MD-2, IL-6, TIRAP (Mal), NF-kB, AKT(PKB), PDK (PDPK1), TLR2",7.30E-06,1.94E-04,19,"COX-2 (PTGS2), IL-1 beta, TLR1, PI3K cat class IA, Pellino 1, iNOS, CD14, Pellino 2, TLR10, IL-8, TLR6, Lyn, TLR4, MD-2, IL-6, TIRAP (Mal), NF-kB, AKT(PKB), TLR2"
71,Inter-cellular relations in COPD (general schema),30,6.98E-07,2.01E-05,1.04E-06,2.01E-05,13,"IL-1 beta, RelA (p65 NF-kB subunit), GRO-1, IP10, CCL2, I-TAC, IL-8, EGFR, IL-6, TGF-beta, TGF-alpha, CTGF, MMP-9",6.98E-07,3.28E-05,13,"IL-1 beta, RelA (p65 NF-kB subunit), GRO-1, IP10, CCL2, I-TAC, IL-8, EGFR, IL-6, TGF-beta, TGF-alpha, CTGF, MMP-9"
72,IL-6 signaling in breast cancer cells,53,7.14E-07,1.46E-05,7.14E-07,1.46E-05,18,"STAT3, N-cadherin, PI3K cat class IA, RelA (p65 NF-kB subunit), IP10, ESR1 (nuclear), Bcl-2, Fascin, ERK1/2, CYP19, IL-6, SNAIL1, SOS, AKT(PKB), Jagged1, Vimentin, Carbonic anhydrase IX, MDR1",4.66E-05,6.74E-04,15,"N-cadherin, PI3K cat class IA, RelA (p65 NF-kB subunit), IP10, ESR1 (nuclear), Bcl-2, Fascin, CYP19, IL-6, SOS, AKT(PKB), Jagged1, Vimentin, Carbonic anhydrase IX, MDR1"
73,K-RAS signaling in lung cancer,48,7.37E-07,1.49E-05,7.37E-07,1.49E-05,17,"COX-2 (PTGS2), GRO-2, Amphiregulin, GRO-1, PTEN, CCL2, PDCD4, EGFR, ERK1/2, ENA-78, Beta-catenin, PA24A, AKT(PKB), SPRY2, PDK (PDPK1), RhoB, MMP-9",2.41E-04,2.48E-03,13,"COX-2 (PTGS2), GRO-2, Amphiregulin, GRO-1, CCL2, PDCD4, EGFR, ENA-78, PA24A, AKT(PKB), SPRY2, RhoB, MMP-9"
74,HGF signaling in colorectal cancer,64,7.99E-07,1.57E-05,7.99E-07,1.57E-05,20,"HGF, COX-2 (PTGS2), Laminin 5, PI3K cat class IA, LAMC2, CD44, PTEN, EGFR, TCF7L2 (TCF4), ERK1/2, MMP-2, Beta-catenin, PLAUR (uPAR), Actin cytoskeletal, SOS, AKT(PKB), LAMB3, HGF receptor (Met), MMP-9, LAMA3 (Epiligrin)",1.35E-04,1.60E-03,16,"HGF, COX-2 (PTGS2), Laminin 5, PI3K cat class IA, LAMC2, CD44, EGFR, TCF7L2 (TCF4), MMP-2, PLAUR (uPAR), SOS, AKT(PKB), LAMB3, HGF receptor (Met), MMP-9, LAMA3 (Epiligrin)"
75,MAPK-independent proliferation of normal and asthmatic smooth muscle cells,64,7.99E-07,1.57E-05,7.99E-07,1.57E-05,20,"STAT3, Histamine H1 receptor, PI3K cat class IA, EDNRB, PLAT (TPA), EGFR, G-protein alpha-i family, PDGF-C, FGF2, NF-kB, PDGF-R-alpha, AKT(PKB), G-protein alpha-q/11, Tryptase, PDGF receptor, PDK (PDPK1), p27KIP1, EDNRA, PDGF-R-beta, IBP3",3.65E-05,5.81E-04,17,"Histamine H1 receptor, PI3K cat class IA, EDNRB, PLAT (TPA), EGFR, G-protein alpha-i family, PDGF-C, FGF2, NF-kB, PDGF-R-alpha, AKT(PKB), G-protein alpha-q/11, Tryptase, PDGF receptor, EDNRA, PDGF-R-beta, IBP3"
76,Basophil migration in asthma,55,8.04E-07,2.44E-05,1.33E-06,2.44E-05,18,"ST2(L), Secretoneurin, CCL13, Eotaxin-2, alpha-4/beta-1 integrin, ICAM1, CCL2, IL-8, G-protein alpha-i family, IL-33, PLAUR (uPAR), FPRL2, IL8RA, Fibronectin, PI3K reg class IB (p101), MMP-9, PLAU (UPA), CCL7",8.04E-07,3.60E-05,18,"ST2(L), Secretoneurin, CCL13, Eotaxin-2, alpha-4/beta-1 integrin, ICAM1, CCL2, IL-8, G-protein alpha-i family, IL-33, PLAUR (uPAR), FPRL2, IL8RA, Fibronectin, PI3K reg class IB (p101), MMP-9, PLAU (UPA), CCL7"
77,Expression targets of Tissue factor signaling in cancer,22,8.70E-07,2.32E-05,1.23E-06,2.32E-05,11,"PTX3, ITGB1, GRO-1, GFPT2, IL-8, PLAUR (uPAR), CTGF, CSF1, Tissue factor, Coagulation factor VII, PLAU (UPA)",8.70E-07,3.66E-05,11,"PTX3, ITGB1, GRO-1, GFPT2, IL-8, PLAUR (uPAR), CTGF, CSF1, Tissue factor, Coagulation factor VII, PLAU (UPA)"
78,Role of fibroblasts in the sensitization phase of allergic contact dermatitis,22,8.70E-07,2.32E-05,1.23E-06,2.32E-05,11,"IL-1 beta, Laminin 5, Elastin, IL-8, MMP-2, IL-6, NF-kB, Collagen IV, Fibronectin, MMP-9, Collagen III",8.70E-07,3.66E-05,11,"IL-1 beta, Laminin 5, Elastin, IL-8, MMP-2, IL-6, NF-kB, Collagen IV, Fibronectin, MMP-9, Collagen III"
79,Plasminogen activators signaling in pancreatic cancer,35,1.29E-06,2.40E-05,1.29E-06,2.40E-05,14,"HGF, RelA (p65 NF-kB subunit), Fra-1, PLAT (TPA), EGFR, ERK1/2, MMP-14, MMP-2, Galectin-1, PLAUR (uPAR), SOS, HGF receptor (Met), MMP-9, PLAU (UPA)",5.60E-06,1.54E-04,13,"HGF, RelA (p65 NF-kB subunit), Fra-1, PLAT (TPA), EGFR, MMP-14, MMP-2, Galectin-1, PLAUR (uPAR), SOS, HGF receptor (Met), MMP-9, PLAU (UPA)"
80,Canonical WNT signaling pathway in colorectal cancer,66,1.38E-06,2.50E-05,1.38E-06,2.50E-05,20,"Galectin-3, PI3K cat class IA, iNOS, DVL-3, CD44, Mucin 2, WNT, BMP4, SLUG, TCF7L2 (TCF4), Beta-catenin, Matrilysin (MMP-7), SFRP1, HGF receptor (Met), FZD7, Dsh, DACT3, TCF7 (TCF1), Frizzled, WNT6",5.60E-05,7.94E-04,17,"Galectin-3, PI3K cat class IA, iNOS, CD44, Mucin 2, WNT, BMP4, SLUG, TCF7L2 (TCF4), Matrilysin (MMP-7), SFRP1, HGF receptor (Met), FZD7, DACT3, TCF7 (TCF1), Frizzled, WNT6"
81,Proteases and EGFR-activated mucin production in airway epithelium in COPD,50,1.43E-06,2.50E-05,1.43E-06,2.50E-05,17,"PI3K cat class IA, CD44, PTEN, Neuregulin 1, EGFR, Mucin 5AC, Bcl-2, ERK1/2, ErbB3, Mucin 5B, PPARGC1 (PGC1-alpha), TGF-alpha, NF-kB, AKT(PKB), DUOX1, Kallikrein 1, MMP-9",9.44E-05,1.19E-03,14,"PI3K cat class IA, CD44, Neuregulin 1, EGFR, Mucin 5AC, Bcl-2, Mucin 5B, PPARGC1 (PGC1-alpha), TGF-alpha, NF-kB, AKT(PKB), DUOX1, Kallikrein 1, MMP-9"
82,The role of PTEN and PI3K signaling in melanoma,50,1.43E-06,2.50E-05,1.43E-06,2.50E-05,17,"BAD, STAT3, N-cadherin, MCAM, PI3K cat class IA, PTEN, N-Ras, AKT3, p15, Beta-catenin, alpha-5/beta-1 integrin, SNAIL1, Tau (MAPT), AKT(PKB), Caspase-8, PDK (PDPK1), Fibronectin",3.34E-02,9.29E-02,9,"N-cadherin, MCAM, PI3K cat class IA, AKT3, p15, alpha-5/beta-1 integrin, Tau (MAPT), AKT(PKB), Fibronectin"
83,HBV-dependent NF-kB and PI3K/AKT pathways leading to HCC,50,1.43E-06,2.50E-05,1.43E-06,2.50E-05,17,"BAD, Androgen receptor, PI3K cat class IA, RelA (p65 NF-kB subunit), iNOS, PTEN, PKC-alpha, A2M, Cyclin E, SOS, NF-kB, AKT(PKB), p53, PDK (PDPK1), p27KIP1, MMP-9, PLAU (UPA)",1.34E-03,8.35E-03,12,"Androgen receptor, PI3K cat class IA, RelA (p65 NF-kB subunit), iNOS, PKC-alpha, A2M, Cyclin E, SOS, NF-kB, AKT(PKB), MMP-9, PLAU (UPA)"
84,Development_YAP/TAZ-mediated co-regulation of transcription,56,1.79E-06,3.07E-05,1.79E-06,3.07E-05,18,"GATA-3, RUNX2, ITGB2, Oct-3/4, SOX2, UFO, Neurotractin, CDX2, SLUG, SIP1 (ZFHX1B), Beta-catenin, HBP17, TAZ, SNAIL1, SMAD3, CTGF, UCA1, CDK6",9.36E-05,1.19E-03,15,"GATA-3, RUNX2, ITGB2, Oct-3/4, SOX2, UFO, Neurotractin, CDX2, SLUG, SIP1 (ZFHX1B), HBP17, TAZ, CTGF, UCA1, CDK6"
85,Ligand-independent activation of Androgen receptor in Prostate Cancer,67,1.80E-06,3.07E-05,1.80E-06,3.07E-05,20,"STAT3, Androgen receptor, PI3K cat class IA, Neuregulin 1, Tcf(Lef), EGFR, N-Ras, ErbB3, Beta-catenin, PP2A regulatory, FGF2, SOS, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), Frizzled, IBP3, Kallikrein 3 (PSA), Prolactin receptor",6.34E-03,2.75E-02,13,"Androgen receptor, PI3K cat class IA, Neuregulin 1, Tcf(Lef), EGFR, PP2A regulatory, FGF2, SOS, AKT(PKB), Frizzled, IBP3, Kallikrein 3 (PSA), Prolactin receptor"
86,Cigarette smoke-induced inflammatory signaling in airway epithelial cells,36,1.93E-06,3.19E-05,1.93E-06,3.19E-05,14,"COX-2 (PTGS2), IL-1 beta, Amphiregulin, RelA (p65 NF-kB subunit), ICAM1, PKC-alpha, MSR1, IL-8, EGFR, ERK1/2, ErbB3, sICAM1, IL-6, TGF-alpha",4.52E-05,6.74E-04,12,"COX-2 (PTGS2), IL-1 beta, Amphiregulin, RelA (p65 NF-kB subunit), ICAM1, PKC-alpha, MSR1, IL-8, EGFR, sICAM1, IL-6, TGF-alpha"
87,CHDI_Correlations from Discovery data_Causal network,73,1.95E-06,3.19E-05,1.95E-06,3.19E-05,21,"Syk, Tuberin, PI3K cat class IA, PTEN, CCL2, Kir3.4, WNT, G-protein alpha-i family, TCF7L2 (TCF4), ERK1/2, p15, Beta-catenin, SOS, MEF2, SMAD3, PDGF-R-alpha, AKT(PKB), PI3K reg class IB (p101), Dsh, Frizzled, IP3 receptor",1.95E-03,1.11E-02,15,"Syk, PI3K cat class IA, CCL2, Kir3.4, WNT, G-protein alpha-i family, TCF7L2 (TCF4), p15, SOS, MEF2, PDGF-R-alpha, AKT(PKB), PI3K reg class IB (p101), Frizzled, IP3 receptor"
88,PI3K signaling in gastric cancer,51,1.95E-06,3.19E-05,1.95E-06,3.19E-05,17,"BAD, HGF, PI3K cat class IA, RelA (p65 NF-kB subunit), PTEN, Neuregulin 1, IL-8, EGFR, ErbB3, Beta-catenin, PRNP, AKT(PKB), G-protein alpha-q/11, PDK (PDPK1), HGF receptor (Met), BMP2, MDR1",1.61E-03,9.73E-03,12,"HGF, PI3K cat class IA, RelA (p65 NF-kB subunit), Neuregulin 1, IL-8, EGFR, PRNP, AKT(PKB), G-protein alpha-q/11, HGF receptor (Met), BMP2, MDR1"
89,Regulation of angiogenesis in prostate cancer,51,1.95E-06,3.19E-05,1.95E-06,3.19E-05,17,"COX-2 (PTGS2), Androgen receptor, Tuberin, TIE2, PI3K cat class IA, CCL2, IL-8, TGF-beta receptor type II, EGFR, FOLH1 (GCP2), Angiopoietin 1, AKT(PKB), Collagen IV, IL8RA, PDK (PDPK1), MMP-9, PLAU (UPA)",2.83E-05,5.27E-04,15,"COX-2 (PTGS2), Androgen receptor, TIE2, PI3K cat class IA, CCL2, IL-8, TGF-beta receptor type II, EGFR, FOLH1 (GCP2), Angiopoietin 1, AKT(PKB), Collagen IV, IL8RA, MMP-9, PLAU (UPA)"
90,Immune response_IL-10 signaling pathway,62,2.09E-06,3.38E-05,2.09E-06,3.38E-05,19,"STAT3, COX-2 (PTGS2), IL-1 beta, MHC class II, PI3K cat class IA, iNOS, CD14, ICAM1, IRS-2, IL-8, Bcl-2, CRP2, IL-6, Fc gamma RII beta, NF-kB, AKT(PKB), Fc gamma RII alpha, PDK (PDPK1), MMP-9",2.33E-05,4.56E-04,17,"COX-2 (PTGS2), IL-1 beta, MHC class II, PI3K cat class IA, iNOS, CD14, ICAM1, IRS-2, IL-8, Bcl-2, CRP2, IL-6, Fc gamma RII beta, NF-kB, AKT(PKB), Fc gamma RII alpha, MMP-9"
91,Tumor-stroma interactions in pancreatic cancer,28,2.18E-06,4.74E-05,3.13E-06,4.74E-05,12,"HGF, Galectin-3, PTCH1, MMP-2, alpha-5/beta-1 integrin, FGF2, GLI-1, OSF-2, HGF receptor (Met), Fibronectin, CD147, PDGF-R-beta",2.18E-06,7.79E-05,12,"HGF, Galectin-3, PTCH1, MMP-2, alpha-5/beta-1 integrin, FGF2, GLI-1, OSF-2, HGF receptor (Met), Fibronectin, CD147, PDGF-R-beta"
92,"Signal transduction_Angiotensin II/ AGTR1 signaling via p38, ERK and PI3K",98,2.46E-06,3.93E-05,2.46E-06,3.93E-05,25,"Syk, COX-2 (PTGS2), PI3K cat class IA, RECK, CYP11B2, CCL2, ETS1, cPLA2, EGFR, TLR4, ERK1/2, MEF2C, MMP-14, MMP-2, CMYA3, PDGF-C, IL-6, PPARGC1 (PGC1-alpha), Fyn, SOS, AKT(PKB), OSF-2, PDK (PDPK1), CaMK II delta, PDGF-R-beta",1.55E-05,3.56E-04,23,"Syk, COX-2 (PTGS2), PI3K cat class IA, RECK, CYP11B2, CCL2, ETS1, cPLA2, EGFR, TLR4, MEF2C, MMP-14, MMP-2, CMYA3, PDGF-C, IL-6, PPARGC1 (PGC1-alpha), Fyn, SOS, AKT(PKB), OSF-2, CaMK II delta, PDGF-R-beta"
93,"Chemokines in inflammation in adipose tissue and liver in obesity, type 2 diabetes and metabolic syndrome X",48,2.49E-06,5.46E-05,3.91E-06,5.46E-05,16,"IL-1 beta, MHC class II, CD14, ITGA4, ICAM1, CD44, CCL2, CMKLR1, IL-8, TLR4, CX3CR1, IL-6, PLAUR (uPAR), CCR5, EMR1, TLR2",2.49E-06,8.30E-05,16,"IL-1 beta, MHC class II, CD14, ITGA4, ICAM1, CD44, CCL2, CMKLR1, IL-8, TLR4, CX3CR1, IL-6, PLAUR (uPAR), CCR5, EMR1, TLR2"
94,"Stem cells_Cooperation between Hedgehog, IGF-2 and HGF signaling pathways in medulloblastoma stem cells",32,2.51E-06,3.97E-05,2.51E-06,3.97E-05,13,"BAD, HGF, PI3K cat class IA, PTCH1, Tcf(Lef), TCF7L2 (TCF4), Bcl-2, Beta-catenin, GLI-1, AKT(PKB), PDK (PDPK1), HGF receptor (Met), GLI-2",3.55E-04,3.32E-03,10,"HGF, PI3K cat class IA, PTCH1, Tcf(Lef), TCF7L2 (TCF4), Bcl-2, GLI-1, AKT(PKB), HGF receptor (Met), GLI-2"
95,Development_Neural stem cell lineage commitment (schema),38,2.73E-06,5.54E-05,4.10E-06,5.54E-05,14,"CNTN1 (F3), Myelin basic protein, MAP-1B, PTCH1, WNT7A, BMP4, MAP2, LIF, Nestin, MCT1 (SLC16A1), PDGF-R-alpha, Vimentin, GLAST1/EAAT1, BMP2",2.73E-06,8.67E-05,14,"CNTN1 (F3), Myelin basic protein, MAP-1B, PTCH1, WNT7A, BMP4, MAP2, LIF, Nestin, MCT1 (SLC16A1), PDGF-R-alpha, Vimentin, GLAST1/EAAT1, BMP2"
96,Immune response_IL-18 signaling,63,2.74E-06,4.28E-05,2.74E-06,4.28E-05,19,"COX-2 (PTGS2), IL-1 beta, IL-18R1, PI3K cat class IA, iNOS, ICAM1, CCL2, IL-8, IL18RAP, Bcl-2, ERK1/2, IL-6, SOS, NF-kB, AKT(PKB), PDK (PDPK1), Fibronectin, MMP-9, CD147",2.93E-05,5.32E-04,17,"COX-2 (PTGS2), IL-1 beta, IL-18R1, PI3K cat class IA, iNOS, ICAM1, CCL2, IL-8, IL18RAP, Bcl-2, IL-6, SOS, NF-kB, AKT(PKB), Fibronectin, MMP-9, CD147"
97,Endothelin-1- and TNF-alpha-induced inflammatory response in asthmatic airway fibroblasts,20,2.79E-06,5.46E-05,3.81E-06,5.46E-05,10,"COX-2 (PTGS2), IL-1 beta, NGF, TGF-beta 2, RelA (p65 NF-kB subunit), ICAM1, IL-33, IL-6, NF-kB, EDNRA",2.79E-06,8.67E-05,10,"COX-2 (PTGS2), IL-1 beta, NGF, TGF-beta 2, RelA (p65 NF-kB subunit), ICAM1, IL-33, IL-6, NF-kB, EDNRA"
98,Development_Early embryonal hypaxial myogenesis,37,2.83E-06,4.38E-05,2.83E-06,4.38E-05,14,"PKC, PTCH1, WNT7A, FGFR4, BMP4, Adenylate cyclase, Beta-catenin, GLI-1, SMAD3, FZD7, Dsh, Frizzled, GLI-2, WNT6",2.96E-04,2.90E-03,11,"PKC, PTCH1, WNT7A, FGFR4, BMP4, Adenylate cyclase, GLI-1, FZD7, Frizzled, GLI-2, WNT6"
99,Mucin expression in CF airways,69,2.99E-06,4.57E-05,2.99E-06,4.57E-05,20,"COX-2 (PTGS2), PGE2R2, IL-1 beta, PGE2R4, PI3K cat class IA, PKC-theta, PKC-alpha, Neuregulin 1, Mucin 2, EGFR, Mucin 5AC, ERK1/2, ErbB3, PGF2aR, Mucin 5B, TGF-alpha, SOS, AKT(PKB), G-protein alpha-q/11, IP3 receptor",2.83E-05,5.27E-04,18,"COX-2 (PTGS2), PGE2R2, IL-1 beta, PGE2R4, PI3K cat class IA, PKC-theta, PKC-alpha, Neuregulin 1, Mucin 2, EGFR, Mucin 5AC, PGF2aR, Mucin 5B, TGF-alpha, SOS, AKT(PKB), G-protein alpha-q/11, IP3 receptor"
100,Bone metastases in Prostate Cancer,29,3.41E-06,6.28E-05,4.89E-06,6.28E-05,12,"RUNX2, CCL2, WNT, G-protein alpha-i family, PTHR1, PTHrP, Osteoprotegerin, MMP-9, Frizzled, EDNRA, IBP3, Kallikrein 3 (PSA)",3.41E-06,1.02E-04,12,"RUNX2, CCL2, WNT, G-protein alpha-i family, PTHR1, PTHrP, Osteoprotegerin, MMP-9, Frizzled, EDNRA, IBP3, Kallikrein 3 (PSA)"
101,TGF-beta-induced fibroblast/ myofibroblast migration and extracellular matrix production in asthmatic airways,64,3.56E-06,5.19E-05,3.56E-06,5.19E-05,19,"ITGA1, Biglycan, TGF-beta 2, ITGB1, PI3K cat class IA, COL4A1, MMP-13, TGF-beta 3, TGF-beta receptor type II, ERK1/2, MMP-2, SMAD3, AKT(PKB), COL5A1, Collagen IV, ITGA5, Fibronectin, MMP-9, Collagen III",3.65E-05,5.81E-04,17,"ITGA1, Biglycan, TGF-beta 2, ITGB1, PI3K cat class IA, COL4A1, MMP-13, TGF-beta 3, TGF-beta receptor type II, MMP-2, AKT(PKB), COL5A1, Collagen IV, ITGA5, Fibronectin, MMP-9, Collagen III"
102,Immune response_IFN-alpha/beta signaling via JAK/STAT,64,3.56E-06,5.19E-05,3.56E-06,5.19E-05,19,"STAT3, IFI17, TAP1 (PSF1), IFI27, IP10, ISG15, STAT4, CCL2, IFI6, I-TAC, ISG54, Bcl-2, RIG-G, RSAD2, Caspase-8, p53, ERAP140, IFN-beta, XAF1",1.35E-04,1.60E-03,16,"IFI17, TAP1 (PSF1), IFI27, IP10, ISG15, STAT4, CCL2, IFI6, I-TAC, ISG54, Bcl-2, RIG-G, RSAD2, ERAP140, IFN-beta, XAF1"
103,Immune response_Inhibitory PD-1 signaling in T cells,53,3.57E-06,5.19E-05,3.57E-06,5.19E-05,17,"Syk, GATA-3, MHC class II, PI3K cat class IA, PD-L2, Lck, PKC-theta, ICAM1, PTEN, Cyclin E, ERK1/2, p15, SMAD3, AKT(PKB), PDK (PDPK1), p27KIP1, PD-L1",6.92E-03,2.93E-02,11,"Syk, GATA-3, MHC class II, PI3K cat class IA, PD-L2, PKC-theta, ICAM1, Cyclin E, p15, AKT(PKB), PD-L1"
104,Non-genomic signaling of ESR2 (membrane) in lung cancer cells,53,3.57E-06,5.19E-05,3.57E-06,5.19E-05,17,"nAChR alpha-7, PI3K cat class IA, Amphiregulin, EGFR, N-Ras, G-protein alpha-i family, Adenylate cyclase, ERK1/2, nAChR alpha-4, CYP19, TGF-alpha, SOS, ERK2 (MAPK1), AKT(PKB), Caveolin-1, PDK (PDPK1), ERK1 (MAPK3)",2.29E-03,1.26E-02,12,"nAChR alpha-7, PI3K cat class IA, Amphiregulin, EGFR, G-protein alpha-i family, Adenylate cyclase, nAChR alpha-4, CYP19, TGF-alpha, SOS, AKT(PKB), Caveolin-1"
105,Immune response_IFN-alpha/beta signaling via PI3K and NF-kB pathways,94,3.84E-06,5.46E-05,3.84E-06,5.46E-05,24,"STAT3, PCNA, IFI17, Tuberin, PI3K cat class IA, RelA (p65 NF-kB subunit), IFIT1, ISG15, IRS-2, PKC-alpha, I-TAC, PDCD4, Cyclin E, ISG54, NMI, ERK1/2, p15, RSAD2, NF-kB, AKT(PKB), PDK (PDPK1), p16INK4, p27KIP1, IFN-beta",1.70E-03,1.01E-02,18,"IFI17, PI3K cat class IA, RelA (p65 NF-kB subunit), IFIT1, ISG15, IRS-2, PKC-alpha, I-TAC, PDCD4, Cyclin E, ISG54, NMI, p15, RSAD2, NF-kB, AKT(PKB), p16INK4, IFN-beta"
106,Signal transduction_Adenosine A3 receptor signaling pathway,48,3.91E-06,5.46E-05,3.91E-06,5.46E-05,16,"BAD, STAT3, IL-1 beta, PI3K cat class IA, RelA (p65 NF-kB subunit), PKC, G-protein alpha-i family, Adenylate cyclase, Bcl-2, ERK1/2, Rho GTPase, AKT(PKB), G-protein alpha-q/11, PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor",9.11E-04,6.31E-03,12,"IL-1 beta, PI3K cat class IA, RelA (p65 NF-kB subunit), PKC, G-protein alpha-i family, Adenylate cyclase, Bcl-2, Rho GTPase, AKT(PKB), G-protein alpha-q/11, PI3K reg class IB (p101), IP3 receptor"
107,Translation_Non-genomic (rapid) action of Androgen Receptor,43,4.11E-06,5.54E-05,4.11E-06,5.54E-05,15,"Androgen receptor, Tuberin, PTEN, Neuregulin 1, Tcf(Lef), WNT, EGFR, Beta-catenin, SOS, NF-kB, ERK2 (MAPK1), AKT(PKB), Caveolin-1, Dsh, Frizzled",4.23E-03,2.03E-02,10,"Androgen receptor, Neuregulin 1, Tcf(Lef), WNT, EGFR, SOS, NF-kB, AKT(PKB), Caveolin-1, Frizzled"
108,"POMC, alpha-MSH and AGRP in regulation of food intake and energy expenditure in obesity in hypothalamus",43,4.11E-06,5.54E-05,4.11E-06,5.54E-05,15,"proACTH, POMC, Adenylate cyclase type II, Thyroliberin, PKC-alpha, G-protein alpha-i family, PC1, beta-LPH, Adenylate cyclase type IV, Beta-MSH / Beta-Endorphin, ERK2 (MAPK1), PC2, alpha-MSH, ERK1 (MAPK3), IP3 receptor",6.99E-05,9.44E-04,13,"proACTH, POMC, Adenylate cyclase type II, Thyroliberin, PKC-alpha, G-protein alpha-i family, PC1, beta-LPH, Adenylate cyclase type IV, Beta-MSH / Beta-Endorphin, PC2, alpha-MSH, IP3 receptor"
109,FGF signaling in Prostate Cancer,43,4.11E-06,5.54E-05,4.11E-06,5.54E-05,15,"STAT3, Androgen receptor, PI3K cat class IA, PTEN, FGFR4, Matrilysin (MMP-7), HBP17, FGF2, SOS, ERK2 (MAPK1), AKT(PKB), SPRY2, PDK (PDPK1), ERK1 (MAPK3), FGF9",4.23E-03,2.03E-02,10,"Androgen receptor, PI3K cat class IA, FGFR4, Matrilysin (MMP-7), HBP17, FGF2, SOS, AKT(PKB), SPRY2, FGF9"
110,"Disruption of apoptosis, proliferation and shedding of epithelial cells in asthma",54,4.76E-06,6.28E-05,4.76E-06,6.28E-05,17,"IL-1 beta, TGF-beta 2, TNF-R2, Amphiregulin, EDNRB, Desmocollin 3, ICAM1, EGFR, Bcl-2, ERK1/2, p15, TGF-alpha, NF-kB, SMAD3, p53, p27KIP1, MMP-9",8.30E-04,5.94E-03,13,"IL-1 beta, TGF-beta 2, TNF-R2, Amphiregulin, EDNRB, Desmocollin 3, ICAM1, EGFR, Bcl-2, p15, TGF-alpha, NF-kB, MMP-9"
111,Th17 cells in CF,54,4.76E-06,6.28E-05,4.76E-06,6.28E-05,17,"STAT3, IL-1 beta, MHC class II, CCL20, GRO-1, CD14, GCP2, ROR-alpha, ICAM1, IL-8, ROR-gamma, TGF-beta receptor type II, TLR4, ERK1/2, MD-2, IL-6, NF-kB",5.92E-05,8.23E-04,15,"IL-1 beta, MHC class II, CCL20, GRO-1, CD14, GCP2, ROR-alpha, ICAM1, IL-8, ROR-gamma, TGF-beta receptor type II, TLR4, MD-2, IL-6, NF-kB"
112,Inhibition of neutrophil migration by proresolving lipid mediators in COPD,71,4.86E-06,6.28E-05,4.86E-06,6.28E-05,20,"IL-1 beta, TNF-R2, cPKC (conventional), PKC, ITGB2, ICAM1, MSN (moesin), IL-8, G-protein alpha-i family, TLR4, Actin cytoskeletal, Rac2, CCR5, NF-kB, IL8RA, ICAM2, PI3K reg class IB (p101), TLR2, IP3 receptor, PREX1",1.15E-05,2.73E-04,19,"IL-1 beta, TNF-R2, cPKC (conventional), PKC, ITGB2, ICAM1, MSN (moesin), IL-8, G-protein alpha-i family, TLR4, Rac2, CCR5, NF-kB, IL8RA, ICAM2, PI3K reg class IB (p101), TLR2, IP3 receptor, PREX1"
113,Prostate Cancer: candidate susceptibility genes in inflammatory pathways,29,4.89E-06,6.28E-05,4.89E-06,6.28E-05,12,"IL-1 beta, TLR1, TNF-R2, TLR10, MSR1, IL-8, TLR6, TLR4, IL-6, NF-kB, IL8RA, p53",2.35E-05,4.56E-04,11,"IL-1 beta, TLR1, TNF-R2, TLR10, MSR1, IL-8, TLR6, TLR4, IL-6, NF-kB, IL8RA"
114,Inflammatory response in ischemia-reperfusion injury during myocardial infarction,21,4.89E-06,7.94E-05,6.67E-06,7.94E-05,10,"IL-1 beta, ICAM1, CCL2, IL-8, TLR4, IL-6, NF-kB, IL8RA, C3a, TLR2",4.89E-06,1.40E-04,10,"IL-1 beta, ICAM1, CCL2, IL-8, TLR4, IL-6, NF-kB, IL8RA, C3a, TLR2"
115,Muscle contraction_GPCRs in the regulation of smooth muscle tone,83,4.98E-06,6.35E-05,4.98E-06,6.35E-05,22,"PGE2R2, Histamine H1 receptor, MaxiK alpha subunit, TRPC4, TRPC3, Adenosine A2b receptor, PKC-alpha, NCX1, G-protein alpha-i family, Adenylate cyclase, MRLC, Telokin, Myosin II, Beta-2 adrenergic receptor, TRPC6, G-protein alpha-q/11, MELC, MyHC, MLCK, EDNRA, IP3 receptor, ACM3",3.65E-05,5.81E-04,20,"PGE2R2, Histamine H1 receptor, MaxiK alpha subunit, TRPC4, TRPC3, Adenosine A2b receptor, PKC-alpha, NCX1, G-protein alpha-i family, Adenylate cyclase, MRLC, Telokin, Beta-2 adrenergic receptor, TRPC6, G-protein alpha-q/11, MELC, MLCK, EDNRA, IP3 receptor, ACM3"
116,Activation of TNF-alpha-dependent pro-tumoral effect in colorectal cancer,49,5.30E-06,6.70E-05,5.30E-06,6.70E-05,16,"COX-2 (PTGS2), PGE2R2, c-IAP2, RelA (p65 NF-kB subunit), GRO-1, IP10, alpha-4/beta-1 integrin, ICAM1, CCL2, IL-8, ERK1/2, ALDR, IL-6, Beta-catenin, SOS, NF-kB",7.40E-05,9.91E-04,14,"COX-2 (PTGS2), PGE2R2, c-IAP2, RelA (p65 NF-kB subunit), GRO-1, IP10, alpha-4/beta-1 integrin, ICAM1, CCL2, IL-8, ALDR, IL-6, SOS, NF-kB"
117,EGFR signaling pathway in colorectal cancer,60,5.42E-06,6.79E-05,5.42E-06,6.79E-05,18,"BAD, COX-2 (PTGS2), PGE2R4, Amphiregulin, RelA (p65 NF-kB subunit), Trypsin II, PTEN, Trypsin I, Epiregulin, EGFR, NT, ERK1/2, Matrilysin (MMP-7), TGF-alpha, SOS, NF-kB, PDK (PDPK1), ACM3",7.42E-04,5.54E-03,14,"COX-2 (PTGS2), PGE2R4, Amphiregulin, RelA (p65 NF-kB subunit), Trypsin II, Trypsin I, Epiregulin, EGFR, NT, Matrilysin (MMP-7), TGF-alpha, SOS, NF-kB, ACM3"
118,Role of adhesion of SCLC cells in tumor progression,35,5.60E-06,9.09E-05,8.18E-06,9.09E-05,13,"N-cadherin, ITGB1, NCAM1, alpha-4/beta-1 integrin, ICAM1, MMP-14, MMP-2, alpha-5/beta-1 integrin, PTHrP, Caveolin-1, Collagen IV, Fibronectin, ACM3",5.60E-06,1.54E-04,13,"N-cadherin, ITGB1, NCAM1, alpha-4/beta-1 integrin, ICAM1, MMP-14, MMP-2, alpha-5/beta-1 integrin, PTHrP, Caveolin-1, Collagen IV, Fibronectin, ACM3"
119,Disruption of epithelial layer restitution in asthma,34,5.62E-06,6.92E-05,5.62E-06,6.92E-05,13,"HGF, IL-1 beta, TGF-beta 2, ITGB1, EGFR, PLAUR (uPAR), alpha-5/beta-1 integrin, SMAD3, HGF receptor (Met), Fibronectin, MMP-9, PLAU (UPA), EDNRA",2.35E-05,4.56E-04,12,"HGF, IL-1 beta, TGF-beta 2, ITGB1, EGFR, PLAUR (uPAR), alpha-5/beta-1 integrin, HGF receptor (Met), Fibronectin, MMP-9, PLAU (UPA), EDNRA"
120,Development_Epigenetic and transcriptional regulation of oligodendrocyte precursor cell differentiation and myelination,34,5.62E-06,6.92E-05,5.62E-06,6.92E-05,13,"SOX10, Myelin basic protein, HES5, SOX8, TCF7L2 (TCF4), MYT1, Beta-catenin, C11orf9, ID4, Nkx2.2, Jagged1, p27KIP1, Frizzled",1.28E-04,1.55E-03,11,"SOX10, Myelin basic protein, HES5, SOX8, TCF7L2 (TCF4), MYT1, C11orf9, ID4, Nkx2.2, Jagged1, Frizzled"
121,FGF2 signaling in melanoma,39,5.85E-06,7.15E-05,5.85E-06,7.15E-05,14,"STAT3, PI3K cat class IA, Heparanase 1, Fra-1, FGFR4, N-Ras, ERK1/2, MMP-2, FGF2, SOS, Caveolin-1, Collagen IV, SPRY2, Fibronectin",4.90E-04,4.06E-03,11,"PI3K cat class IA, Heparanase 1, Fra-1, FGFR4, MMP-2, FGF2, SOS, Caveolin-1, Collagen IV, SPRY2, Fibronectin"
122,Resolution of inflammation in healing myocardial infarction,25,5.96E-06,7.21E-05,5.96E-06,7.21E-05,11,"STAT3, HGF, TIE2, ERK1/2, MMP-2, Angiopoietin 1, FGF2, NF-kB, AKT(PKB), HGF receptor (Met), MMP-9",2.10E-04,2.26E-03,9,"HGF, TIE2, MMP-2, Angiopoietin 1, FGF2, NF-kB, AKT(PKB), HGF receptor (Met), MMP-9"
123,Probable BMP4-mediated induction of EMT in airway epithelium,21,6.67E-06,7.94E-05,6.67E-06,7.94E-05,10,"N-cadherin, BMP4, SLUG, SIP1 (ZFHX1B), MMP-2, Beta-catenin, SNAIL1, COL5A1, TCF8, MMP-9",3.03E-04,2.94E-03,8,"N-cadherin, BMP4, SLUG, SIP1 (ZFHX1B), MMP-2, COL5A1, TCF8, MMP-9"
124,Colorectal cancer (general schema),30,7.45E-06,8.73E-05,7.45E-06,8.73E-05,12,"HGF, PTCH1, IL-8, WNT, TGF-beta receptor type II, EGFR, IL-6, Beta-catenin, IL8RA, HGF receptor (Met), Ephrin-B receptors, Frizzled",3.42E-05,5.81E-04,11,"HGF, PTCH1, IL-8, WNT, TGF-beta receptor type II, EGFR, IL-6, IL8RA, HGF receptor (Met), Ephrin-B receptors, Frizzled"
125,Role of adipose tissue hypoxia in obesity and type 2 diabetes,30,7.45E-06,8.73E-05,7.45E-06,8.73E-05,12,"PDK1, IL-1 beta, RelA (p65 NF-kB subunit), Lysyl oxidase, Adiponectin, CCL2, Angiopoietin 1, IL-6, MCT1 (SLC16A1), MMP-9, C/EBPalpha, IBP3",3.42E-05,5.81E-04,11,"IL-1 beta, RelA (p65 NF-kB subunit), Lysyl oxidase, Adiponectin, CCL2, Angiopoietin 1, IL-6, MCT1 (SLC16A1), MMP-9, C/EBPalpha, IBP3"
126,Role of DNA methylation in progression of multiple myeloma,45,7.83E-06,9.09E-05,7.83E-06,9.09E-05,15,"STAT3, p14ARF, ESR1 (nuclear), DKK3, WNT, p15, IL-6, Beta-catenin, NF-kB, SFRP1, p53, p16INK4, Dexras1, Frizzled, CDK6",4.84E-04,4.06E-03,12,"p14ARF, ESR1 (nuclear), DKK3, WNT, p15, IL-6, NF-kB, SFRP1, p16INK4, Dexras1, Frizzled, CDK6"
127,Interleukins-induced inflammatory response in asthmatic airway fibroblasts,35,8.18E-06,9.09E-05,8.18E-06,9.09E-05,13,"COX-2 (PTGS2), GRO-2, IL-1 beta, NGF, RelA (p65 NF-kB subunit), GRO-1, ICAM1, CCL2, IL-8, IL-33, ERK1/2, IL-6, NF-kB",3.28E-05,5.73E-04,12,"COX-2 (PTGS2), GRO-2, IL-1 beta, NGF, RelA (p65 NF-kB subunit), GRO-1, ICAM1, CCL2, IL-8, IL-33, IL-6, NF-kB"
128,Role of growth factor receptors transactivation by Hyaluronic acid / CD44 signaling in tumor progression,35,8.18E-06,9.09E-05,8.18E-06,9.09E-05,13,"HGF, Ankyrin 1, PI3K cat class IA, CD44, PKC-alpha, EGFR, ERK1/2, MMP-2, PTHrP, SMAD3, HGF receptor (Met), MMP-9, MDR1",1.71E-04,1.94E-03,11,"HGF, Ankyrin 1, PI3K cat class IA, CD44, PKC-alpha, EGFR, MMP-2, PTHrP, HGF receptor (Met), MMP-9, MDR1"
129,IL-1 beta- and Endothelin-1-induced fibroblast/ myofibroblast migration and extracellular matrix production in asthmatic airways,40,8.24E-06,9.09E-05,8.24E-06,9.09E-05,14,"IL-1 beta, COL4A1, EDNRB, CCL2, ERK1/2, MMP-2, Versican, NF-kB, CTGF, PDGF-R-alpha, Fibronectin, EDNRA, PDGF-R-beta, Collagen III",2.97E-05,5.32E-04,13,"IL-1 beta, COL4A1, EDNRB, CCL2, MMP-2, Versican, NF-kB, CTGF, PDGF-R-alpha, Fibronectin, EDNRA, PDGF-R-beta, Collagen III"
130,Cell adhesion_IL-8 family-dependent cell migration and adhesion,40,8.24E-06,9.09E-05,8.24E-06,9.09E-05,14,"GRO-2, GRO-1, GCP2, ITGB2, ICAM1, IL-8, G-protein alpha-i family, ERK1/2, ENA-78, EBP50, IL8RA, PI3K reg class IB (p101), GRO-3, IP3 receptor",2.97E-05,5.32E-04,13,"GRO-2, GRO-1, GCP2, ITGB2, ICAM1, IL-8, G-protein alpha-i family, ENA-78, EBP50, IL8RA, PI3K reg class IB (p101), GRO-3, IP3 receptor"
131,Impaired inhibitory action of lipoxins on neutrophil migration in CF,56,8.26E-06,9.09E-05,8.26E-06,9.09E-05,17,"ITGB2, ICAM1, IL-8, G-protein alpha-i family, MRLC, ERK1/2, Myosin II, Actin cytoskeletal, Rac2, AKT(PKB), MELC, IL8RA, PDK (PDPK1), MYLK1, PI3K reg class IB (p101), MLCK, PREX1",1.19E-03,7.56E-03,13,"ITGB2, ICAM1, IL-8, G-protein alpha-i family, MRLC, Rac2, AKT(PKB), MELC, IL8RA, MYLK1, PI3K reg class IB (p101), MLCK, PREX1"
132,MAPK-mediated proliferation of normal and asthmatic smooth muscle cells,56,8.26E-06,9.09E-05,8.26E-06,9.09E-05,17,"Amphiregulin, EDNRB, LPAR1, PKC-alpha, PLAT (TPA), EGFR, N-Ras, G-protein alpha-i family, ERK1/2, PDGF-C, FGF2, SOS, PDGF-R-alpha, PDGF receptor, EDNRA, IP3 receptor, PDGF-R-beta",9.36E-05,1.19E-03,15,"Amphiregulin, EDNRB, LPAR1, PKC-alpha, PLAT (TPA), EGFR, G-protein alpha-i family, PDGF-C, FGF2, SOS, PDGF-R-alpha, PDGF receptor, EDNRA, IP3 receptor, PDGF-R-beta"
133,"Development_Hedgehog, BMP and Parathyroid hormone in osteogenesis",51,9.49E-06,1.04E-04,9.49E-06,1.04E-04,16,"EGR2 (Krox20), RUNX2, PTCH1, BMP6, Adenylate cyclase, ERK1/2, PTHR1, ALPL, TAZ, PTHrP, GLI-1, Osteoprotegerin, G-protein alpha-q/11, DLX5, BMP2, GLI-2",2.83E-05,5.27E-04,15,"EGR2 (Krox20), RUNX2, PTCH1, BMP6, Adenylate cyclase, PTHR1, ALPL, TAZ, PTHrP, GLI-1, Osteoprotegerin, G-protein alpha-q/11, DLX5, BMP2, GLI-2"
134,Immune response_Classical complement pathway,53,1.06E-05,1.61E-04,1.64E-05,1.61E-04,16,"C1r, C4a, C1 inhibitor, C6, C3, Factor I, C3b, C3c, C4b, Clusterin, C7, iC3b, C3dg, C3a, C4, C1s",1.06E-05,2.63E-04,16,"C1r, C4a, C1 inhibitor, C6, C3, Factor I, C3b, C3c, C4b, Clusterin, C7, iC3b, C3dg, C3a, C4, C1s"
135,Fibroblast differentiation to myofibroblasts in asthmatic airways,31,1.11E-05,1.21E-04,1.11E-05,1.21E-04,12,"ITGB1, PI3K cat class IA, EDNRB, TGF-beta receptor type II, ERK1/2, ACTA2, alpha-5/beta-1 integrin, SMAD3, AKT(PKB), ITGA5, Fibronectin, EDNRA",2.65E-04,2.70E-03,10,"ITGB1, PI3K cat class IA, EDNRB, TGF-beta receptor type II, ACTA2, alpha-5/beta-1 integrin, AKT(PKB), ITGA5, Fibronectin, EDNRA"
136,Maturation and migration of dendritic cells in skin sensitization,41,1.14E-05,1.23E-04,1.14E-05,1.23E-04,14,"MHC class II alpha chain, IL-1 beta, TNF-R2, HLA-DRB1, MHC class II, ICAM1, HLA-DRB, IL-8, ERK1/2, IL-6, CD83, HLA-DRA1, NF-kB, MHC class II beta chain",3.99E-05,6.29E-04,13,"MHC class II alpha chain, IL-1 beta, TNF-R2, HLA-DRB1, MHC class II, ICAM1, HLA-DRB, IL-8, IL-6, CD83, HLA-DRA1, NF-kB, MHC class II beta chain"
137,E-cadherin signaling and its regulation in gastric cancer,36,1.17E-05,1.24E-04,1.17E-05,1.24E-04,13,"HGF, WNT, SLUG, EGFR, SIP1 (ZFHX1B), Beta-catenin, SNAIL1, HGF receptor (Met), TCF8, Dsh, Actin, BMP2, Frizzled",1.00E-03,6.49E-03,10,"HGF, WNT, SLUG, EGFR, SIP1 (ZFHX1B), HGF receptor (Met), TCF8, Actin, BMP2, Frizzled"
138,PR action in breast cancer: stimulation of cell growth and proliferation,36,1.17E-05,1.24E-04,1.17E-05,1.24E-04,13,"STAT3, ESR1 (nuclear), Neuregulin 1, Cyclin E, EGFR, ERK1/2, MMP-2, ErbB3, ESR1 (membrane), SOS, MMP-9, PR (membrane), PR (nuclear)",1.00E-03,6.49E-03,10,"ESR1 (nuclear), Neuregulin 1, Cyclin E, EGFR, MMP-2, ESR1 (membrane), SOS, MMP-9, PR (membrane), PR (nuclear)"
139,Immune response_M-CSF-receptor signaling pathway,81,1.18E-05,1.24E-04,1.18E-05,1.24E-04,21,"STAT3, Syk, PI3K cat class IA, PKC, FMIP, Tcf(Lef), MSR1, ETS1, IL-34, ERK1/2, Beta-catenin, Fyn, Rac2, NF-kB, AKT(PKB), CSF1, SOS1, PDK (PDPK1), GRAP2, PLAU (UPA), IP3 receptor",7.82E-04,5.69E-03,17,"Syk, PI3K cat class IA, PKC, FMIP, Tcf(Lef), MSR1, ETS1, IL-34, Fyn, Rac2, NF-kB, AKT(PKB), CSF1, SOS1, GRAP2, PLAU (UPA), IP3 receptor"
140,FGF2 in multiple myeloma,18,1.19E-05,1.24E-04,1.19E-05,1.24E-04,9,"PI3K cat class IA, Heparanase 1, FGFR4, IL-6, FGF2, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",3.86E-03,1.90E-02,6,"PI3K cat class IA, Heparanase 1, FGFR4, IL-6, FGF2, AKT(PKB)"
141,EGFR family signaling in pancreatic cancer,75,1.20E-05,1.25E-04,1.20E-05,1.25E-04,20,"STAT3, COX-2 (PTGS2), Tuberin, PI3K cat class IA, Cyclin E, EGFR, N-Ras, Neuropilin-1, Bcl-2, ERK1/2, MMP-2, ErbB3, TGF-alpha, SOS, NF-kB, AKT(PKB), PDK (PDPK1), p27KIP1, MMP-9, PLAU (UPA)",1.62E-02,5.40E-02,13,"COX-2 (PTGS2), PI3K cat class IA, Cyclin E, EGFR, Neuropilin-1, Bcl-2, MMP-2, TGF-alpha, SOS, NF-kB, AKT(PKB), MMP-9, PLAU (UPA)"
142,Immune response_Lysophosphatidic acid signaling via NF-kB,52,1.25E-05,1.28E-04,1.25E-05,1.28E-04,16,"COX-2 (PTGS2), PKD, CCL20, RelA (p65 NF-kB subunit), PKC, LPAR1, ICAM1, CCL2, IL-8, ERK1/2, MMP-2, IL-6, NF-kB, GRO-3, A20, MMP-9",3.64E-05,5.81E-04,15,"COX-2 (PTGS2), PKD, CCL20, RelA (p65 NF-kB subunit), PKC, LPAR1, ICAM1, CCL2, IL-8, MMP-2, IL-6, NF-kB, GRO-3, A20, MMP-9"
143,IGF signaling in HCC,52,1.25E-05,1.28E-04,1.25E-05,1.28E-04,16,"HGF, PI3K cat class IA, Amphiregulin, PKC, IRS-2, EGFR, ERK1/2, MMP-2, TGF-alpha, SOS, AKT(PKB), PDK (PDPK1), HGF receptor (Met), Jagged1, MMP-9, IBP3",1.50E-04,1.75E-03,14,"HGF, PI3K cat class IA, Amphiregulin, PKC, IRS-2, EGFR, MMP-2, TGF-alpha, SOS, AKT(PKB), HGF receptor (Met), Jagged1, MMP-9, IBP3"
144,Immune response_Histamine H1 receptor signaling in immune response,47,1.43E-05,1.45E-04,1.43E-05,1.45E-04,15,"Histamine H1 receptor, RelA (p65 NF-kB subunit), MMP-13, iNOS, ICAM1, PKC-alpha, IL-8, cPLA2, IL-6, ERK2 (MAPK1), G-protein alpha-q/11, Tissue factor, ERK1 (MAPK3), MMP-9, IP3 receptor",1.91E-04,2.09E-03,13,"Histamine H1 receptor, RelA (p65 NF-kB subunit), MMP-13, iNOS, ICAM1, PKC-alpha, IL-8, cPLA2, IL-6, G-protein alpha-q/11, Tissue factor, MMP-9, IP3 receptor"
145,Development_Positive regulation of WNT/Beta-catenin signaling at the receptor level,64,1.47E-05,1.48E-04,1.47E-05,1.48E-04,18,"Biglycan, RECK, CD44, LGR6, Tcf(Lef), WNT7A, WNT, EGFR, ERK1/2, R-spondins, WLS, LGR5, SFRP1, Caveolin-1, GPR124, WNT5B, Dsh, Frizzled",1.35E-04,1.60E-03,16,"Biglycan, RECK, CD44, LGR6, Tcf(Lef), WNT7A, WNT, EGFR, R-spondins, WLS, LGR5, SFRP1, Caveolin-1, GPR124, WNT5B, Frizzled"
146,"Signal transduction_Angiotensin II/AGTR1 signaling via Notch, Beta-catenin and NF-kB pathways",76,1.49E-05,1.50E-04,1.49E-05,1.50E-04,20,"RelA (p65 NF-kB subunit), PKC, HES5, CCL2, IL-8, TCF7L2 (TCF4), ERK1/2, MMP-2, IL-6, Beta-catenin, ACTA2, SNAIL1, NF-kB, TRPC6, CTGF, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), Fibronectin, MMP-9",2.95E-03,1.56E-02,15,"RelA (p65 NF-kB subunit), PKC, HES5, CCL2, IL-8, TCF7L2 (TCF4), MMP-2, IL-6, ACTA2, NF-kB, TRPC6, CTGF, AKT(PKB), Fibronectin, MMP-9"
147,Growth factors in regulation of oligodendrocyte precursor cells survival in multiple sclerosis,42,1.57E-05,1.56E-04,1.57E-05,1.56E-04,14,"BAD, NGF, NGFR(TNFRSF16), PI3K cat class IA, RelA (p65 NF-kB subunit), Neuregulin 1, Lyn, Bcl-2, ErbB3, Fyn, PDGF-R-alpha, AKT(PKB), PDK (PDPK1), IBP",9.73E-04,6.42E-03,11,"NGF, NGFR(TNFRSF16), PI3K cat class IA, RelA (p65 NF-kB subunit), Neuregulin 1, Lyn, Bcl-2, Fyn, PDGF-R-alpha, AKT(PKB), IBP"
148,Th1 and Th17 cells in an autoimmune mechanism of emphysema formation in smokers,28,1.59E-05,2.07E-04,2.20E-05,2.07E-04,11,"MHC class II, CCL20, IP10, ROR-alpha, CD44, Alpha 1-antitrypsin, Elastin, ROR-gamma, MMP-12, CCR5, MMP-9",1.59E-05,3.56E-04,11,"MHC class II, CCL20, IP10, ROR-alpha, CD44, Alpha 1-antitrypsin, Elastin, ROR-gamma, MMP-12, CCR5, MMP-9"
149,Immune response_HMGB1/RAGE signaling pathway,53,1.64E-05,1.61E-04,1.64E-05,1.61E-04,16,"IL-1 beta, Chromogranin A, PI3K cat class IA, iNOS, ICAM1, PLAT (TPA), IL-8, TLR4, ERK1/2, MEF2C, IL-6, NF-kB, AKT(PKB), Tissue factor, Secretogranin II, TLR2",4.66E-05,6.74E-04,15,"IL-1 beta, Chromogranin A, PI3K cat class IA, iNOS, ICAM1, PLAT (TPA), IL-8, TLR4, MEF2C, IL-6, NF-kB, AKT(PKB), Tissue factor, Secretogranin II, TLR2"
150,Interaction of deficient alpha-MSH signaling with TNF-alpha in melanoma,33,1.66E-05,2.14E-04,2.35E-05,2.14E-04,12,"COX-2 (PTGS2), N-cadherin, ITGB1, RelA (p65 NF-kB subunit), ICAM1, SLUG, SIP1 (ZFHX1B), NF-kB, alpha-MSH, Fibronectin, Vimentin, MMP-9",1.66E-05,3.59E-04,12,"COX-2 (PTGS2), N-cadherin, ITGB1, RelA (p65 NF-kB subunit), ICAM1, SLUG, SIP1 (ZFHX1B), NF-kB, alpha-MSH, Fibronectin, Vimentin, MMP-9"
151,"Immune response_T cell co-signaling receptors, schema",55,1.79E-05,2.50E-04,2.75E-05,2.50E-04,16,"MHC class II, PD-L2, CD30(TNFRSF8), CD70(TNFSF7), GITRL, Nectin-3, CD137 ligand(TNFSF9), Collagen II, DPP4, Collagen V, CD137(TNFRSF9), LIGHT(TNFSF14), Collagen VI, Galectin-9, PD-L1, Collagen III",1.79E-05,3.83E-04,16,"MHC class II, PD-L2, CD30(TNFRSF8), CD70(TNFSF7), GITRL, Nectin-3, CD137 ligand(TNFSF9), Collagen II, DPP4, Collagen V, CD137(TNFRSF9), LIGHT(TNFSF14), Collagen VI, Galectin-9, PD-L1, Collagen III"
152,Role of alpha-V/ beta-6 integrin in colorectal cancer,23,1.82E-05,1.77E-04,1.82E-05,1.77E-04,10,"PKC, ETS1, Bcl-2, ERK1/2, MMP-2, ERK2 (MAPK1), Collagen IV, Fibronectin, MMP-9, PLAU (UPA)",6.21E-04,4.76E-03,8,"PKC, ETS1, Bcl-2, MMP-2, Collagen IV, Fibronectin, MMP-9, PLAU (UPA)"
153,Signal transduction_PDGF signaling via MAPK cascades,65,1.86E-05,1.80E-04,1.86E-05,1.80E-04,18,"COX-2 (PTGS2), MMP-13, Fra-1, ERK1/2, MMP-2, PDGF-C, IL-6, PDGFR-ab, TRPC6, PDGF-R-alpha, ERK2 (MAPK1), SOS1, PDGF receptor, Tissue factor, p27KIP1, MMP-9, Phox1 (PRRX1), PDGF-R-beta",5.51E-04,4.43E-03,15,"COX-2 (PTGS2), MMP-13, Fra-1, MMP-2, PDGF-C, IL-6, PDGFR-ab, TRPC6, PDGF-R-alpha, SOS1, PDGF receptor, Tissue factor, MMP-9, Phox1 (PRRX1), PDGF-R-beta"
154,Release of pro-inflammatory factors and proteases by alveolar macrophages in asthma,44,1.94E-05,2.53E-04,2.86E-05,2.53E-04,14,"GRO-2, IL-1 beta, GRO-1, iNOS, IL-30, IP10, CCL2, IL-8, TLR4, SP-D, IL-6, NF-kB, MMP-9, TLR2",1.94E-05,4.08E-04,14,"GRO-2, IL-1 beta, GRO-1, iNOS, IL-30, IP10, CCL2, IL-8, TLR4, SP-D, IL-6, NF-kB, MMP-9, TLR2"
155,DKK1 signaling in multiple myeloma,19,2.07E-05,1.99E-04,2.07E-05,1.99E-04,9,"RelA (p65 NF-kB subunit), Tcf(Lef), ALPL, IL-6, Beta-catenin, Osteoprotegerin, Dsh, BMP2, Frizzled",9.23E-04,6.32E-03,7,"RelA (p65 NF-kB subunit), Tcf(Lef), ALPL, IL-6, Osteoprotegerin, BMP2, Frizzled"
156,Prostaglandins and leukotrienes-mediated induction of expression of mucins in normal and asthmatic epithelium ,43,2.13E-05,2.03E-04,2.13E-05,2.03E-04,14,"PGE2R2, PGE2R4, PKC-alpha, Mucin 2, EGFR, Mucin 5AC, G-protein alpha-i family, Adenylate cyclase, ERK1/2, PGF2aR, Mucin 5B, NF-kB, G-protein alpha-q/11, IP3 receptor",6.99E-05,9.44E-04,13,"PGE2R2, PGE2R4, PKC-alpha, Mucin 2, EGFR, Mucin 5AC, G-protein alpha-i family, Adenylate cyclase, PGF2aR, Mucin 5B, NF-kB, G-protein alpha-q/11, IP3 receptor"
157,Immune response_Lectin induced complement pathway,50,2.17E-05,2.79E-04,3.26E-05,2.79E-04,15,"MBL2, C4a, C1 inhibitor, C6, C3, Factor I, C3b, C3c, C4b, Clusterin, C7, iC3b, C3dg, C3a, C4",2.17E-05,4.45E-04,15,"MBL2, C4a, C1 inhibitor, C6, C3, Factor I, C3b, C3c, C4b, Clusterin, C7, iC3b, C3dg, C3a, C4"
158,HGF signaling in pancreatic cancer,28,2.20E-05,2.07E-04,2.20E-05,2.07E-04,11,"HGF, PI3K cat class IA, Neuropilin-1, ERK1/2, MMP-2, SOS, p53, HGF receptor (Met), p27KIP1, MMP-9, PLAU (UPA)",2.62E-03,1.40E-02,8,"HGF, PI3K cat class IA, Neuropilin-1, MMP-2, SOS, HGF receptor (Met), MMP-9, PLAU (UPA)"
159,Role of Th17 cells in asthma,28,2.20E-05,2.07E-04,2.20E-05,2.07E-04,11,"GRO-2, GRO-1, ICAM1, IL-8, EGFR, MRLC, ALOX5, ERK1/2, Myosin II, NF-kB, GRO-3",5.54E-04,4.43E-03,9,"GRO-2, GRO-1, ICAM1, IL-8, EGFR, MRLC, ALOX5, NF-kB, GRO-3"
160,Pro-oncogenic action of Estradiol/ Estrogen receptors in ovarian cancer,60,2.28E-05,2.12E-04,2.28E-05,2.12E-04,17,"STAT3, BETA-IG-H3, PI3K cat class IA, RelA (p65 NF-kB subunit), ESR1 (nuclear), CD44, Fra-1, Cyclin E, EGFR, ESR1 (membrane), ERK2 (MAPK1), AKT(PKB), TFF1, Fibronectin, MMP-9, PLAU (UPA), IBP3",2.17E-04,2.32E-03,15,"BETA-IG-H3, PI3K cat class IA, RelA (p65 NF-kB subunit), ESR1 (nuclear), CD44, Fra-1, Cyclin E, EGFR, ESR1 (membrane), AKT(PKB), TFF1, Fibronectin, MMP-9, PLAU (UPA), IBP3"
161,Development_Self-renewal and pluripotency maintenance of human embryonic stem cells,33,2.35E-05,2.14E-04,2.35E-05,2.14E-04,12,"p14ARF, Oct-3/4, SOX2, CGB3, CDX2, BMP4, CG alpha, LIN-28, FGF2, p53, PBX1, PAX6",9.39E-05,1.19E-03,11,"p14ARF, Oct-3/4, SOX2, CGB3, CDX2, BMP4, CG alpha, LIN-28, FGF2, PBX1, PAX6"
162,SHH signaling in melanoma,33,2.35E-05,2.14E-04,2.35E-05,2.14E-04,12,"N-cadherin, PTCH1, SLUG, N-Ras, MMP-2, GLI-1, SMAD3, PDGF-R-alpha, PDK (PDPK1), Vimentin, MMP-9, GLI-2",2.05E-03,1.15E-02,9,"N-cadherin, PTCH1, SLUG, MMP-2, GLI-1, PDGF-R-alpha, Vimentin, MMP-9, GLI-2"
163,Development_Role of cell-cell and ECM-cell interactions in oligodendrocyte differentiation and myelination,34,2.35E-05,2.80E-04,3.32E-05,2.80E-04,12,"ITGB1, Myelin basic protein, Claudin-11, NGFR(TNFRSF16), Caspr1, Tetraspanin-2, NCAM1, Connexin 26, Connexin 32, Connexin 30, Fyn, Connexin 45",2.35E-05,4.56E-04,12,"ITGB1, Myelin basic protein, Claudin-11, NGFR(TNFRSF16), Caspr1, Tetraspanin-2, NCAM1, Connexin 26, Connexin 32, Connexin 30, Fyn, Connexin 45"
164,IGF signaling in lung cancer,44,2.86E-05,2.53E-04,2.86E-05,2.53E-04,14,"BAD, Tuberin, PI3K cat class IA, IRS-2, ERK1/2, MMP-2, SOS, AKT(PKB), IBP4, PDK (PDPK1), MMP-9, IBP, PLAU (UPA), IBP3",5.04E-03,2.31E-02,10,"PI3K cat class IA, IRS-2, MMP-2, SOS, AKT(PKB), IBP4, MMP-9, IBP, PLAU (UPA), IBP3"
165,Development_Ligand-independent activation of ESR1 and ESR2,44,2.86E-05,2.53E-04,2.86E-05,2.53E-04,14,"PI3K cat class IA, Adenylate cyclase type V, ESR1 (nuclear), Neuregulin 1, EGFR, ERK1/2, ErbB3, SOS, ERK2 (MAPK1), AKT(PKB), Caveolin-1, TFF1, PDK (PDPK1), ERK1 (MAPK3)",1.53E-02,5.25E-02,9,"PI3K cat class IA, Adenylate cyclase type V, ESR1 (nuclear), Neuregulin 1, EGFR, SOS, AKT(PKB), Caveolin-1, TFF1"
166,Transition of HCC cells to invasive and migratory phenotype,44,2.86E-05,2.53E-04,2.86E-05,2.53E-04,14,"N-cadherin, PI3K cat class IA, SIP1 (ZFHX1B), MMP-14, MMP-2, Beta-catenin, Matrilysin (MMP-7), SNAIL1, AKT(PKB), Caspase-8, p53, PDK (PDPK1), Vimentin, MMP-9",1.53E-02,5.25E-02,9,"N-cadherin, PI3K cat class IA, SIP1 (ZFHX1B), MMP-14, MMP-2, Matrilysin (MMP-7), AKT(PKB), Vimentin, MMP-9"
167,"Role of microRNAs in cell migration, survival and angiogenesis in colorectal cancer",67,2.92E-05,2.57E-04,2.92E-05,2.57E-04,18,"COX-2 (PTGS2), PGE2R4, PTEN, Fra-1, UFO, PDCD4, TGF-beta receptor type II, Neuropilin-1, Bcl-2, MMP-2, Clusterin, CTGF, AKT(PKB), SPRY2, p53, HGF receptor (Met), RhoB, MMP-9",2.40E-04,2.48E-03,16,"COX-2 (PTGS2), PGE2R4, Fra-1, UFO, PDCD4, TGF-beta receptor type II, Neuropilin-1, Bcl-2, MMP-2, Clusterin, CTGF, AKT(PKB), SPRY2, HGF receptor (Met), RhoB, MMP-9"
168,Role of tumor microenvironment in plexiform neurofibroma formation in neurofibromatosis type 1,39,3.15E-05,2.71E-04,3.15E-05,2.71E-04,13,"NGF, PI3K cat class IA, alpha-4/beta-1 integrin, ERK1/2, MMP-2, FGF2, Rac2, SOS, AKT(PKB), Tryptase, PDK (PDPK1), Fibronectin, PDGF-R-beta",4.90E-04,4.06E-03,11,"NGF, PI3K cat class IA, alpha-4/beta-1 integrin, MMP-2, FGF2, Rac2, SOS, AKT(PKB), Tryptase, Fibronectin, PDGF-R-beta"
169,HGF signaling in melanoma,39,3.15E-05,2.71E-04,3.15E-05,2.71E-04,13,"HGF, N-cadherin, PI3K cat class IA, CD44, PKC-alpha, SLUG, N-Ras, ERK1/2, Beta-catenin, AKT(PKB), alpha-MSH, HGF receptor (Met), Fibronectin",1.95E-03,1.11E-02,10,"HGF, N-cadherin, PI3K cat class IA, CD44, PKC-alpha, SLUG, AKT(PKB), alpha-MSH, HGF receptor (Met), Fibronectin"
170,Cell cycle progression in Prostate Cancer,39,3.15E-05,2.71E-04,3.15E-05,2.71E-04,13,"STAT3, Androgen receptor, Tuberin, Tcf(Lef), WNT, ERK1/2, IL-6, Beta-catenin, AKT(PKB), p27KIP1, Frizzled, Prolactin receptor, CDK6",2.14E-02,6.53E-02,8,"Androgen receptor, Tcf(Lef), WNT, IL-6, AKT(PKB), Frizzled, Prolactin receptor, CDK6"
171,Immune response_TSLP signalling,39,3.15E-05,2.71E-04,3.15E-05,2.71E-04,13,"STAT3, PI3K cat class IA, IL7RA, CISH, STAT4, CCL2, IL-8, Bcl-2, ERK1/2, IL-6, NF-kB, AKT(PKB), PDK (PDPK1)",1.95E-03,1.11E-02,10,"PI3K cat class IA, IL7RA, CISH, STAT4, CCL2, IL-8, Bcl-2, IL-6, NF-kB, AKT(PKB)"
172,Langerhans cell migration to lymph nodes in allergic contact dermatitis,35,3.28E-05,3.71E-04,4.62E-05,3.71E-04,12,"IL-1 beta, Laminin 5, TNF-R2, CCL20, alpha-4/beta-1 integrin, ICAM1, CD44, GITRL, Collagen IV, Fibronectin, MMP-9, MDR1",3.28E-05,5.73E-04,12,"IL-1 beta, Laminin 5, TNF-R2, CCL20, alpha-4/beta-1 integrin, ICAM1, CD44, GITRL, Collagen IV, Fibronectin, MMP-9, MDR1"
173,Apoptosis and survival_Role of CDK5 in neuronal death and survival,34,3.32E-05,2.80E-04,3.32E-05,2.80E-04,12,"BAD, NGF, NGFR(TNFRSF16), PI3K cat class IA, Neuregulin 1, Bcl-2, ERK1/2, ErbB3, SOS, AKT(PKB), p53, PDK (PDPK1)",2.99E-02,8.48E-02,7,"NGF, NGFR(TNFRSF16), PI3K cat class IA, Neuregulin 1, Bcl-2, SOS, AKT(PKB)"
174,Signal transduction_Adenosine A1 receptor signaling pathway,62,3.63E-05,3.03E-04,3.63E-05,3.03E-04,17,"BAD, STAT3, G-protein alpha-15, PKC, PKC-alpha, EGFR, G-protein alpha-i family, Adenylate cyclase, ERK1/2, MMP-2, ADA, NF-kB, AKT(PKB), G-protein alpha-q/11, PDK (PDPK1), SFK, IP3 receptor",3.16E-03,1.65E-02,13,"G-protein alpha-15, PKC, PKC-alpha, EGFR, G-protein alpha-i family, Adenylate cyclase, MMP-2, ADA, NF-kB, AKT(PKB), G-protein alpha-q/11, SFK, IP3 receptor"
175,Glucocorticoid-induced elevation of intraocular pressure as glaucoma risk factor,62,3.63E-05,3.03E-04,3.63E-05,3.03E-04,17,"COX-2 (PTGS2), ITGB1, Laminin 5, PI3K cat class IA, COL4A1, PLAT (TPA), ITGB3, Elastin, EGFR, MMP-2, Actin cytoskeletal, LAMB3, Collagen IV, HGF receptor (Met), Fibronectin, LAMA1, MLCK",8.98E-05,1.18E-03,16,"COX-2 (PTGS2), ITGB1, Laminin 5, PI3K cat class IA, COL4A1, PLAT (TPA), ITGB3, Elastin, EGFR, MMP-2, LAMB3, Collagen IV, HGF receptor (Met), Fibronectin, LAMA1, MLCK"
176,Influence of bone marrow cell environment on progression of multiple myeloma,52,3.64E-05,4.18E-04,5.43E-05,4.18E-04,15,"HGF, IL-1 beta, ITGB1, PI3K cat class IA, alpha-4/beta-1 integrin, PTCH1, CD44, PKC-alpha, IL-6, alpha-5/beta-1 integrin, FGF2, HGF receptor (Met), Fibronectin, PI3K reg class IB (p101), IP3 receptor",3.64E-05,5.81E-04,15,"HGF, IL-1 beta, ITGB1, PI3K cat class IA, alpha-4/beta-1 integrin, PTCH1, CD44, PKC-alpha, IL-6, alpha-5/beta-1 integrin, FGF2, HGF receptor (Met), Fibronectin, PI3K reg class IB (p101), IP3 receptor"
177,Development_Endothelial differentiation during embryonic development,51,4.23E-05,3.51E-04,4.23E-05,3.51E-04,15,"TIE2, PI3K cat class IA, PKC, ETS1, WNT, BMP4, SOX18, Neuropilin-1, ERK1/2, Angiopoietin 1, FOXC2, Beta-catenin, AKT(PKB), FOXC1, GLI-2",4.60E-04,4.02E-03,13,"TIE2, PI3K cat class IA, PKC, ETS1, WNT, BMP4, SOX18, Neuropilin-1, Angiopoietin 1, FOXC2, AKT(PKB), FOXC1, GLI-2"
178,IL-6 signaling in Prostate Cancer,40,4.27E-05,3.53E-04,4.27E-05,3.53E-04,13,"STAT3, Androgen receptor, BMX, PI3K cat class IA, PTEN, IL-6, SOS, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), p27KIP1, Pim-1, Kallikrein 3 (PSA)",2.47E-02,7.23E-02,8,"Androgen receptor, BMX, PI3K cat class IA, IL-6, SOS, AKT(PKB), Pim-1, Kallikrein 3 (PSA)"
179,Renal tubulointerstitial injury in Lupus Nephritis ,65,4.54E-05,5.01E-04,7.00E-05,5.01E-04,17,"IL-1 beta, TNF-R2, MHC class II, RelA (p65 NF-kB subunit), alpha-4/beta-1 integrin, ICAM1, CD44, CCL2, CMKLR1, IL-8, IL-6, CCR5, CSF1, Fibronectin, Vimentin, PLAU (UPA), Collagen III",4.54E-05,6.74E-04,17,"IL-1 beta, TNF-R2, MHC class II, RelA (p65 NF-kB subunit), alpha-4/beta-1 integrin, ICAM1, CD44, CCL2, CMKLR1, IL-8, IL-6, CCR5, CSF1, Fibronectin, Vimentin, PLAU (UPA), Collagen III"
180,Role of osteoblasts in bone lesions formation in multiple myeloma,35,4.62E-05,3.71E-04,4.62E-05,3.71E-04,12,"HGF, RUNX2, alpha-4/beta-1 integrin, WNT, ALPL, Beta-catenin, TAZ, CCR5, Osteoprotegerin, TCF7 (TCF1), BMP2, Frizzled",1.71E-04,1.94E-03,11,"HGF, RUNX2, alpha-4/beta-1 integrin, WNT, ALPL, TAZ, CCR5, Osteoprotegerin, TCF7 (TCF1), BMP2, Frizzled"
181,Pro-oncogenic action of Androgen receptor in breast cancer,35,4.62E-05,3.71E-04,4.62E-05,3.71E-04,12,"Androgen receptor, PIP, AKR1C3, RUNX2, ERK1/2, ErbB3, Beta-catenin, SGK1, FASN, HNF3-alpha, TCF8, Kallikrein 3 (PSA)",1.13E-02,4.22E-02,8,"Androgen receptor, PIP, AKR1C3, RUNX2, SGK1, HNF3-alpha, TCF8, Kallikrein 3 (PSA)"
182,Mechanisms of CAM-DR in multiple myeloma,35,4.62E-05,3.71E-04,4.62E-05,3.71E-04,12,"STAT3, ITGB1, c-IAP2, alpha-4/beta-1 integrin, ICAM1, Cyclin E, WNT3, alpha-5/beta-1 integrin, Fibronectin, p27KIP1, Dsh, Frizzled",3.18E-03,1.65E-02,9,"ITGB1, c-IAP2, alpha-4/beta-1 integrin, ICAM1, Cyclin E, WNT3, alpha-5/beta-1 integrin, Fibronectin, Frizzled"
183,Extracellular matrix-regulated proliferation of airway smooth muscle cells in asthma,35,4.62E-05,3.71E-04,4.62E-05,3.71E-04,12,"PI3K cat class IA, alpha-4/beta-1 integrin, TGF-beta receptor type II, EGFR, ERK1/2, alpha-5/beta-1 integrin, SMAD3, CTGF, Collagen IV, Fibronectin, LAMA1, Collagen III",7.87E-04,5.69E-03,10,"PI3K cat class IA, alpha-4/beta-1 integrin, TGF-beta receptor type II, EGFR, alpha-5/beta-1 integrin, CTGF, Collagen IV, Fibronectin, LAMA1, Collagen III"
184,Immune response_Alternative complement pathway,53,4.66E-05,5.00E-04,6.93E-05,5.00E-04,15,"PTX3, C5L2, FHR-1, C6, C3, Factor I, C3b, C3c, Clusterin, C7, Factor H, iC3b, C3dg, FHR-5, C3a",4.66E-05,6.74E-04,15,"PTX3, C5L2, FHR-1, C6, C3, Factor I, C3b, C3c, Clusterin, C7, Factor H, iC3b, C3dg, FHR-5, C3a"
185,Inhibition of Ephrin receptors in colorectal cancer,30,4.70E-05,3.73E-04,4.70E-05,3.73E-04,11,"Ephrin-A receptor 7, WNT, Ephrin-B receptor 2, TCF7L2 (TCF4), Beta-catenin, Ephrin-A receptors, SMAD3, Ephrin-B receptor 1, Ephrin-B receptors, Ephrin-A receptor 2, Frizzled",9.73E-04,6.42E-03,9,"Ephrin-A receptor 7, WNT, Ephrin-B receptor 2, TCF7L2 (TCF4), Ephrin-A receptors, Ephrin-B receptor 1, Ephrin-B receptors, Ephrin-A receptor 2, Frizzled"
186,Development_Transcription factors in segregation of hepatocytic lineage,30,4.70E-05,3.73E-04,4.70E-05,3.73E-04,11,"p14ARF, Activin A, Alpha 1-antitrypsin, A2M, TGF-beta receptor type II, Activin, Follistatin, Beta-catenin, HGF receptor (Met), p16INK4, C/EBPalpha",1.95E-04,2.12E-03,10,"p14ARF, Activin A, Alpha 1-antitrypsin, A2M, TGF-beta receptor type II, Activin, Follistatin, HGF receptor (Met), p16INK4, C/EBPalpha"
187,Epigenetic alterations in ovarian cancer,82,4.94E-05,3.87E-04,4.94E-05,3.87E-04,20,"GSTP1, N-cadherin, Maspin, HOXA10, Gamma-synuclein, ESR1 (nuclear), AL1A1, MMP-2, p15, H-cadherin, SNAIL1, GLI-1, p16INK4, p27KIP1, DACT3, Ephrin-A receptor 2, MMP-9, GLI-2, CYP11A1, CDK6",3.11E-04,2.97E-03,18,"GSTP1, N-cadherin, Maspin, HOXA10, Gamma-synuclein, ESR1 (nuclear), AL1A1, MMP-2, p15, H-cadherin, GLI-1, p16INK4, DACT3, Ephrin-A receptor 2, MMP-9, GLI-2, CYP11A1, CDK6"
188,Neurophysiological process_Receptor-mediated axon growth repulsion,46,4.99E-05,3.87E-04,4.99E-05,3.87E-04,14,"RHO6, Plexin A2, Semaphorin 3A, EGFR, F-Actin cytoskeleton, Neuropilin-1, Actin cytoskeletal, Fyn, Ephrin-A receptors, CRMP2, Tau (MAPT), c-Fes, Pleiotrophin (OSF1), Ephrin-A receptor 2",6.02E-04,4.74E-03,12,"RHO6, Plexin A2, Semaphorin 3A, EGFR, Neuropilin-1, Fyn, Ephrin-A receptors, CRMP2, Tau (MAPT), c-Fes, Pleiotrophin (OSF1), Ephrin-A receptor 2"
189,Signal transduction_PTEN pathway,46,4.99E-05,3.87E-04,4.99E-05,3.87E-04,14,"BAD, PCNA, Tuberin, PI3K cat class IA, PTEN, Tcf(Lef), EGFR, ERK1/2, Beta-catenin, alpha-5/beta-1 integrin, SOS, AKT(PKB), p53, PDK (PDPK1)",2.33E-01,3.74E-01,6,"PI3K cat class IA, Tcf(Lef), EGFR, alpha-5/beta-1 integrin, SOS, AKT(PKB)"
190,FGF signaling in pancreatic cancer,46,4.99E-05,3.87E-04,4.99E-05,3.87E-04,14,"PI3K cat class IA, Heparanase 1, PLAT (TPA), ERK1/2, MMP-14, Beta-catenin, HBP17, FGF2, SOS, NF-kB, AKT(PKB), PDK (PDPK1), MMP-9, PLAU (UPA)",2.17E-03,1.21E-02,11,"PI3K cat class IA, Heparanase 1, PLAT (TPA), MMP-14, HBP17, FGF2, SOS, NF-kB, AKT(PKB), MMP-9, PLAU (UPA)"
191,Th2 cytokine- and TNF-alpha-induced profibrotic response in asthmatic airway fibroblasts/ myofibroblasts,52,5.43E-05,4.18E-04,5.43E-05,4.18E-04,15,"COX-2 (PTGS2), IL-1 beta, NGF, Biglycan, ETS1, ERK1/2, MMP-2, BDKRB1, ACTA2, NF-kB, SMAD3, PDGF-R-alpha, AKT(PKB), MMP-9, Collagen III",5.64E-04,4.48E-03,13,"COX-2 (PTGS2), IL-1 beta, NGF, Biglycan, ETS1, MMP-2, BDKRB1, ACTA2, NF-kB, PDGF-R-alpha, AKT(PKB), MMP-9, Collagen III"
192,Putative role of Estrogen receptor and Androgen receptor signaling in progression of lung cancer,58,5.64E-05,4.27E-04,5.64E-05,4.27E-04,16,"BAD, Androgen receptor, Tuberin, CYP1A1, ESR1 (nuclear), EGFR, G-protein alpha-i family, Bcl-2, ERK1/2, CYP19, ESR1 (membrane), SOS, ERK2 (MAPK1), Caveolin-1, ERK1 (MAPK3), Kallikrein 3 (PSA)",1.37E-02,4.85E-02,11,"Androgen receptor, CYP1A1, ESR1 (nuclear), EGFR, G-protein alpha-i family, Bcl-2, CYP19, ESR1 (membrane), SOS, Caveolin-1, Kallikrein 3 (PSA)"
193,Role of integrins in eosinophil degranulation in asthma,58,5.64E-05,4.27E-04,5.64E-05,4.27E-04,16,"Galectin-3, PI3K cat class IA, PKC, CCL13, Eotaxin-2, alpha-4/beta-1 integrin, ICAM1, C3b, G-protein alpha-i family, SP-D, ERK1/2, ERK2 (MAPK1), Fc gamma RII alpha, PRG2, Fibronectin, CCL7",5.15E-04,4.24E-03,14,"Galectin-3, PI3K cat class IA, PKC, CCL13, Eotaxin-2, alpha-4/beta-1 integrin, ICAM1, C3b, G-protein alpha-i family, SP-D, Fc gamma RII alpha, PRG2, Fibronectin, CCL7"
194,Cytoskeleton remodeling_Regulation of actin cytoskeleton organization by the kinase effectors of Rho GTPases,58,5.64E-05,4.27E-04,5.64E-05,4.27E-04,16,"Actomyosin, PAK, Rac1-related, MSN (moesin), ERM proteins, F-Actin cytoskeleton, MRLC, RhoA-related, Myosin II, Caldesmon, Actin cytoskeletal, Rac2, CPI-17, RhoB, MyHC, MLCK",1.37E-02,4.85E-02,11,"PAK, Rac1-related, MSN (moesin), ERM proteins, MRLC, RhoA-related, Caldesmon, Rac2, CPI-17, RhoB, MLCK"
195,Main growth factor signaling cascades in multiple myeloma cells,41,5.73E-05,4.29E-04,5.73E-05,4.29E-04,13,"BAD, STAT3, PI3K cat class IA, PTEN, IRS-2, N-Ras, FGF2, SOS, NF-kB, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",1.62E-01,2.85E-01,6,"PI3K cat class IA, IRS-2, FGF2, SOS, NF-kB, AKT(PKB)"
196,Pro-tumoral TNF-alpha signaling in melanoma,41,5.73E-05,4.29E-04,5.73E-05,4.29E-04,13,"ITGB1, TNF-R2, PI3K cat class IA, ITGA4, alpha-4/beta-1 integrin, IL-8, MMP-2, alpha-5/beta-1 integrin, NF-kB, AKT(PKB), PDK (PDPK1), Fibronectin, MMP-9",1.87E-04,2.08E-03,12,"ITGB1, TNF-R2, PI3K cat class IA, ITGA4, alpha-4/beta-1 integrin, IL-8, MMP-2, alpha-5/beta-1 integrin, NF-kB, AKT(PKB), Fibronectin, MMP-9"
197,WNT signaling in gastric cancer,36,6.35E-05,4.73E-04,6.35E-05,4.73E-04,12,"CD44, DKK3, Tcf(Lef), WNT7A, WNT, TCF7L2 (TCF4), WNT3, Beta-catenin, Matrilysin (MMP-7), SFRP1, Dsh, Frizzled",1.00E-03,6.49E-03,10,"CD44, DKK3, Tcf(Lef), WNT7A, WNT, TCF7L2 (TCF4), WNT3, Matrilysin (MMP-7), SFRP1, Frizzled"
198,Hypoxia-induced EMT in cancer and fibrosis,13,6.38E-05,4.73E-04,6.38E-05,4.73E-04,7,"Lysyl oxidase, ETS1, SLUG, LOXL2, SIP1 (ZFHX1B), SNAIL1, TCF8",5.30E-04,4.31E-03,6,"Lysyl oxidase, ETS1, SLUG, LOXL2, SIP1 (ZFHX1B), TCF8"
199,Mitogenic action of ESR1 (membrane) in breast cancer,47,6.50E-05,4.74E-04,6.50E-05,4.74E-04,14,"ESR1 (nuclear), Cyclin E, EGFR, ERK1/2, MMP-2, ErbB3, ESR1 (membrane), SGK1, SOS, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), p27KIP1, MMP-9",2.31E-02,6.90E-02,9,"ESR1 (nuclear), Cyclin E, EGFR, MMP-2, ESR1 (membrane), SGK1, SOS, AKT(PKB), MMP-9"
200,Canonical Leptin pathways in breast cancer,47,6.50E-05,4.74E-04,6.50E-05,4.74E-04,14,"STAT3, IL-1 beta, PI3K cat class IA, RelA (p65 NF-kB subunit), ESR1 (nuclear), IRS-2, Tcf(Lef), ERK1/2, CYP19, Beta-catenin, SOS, NF-kB, AKT(PKB), PDK (PDPK1)",8.21E-03,3.32E-02,10,"IL-1 beta, PI3K cat class IA, RelA (p65 NF-kB subunit), ESR1 (nuclear), IRS-2, Tcf(Lef), CYP19, SOS, NF-kB, AKT(PKB)"
201,Development_TGF-beta-dependent induction of EMT via MAPK ,47,6.50E-05,4.74E-04,6.50E-05,4.74E-04,14,"TGF-beta 2, ITGB1, PTEN, TGF-beta 3, ITGB3, TGF-beta receptor type II, ERK1/2, MMP-2, TGF-beta, SNAIL1, SOS, Fibronectin, Vimentin, Claudin-1",2.61E-03,1.40E-02,11,"TGF-beta 2, ITGB1, TGF-beta 3, ITGB3, TGF-beta receptor type II, MMP-2, TGF-beta, SOS, Fibronectin, Vimentin, Claudin-1"
202,Development_EGFR signaling pathway,71,6.75E-05,4.90E-04,6.75E-05,4.90E-04,18,"STAT3, PI3K cat class IA, Amphiregulin, PKC-theta, PKC-alpha, Epiregulin, EGFR, ERK1/2, MMP-2, MKP-2, TGF-alpha, SOS, NF-kB, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), MMP-9",1.04E-02,4.02E-02,13,"PI3K cat class IA, Amphiregulin, PKC-theta, PKC-alpha, Epiregulin, EGFR, MMP-2, MKP-2, TGF-alpha, SOS, NF-kB, AKT(PKB), MMP-9"
203,Androstenedione and testosterone biosynthesis and metabolism p.2,32,6.81E-05,6.33E-04,9.32E-05,6.33E-04,11,"UGT2B28, AKR1C3, UGT1A1, AKR1C4, UGT1A10, UGT2B15, AKR1C1, AKR1C2, UGT1A8, UGT2B17, UGT1A4",6.81E-05,9.38E-04,11,"UGT2B28, AKR1C3, UGT1A1, AKR1C4, UGT1A10, UGT2B15, AKR1C1, AKR1C2, UGT1A8, UGT2B17, UGT1A4"
204,Macrophage-induced immunosuppression in the tumor microenvironment,97,6.95E-05,5.00E-04,6.95E-05,5.00E-04,22,"STAT3, COX-2 (PTGS2), S1P1 receptor, IDO1, TIE2, CCL20, PD-L2, Adenosine A2b receptor, CD44, CCL2, MSR1, IL-34, CCR8, ERK1/2, IL-6, 5'-NTD, CD94, ALOX15B, HLA-G, CSF1, CAT-2, PD-L1",3.58E-04,3.33E-03,20,"COX-2 (PTGS2), S1P1 receptor, IDO1, TIE2, CCL20, PD-L2, Adenosine A2b receptor, CD44, CCL2, MSR1, IL-34, CCR8, IL-6, 5'-NTD, CD94, ALOX15B, HLA-G, CSF1, CAT-2, PD-L1"
205,Inhibition of apoptosis in pancreatic cancer,59,7.08E-05,5.04E-04,7.08E-05,5.04E-04,16,"BAD, STAT3, COX-2 (PTGS2), PI3K cat class IA, RelA (p65 NF-kB subunit), PKR2, PTEN, EGFR, G-protein alpha-i family, Neuropilin-1, Bcl-2, ALOX5, ERK1/2, IL-6, AKT(PKB), p53",1.55E-02,5.26E-02,11,"COX-2 (PTGS2), PI3K cat class IA, RelA (p65 NF-kB subunit), PKR2, EGFR, G-protein alpha-i family, Neuropilin-1, Bcl-2, ALOX5, IL-6, AKT(PKB)"
206,Inhibition of apoptosis in gastric cancer,42,7.59E-05,5.38E-04,7.59E-05,5.38E-04,13,"BAD, HGF, c-IAP2, Caspase-10, RUNX3, c-IAP1, TGF-beta receptor type II, Bcl-2, NF-kB, AKT(PKB), Caspase-8, HGF receptor (Met), XAF1",9.73E-04,6.42E-03,11,"HGF, c-IAP2, Caspase-10, RUNX3, c-IAP1, TGF-beta receptor type II, Bcl-2, NF-kB, AKT(PKB), HGF receptor (Met), XAF1"
207,Development_Role of proteases in hematopoietic stem cell mobilization,18,8.35E-05,6.97E-04,1.07E-04,6.97E-04,8,"alpha-4/beta-1 integrin, CD44, MMP-14, MMP-2, alpha-5/beta-1 integrin, DPP4, Fibronectin, MMP-9",8.35E-05,1.11E-03,8,"alpha-4/beta-1 integrin, CD44, MMP-14, MMP-2, alpha-5/beta-1 integrin, DPP4, Fibronectin, MMP-9"
208,Immune response_C3a signaling,48,8.39E-05,5.89E-04,8.39E-05,5.89E-04,14,"IL-1 beta, NGF, MHC class II, RelA (p65 NF-kB subunit), CCL2, IL-8, G-protein alpha-i family, Adenylate cyclase, ERK1/2, IL-6, AKT(PKB), C3a, PI3K reg class IB (p101), IP3 receptor",2.41E-04,2.48E-03,13,"IL-1 beta, NGF, MHC class II, RelA (p65 NF-kB subunit), CCL2, IL-8, G-protein alpha-i family, Adenylate cyclase, IL-6, AKT(PKB), C3a, PI3K reg class IB (p101), IP3 receptor"
209,Cell adhesion_Integrin-mediated cell adhesion and migration,48,8.39E-05,5.89E-04,8.39E-05,5.89E-04,14,"alpha-11/beta-1 integrin, MRLC, ERK1/2, alpha-5/beta-1 integrin, Actin cytoskeletal, alpha-1/beta-1 integrin, Collagen II, ERK2 (MAPK1), Collagen IV, MELC, Fibronectin, MyHC, MYLK1, MLCK",9.56E-03,3.74E-02,10,"alpha-11/beta-1 integrin, MRLC, alpha-5/beta-1 integrin, alpha-1/beta-1 integrin, Collagen II, Collagen IV, MELC, Fibronectin, MYLK1, MLCK"
210,Development_Beta-adrenergic receptors transactivation of EGFR,37,8.60E-05,5.95E-04,8.60E-05,5.95E-04,12,"Tuberin, PI3K cat class IA, ADAM12, CD44, EGFR, G-protein alpha-i family, ERK1/2, SOS, Beta-2 adrenergic receptor, ERK2 (MAPK1), MYLK1, ERK1 (MAPK3)",1.57E-02,5.27E-02,8,"PI3K cat class IA, ADAM12, CD44, EGFR, G-protein alpha-i family, SOS, Beta-2 adrenergic receptor, MYLK1"
211,TLR and EGFR-induced inflammatory signaling in normal and asthmatic airway epithelium,22,8.60E-05,5.95E-04,8.60E-05,5.95E-04,9,"IL-8, TLR6, EGFR, ERK1/2, TGF-alpha, DUOX1, TLR3, MMP-9, TLR2",4.39E-04,3.91E-03,8,"IL-8, TLR6, EGFR, TGF-alpha, DUOX1, TLR3, MMP-9, TLR2"
212,Origin of Langerhans cells in the steady-state and under inflammatory conditions,22,8.60E-05,5.95E-04,8.60E-05,5.95E-04,9,"IL-1 beta, CXCL14, CCL20, RUNX3, CCL2, IL-34, TGF-beta receptor type II, SMAD3, CSF1",4.39E-04,3.91E-03,8,"IL-1 beta, CXCL14, CCL20, RUNX3, CCL2, IL-34, TGF-beta receptor type II, CSF1"
213,IGF family signaling in colorectal cancer,60,8.83E-05,6.08E-04,8.83E-05,6.08E-04,16,"COX-2 (PTGS2), RelA (p65 NF-kB subunit), PTEN, IRS-2, IL-8, ERK1/2, Clusterin, Beta-catenin, SOS, NF-kB, ERK2 (MAPK1), AKT(PKB), ERK1 (MAPK3), IBP, C/EBPalpha, IBP3",1.75E-02,5.79E-02,11,"COX-2 (PTGS2), RelA (p65 NF-kB subunit), IRS-2, IL-8, Clusterin, SOS, NF-kB, AKT(PKB), IBP, C/EBPalpha, IBP3"
214,"Development_Role of Ceramide 1-phosphate, Sphingosine 1-phosphate and Complement cascade in hematopoietic stem cell homing",32,9.32E-05,6.33E-04,9.32E-05,6.33E-04,11,"COX-2 (PTGS2), PGE2R2, PGE2R4, S1P1 receptor, alpha-4/beta-1 integrin, ERK1/2, iC3b, AKT(PKB), PGE2R3, C3a, MMP-9",3.55E-04,3.32E-03,10,"COX-2 (PTGS2), PGE2R2, PGE2R4, S1P1 receptor, alpha-4/beta-1 integrin, iC3b, AKT(PKB), PGE2R3, C3a, MMP-9"
215,Upregulation of IL-8 expression in colorectal cancer,32,9.32E-05,6.33E-04,9.32E-05,6.33E-04,11,"IL-1 beta, RelA (p65 NF-kB subunit), IL-8, WNT, TGF-beta receptor type II, NT, TCF7L2 (TCF4), Beta-catenin, SNAIL1, Frizzled, WNT6",1.62E-03,9.73E-03,9,"IL-1 beta, RelA (p65 NF-kB subunit), IL-8, WNT, TGF-beta receptor type II, NT, TCF7L2 (TCF4), Frizzled, WNT6"
216,"Chemotaxis_CCL16-, CCL20-, CXCL16- and CCL25-mediated cell migration",43,9.96E-05,6.67E-04,9.96E-05,6.67E-04,13,"CCL20, MMP-13, CCR8, G-protein alpha-i family, MMP-2, MMP-8, CCR5, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), MMP-9, MLCK, IP3 receptor",3.06E-04,2.94E-03,12,"CCL20, MMP-13, CCR8, G-protein alpha-i family, MMP-2, MMP-8, CCR5, AKT(PKB), PI3K reg class IB (p101), MMP-9, MLCK, IP3 receptor"
217,"NF-kB-, AP-1- and MAPKs-mediated proinflammatory cytokine production by eosinophils in asthma",43,9.96E-05,6.67E-04,9.96E-05,6.67E-04,13,"IL-1 beta, ST2(L), GRO-1, CCL2, IL-8, IL-33, ERK1/2, ENA-78, IL-6, NF-kB, ERK2 (MAPK1), Tryptase, PRG2",1.20E-03,7.56E-03,11,"IL-1 beta, ST2(L), GRO-1, CCL2, IL-8, IL-33, ENA-78, IL-6, NF-kB, Tryptase, PRG2"
218,Immune response_Substance P-stimulated expression of proinflammatory cytokines via MAPKs,43,9.96E-05,6.67E-04,9.96E-05,6.67E-04,13,"COX-2 (PTGS2), GRO-2, PKC-theta, CCL13, CCL2, PKC-alpha, IL-8, ERK1/2, IL-6, AKT(PKB), PDK (PDPK1), GRO-3, IP3 receptor",1.20E-03,7.56E-03,11,"COX-2 (PTGS2), GRO-2, PKC-theta, CCL13, CCL2, PKC-alpha, IL-8, IL-6, AKT(PKB), GRO-3, IP3 receptor"
219,Putative pathways of activation of classical complement system in major depressive disorder,28,1.01E-04,8.34E-04,1.35E-04,8.34E-04,10,"IL-1 beta, C6, C3, C4B protein, C3b, C4b, IL-6, C7, C4A protein, C4",1.01E-04,1.26E-03,10,"IL-1 beta, C6, C3, C4B protein, C3b, C4b, IL-6, C7, C4A protein, C4"
220,Role of neuropeptides in pathogenesis of SCLC,67,1.06E-04,6.97E-04,1.06E-04,6.97E-04,17,"GRP-R, cPKC (conventional), PKC, Neprilysin, PKC-alpha, EGFR, NT, ERK1/2, ErbB3, BDKRB1, Fyn, BDKRB2, SOS, AKT(PKB), G-protein alpha-q/11, Neuromedin B, IP3 receptor",7.74E-04,5.69E-03,15,"GRP-R, cPKC (conventional), PKC, Neprilysin, PKC-alpha, EGFR, NT, BDKRB1, Fyn, BDKRB2, SOS, AKT(PKB), G-protein alpha-q/11, Neuromedin B, IP3 receptor"
221,Development_Growth factors in regulation of oligodendrocyte progenitor cell proliferation,67,1.06E-04,6.97E-04,1.06E-04,6.97E-04,17,"HGF, NGF, Myelin basic protein, PI3K cat class IA, PKC, Neuregulin 1, Lyn, EGFR, ERK1/2, Fyn, FGF2, SOS, PDGF-R-alpha, AKT(PKB), PDK (PDPK1), HGF receptor (Met), Fibronectin",7.74E-04,5.69E-03,15,"HGF, NGF, Myelin basic protein, PI3K cat class IA, PKC, Neuregulin 1, Lyn, EGFR, Fyn, FGF2, SOS, PDGF-R-alpha, AKT(PKB), HGF receptor (Met), Fibronectin"
222,Glucocorticoids-mediated inhibition of pro-constrictory and pro-inflammatory signaling in airway smooth muscle cells,49,1.08E-04,6.97E-04,1.08E-04,6.97E-04,14,"COX-2 (PTGS2), IL-1 beta, RelA (p65 NF-kB subunit), GRO-1, CD38, MRLC, ERK1/2, IL-6, Myosin II, PA24A, Beta-2 adrenergic receptor, NF-kB, CPI-17, PLA2",1.11E-03,7.05E-03,12,"COX-2 (PTGS2), IL-1 beta, RelA (p65 NF-kB subunit), GRO-1, CD38, MRLC, IL-6, PA24A, Beta-2 adrenergic receptor, NF-kB, CPI-17, PLA2"
223,Mechanisms of drug resistance in multiple myeloma,49,1.08E-04,6.97E-04,1.08E-04,6.97E-04,14,"BAD, STAT3, CD44, IL-8, TCF7L2 (TCF4), Bcl-2, ERK1/2, IL-6, Beta-catenin, NOXA, IL8RA, Jagged1, Frizzled, MDR1",1.11E-02,4.21E-02,10,"CD44, IL-8, TCF7L2 (TCF4), Bcl-2, IL-6, NOXA, IL8RA, Jagged1, Frizzled, MDR1"
224,Th17 cells in CF (mouse model),49,1.08E-04,6.97E-04,1.08E-04,6.97E-04,14,"STAT3, IL-1 beta, MHC class II, GRO-1, CD14, GCP2, ICAM1, ROR-gamma, TGF-beta receptor type II, TLR4, MD-2, IL-6, NF-kB, SMAD3",1.11E-03,7.05E-03,12,"IL-1 beta, MHC class II, GRO-1, CD14, GCP2, ICAM1, ROR-gamma, TGF-beta receptor type II, TLR4, MD-2, IL-6, NF-kB"
225,Role and regulation of Prostaglandin E2 in gastric cancer,49,1.08E-04,6.97E-04,1.08E-04,6.97E-04,14,"COX-2 (PTGS2), PGE2R2, IL-1 beta, PGE2R4, CCL2, IL-8, EGFR, Adenylate cyclase, ERK1/2, PLAUR (uPAR), SOS, Jagged1, PLAU (UPA), TLR2",3.01E-04,2.93E-03,13,"COX-2 (PTGS2), PGE2R2, IL-1 beta, PGE2R4, CCL2, IL-8, EGFR, Adenylate cyclase, PLAUR (uPAR), SOS, Jagged1, PLAU (UPA), TLR2"
226,Development_c-Kit ligand signaling pathway during hemopoiesis,61,1.09E-04,7.07E-04,1.09E-04,7.07E-04,16,"BAD, STAT3, PI3K cat class IA, PLGF, PKC-alpha, Lyn, SLUG, ERK1/2, Fyn, SOS, AKT(PKB), PDK (PDPK1), GRAP2, p27KIP1, MMP-9, IP3 receptor",1.96E-02,6.28E-02,11,"PI3K cat class IA, PLGF, PKC-alpha, Lyn, SLUG, Fyn, SOS, AKT(PKB), GRAP2, MMP-9, IP3 receptor"
227,PGE2 pathways in cancer,55,1.10E-04,7.07E-04,1.10E-04,7.07E-04,15,"COX-2 (PTGS2), PGE2R2, PGE2R4, Amphiregulin, Tcf(Lef), EGFR, G-protein alpha-i family, Adenylate cyclase, TCF7L2 (TCF4), Beta-catenin, TGF-alpha, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",9.21E-03,3.66E-02,11,"COX-2 (PTGS2), PGE2R2, PGE2R4, Amphiregulin, Tcf(Lef), EGFR, G-protein alpha-i family, Adenylate cyclase, TCF7L2 (TCF4), TGF-alpha, AKT(PKB)"
228,Proteases and EGFR-induced mucin synthesis in normal and asthmatic epithelium,55,1.10E-04,7.07E-04,1.10E-04,7.07E-04,15,"Amphiregulin, ICAM1, CD44, PKC-alpha, Mucin 2, EGFR, Mucin 5AC, ERK1/2, Mucin 5B, TGF-alpha, NF-kB, G-protein alpha-q/11, DUOX1, Kallikrein 1, IP3 receptor",2.86E-04,2.88E-03,14,"Amphiregulin, ICAM1, CD44, PKC-alpha, Mucin 2, EGFR, Mucin 5AC, Mucin 5B, TGF-alpha, NF-kB, G-protein alpha-q/11, DUOX1, Kallikrein 1, IP3 receptor"
229,G-protein signaling_Regulation of Cyclic AMP levels by ACM,45,1.18E-04,9.84E-04,1.67E-04,9.84E-04,13,"PDE1C, Adenylate cyclase type V, Adenylate cyclase type II, PKC-alpha, G-protein alpha-i family, ACM4, PDE1A, Adenylate cyclase type IV, G-protein alpha-q/11, PDE1B, IP3 receptor, ACM3, Adenylate cyclase type VII",1.18E-04,1.45E-03,13,"PDE1C, Adenylate cyclase type V, Adenylate cyclase type II, PKC-alpha, G-protein alpha-i family, ACM4, PDE1A, Adenylate cyclase type IV, G-protein alpha-q/11, PDE1B, IP3 receptor, ACM3, Adenylate cyclase type VII"
230,"IGF family, invasion and metastasis in colorectal cancer",33,1.28E-04,8.13E-04,1.28E-04,8.13E-04,11,"ITGB1, PI3K cat class IA, PLAT (TPA), Beta-catenin, PLAUR (uPAR), alpha-1/beta-1 integrin, Collagen IV, IBP6, Fibronectin, ERK1 (MAPK3), PLAU (UPA)",2.05E-03,1.15E-02,9,"ITGB1, PI3K cat class IA, PLAT (TPA), PLAUR (uPAR), alpha-1/beta-1 integrin, Collagen IV, IBP6, Fibronectin, PLAU (UPA)"
231,Immune response_TLR3 and TLR4 induced TICAM1-specific signaling pathway,33,1.28E-04,8.13E-04,1.28E-04,8.13E-04,11,"PI3K cat class IA, CD14, TLR4, Beclin 1, MD-2, TIRAP (Mal), NF-kB, AKT(PKB), PDK (PDPK1), TLR3, IFN-beta",2.05E-03,1.15E-02,9,"PI3K cat class IA, CD14, TLR4, MD-2, TIRAP (Mal), NF-kB, AKT(PKB), TLR3, IFN-beta"
232,Signal transduction_mTORC2 downstream signaling,68,1.29E-04,8.13E-04,1.29E-04,8.13E-04,17,"BAD, Tuberin, SLC12A1, cPKC (conventional), IL7RA, PKC, PKC-alpha, IMP1(ZBP1), TLR4, F-Actin cytoskeleton, Beta-catenin, SGK1, AKT(PKB), p53, FASN, p27KIP1, PREX1",8.40E-02,1.77E-01,10,"SLC12A1, cPKC (conventional), IL7RA, PKC, PKC-alpha, IMP1(ZBP1), TLR4, SGK1, AKT(PKB), PREX1"
233,Role of CD8+ Tc1 cells in COPD,44,1.29E-04,8.14E-04,1.29E-04,8.14E-04,13,"STAT3, IL-15, IL-18R1, IP10, STAT4, CCL2, CX3CR1, Bcl-2, MMP-12, CCR5, NF-kB, Cathepsin S, MMP-9",3.87E-04,3.50E-03,12,"IL-15, IL-18R1, IP10, STAT4, CCL2, CX3CR1, Bcl-2, MMP-12, CCR5, NF-kB, Cathepsin S, MMP-9"
234,Rho-dependent regulation of normal and asthmatic smooth muscle contraction,28,1.35E-04,8.34E-04,1.35E-04,8.34E-04,10,"Histamine H1 receptor, PKC, LPAR1, G-protein alpha-i family, MRLC, Myosin II, CPI-17, G-protein alpha-q/11, EDNRA, ACM3",5.54E-04,4.43E-03,9,"Histamine H1 receptor, PKC, LPAR1, G-protein alpha-i family, MRLC, CPI-17, G-protein alpha-q/11, EDNRA, ACM3"
235,Regulation of Beta-catenin activity  in melanoma,28,1.35E-04,8.34E-04,1.35E-04,8.34E-04,10,"IMP1(ZBP1), N-Ras, Bcl-2, MMP-2, Beta-catenin, AKT(PKB), alpha-MSH, p16INK4, NRCAM, MMP-9",2.62E-03,1.40E-02,8,"IMP1(ZBP1), Bcl-2, MMP-2, AKT(PKB), alpha-MSH, p16INK4, NRCAM, MMP-9"
236,"Immune response_IL-4-induced regulators of cell growth, survival, differentiation and metabolism",62,1.35E-04,8.34E-04,1.35E-04,8.34E-04,16,"STAT3, GATA-3, EGR2 (Krox20), CISH, MMP-13, ATP6V0D2, DHA2, Cyclin E, Bcl-2, Osteoprotegerin, AKT(PKB), p27KIP1, Cathepsin V, ACADL, GFI-1, CDK6",1.05E-03,6.77E-03,14,"GATA-3, EGR2 (Krox20), CISH, MMP-13, ATP6V0D2, DHA2, Cyclin E, Bcl-2, Osteoprotegerin, AKT(PKB), Cathepsin V, ACADL, GFI-1, CDK6"
237,"Cigarette smoke-induced proliferation, metaplasia and survival of airway epithelial cells ",50,1.37E-04,8.34E-04,1.37E-04,8.34E-04,14,"PCNA, nAChR alpha-7, PI3K cat class IA, Amphiregulin, Keratin 14, Fra-1, EGFR, ERK1/2, nAChR alpha-4, MMP-2, Keratin 5, ErbB3, PDK (PDPK1), MMP-9",1.27E-02,4.65E-02,10,"nAChR alpha-7, PI3K cat class IA, Amphiregulin, Keratin 14, Fra-1, EGFR, nAChR alpha-4, MMP-2, Keratin 5, MMP-9"
238,Angiogenesis in HCC,50,1.37E-04,8.34E-04,1.37E-04,8.34E-04,14,"STAT3, COX-2 (PTGS2), TIE2, Heparanase 1, CCL2, IL-8, TGF-beta receptor type II, EGFR, MMP-2, Angiopoietin 1, FGF2, NF-kB, Ephrin-B receptors, MMP-9",3.73E-04,3.43E-03,13,"COX-2 (PTGS2), TIE2, Heparanase 1, CCL2, IL-8, TGF-beta receptor type II, EGFR, MMP-2, Angiopoietin 1, FGF2, NF-kB, Ephrin-B receptors, MMP-9"
239,IGF-1 signaling in multiple myeloma,50,1.37E-04,8.34E-04,1.37E-04,8.34E-04,14,"BAD, ITGB1, c-IAP2, PI3K cat class IA, PTEN, IRS-2, ERK1/2, SOS, NF-kB, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), Fibronectin, ERK1 (MAPK3)",7.81E-02,1.69E-01,8,"ITGB1, c-IAP2, PI3K cat class IA, IRS-2, SOS, NF-kB, AKT(PKB), Fibronectin"
240,Mitogenic action of ErbB2 in breast cancer,56,1.38E-04,8.38E-04,1.38E-04,8.38E-04,15,"Tuberin, PI3K cat class IA, Neuregulin 1, Cyclin E, EGFR, TCF7L2 (TCF4), ERK1/2, ErbB3, Beta-catenin, SOS, NF-kB, AKT(PKB), PDK (PDPK1), ER81, p27KIP1",6.25E-02,1.43E-01,9,"PI3K cat class IA, Neuregulin 1, Cyclin E, EGFR, TCF7L2 (TCF4), SOS, NF-kB, AKT(PKB), ER81"
241,Development_ERBB-family signaling,39,1.52E-04,9.18E-04,1.52E-04,9.18E-04,12,"PI3K cat class IA, Amphiregulin, Neuregulin 3, Neuregulin 1, Epiregulin, EGFR, ERK1/2, ErbB3, TGF-alpha, SOS, NF-kB, AKT(PKB)",1.95E-03,1.11E-02,10,"PI3K cat class IA, Amphiregulin, Neuregulin 3, Neuregulin 1, Epiregulin, EGFR, TGF-alpha, SOS, NF-kB, AKT(PKB)"
242,Cell adhesion_PLAU signaling,39,1.52E-04,9.18E-04,1.52E-04,9.18E-04,12,"HGF, PI3K cat class IA, SERPINE2, PLAT (TPA), EGFR, ERK1/2, PAI2, PLAUR (uPAR), SOS, AKT(PKB), HGF receptor (Met), PLAU (UPA)",4.90E-04,4.06E-03,11,"HGF, PI3K cat class IA, SERPINE2, PLAT (TPA), EGFR, PAI2, PLAUR (uPAR), SOS, AKT(PKB), HGF receptor (Met), PLAU (UPA)"
243,Calcium-dependent regulation of normal and asthmatic smooth muscle contraction,69,1.56E-04,9.37E-04,1.56E-04,9.37E-04,17,"Histamine H1 receptor, TRPC4, EDNRB, TRPC3, CD38, NCX1, G-protein alpha-i family, MRLC, Myosin II, BDKRB2, TRPC6, Tryptase, MYLK1, MLCK, EDNRA, IP3 receptor, ACM3",3.44E-04,3.26E-03,16,"Histamine H1 receptor, TRPC4, EDNRB, TRPC3, CD38, NCX1, G-protein alpha-i family, MRLC, BDKRB2, TRPC6, Tryptase, MYLK1, MLCK, EDNRA, IP3 receptor, ACM3"
244,Regulation of relaxation of airway smooth muscle cells,45,1.67E-04,9.84E-04,1.67E-04,9.84E-04,13,"PGE2R2, PGE2R4, Adenylate cyclase type II, PGD2R, PACAP, F-Actin cytoskeleton, VIP receptor 1, VIP receptor 2, Adenylate cyclase type IV, Beta-2 adrenergic receptor, PGE2R3, MLCK, IP3 receptor",4.84E-04,4.06E-03,12,"PGE2R2, PGE2R4, Adenylate cyclase type II, PGD2R, PACAP, VIP receptor 1, VIP receptor 2, Adenylate cyclase type IV, Beta-2 adrenergic receptor, PGE2R3, MLCK, IP3 receptor"
245,Role of alpha-6/beta-4 integrins in carcinoma progression,45,1.67E-04,9.84E-04,1.67E-04,9.84E-04,13,"HGF, Laminin 5, PI3K cat class IA, IRS-2, PKC-alpha, Neuregulin 1, EGFR, ErbB3, Actin cytoskeletal, AKT(PKB), PDK (PDPK1), HGF receptor (Met), IP3 receptor",5.97E-03,2.61E-02,10,"HGF, Laminin 5, PI3K cat class IA, IRS-2, PKC-alpha, Neuregulin 1, EGFR, AKT(PKB), HGF receptor (Met), IP3 receptor"
246,Role of cell adhesion molecules in progression of pancreatic cancer,45,1.67E-04,9.84E-04,1.67E-04,9.84E-04,13,"IL-1 beta, ITGB1, iNOS, NCAM1, Tcf(Lef), ERK1/2, Beta-catenin, alpha-5/beta-1 integrin, SOS, Collagen IV, ITGA5, Fibronectin, SIAT8B",1.80E-03,1.06E-02,11,"IL-1 beta, ITGB1, iNOS, NCAM1, Tcf(Lef), alpha-5/beta-1 integrin, SOS, Collagen IV, ITGA5, Fibronectin, SIAT8B"
247,Cell adhesion_Plasmin signaling,35,1.71E-04,1.27E-03,2.32E-04,1.27E-03,11,"TGF-beta 2, PI3K cat class IA, MMP-13, TFPI-2, PLAT (TPA), C1 inhibitor, TGF-beta receptor type II, FGF2, Collagen IV, Fibronectin, PLAU (UPA)",1.71E-04,1.94E-03,11,"TGF-beta 2, PI3K cat class IA, MMP-13, TFPI-2, PLAT (TPA), C1 inhibitor, TGF-beta receptor type II, FGF2, Collagen IV, Fibronectin, PLAU (UPA)"
248,Apoptotic pathways and resistance to apoptosis in lung cancer cells,57,1.71E-04,9.97E-04,1.71E-04,9.97E-04,15,"BAD, c-IAP2, Caspase-10, PKC-alpha, microRNA 221, c-IAP1, Bcl-2, miR-221-3p, ERK1/2, FGF2, NF-kB, Caspase-1, Caspase-8, p53, p27KIP1",3.03E-02,8.54E-02,10,"c-IAP2, Caspase-10, PKC-alpha, microRNA 221, c-IAP1, Bcl-2, miR-221-3p, FGF2, NF-kB, Caspase-1"
249,Inflammatory factors-induced expression of mucins in normal and asthmatic epithelium,51,1.72E-04,9.97E-04,1.72E-04,9.97E-04,14,"COX-2 (PTGS2), CLCA1, Histamine H1 receptor, IL-1 beta, Mucin 2, IL-8, Mucin 5AC, ALOX5, ERK1/2, Mucin 5B, IL-6, SOS, IL8RA, C3a",4.60E-04,4.02E-03,13,"COX-2 (PTGS2), CLCA1, Histamine H1 receptor, IL-1 beta, Mucin 2, IL-8, Mucin 5AC, ALOX5, Mucin 5B, IL-6, SOS, IL8RA, C3a"
250,Immune response_Histamine signaling in dendritic cells,51,1.72E-04,9.97E-04,1.72E-04,9.97E-04,14,"Histamine H1 receptor, IL-1 beta, RelA (p65 NF-kB subunit), CCL2, PKC-alpha, IL-8, G-protein alpha-i family, Adenylate cyclase, IL-6, ERK2 (MAPK1), G-protein alpha-q/11, Histamine H3 receptor, ERK1 (MAPK3), IP3 receptor",1.61E-03,9.73E-03,12,"Histamine H1 receptor, IL-1 beta, RelA (p65 NF-kB subunit), CCL2, PKC-alpha, IL-8, G-protein alpha-i family, Adenylate cyclase, IL-6, G-protein alpha-q/11, Histamine H3 receptor, IP3 receptor"
251,IL-6 signaling in multiple myeloma,51,1.72E-04,9.97E-04,1.72E-04,9.97E-04,14,"BAD, STAT3, PI3K cat class IA, Lyn, N-Ras, ERK1/2, IL-6, FGF2, SOS, AKT(PKB), p53, PDK (PDPK1), p27KIP1, CDK6",1.74E-01,3.02E-01,7,"PI3K cat class IA, Lyn, IL-6, FGF2, SOS, AKT(PKB), CDK6"
252,Some pathways of EMT in cancer cells,51,1.72E-04,9.97E-04,1.72E-04,9.97E-04,14,"STAT3, Tuberin, PI3K cat class IA, RelA (p65 NF-kB subunit), EGFR, Bcl-2, Beta-catenin, SNAIL1, SOS, PDGF-R-alpha, AKT(PKB), PDGF receptor, EDNRA, PDGF-R-beta",1.46E-02,5.06E-02,10,"PI3K cat class IA, RelA (p65 NF-kB subunit), EGFR, Bcl-2, SOS, PDGF-R-alpha, AKT(PKB), PDGF receptor, EDNRA, PDGF-R-beta"
253,Development_FGF2 signaling during embryonic stem cell differentiation,34,1.74E-04,9.97E-04,1.74E-04,9.97E-04,11,"NCAM1, PTCH1, Activin A, SOX2, ERK1/2, Nestin, FGF2, SOS, SPRY2, PAX6, SOX3",6.11E-04,4.75E-03,10,"NCAM1, PTCH1, Activin A, SOX2, Nestin, FGF2, SOS, SPRY2, PAX6, SOX3"
254,Nicotine / Beta-adrenergic signaling in lung cancer,34,1.74E-04,9.97E-04,1.74E-04,9.97E-04,11,"BAD, PKC-alpha, G-protein alpha-i family, Adenylate cyclase, ERK1/2, SOS, Beta-2 adrenergic receptor, AKT(PKB), PDK (PDPK1), Beta-adrenergic receptor, PI3K reg class IB (p101)",9.41E-03,3.71E-02,8,"PKC-alpha, G-protein alpha-i family, Adenylate cyclase, SOS, Beta-2 adrenergic receptor, AKT(PKB), Beta-adrenergic receptor, PI3K reg class IB (p101)"
255,Immune response_Induction of the antigen presentation machinery by IFN-gamma,53,1.87E-04,1.43E-03,2.68E-04,1.43E-03,14,"TAP1 (PSF1), HLA-DRB1, MHC class II, PSMB8(LMP7), HLA-B, NLRC5, HLA-A, TAP2 (PSF2), CIITA, PSMB9, HLA-F, HLA-DRA1, HLA-DMB, Cathepsin S",1.87E-04,2.08E-03,14,"TAP1 (PSF1), HLA-DRB1, MHC class II, PSMB8(LMP7), HLA-B, NLRC5, HLA-A, TAP2 (PSF2), CIITA, PSMB9, HLA-F, HLA-DRA1, HLA-DMB, Cathepsin S"
256,Pro-oncogenic action of PTHrP in breast cancer,29,1.89E-04,1.08E-03,1.89E-04,1.08E-03,10,"ITGB1, MMP-13, PKC-alpha, Bcl-2, ERK1/2, PTHR1, PTHrP, G-protein alpha-q/11, ITGA5, IP3 receptor",7.40E-04,5.54E-03,9,"ITGB1, MMP-13, PKC-alpha, Bcl-2, PTHR1, PTHrP, G-protein alpha-q/11, ITGA5, IP3 receptor"
257,Hedgehog signaling in breast cancer,24,1.90E-04,1.08E-03,1.90E-04,1.08E-03,9,"PTCH1, Cyclin E, MMP-2, PTHrP, GLI-1, p53, MMP-9, MDR1, GLI-2",8.58E-04,6.05E-03,8,"PTCH1, Cyclin E, MMP-2, PTHrP, GLI-1, MMP-9, MDR1, GLI-2"
258,Development_Dopamine D2 receptor transactivation of EGFR,24,1.90E-04,1.08E-03,1.90E-04,1.08E-03,9,"PI3K cat class IA, ADAM12, EGFR, G-protein alpha-i family, SOS, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3)",1.75E-02,5.79E-02,6,"PI3K cat class IA, ADAM12, EGFR, G-protein alpha-i family, SOS, AKT(PKB)"
259,Development_Schema: SMAD-dependent TGF-beta family signaling in embryonic stem cells,24,1.90E-04,1.08E-03,1.90E-04,1.08E-03,9,"MSX-2, Activin A, Oct-3/4, SOX2, Gremlin, BMP4, FGF2, SMAD3, BMP2",8.58E-04,6.05E-03,8,"MSX-2, Activin A, Oct-3/4, SOX2, Gremlin, BMP4, FGF2, BMP2"
260,Development_Schema: FGF signaling in embryonic stem cell self-renewal and differentiation,47,1.91E-04,1.43E-03,2.69E-04,1.43E-03,13,"NCAM1, PTCH1, Activin A, SOX2, Gremlin, BMP4, Mixl1, WNT3, Nestin, FGF2, SPRY2, BMP2, PAX6",1.91E-04,2.09E-03,13,"NCAM1, PTCH1, Activin A, SOX2, Gremlin, BMP4, Mixl1, WNT3, Nestin, FGF2, SPRY2, BMP2, PAX6"
261,Development_H3K27 demethylases in differentiation of stem cells,40,1.99E-04,1.12E-03,1.99E-04,1.12E-03,12,"RelA (p65 NF-kB subunit), BMP4, Nestin, HOXA1, HOXA7, HOXA3, SMAD3, DLX5, HOXB1, HOXA11, BMP2, PAX6",6.22E-04,4.76E-03,11,"RelA (p65 NF-kB subunit), BMP4, Nestin, HOXA1, HOXA7, HOXA3, DLX5, HOXB1, HOXA11, BMP2, PAX6"
262,CHDI_Correlations from Replication data_Causal network (negative correlations),40,1.99E-04,1.12E-03,1.99E-04,1.12E-03,12,"PKC, WNT, TCF7L2 (TCF4), Beta-catenin, PLAUR (uPAR), AKT(PKB), Collagen IV, Fibronectin, Dsh, PLAU (UPA), Frizzled, ACM3",2.40E-03,1.31E-02,10,"PKC, WNT, TCF7L2 (TCF4), PLAUR (uPAR), AKT(PKB), Collagen IV, Fibronectin, PLAU (UPA), Frizzled, ACM3"
263,CHDI_Correlations from Replication data_Cytoskeleton and adhesion module,64,2.02E-04,1.13E-03,2.02E-04,1.13E-03,16,"MHC class II, ITGB2, ICAM1, MRLC, PLAUR (uPAR), Actin cytoskeletal, Fyn, AKT(PKB), Collagen IV, MELC, Fibronectin, MyHC, PI3K reg class IB (p101), Ephrin-B receptors, PLAU (UPA), IP3 receptor",1.46E-03,9.03E-03,14,"MHC class II, ITGB2, ICAM1, MRLC, PLAUR (uPAR), Fyn, AKT(PKB), Collagen IV, MELC, Fibronectin, PI3K reg class IB (p101), Ephrin-B receptors, PLAU (UPA), IP3 receptor"
264,Immune response _CCR3 signaling in eosinophils,77,2.07E-04,1.15E-03,2.07E-04,1.15E-03,18,"iNOS, CCL13, Eotaxin-2, PKC-alpha, cPLA2, G-protein alpha-i family, MRLC, Myosin II, Actin cytoskeletal, Rac2, ERK2 (MAPK1), MELC, PDK (PDPK1), MyHC, PI3K reg class IB (p101), MLCK, IP3 receptor, CCL7",1.99E-02,6.29E-02,13,"iNOS, CCL13, Eotaxin-2, PKC-alpha, cPLA2, G-protein alpha-i family, MRLC, Rac2, MELC, PI3K reg class IB (p101), MLCK, IP3 receptor, CCL7"
265,Immune response_IFN-alpha/beta signaling via MAPKs,77,2.07E-04,1.15E-03,2.07E-04,1.15E-03,18,"TAP1 (PSF1), Lck, PKC-theta, IP10, ISG15, ISG54, TCF7L2 (TCF4), RIG-G, ERK1/2, Beta-catenin, Matrilysin (MMP-7), RSAD2, SMAD3, AKT(PKB), p27KIP1, FZD7, IFN-beta, PL scramblase 1",1.99E-02,6.29E-02,13,"TAP1 (PSF1), PKC-theta, IP10, ISG15, ISG54, TCF7L2 (TCF4), RIG-G, Matrilysin (MMP-7), RSAD2, AKT(PKB), FZD7, IFN-beta, PL scramblase 1"
266,Signal transduction_Leptin signaling in non-neuronal cells,58,2.11E-04,1.17E-03,2.11E-04,1.17E-03,15,"NMDA receptor, STAT3, PI3K cat class IA, TRPC4, RelA (p65 NF-kB subunit), SUR1, PTEN, IRS-2, ACACB, IL-8, Bcl-2, IL-6, AKT(PKB), Kir6.2, PDK (PDPK1)",5.03E-03,2.31E-02,12,"NMDA receptor, PI3K cat class IA, TRPC4, RelA (p65 NF-kB subunit), SUR1, IRS-2, ACACB, IL-8, Bcl-2, IL-6, AKT(PKB), Kir6.2"
267,Th2 cytokine- and TNF-alpha-induced inflammatory response in asthmatic airway fibroblasts,35,2.32E-04,1.27E-03,2.32E-04,1.27E-03,11,"COX-2 (PTGS2), ITGB1, RelA (p65 NF-kB subunit), ICAM1, CCL2, IL-8, ERK1/2, IL-6, alpha-5/beta-1 integrin, NF-kB, ITGA5",7.87E-04,5.69E-03,10,"COX-2 (PTGS2), ITGB1, RelA (p65 NF-kB subunit), ICAM1, CCL2, IL-8, IL-6, alpha-5/beta-1 integrin, NF-kB, ITGA5"
268,Role of Tissue factor in cancer independent of coagulation protease signaling,35,2.32E-04,1.27E-03,2.32E-04,1.27E-03,11,"Laminin 5, PKC-alpha, Lyn, ERK1/2, Actin cytoskeletal, SOS, ERK2 (MAPK1), AKT(PKB), Tissue factor, Coagulation factor VII, ERK1 (MAPK3)",3.46E-02,9.44E-02,7,"Laminin 5, PKC-alpha, Lyn, SOS, AKT(PKB), Tissue factor, Coagulation factor VII"
269,Common mechanisms of Th17 cell migration,48,2.41E-04,1.71E-03,3.38E-04,1.71E-03,13,"MCAM, CCL20, IP10, alpha-4/beta-1 integrin, ICAM1, CCL2, I-TAC, G-protein alpha-i family, Collagen II, CCR5, PI3K reg class IB (p101), IP3 receptor, CCL7",2.41E-04,2.48E-03,13,"MCAM, CCL20, IP10, alpha-4/beta-1 integrin, ICAM1, CCL2, I-TAC, G-protein alpha-i family, Collagen II, CCR5, PI3K reg class IB (p101), IP3 receptor, CCL7"
270,Transcription_Role of VDR in regulation of genes involved in osteoporosis,59,2.59E-04,1.40E-03,2.59E-04,1.40E-03,15,"Androgen receptor, IL-1 beta, TRPC3, RUNX2, Fra-1, CDX2, CG alpha, CYP24A1, CYP19, PTHR1, IL-6, SMAD3, Calcitonin receptor, Osteoprotegerin, CALB1",6.20E-04,4.76E-03,14,"Androgen receptor, IL-1 beta, TRPC3, RUNX2, Fra-1, CDX2, CG alpha, CYP24A1, CYP19, PTHR1, IL-6, Calcitonin receptor, Osteoprotegerin, CALB1"
271,Development_Role of BMP signaling in embryonic stem cell neural differentiation,30,2.59E-04,1.40E-03,2.59E-04,1.40E-03,10,"NCAM1, IRX1, SOX2, BMP4, ERK1/2, Follistatin, Chordin, Tubulin beta 2B, BMP2, SOX3",9.73E-04,6.42E-03,9,"NCAM1, IRX1, SOX2, BMP4, Follistatin, Chordin, Tubulin beta 2B, BMP2, SOX3"
272,Development_WNT/Beta-catenin signaling in cell differentiation,30,2.59E-04,1.40E-03,2.59E-04,1.40E-03,10,"Tcf(Lef), ROR-gamma, WNT, SLUG, Follistatin, Beta-catenin, TCF7 (TCF1), CDX1, BMP2, Frizzled",9.73E-04,6.42E-03,9,"Tcf(Lef), ROR-gamma, WNT, SLUG, Follistatin, TCF7 (TCF1), CDX1, BMP2, Frizzled"
273,Arachidonic acid metabolites production in alveolar macrophages in asthma,31,2.65E-04,1.76E-03,3.51E-04,1.76E-03,10,"COX-2 (PTGS2), IL-1 beta, PLA2(hGIIA), CCL2, IL-8, cPLA2, TLR4, ALOX5, NF-kB, TLR2",2.65E-04,2.70E-03,10,"COX-2 (PTGS2), IL-1 beta, PLA2(hGIIA), CCL2, IL-8, cPLA2, TLR4, ALOX5, NF-kB, TLR2"
274,Development_Role of growth factors in the maintenance of embryonic stem cell pluripotency,53,2.68E-04,1.43E-03,2.68E-04,1.43E-03,14,"PI3K cat class IA, Activin A, Oct-3/4, SOX2, Neuregulin 1, TGF-beta receptor type II, ERK1/2, ErbB3, Myosin II, FGF2, SOS, SMAD3, AKT(PKB), PDK (PDPK1)",4.65E-02,1.16E-01,9,"PI3K cat class IA, Activin A, Oct-3/4, SOX2, Neuregulin 1, TGF-beta receptor type II, FGF2, SOS, AKT(PKB)"
275,Chemotaxis_CCR1 signaling,53,2.68E-04,1.43E-03,2.68E-04,1.43E-03,14,"STAT3, G-protein alpha-15, CCL13, IL-8, cPLA2, G-protein alpha-i family, Adenylate cyclase, ERK1/2, IL-6, NF-kB, PI3K reg class IB (p101), MMP-9, IP3 receptor, CCL7",2.29E-03,1.26E-02,12,"G-protein alpha-15, CCL13, IL-8, cPLA2, G-protein alpha-i family, Adenylate cyclase, IL-6, NF-kB, PI3K reg class IB (p101), MMP-9, IP3 receptor, CCL7"
276,Development_HGF signaling pathway,47,2.69E-04,1.43E-03,2.69E-04,1.43E-03,13,"STAT3, HGF, COX-2 (PTGS2), PI3K cat class IA, TCF7L2 (TCF4), ERK1/2, Beta-catenin, SNAIL1, SOS, AKT(PKB), PDK (PDPK1), HGF receptor (Met), PLAU (UPA)",5.79E-02,1.34E-01,8,"HGF, COX-2 (PTGS2), PI3K cat class IA, TCF7L2 (TCF4), SOS, AKT(PKB), HGF receptor (Met), PLAU (UPA)"
277,Dual role of BMP signaling in gastric cancer,25,2.73E-04,1.44E-03,2.73E-04,1.44E-03,9,"PI3K cat class IA, RelA (p65 NF-kB subunit), Mucin 2, CDX2, BMP4, SNAIL1, AKT(PKB), PDK (PDPK1), BMP2",5.44E-03,2.44E-02,7,"PI3K cat class IA, RelA (p65 NF-kB subunit), Mucin 2, CDX2, BMP4, AKT(PKB), BMP2"
278,Role of fibroblasts and keratinocytes in the elicitation phase of allergic contact dermatitis,26,2.96E-04,1.89E-03,3.83E-04,1.89E-03,9,"GRO-2, IL-1 beta, CCL20, GRO-1, IP10, CCL2, IL-8, CCR5, IL8RA",2.96E-04,2.90E-03,9,"GRO-2, IL-1 beta, CCL20, GRO-1, IP10, CCL2, IL-8, CCR5, IL8RA"
279,Gamma-secretase regulation of osteogenesis,37,2.96E-04,1.94E-03,3.99E-04,1.94E-03,11,"RelA (p65 NF-kB subunit), RUNX2, CD44, CD44 soluble, CD44 (EXT), ALPL, CD44 (ICD), NF-kB, Osteoprotegerin, CSF1, Jagged1",2.96E-04,2.90E-03,11,"RelA (p65 NF-kB subunit), RUNX2, CD44, CD44 soluble, CD44 (EXT), ALPL, CD44 (ICD), NF-kB, Osteoprotegerin, CSF1, Jagged1"
280,Cytoskeleton remodeling_Keratin filaments,36,3.06E-04,1.60E-03,3.06E-04,1.60E-03,11,"Tubulin beta, Keratin 17, Keratin 5/14, Keratin 14, Keratin 5, Keratin 16, Keratin 6C, Actin cytoskeletal, Keratin 6A, Keratin 2, Vimentin",1.00E-03,6.49E-03,10,"Tubulin beta, Keratin 17, Keratin 5/14, Keratin 14, Keratin 5, Keratin 16, Keratin 6C, Keratin 6A, Keratin 2, Vimentin"
281,IGF-1 signaling in pancreatic cancer,36,3.06E-04,1.60E-03,3.06E-04,1.60E-03,11,"STAT3, COX-2 (PTGS2), PI3K cat class IA, NUAK1, IRS-2, ERK1/2, MMP-14, MMP-2, SOS, PDK (PDPK1), MMP-9",1.34E-02,4.78E-02,8,"COX-2 (PTGS2), PI3K cat class IA, NUAK1, IRS-2, MMP-14, MMP-2, SOS, MMP-9"
282,CHDI_Correlations from Discovery data_Causal network (positive),36,3.06E-04,1.60E-03,3.06E-04,1.60E-03,11,"STAT3, TIE2, GABA-A receptor, MMP-2, alpha-5/beta-1 integrin, Actin cytoskeletal, Collagen IV, Actin, Ephrin-B receptors, LAMA3 (Epiligrin), Collagen III",3.91E-03,1.92E-02,9,"TIE2, GABA-A receptor, MMP-2, alpha-5/beta-1 integrin, Collagen IV, Actin, Ephrin-B receptors, LAMA3 (Epiligrin), Collagen III"
283,Development_VEGF signaling via VEGFR2 - generic cascades,93,3.13E-04,1.63E-03,3.13E-04,1.63E-03,20,"COX-2 (PTGS2), PI3K cat class IA, iNOS, PKC, CCL2, PKC-alpha, TCF7L2 (TCF4), ERK1/2, Beta-catenin, PLAUR (uPAR), Actin cytoskeletal, Fyn, SOS, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), PLAU (UPA), MLCK, IP3 receptor",3.94E-02,1.04E-01,14,"COX-2 (PTGS2), PI3K cat class IA, iNOS, PKC, CCL2, PKC-alpha, TCF7L2 (TCF4), PLAUR (uPAR), Fyn, SOS, AKT(PKB), PLAU (UPA), MLCK, IP3 receptor"
284,"Immune response_IL-2 signaling via ERK, PI3K, and PLC-gamma",73,3.23E-04,1.67E-03,3.23E-04,1.67E-03,17,"STAT3, Syk, PI3K cat class IA, Lck, PKC-theta, IRS-2, Cyclin E, Lyn, Bcl-2, ERK1/2, Fyn, NF-kB, ERK2 (MAPK1), AKT(PKB), SOS1, p27KIP1, ERK1 (MAPK3)",6.27E-02,1.43E-01,11,"Syk, PI3K cat class IA, PKC-theta, IRS-2, Cyclin E, Lyn, Bcl-2, Fyn, NF-kB, AKT(PKB), SOS1"
285,Mast cell migration in asthma,73,3.23E-04,1.67E-03,3.23E-04,1.67E-03,17,"TGF-beta 2, IP10, CD44, CCL2, TGF-beta 3, I-TAC, IL-8, TGF-beta receptor type II, G-protein alpha-i family, ERK1/2, alpha-5/beta-1 integrin, FGF2, PDGF receptor, IL8RA, Fibronectin, C3a, PI3K reg class IB (p101)",6.72E-04,5.12E-03,16,"TGF-beta 2, IP10, CD44, CCL2, TGF-beta 3, I-TAC, IL-8, TGF-beta receptor type II, G-protein alpha-i family, alpha-5/beta-1 integrin, FGF2, PDGF receptor, IL8RA, Fibronectin, C3a, PI3K reg class IB (p101)"
286,Regulation and signaling of HGF receptor (Met) and MSP receptor (RON) in lung cancer,73,3.23E-04,1.67E-03,3.23E-04,1.67E-03,17,"STAT3, HGF, COX-2 (PTGS2), IL-1 beta, PI3K cat class IA, PKC-alpha, ERK1/2, MMP-2, IL-6, Beta-catenin, FGF2, Delta-catenin, SOS, AKT(PKB), PDK (PDPK1), HGF receptor (Met), MMP-9",1.30E-02,4.75E-02,13,"HGF, COX-2 (PTGS2), IL-1 beta, PI3K cat class IA, PKC-alpha, MMP-2, IL-6, FGF2, Delta-catenin, SOS, AKT(PKB), HGF receptor (Met), MMP-9"
287,Development_TGF-beta family mediated differentiation of embryonic stem cells,42,3.31E-04,1.68E-03,3.31E-04,1.68E-03,12,"Activin A, Oct-3/4, SOX2, TGF-beta receptor type II, BMP4, Mixl1, Nestin, TAZ, HOXA1, SMAD3, PAX6, SOX3",9.73E-04,6.42E-03,11,"Activin A, Oct-3/4, SOX2, TGF-beta receptor type II, BMP4, Mixl1, Nestin, TAZ, HOXA1, PAX6, SOX3"
288,Chemoresistance pathways mediated by constitutive activation of PI3K pathway and BCL-2 in small cell lung cancer,42,3.31E-04,1.68E-03,3.31E-04,1.68E-03,12,"Laminin 5, BMX, PI3K cat class IA, LAMC2, Bcl-2, alpha-5/beta-1 integrin, FGF2, AKT(PKB), Collagen IV, p53, PDK (PDPK1), Fibronectin",3.53E-03,1.80E-02,10,"Laminin 5, BMX, PI3K cat class IA, LAMC2, Bcl-2, alpha-5/beta-1 integrin, FGF2, AKT(PKB), Collagen IV, Fibronectin"
289,Immune response_HSP60 and HSP70/ TLR signaling pathway,54,3.31E-04,1.68E-03,3.31E-04,1.68E-03,14,"IL-1 beta, MHC class II, iNOS, CD14, ICAM1, IL-8, TLR4, ERK1/2, MD-2, IL-6, TIRAP (Mal), CD83, NF-kB, TLR2",8.30E-04,5.94E-03,13,"IL-1 beta, MHC class II, iNOS, CD14, ICAM1, IL-8, TLR4, MD-2, IL-6, TIRAP (Mal), CD83, NF-kB, TLR2"
290,Role of IL-23/ T17 pathogenic axis in psoriasis,54,3.31E-04,1.68E-03,3.31E-04,1.68E-03,14,"STAT3, IL-15, IL-1 beta, MHC class II, IL-15RA, CCL20, IL-8, ROR-gamma, ERK1/2, IL-6, sIL-15RA, NF-kB, AKT(PKB), IL22RA1",2.71E-03,1.44E-02,12,"IL-15, IL-1 beta, MHC class II, IL-15RA, CCL20, IL-8, ROR-gamma, IL-6, sIL-15RA, NF-kB, AKT(PKB), IL22RA1"
291,Deregulation of canonical WNT signaling in major depressive disorder,31,3.51E-04,1.76E-03,3.51E-04,1.76E-03,10,"MAP-1B, Tcf(Lef), WNT7A, WNT, TCF7L2 (TCF4), Beta-catenin, Tau (MAPT), Dsh, TCF7 (TCF1), Frizzled",5.21E-03,2.38E-02,8,"MAP-1B, Tcf(Lef), WNT7A, WNT, TCF7L2 (TCF4), Tau (MAPT), TCF7 (TCF1), Frizzled"
292,Mechanisms of K-RAS addiction in lung cancer cells,31,3.51E-04,1.76E-03,3.51E-04,1.76E-03,10,"BAD, Syk, PTEN, IL-8, Bcl-2, ERK1/2, AKT(PKB), Stk33, Vimentin, TCF8",1.85E-02,5.95E-02,7,"Syk, IL-8, Bcl-2, AKT(PKB), Stk33, Vimentin, TCF8"
293,Eosinophil survival in asthma,67,3.55E-04,1.76E-03,3.55E-04,1.76E-03,16,"TRUNDD(TNFRSF10D), Syk, IL-15, PGE2R2, NGF, ST2(L), c-IAP2, iNOS, Eotaxin-2, ICAM1, PGD2R, Lyn, IL-33, Bcl-2, ERK1/2, Fibronectin",7.74E-04,5.69E-03,15,"TRUNDD(TNFRSF10D), Syk, IL-15, PGE2R2, NGF, ST2(L), c-IAP2, iNOS, Eotaxin-2, ICAM1, PGD2R, Lyn, IL-33, Bcl-2, Fibronectin"
294,Immune response_IL-11 signaling pathway via MEK/ERK and PI3K/AKT cascades,67,3.55E-04,1.76E-03,3.55E-04,1.76E-03,16,"IL-1 beta, RelA (p65 NF-kB subunit), RUNX2, ICAM1, IL-8, Cyclin E, ERK1/2, ALPL, IL-6, Fyn, SNAIL1, SOS, AKT(PKB), PDK (PDPK1), SFK, p27KIP1",1.60E-02,5.35E-02,12,"IL-1 beta, RelA (p65 NF-kB subunit), RUNX2, ICAM1, IL-8, Cyclin E, ALPL, IL-6, Fyn, SOS, AKT(PKB), SFK"
295,Immune response_IFN-gamma in macrophages activation,50,3.73E-04,2.35E-03,5.21E-04,2.35E-03,13,"COX-2 (PTGS2), RelA (p65 NF-kB subunit), iNOS, IL-30, IP10, CCL2, TLR4, Selenoprotein P, IL-6, PAI2, Caspase-1, CLIC5, Pleiotrophin (OSF1)",3.73E-04,3.43E-03,13,"COX-2 (PTGS2), RelA (p65 NF-kB subunit), iNOS, IL-30, IP10, CCL2, TLR4, Selenoprotein P, IL-6, PAI2, Caspase-1, CLIC5, Pleiotrophin (OSF1)"
296,Development_Oligodendrocyte differentiation (general schema),38,3.83E-04,2.34E-03,5.15E-04,2.34E-03,11,"SOX10, Myelin basic protein, EDNRB, BMP4, EGFR, FGF2, TGF-alpha, PDGF-R-alpha, Nkx2.2, BMP2, EDNRA",3.83E-04,3.49E-03,11,"SOX10, Myelin basic protein, EDNRB, BMP4, EGFR, FGF2, TGF-alpha, PDGF-R-alpha, Nkx2.2, BMP2, EDNRA"
297,Hypothetical role of microRNAs in fibrosis development after myocardial infarction,26,3.83E-04,1.89E-03,3.83E-04,1.89E-03,9,"Fibrillin 1, PI3K cat class IA, PTEN, TGF-beta receptor type II, MMP-2, SMAD3, CTGF, AKT(PKB), Collagen III",6.88E-03,2.93E-02,7,"Fibrillin 1, PI3K cat class IA, TGF-beta receptor type II, MMP-2, CTGF, AKT(PKB), Collagen III"
298,Immune response_IL-9 signaling pathway,61,3.83E-04,1.89E-03,3.83E-04,1.89E-03,15,"STAT3, PI3K cat class IA, MC-CPA, CISH, CCL13, IRS-2, CCL2, Mucin 2, Mucin 5AC, Bcl-2, ERK1/2, AKT(PKB), PDK (PDPK1), Pim-1, CCL7",7.65E-03,3.18E-02,12,"PI3K cat class IA, MC-CPA, CISH, CCL13, IRS-2, CCL2, Mucin 2, Mucin 5AC, Bcl-2, AKT(PKB), Pim-1, CCL7"
299,Development_Growth factors in regulation of oligodendrocyte precursor cell survival,37,3.99E-04,1.94E-03,3.99E-04,1.94E-03,11,"BAD, PI3K cat class IA, RelA (p65 NF-kB subunit), Neuregulin 1, Lyn, Bcl-2, ErbB3, Fyn, PDGF-R-alpha, AKT(PKB), PDK (PDPK1)",1.57E-02,5.27E-02,8,"PI3K cat class IA, RelA (p65 NF-kB subunit), Neuregulin 1, Lyn, Bcl-2, Fyn, PDGF-R-alpha, AKT(PKB)"
300,Development_Delta-type opioid receptor mediated cardioprotection,37,3.99E-04,1.94E-03,3.99E-04,1.94E-03,11,"STAT3, PI3K cat class IA, Metenkefalin, ADAM12, EGFR, G-protein alpha-i family, ERK2 (MAPK1), AKT(PKB), Kir6.2, PDK (PDPK1), ERK1 (MAPK3)",4.53E-02,1.14E-01,7,"PI3K cat class IA, Metenkefalin, ADAM12, EGFR, G-protein alpha-i family, AKT(PKB), Kir6.2"
301,Role of alveolar cell senescence in COPD,37,3.99E-04,1.94E-03,3.99E-04,1.94E-03,11,"IGFBP7, RelA (p65 NF-kB subunit), IL-8, ERK1/2, IL-6, CTGF, AKT(PKB), Caveolin-1, p53, p16INK4, IBP3",4.76E-03,2.22E-02,9,"IGFBP7, RelA (p65 NF-kB subunit), IL-8, IL-6, CTGF, AKT(PKB), Caveolin-1, p16INK4, IBP3"
302,Role of IFN-beta in the improvement of blood-brain barrier integrity in multiple sclerosis,27,4.09E-04,2.36E-03,5.27E-04,2.36E-03,9,"TNF-R2, ITGA4, alpha-4/beta-1 integrin, ICAM1, sICAM1, 5'-NTD, NF-kB, IFN-beta, MMP-9",4.09E-04,3.68E-03,9,"TNF-R2, ITGA4, alpha-4/beta-1 integrin, ICAM1, sICAM1, 5'-NTD, NF-kB, IFN-beta, MMP-9"
303,Immune response_IL-3 signaling via ERK and PI3K,102,4.20E-04,2.00E-03,4.20E-04,2.00E-03,21,"BAD, Syk, ITGB1, SGK3, cPKC (conventional), PI3K cat class IA, alpha-4/beta-1 integrin, NGAL, cPLA2, Lyn, Bcl-2, ERK1/2, alpha-5/beta-1 integrin, SOS, AKT(PKB), A-Raf-1, p53, PDK (PDPK1), p27KIP1, PI3K cat class IA (p110-delta), IP3 receptor",4.04E-02,1.06E-01,15,"Syk, ITGB1, SGK3, cPKC (conventional), PI3K cat class IA, alpha-4/beta-1 integrin, NGAL, cPLA2, Lyn, Bcl-2, alpha-5/beta-1 integrin, SOS, AKT(PKB), PI3K cat class IA (p110-delta), IP3 receptor"
304,Th2-cytokines-induced expression of mucins in asthma ,43,4.20E-04,2.00E-03,4.20E-04,2.00E-03,12,"STAT3, GRO-2, CLCA1, TGF-beta 2, GRO-1, Mucin 2, IL-8, TGF-beta receptor type II, Mucin 5AC, ERK1/2, Mucin 5B, IL-6",4.23E-03,2.03E-02,10,"GRO-2, CLCA1, TGF-beta 2, GRO-1, Mucin 2, IL-8, TGF-beta receptor type II, Mucin 5AC, Mucin 5B, IL-6"
305,Cytoskeleton remodeling_Hyaluronic acid/ CD44 signaling pathways,43,4.20E-04,2.00E-03,4.20E-04,2.00E-03,12,"HGF, Ankyrin 1, Lck, CD44, MSN (moesin), ERK1/2, Actin cytoskeletal, Fyn, SOS, HGF receptor (Met), Actin, MLCK",1.32E-02,4.78E-02,9,"HGF, Ankyrin 1, CD44, MSN (moesin), Fyn, SOS, HGF receptor (Met), Actin, MLCK"
306,ESR1 (membrane) 36 kDa isoform signaling in breast cancer,43,4.20E-04,2.00E-03,4.20E-04,2.00E-03,12,"PI3K cat class IA, Gamma-synuclein, PKC-alpha, EGFR, ERK1/2, AL1A1, ESR1 (membrane), SNAIL1, SOS, AKT(PKB), PDK (PDPK1), IP3 receptor",1.32E-02,4.78E-02,9,"PI3K cat class IA, Gamma-synuclein, PKC-alpha, EGFR, AL1A1, ESR1 (membrane), SOS, AKT(PKB), IP3 receptor"
307,Regulation of Tissue factor signaling in cancer,43,4.20E-04,2.00E-03,4.20E-04,2.00E-03,12,"TNF-R2, Heparanase 1, PTEN, EGFR, ERK1/2, ERK2 (MAPK1), AKT(PKB), Tissue factor, p53, PDK (PDPK1), Coagulation factor VII, ERK1 (MAPK3)",1.89E-01,3.20E-01,6,"TNF-R2, Heparanase 1, EGFR, AKT(PKB), Tissue factor, Coagulation factor VII"
308,Neutrophil-derived granule proteins and cytokines in asthma,49,4.21E-04,2.00E-03,4.21E-04,2.00E-03,13,"CHI3L1, Syk, TGF-beta 2, PKC, IP10, IL-8, ERK1/2, Rac2, MMP-8, Tryptase, PRG2, IL8RA, MMP-9",1.11E-03,7.05E-03,12,"CHI3L1, Syk, TGF-beta 2, PKC, IP10, IL-8, Rac2, MMP-8, Tryptase, PRG2, IL8RA, MMP-9"
309,Development_PEDF signaling,49,4.21E-04,2.00E-03,4.21E-04,2.00E-03,13,"IL-1 beta, NGF, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), Fra-1, c-IAP1, Bcl-2, ERK1/2, IL-6, NF-kB, AKT(PKB), PDK (PDPK1)",3.69E-03,1.84E-02,11,"IL-1 beta, NGF, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), Fra-1, c-IAP1, Bcl-2, IL-6, NF-kB, AKT(PKB)"
310,Immune response_Gastrin in inflammatory response,68,4.24E-04,2.00E-03,4.24E-04,2.00E-03,16,"COX-2 (PTGS2), GRO-2, PI3K cat class IA, PKC-alpha, IL-8, EGFR, MEF2C, PAI2, SOS, MEF2, ERK2 (MAPK1), AKT(PKB), G-protein alpha-q/11, PDK (PDPK1), ERK1 (MAPK3), IP3 receptor",7.20E-03,3.03E-02,13,"COX-2 (PTGS2), GRO-2, PI3K cat class IA, PKC-alpha, IL-8, EGFR, MEF2C, PAI2, SOS, MEF2, AKT(PKB), G-protein alpha-q/11, IP3 receptor"
311,Eosinophil adhesion and transendothelial migration in asthma,68,4.24E-04,2.00E-03,4.24E-04,2.00E-03,16,"Galectin-3, PKC, CCL13, Eotaxin-2, alpha-4/beta-1 integrin, ICAM1, CD44, ERK1/2, PLAUR (uPAR), alpha-1/beta-1 integrin, Collagen IV, Fibronectin, C3a, MMP-9, PLAU (UPA), CCL7",9.12E-04,6.31E-03,15,"Galectin-3, PKC, CCL13, Eotaxin-2, alpha-4/beta-1 integrin, ICAM1, CD44, PLAUR (uPAR), alpha-1/beta-1 integrin, Collagen IV, Fibronectin, C3a, MMP-9, PLAU (UPA), CCL7"
312,Eosinophil chemotaxis in asthma,64,4.62E-04,2.83E-03,6.64E-04,2.83E-03,15,"NGF, Secretoneurin, S1P1 receptor, NGFR(TNFRSF16), CCL20, IP10, CCL13, Eotaxin-2, IL-8, CCR8, G-protein alpha-i family, IL8RA, C3a, PI3K reg class IB (p101), CCL7",4.62E-04,4.02E-03,15,"NGF, Secretoneurin, S1P1 receptor, NGFR(TNFRSF16), CCL20, IP10, CCL13, Eotaxin-2, IL-8, CCR8, G-protein alpha-i family, IL8RA, C3a, PI3K reg class IB (p101), CCL7"
313,Putative pathways for stimulation of fat cell differentiation by Bisphenol A,32,4.68E-04,2.20E-03,4.68E-04,2.20E-03,10,"Androgen receptor, PI3K cat class IA, ESR1 (nuclear), TCF7L2 (TCF4), Beta-catenin, PPARGC1 (PGC1-alpha), AKT(PKB), PDK (PDPK1), FASN, C/EBPalpha",2.19E-02,6.60E-02,7,"Androgen receptor, PI3K cat class IA, ESR1 (nuclear), TCF7L2 (TCF4), PPARGC1 (PGC1-alpha), AKT(PKB), C/EBPalpha"
314,Hedgehog signaling in pancreatic cancer,32,4.68E-04,2.20E-03,4.68E-04,2.20E-03,10,"IL-1 beta, RelA (p65 NF-kB subunit), PTCH1, Bcl-2, ERK1/2, SNAIL1, GLI-1, SMAD3, MMP-9, GLI-2",2.19E-02,6.60E-02,7,"IL-1 beta, RelA (p65 NF-kB subunit), PTCH1, Bcl-2, GLI-1, MMP-9, GLI-2"
315,The innate immune response to contact allergens,33,4.69E-04,2.67E-03,6.16E-04,2.67E-03,10,"IL-1 beta, Biglycan, CD14, CCL2, IL-8, TLR4, IL-6, NF-kB, Caspase-1, TLR2",4.69E-04,4.02E-03,10,"IL-1 beta, Biglycan, CD14, CCL2, IL-8, TLR4, IL-6, NF-kB, Caspase-1, TLR2"
316,Influence of multiple myeloma cells on bone marrow stromal cells,33,4.69E-04,2.67E-03,6.16E-04,2.67E-03,10,"COX-2 (PTGS2), IL-1 beta, RelA (p65 NF-kB subunit), ITGA4, ICAM1, FGFR4, IL-6, FGF2, NF-kB, Osteoprotegerin",4.69E-04,4.02E-03,10,"COX-2 (PTGS2), IL-1 beta, RelA (p65 NF-kB subunit), ITGA4, ICAM1, FGFR4, IL-6, FGF2, NF-kB, Osteoprotegerin"
317,Role of GSK3 beta in cardioprotection against myocardial infarction,33,4.69E-04,2.67E-03,6.16E-04,2.67E-03,10,"PI3K cat class IA, CRLR, Metenkefalin, EGFR, Enkephalin A, BDKRB2, MMP-8, AKT(PKB), Kir6.2, RAMP3",4.69E-04,4.02E-03,10,"PI3K cat class IA, CRLR, Metenkefalin, EGFR, Enkephalin A, BDKRB2, MMP-8, AKT(PKB), Kir6.2, RAMP3"
318,Immune response_B cell antigen receptor (BCR) pathway,110,4.72E-04,2.20E-03,4.72E-04,2.20E-03,22,"BAD, Syk, RelA (p65 NF-kB subunit), CalDAG-GEFIII, alpha-4/beta-1 integrin, CKLFSF7, ICAM1, ETS1, Lyn, N-Ras, ERK1/2, BLNK, CIN85, Actin cytoskeletal, NF-kB, AKT(PKB), SOS1, PDK (PDPK1), Fibronectin, PI3K cat class IA (p110-delta), IP3 receptor, CDK6",1.97E-02,6.29E-02,17,"Syk, RelA (p65 NF-kB subunit), CalDAG-GEFIII, alpha-4/beta-1 integrin, CKLFSF7, ICAM1, ETS1, Lyn, BLNK, CIN85, NF-kB, AKT(PKB), SOS1, Fibronectin, PI3K cat class IA (p110-delta), IP3 receptor, CDK6"
319,Development_Negative regulation of WNT/Beta-catenin signaling in the cytoplasm,82,4.73E-04,2.20E-03,4.73E-04,2.20E-03,18,"Prickle-1, CXXC4, PKC-alpha, Tcf(Lef), WNT, RIPK4, Beclin 1, Beta-catenin, TAZ, Nucleoredoxin, p53, Dsh, A20, DACT3, Frizzled, YAP1/TAZ, DACT1, CDK6",1.46E-02,5.06E-02,14,"Prickle-1, CXXC4, PKC-alpha, Tcf(Lef), WNT, RIPK4, TAZ, Nucleoredoxin, A20, DACT3, Frizzled, YAP1/TAZ, DACT1, CDK6"
320,Role of free fatty acids in obesity and type 2 diabetes,45,4.84E-04,2.83E-03,6.61E-04,2.83E-03,12,"COX-2 (PTGS2), IL-1 beta, PI3K cat class IA, RelA (p65 NF-kB subunit), PKC-theta, iNOS, CCL2, TLR4, IL-6, AKT(PKB), IFN-beta, TLR2",4.84E-04,4.06E-03,12,"COX-2 (PTGS2), IL-1 beta, PI3K cat class IA, RelA (p65 NF-kB subunit), PKC-theta, iNOS, CCL2, TLR4, IL-6, AKT(PKB), IFN-beta, TLR2"
321,Immune response_IFN-gamma signaling via PI3K and NF-kB,56,4.96E-04,2.30E-03,4.96E-04,2.30E-03,14,"PI3K cat class IA, RelA (p65 NF-kB subunit), iNOS, IP10, RUNX3, ERK1/2, Beta-catenin, Fyn, NF-kB, AKT(PKB), PDK (PDPK1), TLR3, HLA-B7, PD-L1",1.06E-02,4.04E-02,11,"PI3K cat class IA, RelA (p65 NF-kB subunit), iNOS, IP10, RUNX3, Fyn, NF-kB, AKT(PKB), TLR3, HLA-B7, PD-L1"
322,Role of TGF-beta 1 in fibrosis development after myocardial infarction,38,5.15E-04,2.34E-03,5.15E-04,2.34E-03,11,"Biglycan, EDNRB, TGF-beta receptor type II, MMP-2, ACTA2, SMAD3, CTGF, Fibronectin, MMP-9, EDNRA, Collagen III",1.58E-03,9.62E-03,10,"Biglycan, EDNRB, TGF-beta receptor type II, MMP-2, ACTA2, CTGF, Fibronectin, MMP-9, EDNRA, Collagen III"
323,WNT signaling in invasive-type melanoma cells,38,5.15E-04,2.34E-03,5.15E-04,2.34E-03,11,"STAT3, cPKC (conventional), SFRP3 (FRZB1), PKC, CD44, TCF7L2 (TCF4), MMP-2, Beta-catenin, SNAIL1, TLR3, Vimentin",1.84E-02,5.95E-02,8,"cPKC (conventional), SFRP3 (FRZB1), PKC, CD44, TCF7L2 (TCF4), MMP-2, TLR3, Vimentin"
324,Role of Endothelin-1 in inflammation and vasoconstriction in Sickle cell disease,38,5.15E-04,2.34E-03,5.15E-04,2.34E-03,11,"PI3K cat class IA, RelA (p65 NF-kB subunit), EDNRB, CCL2, PLGF, PKC-alpha, IL-8, ERK1/2, CCR5, AKT(PKB), EDNRA",1.58E-03,9.62E-03,10,"PI3K cat class IA, RelA (p65 NF-kB subunit), EDNRB, CCL2, PLGF, PKC-alpha, IL-8, CCR5, AKT(PKB), EDNRA"
325,WNT signaling in proliferative-type melanoma cells,38,5.15E-04,2.34E-03,5.15E-04,2.34E-03,11,"DVL-3, DKK3, MSG1, WNT, ERK1/2, Beta-catenin, Fibronectin, Dsh, NRCAM, Frizzled, DACT1",5.13E-02,1.23E-01,7,"DKK3, MSG1, WNT, Fibronectin, NRCAM, Frizzled, DACT1"
326,Eosinophil-derived cytokines in airway remodeling in asthma,38,5.15E-04,2.34E-03,5.15E-04,2.34E-03,11,"NGF, TGF-beta 2, Amphiregulin, MMP-17, CD44, PKC-alpha, ERK1/2, FGF2, TGF-alpha, NF-kB, MMP-9",1.58E-03,9.62E-03,10,"NGF, TGF-beta 2, Amphiregulin, MMP-17, CD44, PKC-alpha, FGF2, TGF-alpha, NF-kB, MMP-9"
327,Transition of Smoldering multiple myeloma to active multiple myeloma (schema),17,5.17E-04,2.35E-03,5.17E-04,2.35E-03,7,"IL-1 beta, CCL2, IL-8, N-Ras, IL-6, NF-kB, p53",1.47E-02,5.09E-02,5,"IL-1 beta, CCL2, IL-8, IL-6, NF-kB"
328,IgE- and MGF-induced Lyn-mediated production of cytokines and arachidonic acid metabolites in lung mast cells in asthma,50,5.21E-04,2.35E-03,5.21E-04,2.35E-03,13,"Syk, CCL2, PKC-alpha, IL-8, cPLA2, Lyn, ERK1/2, Fyn, SOS, NF-kB, AKT(PKB), GRAP2, IP3 receptor",1.34E-03,8.35E-03,12,"Syk, CCL2, PKC-alpha, IL-8, cPLA2, Lyn, Fyn, SOS, NF-kB, AKT(PKB), GRAP2, IP3 receptor"
329,Immune response_Antigen presentation by MHC class II,118,5.21E-04,2.35E-03,5.21E-04,2.35E-03,23,"MHC class II alpha chain, Syk, Dectin-1, MHC class II, PI3K cat class IA, Langerin, PKC, PKC-alpha, TLR4, Bcl-2, ERK1/2, Beclin 1, LY75, Fc gamma RII beta, MHC class II beta chain, ARL14, PDK (PDPK1), Dynein 1, cytoplasmic, intermediate chains, RhoB, Cathepsin S, Cathepsin V, TAP, TLR2",4.36E-03,2.05E-02,20,"MHC class II alpha chain, Syk, Dectin-1, MHC class II, PI3K cat class IA, Langerin, PKC, PKC-alpha, TLR4, Bcl-2, LY75, Fc gamma RII beta, MHC class II beta chain, ARL14, Dynein 1, cytoplasmic, intermediate chains, RhoB, Cathepsin S, Cathepsin V, TAP, TLR2"
330,Leptin signaling in colorectal cancer,44,5.29E-04,2.36E-03,5.29E-04,2.36E-03,12,"STAT3, PI3K cat class IA, RelA (p65 NF-kB subunit), PTEN, IL-8, Cyclin E, TCF7L2 (TCF4), ERK1/2, IL-6, Beta-catenin, Matrilysin (MMP-7), AKT(PKB)",4.13E-02,1.07E-01,8,"PI3K cat class IA, RelA (p65 NF-kB subunit), IL-8, Cyclin E, TCF7L2 (TCF4), IL-6, Matrilysin (MMP-7), AKT(PKB)"
331,Inhibition of remyelination in multiple sclerosis: regulation of cytoskeleton proteins,44,5.29E-04,2.36E-03,5.29E-04,2.36E-03,12,"Tubulin beta, Myelin basic protein, NGFR(TNFRSF16), PKC-alpha, MRLC, Myosin II, TGF-beta, Actin cytoskeletal, Fyn, Tau (MAPT), MELC, Fibronectin",5.04E-03,2.31E-02,10,"Tubulin beta, Myelin basic protein, NGFR(TNFRSF16), PKC-alpha, MRLC, TGF-beta, Fyn, Tau (MAPT), MELC, Fibronectin"
332,SHH signaling in oligodendrocyte precursor cells differentiation in multiple sclerosis,13,5.30E-04,2.74E-03,6.38E-04,2.74E-03,6,"SOX10, Myelin basic protein, PTCH1, GLI-1, Nkx2.2, GLI-2",5.30E-04,4.31E-03,6,"SOX10, Myelin basic protein, PTCH1, GLI-1, Nkx2.2, GLI-2"
333,Nociception_Nociceptin receptor signaling,76,5.34E-04,2.37E-03,5.34E-04,2.37E-03,17,"STAT3, TY3H, cPKC (conventional), G-protein alpha-15, Adenylate cyclase type II, PKC, PKC-alpha, Kir3.4, cPLA2, G-protein alpha-i family, Adenylate cyclase, ERK1/2, Kir3.1, AP-2, Actin, ERK1 (MAPK3), IP3 receptor",7.57E-03,3.16E-02,14,"TY3H, cPKC (conventional), G-protein alpha-15, Adenylate cyclase type II, PKC, PKC-alpha, Kir3.4, cPLA2, G-protein alpha-i family, Adenylate cyclase, Kir3.1, AP-2, Actin, IP3 receptor"
334,"Immune response_IL-5 signaling via PI3K, MAPK and NF-kB",76,5.34E-04,2.37E-03,5.34E-04,2.37E-03,17,"Syk, PI3K cat class IA, ITGB2, ICAM1, cPLA2, Lyn, ERK1/2, MMP-2, Fc gamma RII beta, Beta-catenin, Fyn, SOS, NF-kB, AKT(PKB), Fc gamma RII alpha, PDK (PDPK1), MMP-9",7.57E-03,3.16E-02,14,"Syk, PI3K cat class IA, ITGB2, ICAM1, cPLA2, Lyn, MMP-2, Fc gamma RII beta, Fyn, SOS, NF-kB, AKT(PKB), Fc gamma RII alpha, MMP-9"
335,Mechanisms of drug resistance in SCLC,70,5.99E-04,2.64E-03,5.99E-04,2.64E-03,16,"BAD, ITGB1, PI3K cat class IA, RelA (p65 NF-kB subunit), alpha-4/beta-1 integrin, c-IAP1, Bcl-2, ERK1/2, alpha-5/beta-1 integrin, FGF2, AKT(PKB), Collagen IV, Caspase-8, PDK (PDPK1), Fibronectin, MDR1",2.21E-02,6.62E-02,12,"ITGB1, PI3K cat class IA, RelA (p65 NF-kB subunit), alpha-4/beta-1 integrin, c-IAP1, Bcl-2, alpha-5/beta-1 integrin, FGF2, AKT(PKB), Collagen IV, Fibronectin, MDR1"
336,MicroRNAs in melanoma,57,6.02E-04,2.65E-03,6.02E-04,2.65E-03,14,"MaxiK alpha subunit, Cadherin 11, RUNX3, microRNA 221, ITGB3, ETS1, TGF-beta receptor type II, BMP4, N-Ras, miR-221-3p, FGF2, Calponin-1, HGF receptor (Met), p27KIP1",4.34E-03,2.05E-02,12,"MaxiK alpha subunit, Cadherin 11, RUNX3, microRNA 221, ITGB3, ETS1, TGF-beta receptor type II, BMP4, miR-221-3p, FGF2, Calponin-1, HGF receptor (Met)"
337,NK cells in allergic contact dermatitis,34,6.11E-04,3.32E-03,8.01E-04,3.32E-03,10,"MHC class II, CCL20, NCAM1, IP10, ICAM1, CCL2, CIITA, HLA-DRA1, CCR5, NF-kB",6.11E-04,4.75E-03,10,"MHC class II, CCL20, NCAM1, IP10, ICAM1, CCL2, CIITA, HLA-DRA1, CCR5, NF-kB"
338,Normal and pathological TGF-beta-mediated regulation of cell proliferation,33,6.16E-04,2.67E-03,6.16E-04,2.67E-03,10,"ITGB3, TGF-beta receptor type II, Beta-catenin, FGF2, SOS, SMAD3, PDGF-R-alpha, PDGF receptor, p53, PDGF-R-beta",2.57E-02,7.45E-02,7,"ITGB3, TGF-beta receptor type II, FGF2, SOS, PDGF-R-alpha, PDGF receptor, PDGF-R-beta"
339,Development_Role of PKR1 and ILK in cardiac progenitor cells,33,6.16E-04,2.67E-03,6.16E-04,2.67E-03,10,"ITGB1, PI3K cat class IA, alpha-4/beta-1 integrin, Tcf(Lef), ERK1/2, Beta-catenin, SOS, AKT(PKB), G-protein alpha-q/11, Fibronectin",7.80E-03,3.24E-02,8,"ITGB1, PI3K cat class IA, alpha-4/beta-1 integrin, Tcf(Lef), SOS, AKT(PKB), G-protein alpha-q/11, Fibronectin"
340,Development_Signaling pathways in embryonic hepatocyte maturation,51,6.40E-04,2.74E-03,6.40E-04,2.74E-03,13,"STAT3, HGF, PI3K cat class IA, Transferrin, TAT, Beta-catenin, PAH, SOS, OSMR, AKT(PKB), Caspase-8, HGF receptor (Met), C/EBPalpha",1.46E-02,5.06E-02,10,"HGF, PI3K cat class IA, Transferrin, TAT, PAH, SOS, OSMR, AKT(PKB), HGF receptor (Met), C/EBPalpha"
341,Anti-apoptotic action of ErbB2 in breast cancer,51,6.40E-04,2.74E-03,6.40E-04,2.74E-03,13,"BAD, STAT3, Tuberin, Neuregulin 1, EGFR, Bcl-2, ERK1/2, ErbB3, SOS, AKT(PKB), PDK (PDPK1), ITGA5, p27KIP1",3.13E-01,4.68E-01,6,"Neuregulin 1, EGFR, Bcl-2, SOS, AKT(PKB), ITGA5"
342,Epithelial cell anoikis in COPD,51,6.40E-04,2.74E-03,6.40E-04,2.74E-03,13,"BAD, Laminin 5, PI3K cat class IA, IRS-2, Bcl-2, ERK1/2, MMP-12, Actin cytoskeletal, MMP-8, SOS, AKT(PKB), PDK (PDPK1), MMP-9",3.74E-02,9.94E-02,9,"Laminin 5, PI3K cat class IA, IRS-2, Bcl-2, MMP-12, MMP-8, SOS, AKT(PKB), MMP-9"
343,Development_Astrocyte differentiation (general schema),28,7.13E-04,3.02E-03,7.13E-04,3.02E-03,9,"STAT3, CD44, BMP4, LIF, Nestin, MCT1 (SLC16A1), Vimentin, GLAST1/EAAT1, BMP2",2.62E-03,1.40E-02,8,"CD44, BMP4, LIF, Nestin, MCT1 (SLC16A1), Vimentin, GLAST1/EAAT1, BMP2"
344,IL-17 and IL-17F-induced inflammatory signaling in normal and asthmatic airway epithelium,28,7.13E-04,3.02E-03,7.13E-04,3.02E-03,9,"IL-19, GRO-1, IP10, GCP2, ICAM1, IL-8, ERK1/2, ENA-78, IL-6",2.62E-03,1.40E-02,8,"IL-19, GRO-1, IP10, GCP2, ICAM1, IL-8, ENA-78, IL-6"
345,Cell adhesion_Integrin inside-out signaling,58,7.27E-04,3.06E-03,7.27E-04,3.06E-03,14,"ITGB1, ITGB2, ITGB3, G-protein alpha-i family, ERK1/2, alpha-5/beta-1 integrin, Actin cytoskeletal, alpha-1/beta-1 integrin, Collagen II, ERK2 (MAPK1), G-protein alpha-q/11, Fibronectin, ERK1 (MAPK3), IP3 receptor",3.37E-02,9.32E-02,10,"ITGB1, ITGB2, ITGB3, G-protein alpha-i family, alpha-5/beta-1 integrin, alpha-1/beta-1 integrin, Collagen II, G-protein alpha-q/11, Fibronectin, IP3 receptor"
346,Immune response_IL-15 signaling,58,7.27E-04,3.06E-03,7.27E-04,3.06E-03,14,"IL-15, PI3K cat class IA, IL-15RA, Lck, UFO, IL-8, ETS1, Bcl-2, ERK1/2, IL-6, sIL-15RA, SOS, AKT(PKB), PDK (PDPK1)",1.37E-02,4.85E-02,11,"IL-15, PI3K cat class IA, IL-15RA, UFO, IL-8, ETS1, Bcl-2, IL-6, sIL-15RA, SOS, AKT(PKB)"
347,Cigarette smoke-mediated attenuation of antibacterial and antivirus immune response,29,7.40E-04,3.77E-03,9.49E-04,3.77E-03,9,"IL-1 beta, RelA (p65 NF-kB subunit), IP10, ICAM1, IL-8, TLR4, sICAM1, IL-6, IFN-beta",7.40E-04,5.54E-03,9,"IL-1 beta, RelA (p65 NF-kB subunit), IP10, ICAM1, IL-8, TLR4, sICAM1, IL-6, IFN-beta"
348,Immune response_PGE2 in immune and neuroendocrine system interactions,47,7.43E-04,3.98E-03,1.01E-03,3.98E-03,12,"COX-2 (PTGS2), IL-1 beta, PGE2R4, PLA2(hGIIA), GABA-A receptor, cPLA2, G-protein alpha-i family, TLR4, PGF2aR, NF-kB, ACTH, PGE2R3",7.43E-04,5.54E-03,12,"COX-2 (PTGS2), IL-1 beta, PGE2R4, PLA2(hGIIA), GABA-A receptor, cPLA2, G-protein alpha-i family, TLR4, PGF2aR, NF-kB, ACTH, PGE2R3"
349,Translation_Opioid receptors in regulation of translation ,23,7.82E-04,3.25E-03,7.82E-04,3.25E-03,8,"Tuberin, Metenkefalin, G-protein alpha-i family, AKT(PKB), PDK (PDPK1), Leu-enkephalin, PI3K reg class IB (p101), Kappa-type opioid receptor",1.42E-02,5.00E-02,6,"Metenkefalin, G-protein alpha-i family, AKT(PKB), Leu-enkephalin, PI3K reg class IB (p101), Kappa-type opioid receptor"
350,Cytoskeleton remodeling_ESR1 action on cytoskeleton remodeling and cell migration,23,7.82E-04,3.25E-03,7.82E-04,3.25E-03,8,"PI3K cat class IA, ESR1 (nuclear), MSN (moesin), ERM proteins, F-Actin cytoskeleton, ESR1 (membrane), EBP50, AKT(PKB)",3.26E-03,1.68E-02,7,"PI3K cat class IA, ESR1 (nuclear), MSN (moesin), ERM proteins, ESR1 (membrane), EBP50, AKT(PKB)"
351,FGF signaling in gastric cancer,23,7.82E-04,3.25E-03,7.82E-04,3.25E-03,8,"FGFR4, Beta-catenin, FGF2, SOS, ERK2 (MAPK1), ERK1 (MAPK3), MMP-9, PLAU (UPA)",5.11E-02,1.23E-01,5,"FGFR4, FGF2, SOS, MMP-9, PLAU (UPA)"
352,Stem cells_Aberrant Wnt signaling in medulloblastoma stem cells,23,7.82E-04,3.25E-03,7.82E-04,3.25E-03,8,"CD44, WNT, TCF7L2 (TCF4), Beta-catenin, Matrilysin (MMP-7), AKT(PKB), Dsh, Frizzled",1.42E-02,5.00E-02,6,"CD44, WNT, TCF7L2 (TCF4), Matrilysin (MMP-7), AKT(PKB), Frizzled"
353,Development_Role of CDK5 in neuronal development,34,8.01E-04,3.32E-03,8.01E-04,3.32E-03,10,"PI3K cat class IA, VLDLR, Reelin, Beta-catenin, Actin cytoskeletal, Fyn, Delta-catenin, Tau (MAPT), AKT(PKB), Dynein 1, cytoplasmic, intermediate chains",9.41E-03,3.71E-02,8,"PI3K cat class IA, VLDLR, Reelin, Fyn, Delta-catenin, Tau (MAPT), AKT(PKB), Dynein 1, cytoplasmic, intermediate chains"
354,Signal transduction_CXCR4 signaling via PI3K cascade,46,8.19E-04,3.37E-03,8.19E-04,3.37E-03,12,"BAD, PI3K cat class IA, RelA (p65 NF-kB subunit), G-protein alpha-i family, TCF7L2 (TCF4), IL-6, Beta-catenin, SGK1, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), PREX1",2.03E-02,6.35E-02,9,"PI3K cat class IA, RelA (p65 NF-kB subunit), G-protein alpha-i family, TCF7L2 (TCF4), IL-6, SGK1, AKT(PKB), PI3K reg class IB (p101), PREX1"
355,TMPRSS2-ERG fusion in Prostate Cancer,46,8.19E-04,3.37E-03,8.19E-04,3.37E-03,12,"Androgen receptor, MxA, IGSF5 (JAM4), ERG, IL-8, TCF7L2 (TCF4), PEP-19, YB-1, DSCAM, Osteonectin, ICAM2, Kallikrein 3 (PSA)",2.17E-03,1.21E-02,11,"Androgen receptor, MxA, IGSF5 (JAM4), ERG, IL-8, TCF7L2 (TCF4), PEP-19, DSCAM, Osteonectin, ICAM2, Kallikrein 3 (PSA)"
356,The role of UV radiation in melanoma development,40,8.31E-04,3.37E-03,8.31E-04,3.37E-03,11,"POMC, Amphiregulin, EGFR, N-Ras, ERK1/2, TGF-alpha, NF-kB, ERK2 (MAPK1), AKT(PKB), alpha-MSH, p16INK4",2.47E-02,7.23E-02,8,"POMC, Amphiregulin, EGFR, TGF-alpha, NF-kB, AKT(PKB), alpha-MSH, p16INK4"
357,Apoptosis and survival_NGF activation of NF-kB,40,8.31E-04,3.37E-03,8.31E-04,3.37E-03,11,"GSTP1, NGF, NGFR(TNFRSF16), PI3K cat class IA, iNOS, HES5, Bcl-2, Synapsin II, NF-kB, AKT(PKB), PDK (PDPK1)",2.40E-03,1.31E-02,10,"GSTP1, NGF, NGFR(TNFRSF16), PI3K cat class IA, iNOS, HES5, Bcl-2, Synapsin II, NF-kB, AKT(PKB)"
358,Development_WNT/Beta-catenin and NOTCH in induction of osteogenesis,40,8.31E-04,3.37E-03,8.31E-04,3.37E-03,11,"RUNX2, Adiponectin, WNT, ALPL, Beta-catenin, Osteoprotegerin, Jagged1, Dsh, TCF7 (TCF1), Frizzled, C/EBPalpha",8.19E-03,3.32E-02,9,"RUNX2, Adiponectin, WNT, ALPL, Osteoprotegerin, Jagged1, TCF7 (TCF1), Frizzled, C/EBPalpha"
359,Development_Astrocyte differentiation from adult stem cells,40,8.31E-04,3.37E-03,8.31E-04,3.37E-03,11,"STAT3, CD44, BMP4, ERK1/2, LIF, Nestin, SOS, ID4, Nkx2.2, Vimentin, BMP2",8.19E-03,3.32E-02,9,"CD44, BMP4, LIF, Nestin, SOS, ID4, Nkx2.2, Vimentin, BMP2"
360,Inhibition of Vitamin D pathway in Prostate Cancer,40,8.31E-04,3.37E-03,8.31E-04,3.37E-03,11,"Androgen receptor, CYP27A1, RUNX2, CYP24A1, Bcl-2, IL-6, SMAD3, p27KIP1, GFI-1, IBP3, CDK6",8.19E-03,3.32E-02,9,"Androgen receptor, CYP27A1, RUNX2, CYP24A1, Bcl-2, IL-6, GFI-1, IBP3, CDK6"
361,CHDI_Correlations from Replication data_Causal network (positive correlations),79,8.54E-04,3.45E-03,8.54E-04,3.45E-03,17,"NMDA receptor, MHC class II, PI3K cat class IA, Lck, PKC-theta, ICAM1, CD44, PKC-alpha, NR2, CD83, MEF2, NF-kB, AKT(PKB), PI3K reg class IB (p101), NR2A, TLR2, IP3 receptor",1.64E-03,9.84E-03,16,"NMDA receptor, MHC class II, PI3K cat class IA, PKC-theta, ICAM1, CD44, PKC-alpha, NR2, CD83, MEF2, NF-kB, AKT(PKB), PI3K reg class IB (p101), NR2A, TLR2, IP3 receptor"
362,"Immune response_IL-3 signaling via JAK/STAT, p38, JNK and NF-kB",93,8.55E-04,3.45E-03,8.55E-04,3.45E-03,19,"BAD, STAT3, ITGB1, MHC class II, PI3K cat class IA, CISH, DHA2, ICAM1, XBP1, Lyn, Bcl-2, IL-6, TCR gamma locus, NOTCH4, NF-kB, AKT(PKB), Fibronectin, Pim-1, BMP2",3.75E-03,1.86E-02,17,"ITGB1, MHC class II, PI3K cat class IA, CISH, DHA2, ICAM1, XBP1, Lyn, Bcl-2, IL-6, TCR gamma locus, NOTCH4, NF-kB, AKT(PKB), Fibronectin, Pim-1, BMP2"
363,Type 2 diabetes (general schema),14,8.57E-04,4.04E-03,1.03E-03,4.04E-03,6,"IL-1 beta, POMC, Adiponectin, CCL2, Ghrelin, IL-6",8.57E-04,6.05E-03,6,"IL-1 beta, POMC, Adiponectin, CCL2, Ghrelin, IL-6"
364,Development_Regulation of cytoskeleton proteins in oligodendrocyte differentiation and myelination,59,8.72E-04,3.51E-03,8.72E-04,3.51E-03,14,"Tubulin beta, CNTN1 (F3), Myelin basic protein, MAP-1B, NCAM1, MAP2, MRLC, Myosin II, Actin cytoskeletal, Fyn, Tau (MAPT), PDGF-R-alpha, PDGF receptor, MELC",5.81E-03,2.58E-02,12,"Tubulin beta, CNTN1 (F3), Myelin basic protein, MAP-1B, NCAM1, MAP2, MRLC, Fyn, Tau (MAPT), PDGF-R-alpha, PDGF receptor, MELC"
365,Neurophysiological process_ACM regulation of nerve impulse,48,9.11E-04,4.71E-03,1.23E-03,4.71E-03,12,"cPKC (conventional), CACNA1H, TRPC3, PKC, PKC-alpha, G-protein alpha-i family, ACM4, TRPC6, G-protein alpha-q/11, CACNA1I, IP3 receptor, ACM3",9.11E-04,6.31E-03,12,"cPKC (conventional), CACNA1H, TRPC3, PKC, PKC-alpha, G-protein alpha-i family, ACM4, TRPC6, G-protein alpha-q/11, CACNA1I, IP3 receptor, ACM3"
366,Development_Schema: Adult neurogenesis in the Subventricular Zone,19,9.23E-04,4.39E-03,1.13E-03,4.39E-03,7,"TY3H, NCAM1, MAP2, Nestin, DLX2, Vimentin, GLAST1/EAAT1",9.23E-04,6.32E-03,7,"TY3H, NCAM1, MAP2, Nestin, DLX2, Vimentin, GLAST1/EAAT1"
367,Signal transduction_PDGF signaling via JAK-STAT and reactive oxygen species (ROS),66,9.36E-04,3.76E-03,9.36E-04,3.76E-03,15,"STAT3, IP10, CCL13, CCL2, I-TAC, cPLA2, Bcl-2, ERK1/2, PDGF-C, PDGFR-ab, PDGF-R-alpha, PDGF receptor, PDK (PDPK1), PDGF-R-beta, CCL7",1.43E-02,5.00E-02,12,"IP10, CCL13, CCL2, I-TAC, cPLA2, Bcl-2, PDGF-C, PDGFR-ab, PDGF-R-alpha, PDGF receptor, PDGF-R-beta, CCL7"
368,Proinflammatory cytokine production by Th17 cells in asthma,53,9.48E-04,3.77E-03,9.48E-04,3.77E-03,13,"STAT3, COX-2 (PTGS2), IL-1 beta, GATA-3, MHC class II, CCL20, ROR-alpha, C3, IL-8, ROR-gamma, IL-6, NF-kB, C3a",2.29E-03,1.26E-02,12,"COX-2 (PTGS2), IL-1 beta, GATA-3, MHC class II, CCL20, ROR-alpha, C3, IL-8, ROR-gamma, IL-6, NF-kB, C3a"
369,Cell cycle_Influence of Ras and Rho proteins on G1/S Transition,53,9.48E-04,3.77E-03,9.48E-04,3.77E-03,13,"STAT3, PI3K cat class IA, RelA (p65 NF-kB subunit), Cyclin E, Tob1, MRLC, ERK1/2, alpha-5/beta-1 integrin, AKT(PKB), PDK (PDPK1), p27KIP1, MLCK, CDK6",4.65E-02,1.16E-01,9,"PI3K cat class IA, RelA (p65 NF-kB subunit), Cyclin E, Tob1, MRLC, alpha-5/beta-1 integrin, AKT(PKB), MLCK, CDK6"
370,Role of Neuregulin 1 and Thymosin beta-4 in myocardium regeneration after infarction,29,9.49E-04,3.77E-03,9.49E-04,3.77E-03,9,"ITGB1, PI3K cat class IA, PTEN, Neuregulin 1, Angiopoietin 1, alpha-5/beta-1 integrin, AKT(PKB), ITGA5, Fibronectin",3.33E-03,1.71E-02,8,"ITGB1, PI3K cat class IA, Neuregulin 1, Angiopoietin 1, alpha-5/beta-1 integrin, AKT(PKB), ITGA5, Fibronectin"
371,SLE genetic marker-specific pathways in T cells,101,9.57E-04,3.79E-03,9.57E-04,3.79E-03,20,"STAT3, HLA-DRB1, MHC class II, Lck, PKC-theta, TCR beta subunit, CalDAG-GEFIII, ESR1 (nuclear), RUNX3, STAT4, HLA-DRB, ETS1, Bcl-2, ERK1/2, PTPN22, SOS, NF-kB, MHC class II beta chain, A20, IFN-beta",8.78E-03,3.52E-02,17,"HLA-DRB1, MHC class II, PKC-theta, TCR beta subunit, CalDAG-GEFIII, ESR1 (nuclear), RUNX3, STAT4, HLA-DRB, ETS1, Bcl-2, PTPN22, SOS, NF-kB, MHC class II beta chain, A20, IFN-beta"
372,Transcription targets of Androgen receptor involved in Prostate Cancer,42,9.73E-04,4.90E-03,1.29E-03,4.90E-03,11,"Androgen receptor, N-cadherin, IL-8, Versican, Clusterin, IL-6, Matrilysin (MMP-7), ER81, TLR2, IBP3, Kallikrein 3 (PSA)",9.73E-04,6.42E-03,11,"Androgen receptor, N-cadherin, IL-8, Versican, Clusterin, IL-6, Matrilysin (MMP-7), ER81, TLR2, IBP3, Kallikrein 3 (PSA)"
373,PXR-mediated direct regulation of xenobiotic metabolizing enzymes / Human version,42,9.73E-04,4.90E-03,1.29E-03,4.90E-03,11,"CYP27A1, UGT1A1, OATP-A, S14 protein, CYP24A1, CYP2A6, UGT1A4, MDR1, CYP2B6, UGT1A6, CYP11A1",9.73E-04,6.42E-03,11,"CYP27A1, UGT1A1, OATP-A, S14 protein, CYP24A1, CYP2A6, UGT1A4, MDR1, CYP2B6, UGT1A6, CYP11A1"
374,Production and activation of TGF-beta in airway smooth muscle cells,35,1.03E-03,4.04E-03,1.03E-03,4.04E-03,10,"TGF-beta 2, RelA (p65 NF-kB subunit), TGF-beta 3, TGF-beta receptor type II, G-protein alpha-i family, TLR4, ERK1/2, TGF-beta, Tryptase, PLAU (UPA)",3.18E-03,1.65E-02,9,"TGF-beta 2, RelA (p65 NF-kB subunit), TGF-beta 3, TGF-beta receptor type II, G-protein alpha-i family, TLR4, TGF-beta, Tryptase, PLAU (UPA)"
375,Development_VEGF-family signaling,41,1.04E-03,4.06E-03,1.04E-03,4.06E-03,11,"Neuropilin-2, PI3K cat class IA, PLGF, PKC-alpha, Neuropilin-1, ERK1/2, alpha-5/beta-1 integrin, SOS, AKT(PKB), Fibronectin, IP3 receptor",2.92E-03,1.55E-02,10,"Neuropilin-2, PI3K cat class IA, PLGF, PKC-alpha, Neuropilin-1, alpha-5/beta-1 integrin, SOS, AKT(PKB), Fibronectin, IP3 receptor"
376,Immune response_LTBR1 signaling,60,1.04E-03,4.06E-03,1.04E-03,4.06E-03,14,"Syk, COX-2 (PTGS2), PI3K cat class IA, G-protein alpha-15, iNOS, PKC, G-protein alpha-i family, Adenylate cyclase, ERK1/2, AKT(PKB), G-protein alpha-q/11, PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor",6.68E-03,2.88E-02,12,"Syk, COX-2 (PTGS2), PI3K cat class IA, G-protein alpha-15, iNOS, PKC, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), G-protein alpha-q/11, PI3K reg class IB (p101), IP3 receptor"
377,Immune response_TREM1 signaling pathway,60,1.04E-03,4.06E-03,1.04E-03,4.06E-03,14,"BAD, Syk, IL-1 beta, PI3K cat class IA, CCL2, IL-8, TLR4, ERK1/2, IL-6, AKT(PKB), SOS1, PDK (PDPK1), TLR2, IP3 receptor",1.75E-02,5.79E-02,11,"Syk, IL-1 beta, PI3K cat class IA, CCL2, IL-8, TLR4, IL-6, AKT(PKB), SOS1, TLR2, IP3 receptor"
378,Membrane-bound ESR1: interaction with G-proteins signaling,54,1.14E-03,4.39E-03,1.14E-03,4.39E-03,13,"ADAM12, PKC-alpha, EGFR, G-protein alpha-i family, Adenylate cyclase, ERK1/2, MMP-14, MMP-2, ESR1 (membrane), SOS, Caveolin-1, MMP-9, IP3 receptor",2.71E-03,1.44E-02,12,"ADAM12, PKC-alpha, EGFR, G-protein alpha-i family, Adenylate cyclase, MMP-14, MMP-2, ESR1 (membrane), SOS, Caveolin-1, MMP-9, IP3 receptor"
379,NRF2 regulation of oxidative stress response,54,1.14E-03,4.39E-03,1.14E-03,4.39E-03,13,"GSTP1, PI3K cat class IA, UGT1A1, PKC, SLC7A11, Actin cytoskeletal, Fyn, ERK2 (MAPK1), AKT(PKB), GSTA3, p53, PDK (PDPK1), ERK1 (MAPK3)",1.11E-01,2.17E-01,8,"GSTP1, PI3K cat class IA, UGT1A1, PKC, SLC7A11, Fyn, AKT(PKB), GSTA3"
380,Regulation of AKT(PKB)/ GSK3 beta cascade in bipolar disorder,54,1.14E-03,4.39E-03,1.14E-03,4.39E-03,13,"NMDA receptor, NGF, G-protein alpha-i1, PI3K cat class IA, PTEN, Neuregulin 1, G-protein alpha-i family, GFRalpha1, ESR1 (membrane), FGF2, SOS, AKT(PKB), PDK (PDPK1)",8.00E-03,3.30E-02,11,"NMDA receptor, NGF, G-protein alpha-i1, PI3K cat class IA, Neuregulin 1, G-protein alpha-i family, GFRalpha1, ESR1 (membrane), FGF2, SOS, AKT(PKB)"
381,Growth factors in regulation of oligodendrocyte precursor cells proliferation in multiple sclerosis,54,1.14E-03,4.39E-03,1.14E-03,4.39E-03,13,"HGF, NGF, Myelin basic protein, PI3K cat class IA, PKC, ERK1/2, FGF2, SOS, PDGF-R-alpha, AKT(PKB), PDK (PDPK1), HGF receptor (Met), Fibronectin",8.00E-03,3.30E-02,11,"HGF, NGF, Myelin basic protein, PI3K cat class IA, PKC, FGF2, SOS, PDGF-R-alpha, AKT(PKB), HGF receptor (Met), Fibronectin"
382,Development_Role of Thyroid hormone in regulation of oligodendrocyte differentiation,48,1.23E-03,4.71E-03,1.23E-03,4.71E-03,12,"NGF, Myelin basic protein, p14ARF, OATP-A, TCF7L2 (TCF4), p15, PDGF-R-alpha, AKT(PKB), ID4, p53, PDK (PDPK1), p27KIP1",2.63E-02,7.57E-02,9,"NGF, Myelin basic protein, p14ARF, OATP-A, TCF7L2 (TCF4), p15, PDGF-R-alpha, AKT(PKB), ID4"
383,Activation of TGF-beta signaling in advanced colorectal cancer,30,1.25E-03,4.75E-03,1.25E-03,4.75E-03,9,"TGF-beta 2, PI3K cat class IA, IL-8, TGF-beta receptor type II, SNAIL1, SMAD3, AKT(PKB), MMP-9, IBP3",1.55E-02,5.26E-02,7,"TGF-beta 2, PI3K cat class IA, IL-8, TGF-beta receptor type II, AKT(PKB), MMP-9, IBP3"
384,Immune response_Sublytic effects of membrane attack complex,68,1.30E-03,4.90E-03,1.30E-03,4.90E-03,15,"BAD, PKC, cPLA2, EGFR, G-protein alpha-i family, ERK1/2, IL-6, Actin cytoskeletal, SOS, AKT(PKB), Caspase-8, PI3K reg class IB (p101), RGC32, XAF1, IP3 receptor",4.05E-02,1.06E-01,11,"PKC, cPLA2, EGFR, G-protein alpha-i family, IL-6, SOS, AKT(PKB), PI3K reg class IB (p101), RGC32, XAF1, IP3 receptor"
385,Development_EPO-induced Jak-STAT pathway,36,1.31E-03,4.93E-03,1.31E-03,4.93E-03,10,"STAT3, CISH, Lyn, Bcl-2, ERK1/2, SOS, c-Fes, ERK2 (MAPK1), ERK1 (MAPK3), Pim-1",1.02E-01,2.02E-01,6,"CISH, Lyn, Bcl-2, SOS, c-Fes, Pim-1"
386,Immune response_Role of DAP12 receptors in NK cells,55,1.37E-03,5.16E-03,1.37E-03,5.16E-03,13,"Syk, PI3K cat class IA, KLRC3, Lck, PKC-theta, HLA-B, ERK1/2, NKG2C, Actin cytoskeletal, Fyn, CD94, SOS, HLA-G",2.41E-02,7.16E-02,10,"Syk, PI3K cat class IA, KLRC3, PKC-theta, HLA-B, NKG2C, Fyn, CD94, SOS, HLA-G"
387,IGF-1 receptor/EGFR cooperation in lung cancer,25,1.46E-03,5.44E-03,1.46E-03,5.44E-03,8,"BAD, Tuberin, PI3K cat class IA, Amphiregulin, IRS-2, EGFR, AKT(PKB), PDK (PDPK1)",6.95E-02,1.53E-01,5,"PI3K cat class IA, Amphiregulin, IRS-2, EGFR, AKT(PKB)"
388,Activation of pro-oncogenic TGF-beta potential in gastric cancer,25,1.46E-03,5.44E-03,1.46E-03,5.44E-03,8,"GSTP1, TGF-beta 2, TGF-beta 3, TGF-beta receptor type II, MMP-2, SMAD3, Fibronectin, MMP-9",5.44E-03,2.44E-02,7,"GSTP1, TGF-beta 2, TGF-beta 3, TGF-beta receptor type II, MMP-2, Fibronectin, MMP-9"
389,Inhibition of oligodendrocyte precursor cells differentiation by Wnt signaling in multiple sclerosis,25,1.46E-03,5.44E-03,1.46E-03,5.44E-03,8,"WNT, TCF7L2 (TCF4), Beta-catenin, GLI-1, FZD7, Dsh, Frizzled, GLI-2",2.14E-02,6.53E-02,6,"WNT, TCF7L2 (TCF4), GLI-1, FZD7, Frizzled, GLI-2"
390,Development_Alpha-2 adrenergic receptor activation of ERK,62,1.46E-03,5.45E-03,1.46E-03,5.45E-03,14,"G-protein alpha-i1, PI3K cat class IA, ADAM12, cPLA2, EGFR, G-protein alpha-i family, ERK1/2, SOS, ERK2 (MAPK1), Alpha-2A adrenergic receptor, AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), IP3 receptor",5.03E-02,1.23E-01,10,"G-protein alpha-i1, PI3K cat class IA, ADAM12, cPLA2, EGFR, G-protein alpha-i family, SOS, Alpha-2A adrenergic receptor, AKT(PKB), IP3 receptor"
391,Signal transduction_IP3 signaling,49,1.50E-03,5.50E-03,1.50E-03,5.50E-03,12,"Syk, Galpha(q)-specific nucleotide-like GPCRs, PI3K cat class IA, ERK1/2, SOS, MEF2, AKT(PKB), G-protein alpha-q/11, PDGF receptor, PDK (PDPK1), HGF receptor (Met), IP3 receptor",1.11E-02,4.21E-02,10,"Syk, Galpha(q)-specific nucleotide-like GPCRs, PI3K cat class IA, SOS, MEF2, AKT(PKB), G-protein alpha-q/11, PDGF receptor, HGF receptor (Met), IP3 receptor"
392,PDE4 regulation of cyto/chemokine expression in arthritis,49,1.50E-03,5.50E-03,1.50E-03,5.50E-03,12,"PGE2R2, IL-1 beta, PGE2R4, PI3K cat class IA, RelA (p65 NF-kB subunit), Lck, IP10, CCL2, IL-8, ENA-78, IL-6, AKT(PKB)",3.69E-03,1.84E-02,11,"PGE2R2, IL-1 beta, PGE2R4, PI3K cat class IA, RelA (p65 NF-kB subunit), IP10, CCL2, IL-8, ENA-78, IL-6, AKT(PKB)"
393,Tissue Factor signaling in cancer via PAR1 and PAR2,49,1.50E-03,5.50E-03,1.50E-03,5.50E-03,12,"PI3K cat class IA, PKC-alpha, IL-8, EGFR, ERK1/2, TGF-alpha, SOS, AKT(PKB), G-protein alpha-q/11, Tissue factor, Coagulation factor VII, IP3 receptor",3.69E-03,1.84E-02,11,"PI3K cat class IA, PKC-alpha, IL-8, EGFR, TGF-alpha, SOS, AKT(PKB), G-protein alpha-q/11, Tissue factor, Coagulation factor VII, IP3 receptor"
394,Neurophysiological process_HTR2A signaling in the nervous system,49,1.50E-03,5.50E-03,1.50E-03,5.50E-03,12,"NMDA receptor, cPKC (conventional), iNOS, PKC, GABA-A receptor, ERK1/2, AKT(PKB), G-protein alpha-q/11, Caveolin-1, GABA-A receptor gamma-2 subunit, SFK, IP3 receptor",3.69E-03,1.84E-02,11,"NMDA receptor, cPKC (conventional), iNOS, PKC, GABA-A receptor, AKT(PKB), G-protein alpha-q/11, Caveolin-1, GABA-A receptor gamma-2 subunit, SFK, IP3 receptor"
395,Signal transduction_Soluble CXCL16 signaling,49,1.50E-03,5.50E-03,1.50E-03,5.50E-03,12,"STAT3, Tuberin, CD44, IL-8, G-protein alpha-i family, F-Actin cytoskeleton, ERK1/2, MMP-2, NF-kB, AKT(PKB), PDK (PDPK1), MMP-9",1.50E-01,2.70E-01,7,"CD44, IL-8, G-protein alpha-i family, MMP-2, NF-kB, AKT(PKB), MMP-9"
396,Chemotaxis_CXCR3-A signaling,69,1.52E-03,5.56E-03,1.52E-03,5.56E-03,15,"Lck, IP10, STAT4, I-TAC, IL-8, ROR-gamma, ERK1/2, MMP-2, SOS, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), MMP-9, PREX2, IP3 receptor",1.99E-02,6.29E-02,12,"IP10, STAT4, I-TAC, IL-8, ROR-gamma, MMP-2, SOS, AKT(PKB), PI3K reg class IB (p101), MMP-9, PREX2, IP3 receptor"
397,Cytoskeleton remodeling_PDGF signaling via calcium and Rho GTPases,83,1.53E-03,5.58E-03,1.53E-03,5.58E-03,17,"N-cadherin, Schwannomin (NF2), Lysyl oxidase, PKC, F-Actin, PKC-alpha, PDGF-C, Beta-catenin, EBP50, Actin cytoskeletal, Fyn, PDGFR-ab, TRPC6, PDGF-R-alpha, PDGF receptor, IP3 receptor, PDGF-R-beta",3.48E-02,9.49E-02,13,"N-cadherin, Lysyl oxidase, PKC, PKC-alpha, PDGF-C, EBP50, Fyn, PDGFR-ab, TRPC6, PDGF-R-alpha, PDGF receptor, IP3 receptor, PDGF-R-beta"
398,Neurophysiological process_Dopamine D2 receptor transactivation of PDGFR in CNS,26,1.55E-03,6.70E-03,1.93E-03,6.70E-03,8,"NMDA receptor, PKC, G-protein alpha-i family, NR1, PP2A regulatory, PDGF receptor, IP3 receptor, PDGF-R-beta",1.55E-03,9.55E-03,8,"NMDA receptor, PKC, G-protein alpha-i family, NR1, PP2A regulatory, PDGF receptor, IP3 receptor, PDGF-R-beta"
399,Signal transduction_AKT signaling,43,1.59E-03,5.79E-03,1.59E-03,5.79E-03,11,"BAD, PCNA, Tuberin, PI3K cat class IA, PTEN, NF-kB, AKT(PKB), p53, PDK (PDPK1), HGF receptor (Met), p27KIP1",5.53E-01,7.04E-01,4,"PI3K cat class IA, NF-kB, AKT(PKB), HGF receptor (Met)"
400,Effect of H. pylori infection on gastric epithelial cells motility,43,1.59E-03,5.79E-03,1.59E-03,5.79E-03,11,"ITGB1, PKC-alpha, Connexin 32, Lyn, ERK1/2, Beta-catenin, alpha-5/beta-1 integrin, Actin cytoskeletal, Claudin-1, Actin, PTPR-zeta",3.66E-02,9.76E-02,8,"ITGB1, PKC-alpha, Connexin 32, Lyn, alpha-5/beta-1 integrin, Claudin-1, Actin, PTPR-zeta"
401,Regulation of immune cell differentiation by Notch signaling,43,1.59E-03,5.79E-03,1.59E-03,5.79E-03,11,"NOTCH4 (ICD4), GATA-3, PI3K cat class IA, Lck, IFI16, NOTCH4, SMAD3, AKT(PKB), PDK (PDPK1), Jagged1, ADAM19",3.66E-02,9.76E-02,8,"NOTCH4 (ICD4), GATA-3, PI3K cat class IA, IFI16, NOTCH4, AKT(PKB), Jagged1, ADAM19"
402,CCL2 in Prostate Cancer,20,1.60E-03,5.81E-03,1.60E-03,5.81E-03,7,"Tuberin, PTEN, CCL2, G-protein alpha-i family, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101)",1.01E-01,2.01E-01,4,"CCL2, G-protein alpha-i family, AKT(PKB), PI3K reg class IB (p101)"
403,Autocrine production of eosinophil pro-survival cytokines in asthma,31,1.61E-03,5.81E-03,1.61E-03,5.81E-03,9,"IL-15, PI3K cat class IA, alpha-4/beta-1 integrin, ICAM1, CD44, ERK1/2, YB-1, NF-kB, Fibronectin",1.85E-02,5.95E-02,7,"IL-15, PI3K cat class IA, alpha-4/beta-1 integrin, ICAM1, CD44, NF-kB, Fibronectin"
404,Development_Activation of ERK by Kappa-type opioid receptor,31,1.61E-03,5.81E-03,1.61E-03,5.81E-03,9,"PKC-alpha, G-protein alpha-i family, SOS, ERK2 (MAPK1), PDK (PDPK1), PI3K reg class IB (p101), ERK1 (MAPK3), Kappa-type opioid receptor, IP3 receptor",5.61E-02,1.31E-01,6,"PKC-alpha, G-protein alpha-i family, SOS, PI3K reg class IB (p101), Kappa-type opioid receptor, IP3 receptor"
405,FGFR3 signaling in multiple myeloma,37,1.64E-03,5.88E-03,1.64E-03,5.88E-03,10,"STAT3, N-Ras, ERK1/2, FGF2, SOS, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), FGF9",4.33E-01,6.02E-01,4,"FGF2, SOS, AKT(PKB), FGF9"
406,Development_Retinoic acid and retinoic acid receptors in regulation of oligodendrocyte differentiation,37,1.64E-03,5.88E-03,1.64E-03,5.88E-03,10,"Myelin basic protein, p14ARF, DHA2, BMP4, p15, STRA6, PDGF-R-alpha, p53, p27KIP1, BMP2",1.57E-02,5.27E-02,8,"Myelin basic protein, p14ARF, DHA2, BMP4, p15, STRA6, PDGF-R-alpha, BMP2"
407,Attenuation of IFN type I signaling in melanoma cells,37,1.64E-03,5.88E-03,1.64E-03,5.88E-03,10,"STAT3, TAP1 (PSF1), PSMB8(LMP7), IP10, HLA-A, I-TAC, TAP2 (PSF2), PSMB9, TAP, IFN-beta",4.76E-03,2.22E-02,9,"TAP1 (PSF1), PSMB8(LMP7), IP10, HLA-A, I-TAC, TAP2 (PSF2), PSMB9, TAP, IFN-beta"
408,Neurophysiological process_Constitutive and regulated NMDA receptor trafficking,65,1.71E-03,7.77E-03,2.36E-03,7.77E-03,14,"NMDA receptor, Chapsyn-110, cPKC (conventional), PKC, NR2, PACAP, G-protein alpha-i family, Adenylate cyclase, NR1, MALS, Fyn, KIF17, NR2A, IP3 receptor",1.71E-03,1.01E-02,14,"NMDA receptor, Chapsyn-110, cPKC (conventional), PKC, NR2, PACAP, G-protein alpha-i family, Adenylate cyclase, NR1, MALS, Fyn, KIF17, NR2A, IP3 receptor"
409,Immune response_IL-4-responsive genes in type 2 immunity,70,1.77E-03,6.29E-03,1.77E-03,6.29E-03,15,"STAT3, COX-2 (PTGS2), IL-19, GATA-3, CCL13, Eotaxin-2, CCL2, TFF3, Mucin 5AC, IGHE, ACTA2, IGHG4, AKT(PKB), Fibronectin, CCL7",3.54E-03,1.80E-02,14,"COX-2 (PTGS2), IL-19, GATA-3, CCL13, Eotaxin-2, CCL2, TFF3, Mucin 5AC, IGHE, ACTA2, IGHG4, AKT(PKB), Fibronectin, CCL7"
410,Apoptosis and survival_NGF/ TrkA PI3K-mediated signaling,77,1.77E-03,6.29E-03,1.77E-03,6.29E-03,16,"BAD, NGF, PI3K cat class IA, MSN (moesin), CLCN4, MRLC, Bcl-2, ERK1/2, Myosin II, Actin cytoskeletal, Tau (MAPT), SOS, AKT(PKB), PDK (PDPK1), ARAP3, PREX1",8.52E-02,1.80E-01,11,"NGF, PI3K cat class IA, MSN (moesin), CLCN4, MRLC, Bcl-2, Tau (MAPT), SOS, AKT(PKB), ARAP3, PREX1"
411,Role of activation of WNT signaling in the progression of lung cancer,77,1.77E-03,6.29E-03,1.77E-03,6.29E-03,16,"iNOS, DVL-3, RUNX3, Oct-3/4, DKK3, Tcf(Lef), WNT, TCF7L2 (TCF4), WNT3, Beta-catenin, Matrilysin (MMP-7), SFRP1, FZD7, Dsh, CD147, Frizzled",1.99E-02,6.29E-02,13,"iNOS, RUNX3, Oct-3/4, DKK3, Tcf(Lef), WNT, TCF7L2 (TCF4), WNT3, Matrilysin (MMP-7), SFRP1, FZD7, CD147, Frizzled"
412,Development_Thromboxane A2 signaling pathway,50,1.80E-03,6.33E-03,1.80E-03,6.33E-03,12,"cPKC (conventional), PI3K cat class IA, PKC, Tcf(Lef), EGFR, G-protein alpha-i family, Adenylate cyclase, ERK1/2, IL-6, Beta-catenin, AKT(PKB), IP3 receptor",1.27E-02,4.65E-02,10,"cPKC (conventional), PI3K cat class IA, PKC, Tcf(Lef), EGFR, G-protein alpha-i family, Adenylate cyclase, IL-6, AKT(PKB), IP3 receptor"
413,Development_GM-CSF signaling,50,1.80E-03,6.33E-03,1.80E-03,6.33E-03,12,"BAD, STAT3, PI3K cat class IA, CISH, CCL2, Lyn, Bcl-2, ERK1/2, SOS, NF-kB, AKT(PKB), Pim-1",3.34E-02,9.29E-02,9,"PI3K cat class IA, CISH, CCL2, Lyn, Bcl-2, SOS, NF-kB, AKT(PKB), Pim-1"
414,Apoptosis and survival_HTR1A signaling,50,1.80E-03,6.33E-03,1.80E-03,6.33E-03,12,"STAT3, G-protein alpha-i family, Adenylate cyclase, Bcl-2, PP2A regulatory, SOS, NF-kB, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), ERK1 (MAPK3)",7.81E-02,1.69E-01,8,"G-protein alpha-i family, Adenylate cyclase, Bcl-2, PP2A regulatory, SOS, NF-kB, AKT(PKB), PI3K reg class IB (p101)"
415,Immune response_C5a signaling,50,1.80E-03,6.33E-03,1.80E-03,6.33E-03,12,"BAD, IL-1 beta, PKC, IL-8, G-protein alpha-i family, Bcl-2, ERK1/2, Rac2, NF-kB, AKT(PKB), PDK (PDPK1), PREX1",3.34E-02,9.29E-02,9,"IL-1 beta, PKC, IL-8, G-protein alpha-i family, Bcl-2, Rac2, NF-kB, AKT(PKB), PREX1"
416,PDE4 regulation of cyto/chemokine expression in inflammatory skin diseases,50,1.80E-03,6.33E-03,1.80E-03,6.33E-03,12,"IL-1 beta, G-protein alpha-i1, MxA, RelA (p65 NF-kB subunit), iNOS, IP10, CCL2, IL-8, G-protein alpha-i family, Adenylate cyclase, ERK1/2, IL-6",4.35E-03,2.05E-02,11,"IL-1 beta, G-protein alpha-i1, MxA, RelA (p65 NF-kB subunit), iNOS, IP10, CCL2, IL-8, G-protein alpha-i family, Adenylate cyclase, IL-6"
417,Multiple sclerosis (general schema),21,1.81E-03,7.43E-03,2.21E-03,7.43E-03,7,"NGF, ICAM1, LIF, FGF2, Fibronectin, Jagged1, IFN-beta",1.81E-03,1.06E-02,7,"NGF, ICAM1, LIF, FGF2, Fibronectin, Jagged1, IFN-beta"
418,Chemotaxis_Lysophosphatidic acid signaling via GPCRs,129,1.85E-03,6.46E-03,1.85E-03,6.46E-03,23,"cPKC (conventional), PAK, PKC, LPAR1, Tcf(Lef), IL-8, EGFR, G-protein alpha-i family, F-Actin cytoskeleton, Bcl-2, ERK1/2, Beta-catenin, Rho GTPase, Actin cytoskeletal, TAZ, MKL1, CTGF, AKT(PKB), G-protein alpha-q/11, p53, PDK (PDPK1), IP3 receptor, PREX1",7.32E-02,1.59E-01,17,"cPKC (conventional), PAK, PKC, LPAR1, Tcf(Lef), IL-8, EGFR, G-protein alpha-i family, Bcl-2, Rho GTPase, TAZ, MKL1, CTGF, AKT(PKB), G-protein alpha-q/11, IP3 receptor, PREX1"
419,SLE genetic marker-specific pathways in B cells,99,1.86E-03,6.51E-03,1.86E-03,6.51E-03,19,"Syk, BANK, CalDAG-GEFIII, CD38, ETS1, XBP1, Lyn, TLR4, Bcl-2, ERK1/2, BLNK, Fc gamma RII beta, TLR7, SOS, NF-kB, p27KIP1, IFN-beta, IP3 receptor, BLIMP1 (PRDI-BF1)",7.18E-03,3.03E-02,17,"Syk, BANK, CalDAG-GEFIII, CD38, ETS1, XBP1, Lyn, TLR4, Bcl-2, BLNK, Fc gamma RII beta, TLR7, SOS, NF-kB, IFN-beta, IP3 receptor, BLIMP1 (PRDI-BF1)"
420,Muscle contraction_Delta-type opioid receptor in smooth muscle contraction,26,1.93E-03,6.70E-03,1.93E-03,6.70E-03,8,"Metenkefalin, G-protein alpha-i family, MRLC, Myosin II, CPI-17, Leu-enkephalin, PI3K reg class IB (p101), IP3 receptor",6.88E-03,2.93E-02,7,"Metenkefalin, G-protein alpha-i family, MRLC, CPI-17, Leu-enkephalin, PI3K reg class IB (p101), IP3 receptor"
421,Gamma-Secretase regulation of neuronal cell development and function,57,1.94E-03,6.70E-03,1.94E-03,6.70E-03,13,"NMDA receptor, N-cadherin, NGF, NGFR (ICD), NGFR(TNFRSF16), NGFR (CTF), Neuregulin 1, Transgelin, Beta-catenin, ACTA2, N-cadherin (CTF1), N-cadherin (CTF2), Tau (MAPT)",4.34E-03,2.05E-02,12,"NMDA receptor, N-cadherin, NGF, NGFR (ICD), NGFR(TNFRSF16), NGFR (CTF), Neuregulin 1, Transgelin, ACTA2, N-cadherin (CTF1), N-cadherin (CTF2), Tau (MAPT)"
422,CCR7 signaling pathways in dendritic cells in allergic contact dermatitis,57,1.94E-03,6.70E-03,1.94E-03,6.70E-03,13,"alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, ERK1/2, Myosin II, Actin cytoskeletal, Rac2, SOS, AKT(PKB), PDK (PDPK1), Fibronectin, PI3K reg class IB (p101), IP3 receptor",6.86E-02,1.53E-01,9,"alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, Rac2, SOS, AKT(PKB), Fibronectin, PI3K reg class IB (p101), IP3 receptor"
423,K-RAS signaling in pancreatic cancer,44,1.95E-03,6.70E-03,1.95E-03,6.70E-03,11,"RelA (p65 NF-kB subunit), PTEN, IL-8, FGFR4, Bcl-2, ERK1/2, SNAIL1, AKT(PKB), p53, PDK (PDPK1), PLAU (UPA)",2.03E-01,3.41E-01,6,"RelA (p65 NF-kB subunit), IL-8, FGFR4, Bcl-2, AKT(PKB), PLAU (UPA)"
424,Influence of smoking on activation of EGFR signaling in lung cancer cells,44,1.95E-03,6.70E-03,1.95E-03,6.70E-03,11,"Amphiregulin, Fra-1, Epiregulin, EGFR, Adenylate cyclase, ERK1/2, MMP-2, SOS, ERK2 (MAPK1), ERK1 (MAPK3), MMP-9",4.13E-02,1.07E-01,8,"Amphiregulin, Fra-1, Epiregulin, EGFR, Adenylate cyclase, MMP-2, SOS, MMP-9"
425,Complement pathway disruption in thrombotic microangiopathy,39,1.95E-03,8.19E-03,2.52E-03,8.19E-03,10,"IL-1 beta, cPKC (conventional), PKC, C3, IL-8, Factor I, C3b, Factor H, MYLK1, C3a",1.95E-03,1.11E-02,10,"IL-1 beta, cPKC (conventional), PKC, C3, IL-8, Factor I, C3b, Factor H, MYLK1, C3a"
426,PXR-mediated direct regulation of xenobiotic metabolizing enzymes / Rodent version,39,1.95E-03,8.19E-03,2.52E-03,8.19E-03,10,"CYP27A1, UGT1A1, OATP-A, S14 protein, CYP24A1, UGT1A4, MDR1, CYP2B6, UGT1A6, CYP11A1",1.95E-03,1.11E-02,10,"CYP27A1, UGT1A1, OATP-A, S14 protein, CYP24A1, UGT1A4, MDR1, CYP2B6, UGT1A6, CYP11A1"
427,Blood coagulation_Blood coagulation,39,1.95E-03,8.19E-03,2.52E-03,8.19E-03,10,"SERPINE2, Alpha 1-antitrypsin, PLAT (TPA), A2M, Protein C, PAI2, Tissue factor, Coagulation factor VII, Protein S, PLAU (UPA)",1.95E-03,1.11E-02,10,"SERPINE2, Alpha 1-antitrypsin, PLAT (TPA), A2M, Protein C, PAI2, Tissue factor, Coagulation factor VII, Protein S, PLAU (UPA)"
428,Cooperative action of IFN-gamma and TNF-alpha on astrocytes in multiple sclerosis,39,1.95E-03,8.19E-03,2.52E-03,8.19E-03,10,"MHC class II, iNOS, IP10, ICAM1, CCL2, Adenylate cyclase, CIITA, HLA-DRA1, Beta-2 adrenergic receptor, NF-kB",1.95E-03,1.11E-02,10,"MHC class II, iNOS, IP10, ICAM1, CCL2, Adenylate cyclase, CIITA, HLA-DRA1, Beta-2 adrenergic receptor, NF-kB"
429,Myeloid-derived suppressor cells and M2 macrophages in cancer,64,2.02E-03,6.94E-03,2.02E-03,6.94E-03,14,"STAT3, COX-2 (PTGS2), PGE2R2, IL-1 beta, PGE2R4, IDO1, iNOS, TLR4, SLC7A11, IL-6, NF-kB, CSF1, CAT-2, PD-L1",4.22E-03,2.03E-02,13,"COX-2 (PTGS2), PGE2R2, IL-1 beta, PGE2R4, IDO1, iNOS, TLR4, SLC7A11, IL-6, NF-kB, CSF1, CAT-2, PD-L1"
430,Immune response_Role of integrins in NK cells cytotoxicity,38,2.05E-03,6.94E-03,2.05E-03,6.94E-03,10,"alpha-4/beta-1 integrin, ICAM1, IL-8, Lyn, CD94, SOS, ERK2 (MAPK1), Fibronectin, ICAM2, ERK1 (MAPK3)",1.84E-02,5.95E-02,8,"alpha-4/beta-1 integrin, ICAM1, IL-8, Lyn, CD94, SOS, Fibronectin, ICAM2"
431,Insulin-like growth factor family signaling in melanoma,38,2.05E-03,6.94E-03,2.05E-03,6.94E-03,10,"PI3K cat class IA, PKC, IL-8, Cyclin E, ERK1/2, Beta-catenin, AKT(PKB), p53, p27KIP1, IBP3",1.24E-01,2.35E-01,6,"PI3K cat class IA, PKC, IL-8, Cyclin E, AKT(PKB), IBP3"
432,Immune response_IL-6 signaling pathway via JAK/STAT,71,2.05E-03,6.94E-03,2.05E-03,6.94E-03,15,"STAT3, COX-2 (PTGS2), CISH, iNOS, RUNX2, ICAM1, CCL2, Mucin 13, ROR-gamma, ALPL, IL-6, Rac2, AKT(PKB), p27KIP1, CDK6",1.04E-02,4.02E-02,13,"COX-2 (PTGS2), CISH, iNOS, RUNX2, ICAM1, CCL2, Mucin 13, ROR-gamma, ALPL, IL-6, Rac2, AKT(PKB), CDK6"
433,The role of KEAP1/NRF2 pathway in skin sensitization,32,2.06E-03,6.94E-03,2.06E-03,6.94E-03,9,"IL-1 beta, TNF-R2, IL-8, TLR4, ERK1/2, NF-kB, ERK2 (MAPK1), Caspase-1, ERK1 (MAPK3)",6.39E-02,1.45E-01,6,"IL-1 beta, TNF-R2, IL-8, TLR4, NF-kB, Caspase-1"
434,Inhibition of LKB1 / AMPK signaling in breast cancer,32,2.06E-03,6.94E-03,2.06E-03,6.94E-03,9,"Tuberin, PTEN, CYP19, IL-6, PPARGC1 (PGC1-alpha), SNAIL1, AKT(PKB), FASN, Vimentin",1.58E-01,2.82E-01,5,"CYP19, IL-6, PPARGC1 (PGC1-alpha), AKT(PKB), Vimentin"
435,Interleukins-induced inflammatory signaling in normal and asthmatic airway epithelium,32,2.06E-03,6.94E-03,2.06E-03,6.94E-03,9,"IL-1 beta, ST2(L), IP10, IL-8, IL-33, ERK1/2, IL-6, NF-kB, Fibronectin",6.41E-03,2.77E-02,8,"IL-1 beta, ST2(L), IP10, IL-8, IL-33, IL-6, NF-kB, Fibronectin"
436,Development_H3K4 demethylases in stem cell maintenance,32,2.06E-03,6.94E-03,2.06E-03,6.94E-03,9,"PTEN, ACM4, TLX, HOXA1, SCN2A, HOXA7, SCN3A, HOXA5, p27KIP1",2.19E-02,6.60E-02,7,"ACM4, TLX, HOXA1, SCN2A, HOXA7, SCN3A, HOXA5"
437,Development_Schema: Histone H3 demethylases in stem cells,32,2.06E-03,6.94E-03,2.06E-03,6.94E-03,9,"p14ARF, PTEN, p15, HOXA1, SCN2A, HOXA7, p16INK4, p27KIP1, HOXA11",2.19E-02,6.60E-02,7,"p14ARF, p15, HOXA1, SCN2A, HOXA7, p16INK4, HOXA11"
438,Development_Role of G-CSF in hematopoietic stem cell mobilization,21,2.21E-03,7.43E-03,2.21E-03,7.43E-03,7,"STAT3, S1P1 receptor, ICAM1, MMP-14, DPP4, MMP-9, GFI-1",8.93E-03,3.56E-02,6,"S1P1 receptor, ICAM1, MMP-14, DPP4, MMP-9, GFI-1"
439,Oxidative stress_ROS-induced cellular signaling,108,2.24E-03,7.50E-03,2.24E-03,7.50E-03,20,"GSTP1, Syk, COX-2 (PTGS2), IL-1 beta, Tuberin, RelA (p65 NF-kB subunit), iNOS, PKC, HES5, PTEN, IL-8, ERK1/2, IL-6, NOXA, NF-kB, SAE2, AKT(PKB), p53, FASN, Carbonic anhydrase IX",6.16E-02,1.41E-01,15,"GSTP1, Syk, COX-2 (PTGS2), IL-1 beta, RelA (p65 NF-kB subunit), iNOS, PKC, HES5, IL-8, IL-6, NOXA, NF-kB, SAE2, AKT(PKB), Carbonic anhydrase IX"
440,Immune response_CD40 signaling,65,2.36E-03,7.77E-03,2.36E-03,7.77E-03,14,"STAT3, COX-2 (PTGS2), PI3K cat class IA, ICAM1, CCL2, IL-8, Lyn, IL-6, NF-kB, AKT(PKB), p53, PDK (PDPK1), p27KIP1, A20",6.57E-02,1.47E-01,10,"COX-2 (PTGS2), PI3K cat class IA, ICAM1, CCL2, IL-8, Lyn, IL-6, NF-kB, AKT(PKB), A20"
441,Development_Role of IL-8 in angiogenesis,65,2.36E-03,7.77E-03,2.36E-03,7.77E-03,14,"STAT3, PI3K cat class IA, IL-8, EGFR, G-protein alpha-i family, ERK1/2, MMP-14, NF-kB, AKT(PKB), Caveolin-1, IL8RA, PDK (PDPK1), FASN, PI3K reg class IB (p101)",6.57E-02,1.47E-01,10,"PI3K cat class IA, IL-8, EGFR, G-protein alpha-i family, MMP-14, NF-kB, AKT(PKB), Caveolin-1, IL8RA, PI3K reg class IB (p101)"
442,Dysregulation of germinal center response in SLE,65,2.36E-03,7.77E-03,2.36E-03,7.77E-03,14,"STAT3, IL-15, MFGE8, IL-15RA, ESR1 (nuclear), alpha-4/beta-1 integrin, ICAM1, BOB1, Fc gamma RII beta, TLR7, NF-kB, C3dg, RGS16, PI3K cat class IA (p110-delta)",4.85E-03,2.26E-02,13,"IL-15, MFGE8, IL-15RA, ESR1 (nuclear), alpha-4/beta-1 integrin, ICAM1, BOB1, Fc gamma RII beta, TLR7, NF-kB, C3dg, RGS16, PI3K cat class IA (p110-delta)"
443,Retinal ganglion cell damage in glaucoma,45,2.36E-03,7.77E-03,2.36E-03,7.77E-03,11,"BAD, NMDA receptor, NGF, NGFR(TNFRSF16), EDNRB, iNOS, A2M, C3, Factor H, NF-kB, EDNRA",5.97E-03,2.61E-02,10,"NMDA receptor, NGF, NGFR(TNFRSF16), EDNRB, iNOS, A2M, C3, Factor H, NF-kB, EDNRA"
444,Immune response_TNF-R2 signaling pathways,45,2.36E-03,7.77E-03,2.36E-03,7.77E-03,11,"TNF-R2, c-IAP2, BMX, PI3K cat class IA, RelA (p65 NF-kB subunit), c-IAP1, Bcl-2, ERK1/2, NF-kB, AKT(PKB), PDK (PDPK1)",1.77E-02,5.79E-02,9,"TNF-R2, c-IAP2, BMX, PI3K cat class IA, RelA (p65 NF-kB subunit), c-IAP1, Bcl-2, NF-kB, AKT(PKB)"
445,Cell adhesion_Histamine H1 receptor signaling in the interruption of cell barrier integrity,45,2.36E-03,7.77E-03,2.36E-03,7.77E-03,11,"Histamine H1 receptor, PKC-alpha, MRLC, Myosin II, Beta-catenin, Actin cytoskeletal, CPI-17, G-protein alpha-q/11, MELC, MLCK, IP3 receptor",4.65E-02,1.16E-01,8,"Histamine H1 receptor, PKC-alpha, MRLC, CPI-17, G-protein alpha-q/11, MELC, MLCK, IP3 receptor"
446,Proinflammatory mediators production and activation of basophils in asthma,45,2.36E-03,7.77E-03,2.36E-03,7.77E-03,11,"NGF, ST2(L), MHC class II, PI3K cat class IA, DHA2, ITGA4, IL-8, IL-33, ERK1/2, NF-kB, AKT(PKB)",5.97E-03,2.61E-02,10,"NGF, ST2(L), MHC class II, PI3K cat class IA, DHA2, ITGA4, IL-8, IL-33, NF-kB, AKT(PKB)"
447,Blood coagulation_Platelet microparticle generation,72,2.37E-03,7.77E-03,2.37E-03,7.77E-03,15,"IL-1 beta, ITGB1, cPKC (conventional), PKC, MSN (moesin), cPLA2, Actin cytoskeletal, PLA2G7, TRPC6, Alpha-2A adrenergic receptor, Tissue factor, Fibronectin, MyHC, MYLK1, IP3 receptor",1.17E-02,4.32E-02,13,"IL-1 beta, ITGB1, cPKC (conventional), PKC, MSN (moesin), cPLA2, PLA2G7, TRPC6, Alpha-2A adrenergic receptor, Tissue factor, Fibronectin, MYLK1, IP3 receptor"
448,Inhibition of TGF-beta 1 signaling in early colorectal cancer,27,2.52E-03,8.19E-03,2.52E-03,8.19E-03,8,"PI3K cat class IA, TGF-beta receptor type II, MAP2, MMP-2, CEACAM5, SMAD3, AKT(PKB), MMP-9",8.57E-03,3.45E-02,7,"PI3K cat class IA, TGF-beta receptor type II, MAP2, MMP-2, CEACAM5, AKT(PKB), MMP-9"
449,Development_Self-renewal of adult neural stem cells,52,2.57E-03,8.29E-03,2.57E-03,8.29E-03,12,"p14ARF, HES5, PTCH1, PTEN, SOX2, WNT7A, TLX, Nestin, GLI-1, FKHL1, p16INK4, GLI-2",5.96E-03,2.61E-02,11,"p14ARF, HES5, PTCH1, SOX2, WNT7A, TLX, Nestin, GLI-1, FKHL1, p16INK4, GLI-2"
450,Signal transduction_Additional pathways of NF-kB activation (in the cytoplasm),52,2.57E-03,8.29E-03,2.57E-03,8.29E-03,12,"PI3K cat class IA, RelA (p65 NF-kB subunit), Lck, PKC-theta, PKC-alpha, Adenylate cyclase, ERK1/2, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), Pim-1, CDK6",4.18E-02,1.08E-01,9,"PI3K cat class IA, RelA (p65 NF-kB subunit), PKC-theta, PKC-alpha, Adenylate cyclase, AKT(PKB), PI3K reg class IB (p101), Pim-1, CDK6"
451,G-protein signaling_Proinsulin C-peptide signaling,52,2.57E-03,8.29E-03,2.57E-03,8.29E-03,12,"COX-2 (PTGS2), PI3K cat class IA, PKC-alpha, G-protein alpha-i family, Bcl-2, ERK1/2, SOS, NF-kB, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor",1.67E-02,5.55E-02,10,"COX-2 (PTGS2), PI3K cat class IA, PKC-alpha, G-protein alpha-i family, Bcl-2, SOS, NF-kB, AKT(PKB), PI3K reg class IB (p101), IP3 receptor"
452,p53 signaling in Prostate Cancer,33,2.60E-03,8.30E-03,2.60E-03,8.30E-03,9,"Androgen receptor, PI3K cat class IA, p53 (mitochondrial), PTEN, NOXA, AKT(PKB), p53, PDK (PDPK1), IBP3",1.73E-01,3.02E-01,5,"Androgen receptor, PI3K cat class IA, NOXA, AKT(PKB), IBP3"
453,SDF-1 axis in endothelial progenitor cell recruitment in healing myocardial infarction,33,2.60E-03,8.30E-03,2.60E-03,8.30E-03,9,"Tuberin, TIE2, ICAM1, Angiopoietin 1, Rac2, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101)",7.24E-02,1.58E-01,6,"TIE2, ICAM1, Angiopoietin 1, Rac2, AKT(PKB), PI3K reg class IB (p101)"
454,IL-2 as a growth factor for T cells in multiple sclerosis,33,2.60E-03,8.30E-03,2.60E-03,8.30E-03,9,"PCNA, Tuberin, PI3K cat class IA, Cyclin E, Bcl-2, NF-kB, AKT(PKB), PDK (PDPK1), p27KIP1",1.73E-01,3.02E-01,5,"PI3K cat class IA, Cyclin E, Bcl-2, NF-kB, AKT(PKB)"
455,LRRK2 in neurons in Parkinson's disease,33,2.60E-03,8.30E-03,2.60E-03,8.30E-03,9,"Alpha-synuclein, LRRK2, MSN (moesin), ERK1/2, Actin cytoskeletal, Tau (MAPT), eEF1A2, ACTB, eEF1A",7.24E-02,1.58E-01,6,"Alpha-synuclein, LRRK2, MSN (moesin), Tau (MAPT), eEF1A2, eEF1A"
456,Regulation of GSK3 beta in bipolar disorder,46,2.85E-03,9.06E-03,2.85E-03,9.06E-03,11,"IL-1 beta, NGF, WNT, ERK1/2, PP2A regulatory, FGF2, SOS, AKT(PKB), Nucleoredoxin, Dsh, Frizzled",2.03E-02,6.35E-02,9,"IL-1 beta, NGF, WNT, PP2A regulatory, FGF2, SOS, AKT(PKB), Nucleoredoxin, Frizzled"
457,Transcription_Hypoxia- and receptor-mediated HIF-1 activation,46,2.85E-03,9.06E-03,2.85E-03,9.06E-03,11,"STAT3, HGF, IL-1 beta, PI3K cat class IA, LRRK2, Neuregulin 1, EGFR, ERK1/2, AKT(PKB), GPNMB (Osteoactivin), PDK (PDPK1)",5.20E-02,1.23E-01,8,"HGF, IL-1 beta, PI3K cat class IA, LRRK2, Neuregulin 1, EGFR, AKT(PKB), GPNMB (Osteoactivin)"
458,Ubiquitin-proteasome system in Huntington's disease,22,2.99E-03,9.46E-03,2.99E-03,9.46E-03,7,"NMDA receptor, PKC-alpha, NR2, NR1, PSMB9, p53, NR2A",1.14E-02,4.22E-02,6,"NMDA receptor, PKC-alpha, NR2, NR1, PSMB9, NR2A"
459,Inhibition of RUNX3 signaling in gastric cancer,22,2.99E-03,9.46E-03,2.99E-03,9.46E-03,7,"RUNX3, Bcl-2, LMO1, Caspase-8, p27KIP1, MMP-9, MDR1",4.31E-02,1.09E-01,5,"RUNX3, Bcl-2, LMO1, MMP-9, MDR1"
460,Notch signaling in breast cancer,53,3.05E-03,9.61E-03,3.05E-03,9.61E-03,12,"NOTCH4 (ICD4), HES5, ESR1 (nuclear), CD44, SLUG, EGFR, Beta-catenin, NOTCH4, NOXA, TFF1, Jagged1, PLAU (UPA)",6.92E-03,2.93E-02,11,"NOTCH4 (ICD4), HES5, ESR1 (nuclear), CD44, SLUG, EGFR, NOTCH4, NOXA, TFF1, Jagged1, PLAU (UPA)"
461,Proliferative action of Gastrin in gastric cancer,53,3.05E-03,9.61E-03,3.05E-03,9.61E-03,12,"cPKC (conventional), PI3K cat class IA, PKC, PKC-alpha, EGFR, TCF7L2 (TCF4), ERK1/2, Beta-catenin, SOS, G-protein alpha-q/11, PDK (PDPK1), IP3 receptor",4.65E-02,1.16E-01,9,"cPKC (conventional), PI3K cat class IA, PKC, PKC-alpha, EGFR, TCF7L2 (TCF4), SOS, G-protein alpha-q/11, IP3 receptor"
462,IFN-gamma and Th2 cytokines-induced inflammatory signaling in normal and asthmatic airway epithelium,40,3.09E-03,9.69E-03,3.09E-03,9.69E-03,10,"ST2(L), IP10, ICAM1, CCL2, I-TAC, IL-8, ERK1/2, IL-6, NF-kB, Fibronectin",8.19E-03,3.32E-02,9,"ST2(L), IP10, ICAM1, CCL2, I-TAC, IL-8, IL-6, NF-kB, Fibronectin"
463,Stem cells_Pancreatic cancer stem cells in tumor metastasis,40,3.09E-03,9.69E-03,3.09E-03,9.69E-03,10,"G-protein alpha-i family, F-Actin cytoskeleton, MRLC, Myosin II, Fyn, MELC, MyHC, PI3K reg class IB (p101), MLCK, IP3 receptor",6.49E-02,1.46E-01,7,"G-protein alpha-i family, MRLC, Fyn, MELC, PI3K reg class IB (p101), MLCK, IP3 receptor"
464,Noise-induced hair cell death and spiral ganglion neuron degeneration,96,3.16E-03,9.90E-03,3.16E-03,9.90E-03,18,"BAD, NMDA receptor, STAT3, COX-2 (PTGS2), IL-1 beta, iNOS, CCL13, CCL2, ERM proteins, GFRalpha1, F-Actin cytoskeleton, IL-6, AMPK gamma subunit, CACNA1I, Caspase-8, p53, Actin, CACNA1D",9.12E-02,1.87E-01,13,"NMDA receptor, COX-2 (PTGS2), IL-1 beta, iNOS, CCL13, CCL2, ERM proteins, GFRalpha1, IL-6, AMPK gamma subunit, CACNA1I, Actin, CACNA1D"
465,B-regulatory cells and tumor cells intercellular interaction,67,3.17E-03,9.91E-03,3.17E-03,9.91E-03,14,"STAT3, IL-1 beta, ST2(L), TNF-R2, MCAM, RelA (p65 NF-kB subunit), CCL2, TLR4, IL-33, IL-6, TLR7, NF-kB, PD-L1, NF-kB p65/p65",6.34E-03,2.75E-02,13,"IL-1 beta, ST2(L), TNF-R2, MCAM, RelA (p65 NF-kB subunit), CCL2, TLR4, IL-33, IL-6, TLR7, NF-kB, PD-L1, NF-kB p65/p65"
466,Development_Schema: Adult neuron differentiation in the Subventricular and Subgranular Zones,35,3.18E-03,1.21E-02,4.01E-03,1.21E-02,9,"TY3H, NCAM1, SOX2, Chordin-like 1, MAP2, Nestin, DLX2, GAD1, Vimentin",3.18E-03,1.65E-02,9,"TY3H, NCAM1, SOX2, Chordin-like 1, MAP2, Nestin, DLX2, GAD1, Vimentin"
467,Immune response_TLR ligands,35,3.18E-03,1.21E-02,4.01E-03,1.21E-02,9,"TLR1, CD14, TLR10, TLR6, TLR4, MD-2, TLR7, Fibronectin, TLR2",3.18E-03,1.65E-02,9,"TLR1, CD14, TLR10, TLR6, TLR4, MD-2, TLR7, Fibronectin, TLR2"
468,Signal transduction_Erk Interactions: Inhibition of Erk,34,3.25E-03,1.00E-02,3.25E-03,1.00E-02,9,"NMDA receptor, Lck, PKC, ERK1/2, MKP-2, ERK2 (MAPK1), AKT(PKB), MKP-4, PTPRR",8.16E-02,1.73E-01,6,"NMDA receptor, PKC, MKP-2, AKT(PKB), MKP-4, PTPRR"
469,Development_S1P1 receptor signaling via beta-arrestin,34,3.25E-03,1.00E-02,3.25E-03,1.00E-02,9,"G-protein alpha-i1, Tuberin, S1P1 receptor, G-protein alpha-i family, ERK1/2, SOS, ERK2 (MAPK1), ERK1 (MAPK3), PDGF-R-beta",1.89E-01,3.20E-01,5,"G-protein alpha-i1, S1P1 receptor, G-protein alpha-i family, SOS, PDGF-R-beta"
470,G-protein signaling_G-Protein beta/gamma signaling cascades,34,3.25E-03,1.00E-02,3.25E-03,1.00E-02,9,"G-protein alpha-15, Adenylate cyclase type V, Adenylate cyclase type II, ERK1/2, SOS, AKT(PKB), Caveolin-1, PDK (PDPK1), PI3K reg class IB (p101)",2.99E-02,8.48E-02,7,"G-protein alpha-15, Adenylate cyclase type V, Adenylate cyclase type II, SOS, AKT(PKB), Caveolin-1, PI3K reg class IB (p101)"
471,Role of IFN-beta in inhibition of Th1 cell differentiation in multiple sclerosis,34,3.25E-03,1.00E-02,3.25E-03,1.00E-02,9,"IL-18R1, MHC class II, PI3K cat class IA, TLR4, NF-kB, AKT(PKB), PDK (PDPK1), IFN-beta, PD-L1",9.41E-03,3.71E-02,8,"IL-18R1, MHC class II, PI3K cat class IA, TLR4, NF-kB, AKT(PKB), IFN-beta, PD-L1"
472,Impaired inhibition of Th17 cell differentiation by IFN-beta in multiple sclerosis,28,3.25E-03,1.00E-02,3.25E-03,1.00E-02,8,"STAT3, IL-1 beta, IL-30, ROR-alpha, ROR-gamma, TGF-beta receptor type II, IL-6, IFN-beta",1.06E-02,4.04E-02,7,"IL-1 beta, IL-30, ROR-alpha, ROR-gamma, TGF-beta receptor type II, IL-6, IFN-beta"
473,The role of aberrations in CDKN2 locus and CDK4 in familial melanoma,28,3.25E-03,1.00E-02,3.25E-03,1.00E-02,8,"p14ARF, RUNX2, EGFR, p15, p53, p16INK4, FLRT3, CDK6",1.06E-02,4.04E-02,7,"p14ARF, RUNX2, EGFR, p15, p16INK4, FLRT3, CDK6"
474,IL-1 production in melanoma,17,3.32E-03,1.02E-02,3.32E-03,1.02E-02,6,"IL-1 beta, RelA (p65 NF-kB subunit), N-Ras, ERK1/2, NF-kB, Caspase-1",6.11E-02,1.40E-01,4,"IL-1 beta, RelA (p65 NF-kB subunit), NF-kB, Caspase-1"
475,Development_Negative regulation of WNT/Beta-catenin signaling in the nucleus,89,3.33E-03,1.02E-02,3.33E-03,1.02E-02,17,"ZNF703, RUNX3, Oct-3/4, SOX2, Tcf(Lef), WNT, CDX2, TCF7L2 (TCF4), Beta-catenin, HIC5, Dsh, TCF7 (TCF1), CDX1, Frizzled, Menin, Histone H1, DACT1",1.32E-02,4.78E-02,15,"ZNF703, RUNX3, Oct-3/4, SOX2, Tcf(Lef), WNT, CDX2, TCF7L2 (TCF4), HIC5, TCF7 (TCF1), CDX1, Frizzled, Menin, Histone H1, DACT1"
476,EZH2 in Prostate Cancer,29,3.33E-03,1.23E-02,4.12E-03,1.23E-02,8,"Keratin 17, Alpha-synuclein, ITGB2, RUNX3, MSMB, Follistatin, PGE2R3, Ephrin-B receptor 6",3.33E-03,1.71E-02,8,"Keratin 17, Alpha-synuclein, ITGB2, RUNX3, MSMB, Follistatin, PGE2R3, Ephrin-B receptor 6"
477,Degranulation of lung mast cells,63,3.66E-03,1.40E-02,4.91E-03,1.40E-02,13,"Syk, PGE2R2, cPKC (conventional), PI3K cat class IA, Lyn, G-protein alpha-i family, BDKRB1, Fyn, BDKRB2, Beta-2 adrenergic receptor, Tryptase, PGE2R3, IP3 receptor",3.66E-03,1.84E-02,13,"Syk, PGE2R2, cPKC (conventional), PI3K cat class IA, Lyn, G-protein alpha-i family, BDKRB1, Fyn, BDKRB2, Beta-2 adrenergic receptor, Tryptase, PGE2R3, IP3 receptor"
478,Bacterial infections in CF airways,49,3.69E-03,1.39E-02,4.80E-03,1.39E-02,11,"TLR1, iNOS, CD14, IL-8, TLR4, SP-D, MD-2, NF-kB, Cathepsin S, IFN-beta, TLR2",3.69E-03,1.84E-02,11,"TLR1, iNOS, CD14, IL-8, TLR4, SP-D, MD-2, NF-kB, Cathepsin S, IFN-beta, TLR2"
479,Immune response_Bacterial infections in normal airways,49,3.69E-03,1.39E-02,4.80E-03,1.39E-02,11,"IL-1 beta, TLR1, iNOS, CD14, IL-8, TLR4, MD-2, IL-6, TIRAP (Mal), NF-kB, TLR2",3.69E-03,1.84E-02,11,"IL-1 beta, TLR1, iNOS, CD14, IL-8, TLR4, MD-2, IL-6, TIRAP (Mal), NF-kB, TLR2"
480,Immune response_Neurotensin-induced activation of IL-8 in colonocytes,41,3.75E-03,1.15E-02,3.75E-03,1.15E-02,10,"RelA (p65 NF-kB subunit), PKC-alpha, IL-8, NT, G-protein alpha-i family, SOS, NF-kB, ERK2 (MAPK1), ERK1 (MAPK3), IP3 receptor",2.83E-02,8.10E-02,8,"RelA (p65 NF-kB subunit), PKC-alpha, IL-8, NT, G-protein alpha-i family, SOS, NF-kB, IP3 receptor"
481,Regulation of beta-adrenergic receptors signaling in pancreatic cancer,41,3.75E-03,1.15E-02,3.75E-03,1.15E-02,10,"COX-2 (PTGS2), nAChR alpha-7, cPLA2, EGFR, G-protein alpha-i family, Adenylate cyclase, ERK1/2, nAChR alpha-4, IL-6, Beta-2 adrenergic receptor",9.67E-03,3.77E-02,9,"COX-2 (PTGS2), nAChR alpha-7, cPLA2, EGFR, G-protein alpha-i family, Adenylate cyclase, nAChR alpha-4, IL-6, Beta-2 adrenergic receptor"
482,Populations of skin dendritic cells involved in contact hypersensitivity,18,3.86E-03,1.34E-02,4.59E-03,1.34E-02,6,"MHC class II, Langerin, CD1d, LY75, CD83, EMR1",3.86E-03,1.90E-02,6,"MHC class II, Langerin, CD1d, LY75, CD83, EMR1"
483,Action of GSK3 beta in bipolar disorder,23,3.95E-03,1.21E-02,3.95E-03,1.21E-02,7,"MAP-1B, Tcf(Lef), TCF7L2 (TCF4), Bcl-2, Beta-catenin, Tau (MAPT), p53",5.11E-02,1.23E-01,5,"MAP-1B, Tcf(Lef), TCF7L2 (TCF4), Bcl-2, Tau (MAPT)"
484,IL-6 signaling pathway in lung cancer,35,4.01E-03,1.21E-02,4.01E-03,1.21E-02,9,"STAT3, COX-2 (PTGS2), PI3K cat class IA, EGFR, ERK1/2, IL-6, NF-kB, AKT(PKB), PDK (PDPK1)",9.13E-02,1.87E-01,6,"COX-2 (PTGS2), PI3K cat class IA, EGFR, IL-6, NF-kB, AKT(PKB)"
485,NALP3 inflammasome activation in age-related macular degeneration (AMD),35,4.01E-03,1.21E-02,4.01E-03,1.21E-02,9,"IL-1 beta, IL-18R1, CCL20, RelA (p65 NF-kB subunit), IL-6, NF-kB, Caspase-1, Caspase-8, TLR2",1.13E-02,4.22E-02,8,"IL-1 beta, IL-18R1, CCL20, RelA (p65 NF-kB subunit), IL-6, NF-kB, Caspase-1, TLR2"
486,Development_WNT and Notch signaling in early cardiac myogenesis,35,4.01E-03,1.21E-02,4.01E-03,1.21E-02,9,"WNT, MEF2C, Beta-catenin, Jagged1, FZD7, Dsh, TCF7 (TCF1), BMP2, Frizzled",3.46E-02,9.44E-02,7,"WNT, MEF2C, Jagged1, FZD7, TCF7 (TCF1), BMP2, Frizzled"
487,Neuropeptide signaling in pancreatic cancer,48,4.06E-03,1.22E-02,4.06E-03,1.22E-02,11,"HGF, GRP-R, CCL2, PKC-alpha, NT, ERK1/2, NF-kB, G-protein alpha-q/11, HGF receptor (Met), IP3 receptor, NF-kB p65/p65",9.56E-03,3.74E-02,10,"HGF, GRP-R, CCL2, PKC-alpha, NT, NF-kB, G-protein alpha-q/11, HGF receptor (Met), IP3 receptor, NF-kB p65/p65"
488,IL-17-induced mucin expression in CF airways,48,4.06E-03,1.22E-02,4.06E-03,1.22E-02,11,"IL-1 beta, MHC class II, ROR-alpha, ROR-gamma, Mucin 5AC, TLR4, ERK1/2, Mucin 5B, IL-6, NF-kB, TLR2",9.56E-03,3.74E-02,10,"IL-1 beta, MHC class II, ROR-alpha, ROR-gamma, Mucin 5AC, TLR4, Mucin 5B, IL-6, NF-kB, TLR2"
489,Suppression of TGF-beta signaling in pancreatic cancer,29,4.12E-03,1.23E-02,4.12E-03,1.23E-02,8,"Biglycan, ETS1, TGF-beta receptor type II, p15, SMAD3, ERK2 (MAPK1), MMP-9, PLAU (UPA)",4.21E-02,1.08E-01,6,"Biglycan, ETS1, TGF-beta receptor type II, p15, MMP-9, PLAU (UPA)"
490,Abnormalities in cell cycle in SCLC,29,4.12E-03,1.23E-02,4.12E-03,1.23E-02,8,"PCNA, p14ARF, Cyclin E, p15, p53, p16INK4, p27KIP1, CDK6",1.16E-01,2.24E-01,5,"p14ARF, Cyclin E, p15, p16INK4, CDK6"
491,Cell adhesion_Gap junctions,30,4.19E-03,1.47E-02,5.17E-03,1.47E-02,8,"Tubulin beta, PKC, Connexin 26, Connexin 32, Connexin 45, Caveolin-1, Actin, Connexin 31",4.19E-03,2.03E-02,8,"Tubulin beta, PKC, Connexin 26, Connexin 32, Connexin 45, Caveolin-1, Actin, Connexin 31"
492,Aberrant B-Raf signaling in melanoma progression,55,4.21E-03,1.26E-02,4.21E-03,1.26E-02,12,"BAD, ITGB1, Tuberin, ITGB3, MAP2, AKT3, Bcl-2, ERK1/2, Kinase MYT1, ERK2 (MAPK1), AKT(PKB), SPRY2",1.20E-01,2.30E-01,8,"ITGB1, ITGB3, MAP2, AKT3, Bcl-2, Kinase MYT1, AKT(PKB), SPRY2"
493,Role of Thyroid hormone in regulation of oligodendrocyte differentiation in multiple sclerosis,55,4.21E-03,1.26E-02,4.21E-03,1.26E-02,12,"NGF, Myelin basic protein, p14ARF, OATP-A, TCF7L2 (TCF4), p15, PDGF-R-alpha, AKT(PKB), ID4, p53, PDK (PDPK1), p27KIP1",5.68E-02,1.32E-01,9,"NGF, Myelin basic protein, p14ARF, OATP-A, TCF7L2 (TCF4), p15, PDGF-R-alpha, AKT(PKB), ID4"
494,Role of cell adhesion in vaso-occlusion in Sickle cell disease,43,4.23E-03,1.52E-02,5.40E-03,1.52E-02,10,"IL-1 beta, CD14, ITGB2, alpha-4/beta-1 integrin, ICAM1, CD44, IL-8, iC3b, Fc gamma RII alpha, Fibronectin",4.23E-03,2.03E-02,10,"IL-1 beta, CD14, ITGB2, alpha-4/beta-1 integrin, ICAM1, CD44, IL-8, iC3b, Fc gamma RII alpha, Fibronectin"
495,Signal transduction_Modulation of calcium and potassium channels by Adenosine A1 receptor,43,4.23E-03,1.52E-02,5.40E-03,1.52E-02,10,"MaxiK alpha subunit, cPKC (conventional), SUR1, PKC-alpha, cPLA2, G-protein alpha-i family, Adenylate cyclase, SK2, Kir6.2, IP3 receptor",4.23E-03,2.03E-02,10,"MaxiK alpha subunit, cPKC (conventional), SUR1, PKC-alpha, cPLA2, G-protein alpha-i family, Adenylate cyclase, SK2, Kir6.2, IP3 receptor"
496,Development_Gastrin in cell growth and proliferation,62,4.25E-03,1.26E-02,4.25E-03,1.26E-02,13,"STAT3, PI3K cat class IA, PKC-alpha, EGFR, TCF7L2 (TCF4), ERK1/2, Beta-catenin, SOS, ERK2 (MAPK1), G-protein alpha-q/11, PDK (PDPK1), ERK1 (MAPK3), IP3 receptor",3.27E-01,4.85E-01,7,"PI3K cat class IA, PKC-alpha, EGFR, TCF7L2 (TCF4), SOS, G-protein alpha-q/11, IP3 receptor"
497,Ca(2+)-dependent NF-AT signaling in cardiac hypertrophy,57,4.34E-03,1.59E-02,5.71E-03,1.59E-02,12,"Adenylate cyclase type V, TRPC3, PKC-alpha, NCX1, G-protein alpha-i family, MEF2C, MEF2, TRPC6, G-protein alpha-q/11, HAND2, Alpha-1B adrenergic receptor, IP3 receptor",4.34E-03,2.05E-02,12,"Adenylate cyclase type V, TRPC3, PKC-alpha, NCX1, G-protein alpha-i family, MEF2C, MEF2, TRPC6, G-protein alpha-q/11, HAND2, Alpha-1B adrenergic receptor, IP3 receptor"
498,Protein folding and maturation_Posttranslational processing of neuroendocrine peptides,50,4.35E-03,1.58E-02,5.65E-03,1.58E-02,11,"PAM, Trypsin, LargeNN, NT, PC1, PCSK5, LargeNT, PC2, Carboxypeptidase H, NN, NT/NN",4.35E-03,2.05E-02,11,"PAM, Trypsin, LargeNN, NT, PC1, PCSK5, LargeNT, PC2, Carboxypeptidase H, NN, NT/NN"
499,Apoptosis and survival_Apoptotic TNF-family pathways,42,4.52E-03,1.33E-02,4.52E-03,1.33E-02,10,"NGF, TNF-R2, NGFR(TNFRSF16), Caspase-10, c-IAP1, CD70(TNFSF7), GITRL, Bcl-2, LIGHT(TNFSF14), Caspase-8",1.14E-02,4.22E-02,9,"NGF, TNF-R2, NGFR(TNFRSF16), Caspase-10, c-IAP1, CD70(TNFSF7), GITRL, Bcl-2, LIGHT(TNFSF14)"
500,Inhibition of GTPase prenylation by statins in asthma and COPD,42,4.52E-03,1.33E-02,4.52E-03,1.33E-02,10,"COX-2 (PTGS2), RelA (p65 NF-kB subunit), PTEN, IL-8, Mucin 5AC, ERK1/2, IL-6, AKT(PKB), RhoB, p27KIP1",8.05E-02,1.72E-01,7,"COX-2 (PTGS2), RelA (p65 NF-kB subunit), IL-8, Mucin 5AC, IL-6, AKT(PKB), RhoB"
501,Immune response_PIP3 signaling in B lymphocytes,42,4.52E-03,1.33E-02,4.52E-03,1.33E-02,10,"Syk, PI3K cat class IA, PTEN, Lyn, Fc gamma RII beta, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor, PREX1",3.23E-02,9.06E-02,8,"Syk, PI3K cat class IA, Lyn, Fc gamma RII beta, AKT(PKB), PI3K reg class IB (p101), IP3 receptor, PREX1"
502,Signal transduction_Angiotensin II/ AGTR1 signaling via TGF-beta 1 and SMADs,42,4.52E-03,1.33E-02,4.52E-03,1.33E-02,10,"IL-1 beta, TGF-beta receptor type II, ERK1/2, NF-kB, SMAD3, CTGF, AKT(PKB), OSF-2, Caspase-1, FASN",8.05E-02,1.72E-01,7,"IL-1 beta, TGF-beta receptor type II, NF-kB, CTGF, AKT(PKB), OSF-2, Caspase-1"
503,"TNF-alpha, IL-1 beta induce dyslipidemia and inflammation in obesity and type 2 diabetes in adipocytes ",42,4.52E-03,1.33E-02,4.52E-03,1.33E-02,10,"COX-2 (PTGS2), IL-1 beta, PTX3, TNF-R2, iNOS, CCL2, ERK1/2, IL-6, NF-kB, Perilipin",1.14E-02,4.22E-02,9,"COX-2 (PTGS2), IL-1 beta, PTX3, TNF-R2, iNOS, CCL2, IL-6, NF-kB, Perilipin"
504,Rb proteins signaling in multiple myeloma,18,4.59E-03,1.34E-02,4.59E-03,1.34E-02,6,"Cyclin E, p15, IL-6, p16INK4, p27KIP1, CDK6",1.89E-02,6.07E-02,5,"Cyclin E, p15, IL-6, p16INK4, CDK6"
505,Cell adhesion_Integrin inside-out signaling in neutrophils,77,4.65E-03,1.36E-02,4.65E-03,1.36E-02,15,"Syk, GRO-1, iNOS, ITGB2, ICAM1, CD44, IL-8, Lyn, G-protein alpha-i family, ERK2 (MAPK1), IL8RA, PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor, PREX1",1.99E-02,6.29E-02,13,"Syk, GRO-1, iNOS, ITGB2, ICAM1, CD44, IL-8, Lyn, G-protein alpha-i family, IL8RA, PI3K reg class IB (p101), IP3 receptor, PREX1"
506,Cytoskeleton remodeling_Integrin outside-in signaling,49,4.80E-03,1.39E-02,4.80E-03,1.39E-02,11,"alpha-11/beta-1 integrin, Tcf(Lef), ERK1/2, Beta-catenin, alpha-5/beta-1 integrin, Actin cytoskeletal, Collagen II, SOS, AKT(PKB), Collagen IV, Fibronectin",7.09E-02,1.55E-01,8,"alpha-11/beta-1 integrin, Tcf(Lef), alpha-5/beta-1 integrin, Collagen II, SOS, AKT(PKB), Collagen IV, Fibronectin"
507,Development_G-CSF signaling,49,4.80E-03,1.39E-02,4.80E-03,1.39E-02,11,"STAT3, ITGA9, c-IAP2, PI3K cat class IA, Lyn, Bcl-2, ERK1/2, SOS, AKT(PKB), PDK (PDPK1), GFI-1",7.09E-02,1.55E-01,8,"ITGA9, c-IAP2, PI3K cat class IA, Lyn, Bcl-2, SOS, AKT(PKB), GFI-1"
508,Th2-cytokine-induced airway epithelium mucous metaplasia in COPD,70,4.81E-03,1.39E-02,4.81E-03,1.39E-02,14,"CLCA1, iNOS, Adenosine A2b receptor, Mucin 5AC, ERK1/2, PP2A regulatory, Actin cytoskeletal, NF-kB, G-protein alpha-q/11, HAG-2, PDEF, MUNC13, IP3 receptor, NF-kB p65/p65",2.21E-02,6.62E-02,12,"CLCA1, iNOS, Adenosine A2b receptor, Mucin 5AC, PP2A regulatory, NF-kB, G-protein alpha-q/11, HAG-2, PDEF, MUNC13, IP3 receptor, NF-kB p65/p65"
509,Transport_Macropinocytosis regulation by growth factors,63,4.91E-03,1.40E-02,4.91E-03,1.40E-02,13,"HGF, NGF, IRS-2, EGFR, AMPK gamma subunit, Actin cytoskeletal, SOS, PDGF-R-alpha, AKT(PKB), CSF1, PDGF receptor, HGF receptor (Met), PDGF-R-beta",9.91E-03,3.86E-02,12,"HGF, NGF, IRS-2, EGFR, AMPK gamma subunit, SOS, PDGF-R-alpha, AKT(PKB), CSF1, PDGF receptor, HGF receptor (Met), PDGF-R-beta"
510,HBV signaling via protein kinases leading to HCC,36,4.91E-03,1.40E-02,4.91E-03,1.40E-02,9,"Androgen receptor, cPKC (conventional), PKC, PKC-alpha, ERK1/2, SOS, SMAD3, ERK2 (MAPK1), MMP-9",1.02E-01,2.02E-01,6,"Androgen receptor, cPKC (conventional), PKC, PKC-alpha, SOS, MMP-9"
511,Upregulation of MITF in melanoma,36,4.91E-03,1.40E-02,4.91E-03,1.40E-02,9,"SOX10, IMP1(ZBP1), Bcl-2, ERK1/2, ERK2 (MAPK1), alpha-MSH, HGF receptor (Met), p16INK4, p27KIP1",1.02E-01,2.02E-01,6,"SOX10, IMP1(ZBP1), Bcl-2, alpha-MSH, HGF receptor (Met), p16INK4"
512,Development_Thrombospondin 1 signaling,36,4.91E-03,1.40E-02,4.91E-03,1.40E-02,9,"alpha-4/beta-1 integrin, alpha-9/beta-1 integrin, VLDLR, ITGB3, G-protein alpha-i family, Adenylate cyclase, Fyn, FGF2, Caspase-8",1.34E-02,4.78E-02,8,"alpha-4/beta-1 integrin, alpha-9/beta-1 integrin, VLDLR, ITGB3, G-protein alpha-i family, Adenylate cyclase, Fyn, FGF2"
513,Role of FSH and Lutropin in ovarian cancer,56,4.92E-03,1.40E-02,4.92E-03,1.40E-02,12,"COX-2 (PTGS2), TRPC3, CD44, PKC-alpha, Cyclin E, EGFR, Adenylate cyclase, ERK1/2, MMP-2, IL-6, AKT(PKB), MMP-9",1.06E-02,4.04E-02,11,"COX-2 (PTGS2), TRPC3, CD44, PKC-alpha, Cyclin E, EGFR, Adenylate cyclase, MMP-2, IL-6, AKT(PKB), MMP-9"
514,Regulation of Beta-catenin activity in colorectal cancer,56,4.92E-03,1.40E-02,4.92E-03,1.40E-02,12,"PGE2R2, PGE2R4, PI3K cat class IA, DVL-3, PTEN, PDCD4, Adenylate cyclase, ERK1/2, Beta-catenin, SNAIL1, AKT(PKB), IP3 receptor",2.40E-01,3.83E-01,7,"PGE2R2, PGE2R4, PI3K cat class IA, PDCD4, Adenylate cyclase, AKT(PKB), IP3 receptor"
515,Arachidonic acid metabolites production in eosinophils in asthma,44,5.04E-03,1.74E-02,6.42E-03,1.74E-02,10,"COX-2 (PTGS2), PKC, alpha-4/beta-1 integrin, ICAM1, PGD2R, cPLA2, G-protein alpha-i family, ALOX5, PA24A, Fibronectin",5.04E-03,2.31E-02,10,"COX-2 (PTGS2), PKC, alpha-4/beta-1 integrin, ICAM1, PGD2R, cPLA2, G-protein alpha-i family, ALOX5, PA24A, Fibronectin"
516,Tissue factor signaling in lung cancer,24,5.14E-03,1.46E-02,5.14E-03,1.46E-02,7,"PTEN, ERK1/2, AKT(PKB), Tissue factor, p53, PDK (PDPK1), Coagulation factor VII",3.71E-01,5.33E-01,3,"AKT(PKB), Tissue factor, Coagulation factor VII"
517,Cell adhesion_Endothelial cell contacts by non-junctional mechanisms,24,5.14E-03,1.46E-02,5.14E-03,1.46E-02,7,"N-cadherin, F-Actin cytoskeleton, Beta-catenin, alpha-5/beta-1 integrin, alpha-1/beta-1 integrin, Collagen IV, Fibronectin",5.99E-02,1.38E-01,5,"N-cadherin, alpha-5/beta-1 integrin, alpha-1/beta-1 integrin, Collagen IV, Fibronectin"
518,Immune response_IL-7 signaling in B lymphocytes,43,5.40E-03,1.52E-02,5.40E-03,1.52E-02,10,"STAT3, IL7RA, EBF, Lyn, ERK1/2, Fyn, AKT(PKB), SOS1, PDK (PDPK1), Pim-1",8.90E-02,1.85E-01,7,"IL7RA, EBF, Lyn, Fyn, AKT(PKB), SOS1, Pim-1"
519,Neurophysiological process_HTR1A receptor signaling in neuronal cells,43,5.40E-03,1.52E-02,5.40E-03,1.52E-02,10,"NMDA receptor, Kir3.4, G-protein alpha-i family, Adenylate cyclase, MAP2, ERK2 (MAPK1), Kir3.1, PDK (PDPK1), PI3K reg class IB (p101), ERK1 (MAPK3)",8.90E-02,1.85E-01,7,"NMDA receptor, Kir3.4, G-protein alpha-i family, Adenylate cyclase, MAP2, Kir3.1, PI3K reg class IB (p101)"
520,Immune escape mechanisms in Prostate Cancer,25,5.44E-03,1.76E-02,6.57E-03,1.76E-02,7,"TAP1 (PSF1), CCL2, TLR4, TAP2 (PSF2), IL-6, TGF-beta, TAP",5.44E-03,2.44E-02,7,"TAP1 (PSF1), CCL2, TLR4, TAP2 (PSF2), IL-6, TGF-beta, TAP"
521,Defective macrophage-mediated bacterial phagocytosis in COPD,25,5.44E-03,1.76E-02,6.57E-03,1.76E-02,7,"MBL2, C6orf134, MSR1, SP-D, AKT(PKB), RhoB, MARCO",5.44E-03,2.44E-02,7,"MBL2, C6orf134, MSR1, SP-D, AKT(PKB), RhoB, MARCO"
522,T cell generation in COPD,25,5.44E-03,1.76E-02,6.57E-03,1.76E-02,7,"MHC class II, CCL20, Langerin, CCL13, ICAM1, CCL2, CCL7",5.44E-03,2.44E-02,7,"MHC class II, CCL20, Langerin, CCL13, ICAM1, CCL2, CCL7"
523,Development_Stimulation of differentiation of mouse embryonic fibroblasts into adipocytes by extracellular factors,71,5.49E-03,1.54E-02,5.49E-03,1.54E-02,14,"Tuberin, EGR2 (Krox20), Lysyl oxidase, IRS-2, NGAL, Adenylate cyclase, ERK1/2, LIF, SOS, ERK2 (MAPK1), PDK (PDPK1), ERK1 (MAPK3), BMP2, C/EBPalpha",1.90E-01,3.20E-01,9,"EGR2 (Krox20), Lysyl oxidase, IRS-2, NGAL, Adenylate cyclase, LIF, SOS, BMP2, C/EBPalpha"
524,Pro-inflammatory action of Gastrin in gastric cancer,50,5.65E-03,1.58E-02,5.65E-03,1.58E-02,11,"COX-2 (PTGS2), GRO-2, PI3K cat class IA, RelA (p65 NF-kB subunit), IL-8, EGFR, ERK1/2, PAI2, SOS, AKT(PKB), G-protein alpha-q/11",1.27E-02,4.65E-02,10,"COX-2 (PTGS2), GRO-2, PI3K cat class IA, RelA (p65 NF-kB subunit), IL-8, EGFR, PAI2, SOS, AKT(PKB), G-protein alpha-q/11"
525,Signal transduction_CXCR4 signaling via second messengers and JAK/STAT,50,5.65E-03,1.58E-02,5.65E-03,1.58E-02,11,"STAT3, MaxiK alpha subunit, alpha-1 Adrenergic receptor, G-protein alpha-i family, Adenylate cyclase, MRLC, Bcl-2, Beta-2 adrenergic receptor, Alpha-1B adrenergic receptor, MLCK, IP3 receptor",1.27E-02,4.65E-02,10,"MaxiK alpha subunit, alpha-1 Adrenergic receptor, G-protein alpha-i family, Adenylate cyclase, MRLC, Bcl-2, Beta-2 adrenergic receptor, Alpha-1B adrenergic receptor, MLCK, IP3 receptor"
526,Development_Cytokine-mediated regulation of megakaryopoiesis,57,5.71E-03,1.59E-02,5.71E-03,1.59E-02,12,"STAT3, IL-1 beta, NF-E2 (45 kDa), PI3K cat class IA, ERK1/2, LIF, IL-6, NF-kB, FLT3, AKT(PKB), Thrombopoietin, p27KIP1",6.86E-02,1.53E-01,9,"IL-1 beta, NF-E2 (45 kDa), PI3K cat class IA, LIF, IL-6, NF-kB, FLT3, AKT(PKB), Thrombopoietin"
527,Immune response_Role of PKR in stress-induced antiviral cell response,57,5.71E-03,1.59E-02,5.71E-03,1.59E-02,12,"IL-1 beta, RelA (p65 NF-kB subunit), IL-8, TLR4, ERK1/2, IL-6, TIRAP (Mal), NF-kB, Caspase-8, TLR3, IFN-beta, TLR2",3.03E-02,8.54E-02,10,"IL-1 beta, RelA (p65 NF-kB subunit), IL-8, TLR4, IL-6, TIRAP (Mal), NF-kB, TLR3, IFN-beta, TLR2"
528,Role of type 2 innate lymphoid cells in airway allergic inflammation and tissue repair,38,5.75E-03,1.90E-02,7.18E-03,1.90E-02,9,"GATA-3, ST2(L), IL7RA, Amphiregulin, ROR-alpha, ETS1, EGFR, IL-33, PI3K cat class IA (p110-delta)",5.75E-03,2.56E-02,9,"GATA-3, ST2(L), IL7RA, Amphiregulin, ROR-alpha, ETS1, EGFR, IL-33, PI3K cat class IA (p110-delta)"
529,Substance P-mediated inflammation and pain in Sickle cell disease,38,5.75E-03,1.90E-02,7.18E-03,1.90E-02,9,"IL-1 beta, CD14, alpha-4/beta-1 integrin, ICAM1, IL-8, IL-6, NF-kB, Tissue factor, IP3 receptor",5.75E-03,2.56E-02,9,"IL-1 beta, CD14, alpha-4/beta-1 integrin, ICAM1, IL-8, IL-6, NF-kB, Tissue factor, IP3 receptor"
530,Neurophysiological process_Regulation of intrinsic membrane properties and excitability of cortical pyramidal neurons,74,5.95E-03,2.08E-02,8.00E-03,2.08E-02,14,"MaxiK alpha subunit, cPKC (conventional), TRPC4, PKC, G-protein alpha-i family, Adenylate cyclase, SK2, SCN2A, Alpha-2A adrenergic receptor, G-protein alpha-q/11, Kir2.2, IP3 receptor, ACM3, CACNA1D",5.95E-03,2.61E-02,14,"MaxiK alpha subunit, cPKC (conventional), TRPC4, PKC, G-protein alpha-i family, Adenylate cyclase, SK2, SCN2A, Alpha-2A adrenergic receptor, G-protein alpha-q/11, Kir2.2, IP3 receptor, ACM3, CACNA1D"
531,Development_MAG-dependent inhibition of neurite outgrowth,37,5.97E-03,1.65E-02,5.97E-03,1.65E-02,9,"NGF, NGFR (ICD), NGFR(TNFRSF16), NGFR (CTF), MRLC, Myosin II, Actin cytoskeletal, MELC, MyHC",1.13E-01,2.19E-01,6,"NGF, NGFR (ICD), NGFR(TNFRSF16), NGFR (CTF), MRLC, MELC"
532,IL-6 signaling in colorectal cancer,37,5.97E-03,1.65E-02,5.97E-03,1.65E-02,9,"STAT3, TNF-R2, ICAM1, TFF3, Cyclin E, TGF-beta receptor type II, Clusterin, IL-6, p53",4.53E-02,1.14E-01,7,"TNF-R2, ICAM1, TFF3, Cyclin E, TGF-beta receptor type II, Clusterin, IL-6"
533,Role of red blood cell adhesion to endothelium in vaso-occlusion in Sickle cell disease,37,5.97E-03,1.65E-02,5.97E-03,1.65E-02,9,"ITGA4, alpha-4/beta-1 integrin, CD44, IL-8, G-protein alpha-i family, ERK1/2, Beta-2 adrenergic receptor, Fibronectin, CD147",1.57E-02,5.27E-02,8,"ITGA4, alpha-4/beta-1 integrin, CD44, IL-8, G-protein alpha-i family, Beta-2 adrenergic receptor, Fibronectin, CD147"
534,Development_NOTCH-induced EMT,19,6.18E-03,1.70E-02,6.18E-03,1.70E-02,6,"SLUG, NOTCH4, SNAIL1, SMAD3, Fibronectin, Jagged1",8.63E-02,1.80E-01,4,"SLUG, NOTCH4, Fibronectin, Jagged1"
535,Cytoskeleton remodeling_Alpha-1A adrenergic receptor-dependent inhibition of PI3K,19,6.18E-03,1.70E-02,6.18E-03,1.70E-02,6,"MRLC, Myosin II, AKT(PKB), MELC, PDK (PDPK1), MLCK",8.63E-02,1.80E-01,4,"MRLC, AKT(PKB), MELC, MLCK"
536,Putative glucocorticoid- and LABA-mediated inhibition of pro-fibrotic signaling in airway fibroblasts/myofibroblasts,31,6.41E-03,1.74E-02,6.41E-03,1.74E-02,8,"ERK1/2, ACTA2, Beta-2 adrenergic receptor, SMAD3, Fibronectin, MMP-9, C/EBPalpha, Collagen III",5.61E-02,1.31E-01,6,"ACTA2, Beta-2 adrenergic receptor, Fibronectin, MMP-9, C/EBPalpha, Collagen III"
537,Role of inhibition of WNT signaling in the progression of lung cancer,31,6.41E-03,1.74E-02,6.41E-03,1.74E-02,8,"N-cadherin, WNT7A, Beta-catenin, p53, Vimentin, Dsh, MMP-9, Frizzled",1.43E-01,2.61E-01,5,"N-cadherin, WNT7A, Vimentin, MMP-9, Frizzled"
538,Development_Dopamine-induced transactivation of EGFR in SVZ neural stem cells,31,6.41E-03,1.74E-02,6.41E-03,1.74E-02,8,"PKC, ADAM12, EGFR, G-protein alpha-i family, ERK1/2, TGF-alpha, SOS, PAX6",1.85E-02,5.95E-02,7,"PKC, ADAM12, EGFR, G-protein alpha-i family, TGF-alpha, SOS, PAX6"
539,Development_Embryonal epaxial myogenesis,31,6.41E-03,1.74E-02,6.41E-03,1.74E-02,8,"PTCH1, WNT, BMP4, Beta-catenin, GLI-1, SMAD3, Frizzled, WNT6",5.61E-02,1.31E-01,6,"PTCH1, WNT, BMP4, GLI-1, Frizzled, WNT6"
540,Development_Transactivation of PDGFR in non-neuronal cells by Dopamine D2 receptor,31,6.41E-03,1.74E-02,6.41E-03,1.74E-02,8,"PI3K cat class IA, G-protein alpha-i family, SOS, ERK2 (MAPK1), PDGF receptor, ERK1 (MAPK3), IP3 receptor, PDGF-R-beta",5.61E-02,1.31E-01,6,"PI3K cat class IA, G-protein alpha-i family, SOS, PDGF receptor, IP3 receptor, PDGF-R-beta"
541,Immune response_CRTH2 signaling in Th2 cells,44,6.42E-03,1.74E-02,6.42E-03,1.74E-02,10,"BAD, PKC, ITGB2, ICAM1, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor",4.13E-02,1.07E-01,8,"PKC, ITGB2, ICAM1, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), PI3K reg class IB (p101), IP3 receptor"
542,Apoptosis and survival_Apoptotic Activin A signaling,25,6.57E-03,1.76E-02,6.57E-03,1.76E-02,7,"Activin A, SMAD3, ERK2 (MAPK1), AKT(PKB), p53, PDK (PDPK1), ERK1 (MAPK3)",6.74E-01,8.10E-01,2,"Activin A, AKT(PKB)"
543,Development_Trophectoderm differentiation,25,6.57E-03,1.76E-02,6.57E-03,1.76E-02,7,"P-cadherin, Oct-3/4, SOX2, CDX2, BMP4, ASH2, SMAD3",2.14E-02,6.53E-02,6,"P-cadherin, Oct-3/4, SOX2, CDX2, BMP4, ASH2"
544,HBV-dependent transcription regulation leading to HCC,25,6.57E-03,1.76E-02,6.57E-03,1.76E-02,7,"PCNA, EGR2 (Krox20), ESR1 (nuclear), IL-8, MMP-14, MMP-2, FASN",6.95E-02,1.53E-01,5,"EGR2 (Krox20), ESR1 (nuclear), IL-8, MMP-14, MMP-2"
545,Inhibition of TGF-beta signaling in gastric cancer,25,6.57E-03,1.76E-02,6.57E-03,1.76E-02,7,"TGF-beta 2, RUNX3, TGF-beta 3, TGF-beta receptor type II, CEACAM5, SMAD3, LMO1",2.14E-02,6.53E-02,6,"TGF-beta 2, RUNX3, TGF-beta 3, TGF-beta receptor type II, CEACAM5, LMO1"
546,Immune response_IL-33 signaling pathway,58,6.60E-03,1.76E-02,6.60E-03,1.76E-02,12,"ST2(L), PI3K cat class IA, RelA (p65 NF-kB subunit), GRO-1, ICAM1, CCL2, IL-8, IL-33, ERK1/2, IL-6, NF-kB, AKT(PKB)",1.37E-02,4.85E-02,11,"ST2(L), PI3K cat class IA, RelA (p65 NF-kB subunit), GRO-1, ICAM1, CCL2, IL-8, IL-33, IL-6, NF-kB, AKT(PKB)"
547,Signal transduction_PKA signaling,51,6.61E-03,1.76E-02,6.61E-03,1.76E-02,11,"BAD, Androgen receptor, AKAP12, G-protein alpha-i family, Adenylate cyclase, PP2A regulatory, SMAD3, PDE3A, PDK (PDPK1), PKI, Troponin I, cardiac",8.57E-02,1.80E-01,8,"Androgen receptor, AKAP12, G-protein alpha-i family, Adenylate cyclase, PP2A regulatory, PDE3A, PKI, Troponin I, cardiac"
548,Development_Oligodendrocyte differentiation from adult stem cells,51,6.61E-03,1.76E-02,6.61E-03,1.76E-02,11,"CNTN1 (F3), Myelin basic protein, EDNRB, OATP-A, PTCH1, BMP4, ERK1/2, FGF2, PDGF-R-alpha, BMP2, EDNRA",1.46E-02,5.06E-02,10,"CNTN1 (F3), Myelin basic protein, EDNRB, OATP-A, PTCH1, BMP4, FGF2, PDGF-R-alpha, BMP2, EDNRA"
549,Role of XBP1 protein in multiple myeloma,20,6.90E-03,2.11E-02,8.15E-03,2.11E-02,6,"XBP1, BOB1, IL-6, PSMA7, BLIMP1 (PRDI-BF1), ERP5",6.90E-03,2.93E-02,6,"XBP1, BOB1, IL-6, PSMA7, BLIMP1 (PRDI-BF1), ERP5"
550,Aryl hydrocarbon receptor signaling,53,6.92E-03,2.24E-02,8.90E-03,2.24E-02,11,"COX-2 (PTGS2), TY3H, UGT1A1, CYP1A1, ESR1 (nuclear), TGM3, IL-8, Epiregulin, SLUG, H-cadherin, UGT1A6",6.92E-03,2.93E-02,11,"COX-2 (PTGS2), TY3H, UGT1A1, CYP1A1, ESR1 (nuclear), TGM3, IL-8, Epiregulin, SLUG, H-cadherin, UGT1A6"
551,Dysregulation of direct glucose-induced inhibition of Glucagon secretion from alpha-cells in type 2 diabetes  ,53,6.92E-03,2.24E-02,8.90E-03,2.24E-02,11,"MaxiK alpha subunit, Kv2.2, iNOS, CACNA1H, SUR1, CDX2, SCN9A, Kir6.2, PC2, CACNA1D, PAX6",6.92E-03,2.93E-02,11,"MaxiK alpha subunit, Kv2.2, iNOS, CACNA1H, SUR1, CDX2, SCN9A, Kir6.2, PC2, CACNA1D, PAX6"
552,Development_Gastrin in differentiation of the gastric mucosa,38,7.18E-03,1.90E-02,7.18E-03,1.90E-02,9,"Chromogranin A, cPKC (conventional), PKC-theta, PKC, PKC-alpha, ERK1/2, G-protein alpha-q/11, TFF1, IP3 receptor",1.84E-02,5.95E-02,8,"Chromogranin A, cPKC (conventional), PKC-theta, PKC, PKC-alpha, G-protein alpha-q/11, TFF1, IP3 receptor"
553,Cell cycle_Regulation of G1/S transition (part 1),38,7.18E-03,1.90E-02,7.18E-03,1.90E-02,9,"TGF-beta 2, Cyclin E, TGF-beta receptor type II, p15, PP2A regulatory, SMAD3, p16INK4, p27KIP1, CDK6",5.13E-02,1.23E-01,7,"TGF-beta 2, Cyclin E, TGF-beta receptor type II, p15, PP2A regulatory, p16INK4, CDK6"
554,Differentiation of Th2 cells in asthma,45,7.57E-03,2.00E-02,7.57E-03,2.00E-02,10,"Histamine H1 receptor, MHC class II, PI3K cat class IA, CCL20, IP10, CCL2, CCR5, AKT(PKB), PDK (PDPK1), Jagged1",1.77E-02,5.79E-02,9,"Histamine H1 receptor, MHC class II, PI3K cat class IA, CCL20, IP10, CCL2, CCR5, AKT(PKB), Jagged1"
555,Development_FGF-family signaling,52,7.69E-03,2.02E-02,7.69E-03,2.02E-02,11,"PI3K cat class IA, PKC-alpha, FGFR4, FGF2, SOS, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), ERK1 (MAPK3), FGF9, IP3 receptor",9.36E-02,1.91E-01,8,"PI3K cat class IA, PKC-alpha, FGFR4, FGF2, SOS, AKT(PKB), FGF9, IP3 receptor"
556,Development_Endothelin-1/EDNRA signaling,52,7.69E-03,2.02E-02,7.69E-03,2.02E-02,11,"PI3K cat class IA, G-protein alpha-i family, Adenylate cyclase, TCF7L2 (TCF4), ERK1/2, Beta-catenin, SOS, AKT(PKB), G-protein alpha-q/11, EDNRA, IP3 receptor",4.18E-02,1.08E-01,9,"PI3K cat class IA, G-protein alpha-i family, Adenylate cyclase, TCF7L2 (TCF4), SOS, AKT(PKB), G-protein alpha-q/11, EDNRA, IP3 receptor"
557,Stem cells_mGluR3 signaling in glioblastoma stem cells,52,7.69E-03,2.02E-02,7.69E-03,2.02E-02,11,"PTEN, SLC1A2/EAAT2, G-protein alpha-i family, Adenylate cyclase, SLC7A11, ERK1/2, SOS, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), GLAST1/EAAT1",9.36E-02,1.91E-01,8,"SLC1A2/EAAT2, G-protein alpha-i family, Adenylate cyclase, SLC7A11, SOS, AKT(PKB), PI3K reg class IB (p101), GLAST1/EAAT1"
558,EML4/ALK fusion protein in nonsmoking-related lung cancer ,32,7.86E-03,2.05E-02,7.86E-03,2.05E-02,8,"STAT3, PI3K cat class IA, IRS-2, EGFR, ERK1/2, NF-kB, AKT(PKB), p53",1.58E-01,2.82E-01,5,"PI3K cat class IA, IRS-2, EGFR, NF-kB, AKT(PKB)"
559,Immunological synapse between dendritic and CD8+ T cells in allergic contact dermatitis,32,7.86E-03,2.05E-02,7.86E-03,2.05E-02,8,"PD-L2, Lck, ICAM1, CD70(TNFSF7), CD137 ligand(TNFSF9), NF-kB, CD137(TNFRSF9), PD-L1",2.19E-02,6.60E-02,7,"PD-L2, ICAM1, CD70(TNFSF7), CD137 ligand(TNFSF9), NF-kB, CD137(TNFRSF9), PD-L1"
560,Cytoskeleton remodeling_Reverse signaling by Ephrin-B,32,7.86E-03,2.05E-02,7.86E-03,2.05E-02,8,"F-Actin, G-protein alpha-i family, PINCH-2, Beta-catenin, Actin cytoskeletal, Tau (MAPT), SOS, Ephrin-B receptors",1.58E-01,2.82E-01,5,"G-protein alpha-i family, PINCH-2, Tau (MAPT), SOS, Ephrin-B receptors"
561,Signal transduction_ERK1/2 signaling pathway,32,7.86E-03,2.05E-02,7.86E-03,2.05E-02,8,"PKC-alpha, N-Ras, ERK1/2, SOS, ERK2 (MAPK1), SOS1, A-Raf-1, ERK1 (MAPK3)",5.63E-01,7.13E-01,3,"PKC-alpha, SOS, SOS1"
562,Development_FGF2-dependent induction of EMT,20,8.15E-03,2.11E-02,8.15E-03,2.11E-02,6,"IL-1 beta, PI3K cat class IA, FGF2, AKT(PKB), PDK (PDPK1), p27KIP1",1.01E-01,2.01E-01,4,"IL-1 beta, PI3K cat class IA, FGF2, AKT(PKB)"
563,Androstenedione and testosterone biosynthesis and metabolism p.3,40,8.19E-03,2.53E-02,1.02E-02,2.53E-02,9,"CYP11B1, UGT2B28, AKR1C3, AKR1C4, UGT1A10, UGT2B4, UGT2B7, AKR1C2, UGT2B17",8.19E-03,3.32E-02,9,"CYP11B1, UGT2B28, AKR1C3, AKR1C4, UGT1A10, UGT2B4, UGT2B7, AKR1C2, UGT2B17"
564,Th9 cells in asthma,47,8.21E-03,2.55E-02,1.04E-02,2.55E-02,10,"GATA-3, ST2(L), MHC class II, CRLR, RelA (p65 NF-kB subunit), CCL13, Activin A, IL-33, TGF-beta, CCL7",8.21E-03,3.32E-02,10,"GATA-3, ST2(L), MHC class II, CRLR, RelA (p65 NF-kB subunit), CCL13, Activin A, IL-33, TGF-beta, CCL7"
565,Hedgehog signaling in prostate cancer,26,8.28E-03,2.14E-02,8.28E-03,2.14E-02,7,"PTCH1, Bcl-2, Nestin, SNAIL1, GLI-1, IBP6, GLI-2",2.57E-02,7.45E-02,6,"PTCH1, Bcl-2, Nestin, GLI-1, IBP6, GLI-2"
566,Downregulation of MITF in melanoma,26,8.28E-03,2.14E-02,8.28E-03,2.14E-02,7,"STAT3, IL-1 beta, SOX10, IL-6, NF-kB, p27KIP1, GLI-2",8.00E-02,1.72E-01,5,"IL-1 beta, SOX10, IL-6, NF-kB, GLI-2"
567,Immune response_Role of HMGB1 in dendritic cell maturation and migration,26,8.28E-03,2.14E-02,8.28E-03,2.14E-02,7,"IL-15, IL-1 beta, MHC class II, IL-8, ERK1/2, IL-6, NF-kB",2.57E-02,7.45E-02,6,"IL-15, IL-1 beta, MHC class II, IL-8, IL-6, NF-kB"
568,Development_Thrombopoietin signaling via ERK1/2 and PI3K,67,8.40E-03,2.16E-02,8.40E-03,2.16E-02,13,"PDK1, NF-E2 (45 kDa), PI3K cat class IA, RelA (p65 NF-kB subunit), IRS-2, BMP4, ERK1/2, HOXA9, AKT(PKB), SOS1, Thrombopoietin, PDK (PDPK1), p27KIP1",1.48E-01,2.69E-01,9,"NF-E2 (45 kDa), PI3K cat class IA, RelA (p65 NF-kB subunit), IRS-2, BMP4, HOXA9, AKT(PKB), SOS1, Thrombopoietin"
569,"Immune response_Th17, Th22 and Th9 cell differentiation ",39,8.58E-03,2.20E-02,8.58E-03,2.20E-02,9,"STAT3, IL-1 beta, GATA-3, MHC class II, ROR-alpha, ROR-gamma, TGF-beta receptor type II, IL-6, NF-kB",2.14E-02,6.53E-02,8,"IL-1 beta, GATA-3, MHC class II, ROR-alpha, ROR-gamma, TGF-beta receptor type II, IL-6, NF-kB"
570,TrkB signaling in Huntington's disease,39,8.58E-03,2.20E-02,8.58E-03,2.20E-02,9,"NGFR(TNFRSF16), PI3K cat class IA, PKC, NR1, ERK1/2, SOS, PDK (PDPK1), NR2A, IP3 receptor",5.79E-02,1.34E-01,7,"NGFR(TNFRSF16), PI3K cat class IA, PKC, NR1, SOS, NR2A, IP3 receptor"
571,Immune response_HMGB1 release from the cell,39,8.58E-03,2.20E-02,8.58E-03,2.20E-02,9,"IL-1 beta, TNF-R2, PI3K cat class IA, PKC-alpha, TLR4, NF-kB, PDK (PDPK1), TLR2, IP3 receptor",2.14E-02,6.53E-02,8,"IL-1 beta, TNF-R2, PI3K cat class IA, PKC-alpha, TLR4, NF-kB, TLR2, IP3 receptor"
572,Immune response_Differentiation and clonal expansion of CD8+ T cells,39,8.58E-03,2.20E-02,8.58E-03,2.20E-02,9,"STAT3, MHC class II, ICAM1, STAT4, CD70(TNFSF7), CD137 ligand(TNFSF9), NF-kB, CD137(TNFRSF9), IFN-beta",2.14E-02,6.53E-02,8,"MHC class II, ICAM1, STAT4, CD70(TNFSF7), CD137 ligand(TNFSF9), NF-kB, CD137(TNFRSF9), IFN-beta"
573,Immune response_Naive CD4+ T cell differentiation,46,8.89E-03,2.24E-02,8.89E-03,2.24E-02,10,"STAT3, IL-1 beta, GATA-3, MHC class II, ROR-alpha, RUNX3, STAT4, ROR-gamma, IL-6, NF-kB",2.03E-02,6.35E-02,9,"IL-1 beta, GATA-3, MHC class II, ROR-alpha, RUNX3, STAT4, ROR-gamma, IL-6, NF-kB"
574,Immune response_Inhibitory action of Lipoxins on pro-inflammatory TNF-alpha signaling,46,8.89E-03,2.24E-02,8.89E-03,2.24E-02,10,"STAT3, IL-1 beta, TNF-R2, PI3K cat class IA, IL-8, Cyclin E, IL-6, AKT(PKB), PDK (PDPK1), p27KIP1",1.18E-01,2.26E-01,7,"IL-1 beta, TNF-R2, PI3K cat class IA, IL-8, Cyclin E, IL-6, AKT(PKB)"
575,Cytoskeleton remodeling_Regulation of actin cytoskeleton nucleation and polymerization by Rho GTPases,46,8.89E-03,2.24E-02,8.89E-03,2.24E-02,10,"DRF, Rac1-related, FMNL3, FMNL2, F-Actin cytoskeleton, RhoA-related, Actin cytoskeletal, Rac2, RhoB, FNBP1",5.20E-02,1.23E-01,8,"DRF, Rac1-related, FMNL3, FMNL2, RhoA-related, Rac2, RhoB, FNBP1"
576,Development_Endothelin-1/EDNRA transactivation of EGFR,46,8.89E-03,2.24E-02,8.89E-03,2.24E-02,10,"Tuberin, PI3K cat class IA, EGFR, ERK1/2, SOS, AKT(PKB), G-protein alpha-q/11, PDK (PDPK1), EDNRA, IP3 receptor",1.18E-01,2.26E-01,7,"PI3K cat class IA, EGFR, SOS, AKT(PKB), G-protein alpha-q/11, EDNRA, IP3 receptor"
577,Nociception_Expression and role of Nociceptin in immune system,46,8.89E-03,2.24E-02,8.89E-03,2.24E-02,10,"STAT3, IL-1 beta, RelA (p65 NF-kB subunit), ESR1 (nuclear), CaMK II beta, CCL2, TLR4, ERK1/2, LIF, IL-6",5.20E-02,1.23E-01,8,"IL-1 beta, RelA (p65 NF-kB subunit), ESR1 (nuclear), CaMK II beta, CCL2, TLR4, LIF, IL-6"
578,Dual function of Treg cells in cancer development,46,8.89E-03,2.24E-02,8.89E-03,2.24E-02,10,"STAT3, COX-2 (PTGS2), ROR-alpha, ETS1, ROR-gamma, WNT, Neuropilin-1, IL-6, Beta-catenin, 5'-NTD",5.20E-02,1.23E-01,8,"COX-2 (PTGS2), ROR-alpha, ETS1, ROR-gamma, WNT, Neuropilin-1, IL-6, 5'-NTD"
579,"Development_Insulin, IGF-1 and TNF-alpha in brown adipocyte differentiation",53,8.90E-03,2.24E-02,8.90E-03,2.24E-02,11,"Adiponectin, IRS-2, ERK1/2, FOXC2, PPARGC1 (PGC1-alpha), Beta-2 adrenergic receptor, AKT(PKB), FASN, p27KIP1, Perilipin, C/EBPalpha",1.02E-01,2.02E-01,8,"Adiponectin, IRS-2, FOXC2, PPARGC1 (PGC1-alpha), Beta-2 adrenergic receptor, AKT(PKB), Perilipin, C/EBPalpha"
580,Signal transduction_CXCR4 signaling via MAPKs cascades,53,8.90E-03,2.24E-02,8.90E-03,2.24E-02,11,"BAD, PAK, RelA (p65 NF-kB subunit), N-Ras, G-protein alpha-i family, ERK1/2, IL-6, SMAD3, CTGF, GAD1, PREX1",2.00E-01,3.35E-01,7,"PAK, RelA (p65 NF-kB subunit), G-protein alpha-i family, IL-6, CTGF, GAD1, PREX1"
581,Putative pathways of MHC class I-dependent postsynaptic long-term depression in major depressive disorder,21,8.93E-03,2.58E-02,1.05E-02,2.58E-02,6,"MHC Class I alpha chain, TAP1 (PSF1), HLA-B, HLA-A, TAP2 (PSF2), TAP",8.93E-03,3.56E-02,6,"MHC Class I alpha chain, TAP1 (PSF1), HLA-B, HLA-A, TAP2 (PSF2), TAP"
582,Role of tumor-infiltrating B cells in anti-tumor immunity,91,9.79E-03,2.46E-02,9.79E-03,2.46E-02,16,"STAT3, IL-18R1, MHC class II, ADAM-TS9, IP10, NY-ESO-1, CXorf61, SOX2, CD38, I-TAC, G-protein alpha-i family, MAGE-1 antigen, MAGEB2, NF-kB, p53, BLIMP1 (PRDI-BF1)",3.35E-02,9.29E-02,14,"IL-18R1, MHC class II, ADAM-TS9, IP10, NY-ESO-1, CXorf61, SOX2, CD38, I-TAC, G-protein alpha-i family, MAGE-1 antigen, MAGEB2, NF-kB, BLIMP1 (PRDI-BF1)"
583,Stem cells_NOTCH1-induced self-renewal of glioblastoma stem cells,40,1.02E-02,2.53E-02,1.02E-02,2.53E-02,9,"STAT3, HES5, SOX2, BMP4, EGFR, Nestin, p53, Jagged1, BMP2",6.49E-02,1.46E-01,7,"HES5, SOX2, BMP4, EGFR, Nestin, Jagged1, BMP2"
584,Development_FGF2-induced self-renewal of adult neural stem cells,40,1.02E-02,2.53E-02,1.02E-02,2.53E-02,9,"PI3K cat class IA, PKC, ERK1/2, FGF2, SOS, AKT(PKB), PDK (PDPK1), Jagged1, IP3 receptor",6.49E-02,1.46E-01,7,"PI3K cat class IA, PKC, FGF2, SOS, AKT(PKB), Jagged1, IP3 receptor"
585,Th2-cytokines-induced mucous metaplasia in asthma,40,1.02E-02,2.53E-02,1.02E-02,2.53E-02,9,"CLCA1, PI3K cat class IA, IRS-2, Mucin 5AC, ERK1/2, SOS, PGE2R3, HAG-2, PDEF",2.47E-02,7.23E-02,8,"CLCA1, PI3K cat class IA, IRS-2, Mucin 5AC, SOS, PGE2R3, HAG-2, PDEF"
586,Development_FGF signaling in pancreatic and hepatic differentiation of embryonic stem cells,40,1.02E-02,2.53E-02,1.02E-02,2.53E-02,9,"N-cadherin, Activin A, Alpha 1-antitrypsin, FGFR4, BMP4, ERK1/2, FGF2, SOS, BMP2",2.47E-02,7.23E-02,8,"N-cadherin, Activin A, Alpha 1-antitrypsin, FGFR4, BMP4, FGF2, SOS, BMP2"
587,Eosinophil granule protein release in asthma,54,1.03E-02,2.55E-02,1.03E-02,2.55E-02,11,"NGF, ST2(L), cPKC (conventional), PKC, PKC-alpha, IL-33, ERK1/2, CAMP, Tryptase, PRG2, C3a",2.14E-02,6.53E-02,10,"NGF, ST2(L), cPKC (conventional), PKC, PKC-alpha, IL-33, CAMP, Tryptase, PRG2, C3a"
588,Activation of TGF-beta signaling in pancreatic cancer,27,1.03E-02,2.55E-02,1.03E-02,2.55E-02,7,"ICAM1, TGF-beta receptor type II, SLUG, SOS, SMAD3, ERK2 (MAPK1), GLI-2",9.12E-02,1.87E-01,5,"ICAM1, TGF-beta receptor type II, SLUG, SOS, GLI-2"
589,Immune response_Induction of apoptosis and inhibition of proliferation mediated by IFN-gamma,47,1.04E-02,2.55E-02,1.04E-02,2.55E-02,10,"IL-15, IFI17, IDO1, Cyclin E, CTGF, Caspase-1, Caspase-8, p53, p27KIP1, IFN-beta",1.28E-01,2.40E-01,7,"IL-15, IFI17, IDO1, Cyclin E, CTGF, Caspase-1, IFN-beta"
590,Regulation of mast cell survival in asthma,47,1.04E-02,2.55E-02,1.04E-02,2.55E-02,10,"BAD, Syk, NGF, TNF-R2, Bcl-2, ERK1/2, IL-6, alpha-5/beta-1 integrin, AKT(PKB), Fibronectin",5.79E-02,1.34E-01,8,"Syk, NGF, TNF-R2, Bcl-2, IL-6, alpha-5/beta-1 integrin, AKT(PKB), Fibronectin"
591,Development_PIP3 signaling in cardiac myocytes,47,1.04E-02,2.55E-02,1.04E-02,2.55E-02,10,"BAD, HGF, Tuberin, PI3K cat class IA, PTEN, SOS, AKT(PKB), PDK (PDPK1), HGF receptor (Met), PI3K reg class IB (p101)",2.49E-01,3.91E-01,6,"HGF, PI3K cat class IA, SOS, AKT(PKB), HGF receptor (Met), PI3K reg class IB (p101)"
592,Immune response_PGE2 common pathways,47,1.04E-02,2.55E-02,1.04E-02,2.55E-02,10,"COX-2 (PTGS2), PGE2R2, PGE2R4, G-protein alpha-i family, Adenylate cyclase, ERK2 (MAPK1), AKT(PKB), PGE2R3, ERK1 (MAPK3), IP3 receptor",5.79E-02,1.34E-01,8,"COX-2 (PTGS2), PGE2R2, PGE2R4, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), PGE2R3, IP3 receptor"
593,Inhibition of tumor suppressive pathways in pancreatic cancer,21,1.05E-02,2.58E-02,1.05E-02,2.58E-02,6,"p14ARF, p15, SNAIL1, p53, p16INK4, CDK6",1.16E-01,2.24E-01,4,"p14ARF, p15, p16INK4, CDK6"
594,Neurophysiological process_Thyroliberin in cell hyperpolarization and excitability,35,1.13E-02,3.21E-02,1.37E-02,3.21E-02,8,"MaxiK alpha subunit, cPKC (conventional), Thyroliberin, PKC-alpha, Kir3.4, KCNH7, Kir3.1, IP3 receptor",1.13E-02,4.22E-02,8,"MaxiK alpha subunit, cPKC (conventional), Thyroliberin, PKC-alpha, Kir3.4, KCNH7, Kir3.1, IP3 receptor"
595,Muscle contraction_Oxytocin signaling in uterus and mammary gland,62,1.13E-02,2.77E-02,1.13E-02,2.77E-02,12,"COX-2 (PTGS2), PLA2(hGIIA), cPKC (conventional), AKR1C3, PKC, PKC-alpha, cPLA2, EGFR, ERK1/2, PGF2aR, G-protein alpha-q/11, IP3 receptor",2.20E-02,6.61E-02,11,"COX-2 (PTGS2), PLA2(hGIIA), cPKC (conventional), AKR1C3, PKC, PKC-alpha, cPLA2, EGFR, PGF2aR, G-protein alpha-q/11, IP3 receptor"
596,Estradiol metabolism,42,1.14E-02,3.26E-02,1.40E-02,3.26E-02,9,"UGT2B28, UGT1A1, CYP1A1, UGT1A10, SULT1A1, UGT2B7, UGT2B11, UGT2B17, UGT1A4",1.14E-02,4.22E-02,9,"UGT2B28, UGT1A1, CYP1A1, UGT1A10, SULT1A1, UGT2B7, UGT2B11, UGT2B17, UGT1A4"
597,Transition of Monoclonal gammopathy of undetermined significance to active multiple myeloma (schema),22,1.14E-02,3.15E-02,1.33E-02,3.15E-02,6,"NCAM1, MMP-2, p15, Osteoprotegerin, p16INK4, MMP-9",1.14E-02,4.22E-02,6,"NCAM1, MMP-2, p15, Osteoprotegerin, p16INK4, MMP-9"
598,Regulation of Adenylate cyclase and IMPA1 by lithium in major depressive disorder,22,1.14E-02,3.15E-02,1.33E-02,3.15E-02,6,"G-protein alpha-i1, Adenylate cyclase type II, P2X2, G-protein alpha-i family, Adenylate cyclase, Alpha-2A adrenergic receptor",1.14E-02,4.22E-02,6,"G-protein alpha-i1, Adenylate cyclase type II, P2X2, G-protein alpha-i family, Adenylate cyclase, Alpha-2A adrenergic receptor"
599,Th2 cell migration in asthma,34,1.15E-02,2.79E-02,1.15E-02,2.79E-02,8,"Lck, alpha-4/beta-1 integrin, ICAM1, CD44, CCR8, G-protein alpha-i family, Beta-2 adrenergic receptor, PI3K reg class IB (p101)",2.99E-02,8.48E-02,7,"alpha-4/beta-1 integrin, ICAM1, CD44, CCR8, G-protein alpha-i family, Beta-2 adrenergic receptor, PI3K reg class IB (p101)"
600,Role of Apo-2L(TNFSF10) in Prostate Cancer cell apoptosis,34,1.15E-02,2.79E-02,1.15E-02,2.79E-02,8,"TRUNDD(TNFRSF10D), c-IAP2, Caspase-10, c-IAP1, Bcl-2, NF-kB, Osteoprotegerin, Caspase-8",2.99E-02,8.48E-02,7,"TRUNDD(TNFRSF10D), c-IAP2, Caspase-10, c-IAP1, Bcl-2, NF-kB, Osteoprotegerin"
601,G-protein signaling_G-Protein alpha-q signaling cascades,34,1.15E-02,2.79E-02,1.15E-02,2.79E-02,8,"PI3K cat class IA, SOS, NF-kB, AKT(PKB), G-protein alpha-q/11, RGS2, PDK (PDPK1), IP3 receptor",2.99E-02,8.48E-02,7,"PI3K cat class IA, SOS, NF-kB, AKT(PKB), G-protein alpha-q/11, RGS2, IP3 receptor"
602,Immune response_Platelet activating factor/ PTAFR pathway signaling,55,1.18E-02,2.85E-02,1.18E-02,2.85E-02,11,"STAT3, IL-1 beta, PI3K cat class IA, CCL2, G-protein alpha-i family, Adenylate cyclase, F-Actin cytoskeleton, NF-kB, AKT(PKB), MMP-9, IP3 receptor",5.68E-02,1.32E-01,9,"IL-1 beta, PI3K cat class IA, CCL2, G-protein alpha-i family, Adenylate cyclase, NF-kB, AKT(PKB), MMP-9, IP3 receptor"
603,Chemotaxis_CCL2-induced chemotaxis,55,1.18E-02,2.85E-02,1.18E-02,2.85E-02,11,"PI3K cat class IA, CCL2, cPLA2, Lyn, G-protein alpha-i family, ERK1/2, Actin cytoskeletal, PA24A, SOS, PI3K reg class IB (p101), IP3 receptor",5.68E-02,1.32E-01,9,"PI3K cat class IA, CCL2, cPLA2, Lyn, G-protein alpha-i family, PA24A, SOS, PI3K reg class IB (p101), IP3 receptor"
604,Apoptosis and survival_NO synthesis and signaling,55,1.18E-02,2.85E-02,1.18E-02,2.85E-02,11,"NMDA receptor, COX-2 (PTGS2), IL-1 beta, iNOS, ERK1/2, CaMK I, NF-kB, AKT(PKB), PDK (PDPK1), PI3K cat class IA (p110-delta), NF-kB p65/p65",5.68E-02,1.32E-01,9,"NMDA receptor, COX-2 (PTGS2), IL-1 beta, iNOS, CaMK I, NF-kB, AKT(PKB), PI3K cat class IA (p110-delta), NF-kB p65/p65"
605,Development_Fetal brown fat cell differentiation,55,1.18E-02,2.85E-02,1.18E-02,2.85E-02,11,"PI3K cat class IA, IRS-2, Adenylate cyclase, ERK1/2, PPARGC1 (PGC1-alpha), SOS, AKT(PKB), PDK (PDPK1), FASN, C/EBPalpha, Prolactin receptor",1.20E-01,2.30E-01,8,"PI3K cat class IA, IRS-2, Adenylate cyclase, PPARGC1 (PGC1-alpha), SOS, AKT(PKB), C/EBPalpha, Prolactin receptor"
606,Development_Schema: Methods of somatic cell reprogramming into induced pluripotent stem cells,6,1.20E-02,3.14E-02,1.32E-02,3.14E-02,3,"Oct-3/4, SOX2, LIN-28",1.20E-02,4.43E-02,3,"Oct-3/4, SOX2, LIN-28"
607,Immune response_TLR2-induced platelet activation,41,1.20E-02,2.88E-02,1.20E-02,2.88E-02,9,"IL-1 beta, TLR1, PI3K cat class IA, PKC-alpha, cPLA2, ERK1/2, AKT(PKB), TLR2, IP3 receptor",2.83E-02,8.10E-02,8,"IL-1 beta, TLR1, PI3K cat class IA, PKC-alpha, cPLA2, AKT(PKB), TLR2, IP3 receptor"
608,Oxidative stress_Role of IL-8 signaling pathway in respiratory burst,48,1.20E-02,2.88E-02,1.20E-02,2.88E-02,10,"PKC-alpha, IL-8, G-protein alpha-i family, ERK1/2, Rac2, AKT(PKB), IL8RA, PI3K reg class IB (p101), IP3 receptor, PREX1",2.63E-02,7.57E-02,9,"PKC-alpha, IL-8, G-protein alpha-i family, Rac2, AKT(PKB), IL8RA, PI3K reg class IB (p101), IP3 receptor, PREX1"
609,Muscle contraction_Relaxin signaling pathway,48,1.20E-02,2.88E-02,1.20E-02,2.88E-02,10,"LGR7, EDNRB, Adenylate cyclase type V, iNOS, G-protein alpha-i family, ERK1/2, MMP-2, NF-kB, AKT(PKB), MMP-9",2.63E-02,7.57E-02,9,"LGR7, EDNRB, Adenylate cyclase type V, iNOS, G-protein alpha-i family, MMP-2, NF-kB, AKT(PKB), MMP-9"
610,Development_Adiponectin signaling,48,1.20E-02,2.88E-02,1.20E-02,2.88E-02,10,"STAT3, PI3K cat class IA, Adiponectin, ERK1/2, IL-6, FGF2, SOS, AKT(PKB), A-Raf-1, IP3 receptor",1.39E-01,2.55E-01,7,"PI3K cat class IA, Adiponectin, IL-6, FGF2, SOS, AKT(PKB), IP3 receptor"
611,Immune response_IL-12 signaling pathway,48,1.20E-02,2.88E-02,1.20E-02,2.88E-02,10,"STAT3, PI3K cat class IA, GADD45 gamma, Lck, iNOS, RUNX3, STAT4, AKT(PKB), PDK (PDPK1), ERM",1.39E-01,2.55E-01,7,"PI3K cat class IA, GADD45 gamma, iNOS, RUNX3, STAT4, AKT(PKB), ERM"
612,Development_Role of CNTF and LIF in regulation of oligodendrocyte development,28,1.26E-02,3.02E-02,1.26E-02,3.02E-02,7,"STAT3, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), LIF, AKT(PKB), PDK (PDPK1)",1.03E-01,2.04E-01,5,"c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), LIF, AKT(PKB)"
613,Immune response_Innate immune response to RNA viral infection,28,1.26E-02,3.02E-02,1.26E-02,3.02E-02,7,"Caspase-10, IL-8, TLR7, NF-kB, Caspase-8, TLR3, IFN-beta",3.61E-02,9.75E-02,6,"Caspase-10, IL-8, TLR7, NF-kB, TLR3, IFN-beta"
614,NF-AT signaling in cardiac hypertrophy,65,1.27E-02,3.66E-02,1.63E-02,3.66E-02,12,"HDAC9, PI3K cat class IA, PKC-alpha, NCX1, G-protein alpha-i family, MEF2C, LIF, IL-6, AKT(PKB), G-protein alpha-q/11, HAND2, Troponin I, cardiac",1.27E-02,4.65E-02,12,"HDAC9, PI3K cat class IA, PKC-alpha, NCX1, G-protein alpha-i family, MEF2C, LIF, IL-6, AKT(PKB), G-protein alpha-q/11, HAND2, Troponin I, cardiac"
615,Apoptosis and survival_CXCR3-B signaling,63,1.28E-02,3.06E-02,1.28E-02,3.06E-02,12,"STAT3, GATA-3, IP10, IDO2, I-TAC, ITGB3, Adenylate cyclase, Bcl-2, ERK1/2, Beclin 1, p53, IP3 receptor",2.07E-01,3.42E-01,8,"GATA-3, IP10, IDO2, I-TAC, ITGB3, Adenylate cyclase, Bcl-2, IP3 receptor"
616,EGF- and HGF-dependent stimulation of metastasis in gastric cancer,22,1.33E-02,3.15E-02,1.33E-02,3.15E-02,6,"HGF, EGFR, ERK1/2, SOS, HGF receptor (Met), PLAU (UPA)",4.31E-02,1.09E-01,5,"HGF, EGFR, SOS, HGF receptor (Met), PLAU (UPA)"
617,T regulatory cell migration in asthma,22,1.33E-02,3.15E-02,1.33E-02,3.15E-02,6,"Lck, CCR8, G-protein alpha-i family, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101)",1.32E-01,2.45E-01,4,"CCR8, G-protein alpha-i family, AKT(PKB), PI3K reg class IB (p101)"
618,Immune response_IL-15 signaling via JAK-STAT cascade,22,1.33E-02,3.15E-02,1.33E-02,3.15E-02,6,"STAT3, Syk, IL-15, IL-15RA, Bcl-2, sIL-15RA",4.31E-02,1.09E-01,5,"Syk, IL-15, IL-15RA, Bcl-2, sIL-15RA"
619,Immune response_HMGB1/TLR signaling pathway,36,1.34E-02,3.66E-02,1.62E-02,3.66E-02,8,"IL-1 beta, RelA (p65 NF-kB subunit), IL-8, TLR4, IL-6, TIRAP (Mal), IFN-beta, TLR2",1.34E-02,4.78E-02,8,"IL-1 beta, RelA (p65 NF-kB subunit), IL-8, TLR4, IL-6, TIRAP (Mal), IFN-beta, TLR2"
620,Development_Hedgehog and PTH signaling pathways in bone and cartilage development,36,1.34E-02,3.66E-02,1.62E-02,3.66E-02,8,"MMP-13, RUNX2, PTCH1, PTHR1, PTHrP, GLI-1, G-protein alpha-q/11, GLI-2",1.34E-02,4.78E-02,8,"MMP-13, RUNX2, PTCH1, PTHR1, PTHrP, GLI-1, G-protein alpha-q/11, GLI-2"
621,Immune response_IL-5 signaling via JAK/STAT,56,1.34E-02,3.17E-02,1.34E-02,3.17E-02,11,"STAT3, IL-1 beta, c-IAP2, Amphiregulin, CISH, IL-8, XBP1, Bcl-2, PRG2, Pim-1, BLIMP1 (PRDI-BF1)",2.71E-02,7.78E-02,10,"IL-1 beta, c-IAP2, Amphiregulin, CISH, IL-8, XBP1, Bcl-2, PRG2, Pim-1, BLIMP1 (PRDI-BF1)"
622,G-protein signaling_S1P2 receptor signaling pathway,35,1.37E-02,3.21E-02,1.37E-02,3.21E-02,8,"PTEN, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor, Adenylate cyclase type VII",9.13E-02,1.87E-01,6,"G-protein alpha-i family, Adenylate cyclase, AKT(PKB), PI3K reg class IB (p101), IP3 receptor, Adenylate cyclase type VII"
623,Immune response_Th17 cell differentiation,35,1.37E-02,3.21E-02,1.37E-02,3.21E-02,8,"STAT3, IL-1 beta, MHC class II, ROR-alpha, ROR-gamma, TGF-beta receptor type II, IL-6, NF-kB",3.46E-02,9.44E-02,7,"IL-1 beta, MHC class II, ROR-alpha, ROR-gamma, TGF-beta receptor type II, IL-6, NF-kB"
624,Development_Melanocyte development and pigmentation,49,1.39E-02,3.24E-02,1.39E-02,3.24E-02,10,"SOX10, PI3K cat class IA, ERK1/2, Beta-catenin, SOS, AKT(PKB), ACTH, alpha-MSH, PDK (PDPK1), Frizzled",1.50E-01,2.70E-01,7,"SOX10, PI3K cat class IA, SOS, AKT(PKB), ACTH, alpha-MSH, Frizzled"
625,Transcription_CREB signaling pathway,49,1.39E-02,3.24E-02,1.39E-02,3.24E-02,10,"cPKC (conventional), PI3K cat class IA, Galpha(s)-specific amine GPCRs, PKC-alpha, ERK1/2, CDO1, SOS, AKT(PKB), PDK (PDPK1), DREAM",7.09E-02,1.55E-01,8,"cPKC (conventional), PI3K cat class IA, Galpha(s)-specific amine GPCRs, PKC-alpha, CDO1, SOS, AKT(PKB), DREAM"
626,Immune response_PD-1-induced metabolic changes in T cells,49,1.39E-02,3.24E-02,1.39E-02,3.24E-02,10,"PI3K cat class IA, PD-L2, Lck, PTEN, ERK1/2, Fyn, AKT(PKB), PDK (PDPK1), FASN, PD-L1",4.59E-01,6.29E-01,5,"PI3K cat class IA, PD-L2, Fyn, AKT(PKB), PD-L1"
627,Apoptosis and survival_BAD phosphorylation,42,1.40E-02,3.26E-02,1.40E-02,3.26E-02,9,"BAD, PI3K cat class IA, EGFR, Bcl-2, ERK1/2, Beclin 1, SOS, AKT(PKB), PDK (PDPK1)",3.30E-01,4.86E-01,5,"PI3K cat class IA, EGFR, Bcl-2, SOS, AKT(PKB)"
628,Development_NOTCH in inhibition of WNT/Beta-catenin-induced osteogenesis,42,1.40E-02,3.26E-02,1.40E-02,3.26E-02,9,"RUNX2, WNT, ALPL, Beta-catenin, Jagged1, Dsh, TCF7 (TCF1), Frizzled, C/EBPalpha",8.05E-02,1.72E-01,7,"RUNX2, WNT, ALPL, Jagged1, TCF7 (TCF1), Frizzled, C/EBPalpha"
629,Chemotaxis_SDF-1/ CXCR4-induced chemotaxis of immune cells,79,1.41E-02,3.28E-02,1.41E-02,3.28E-02,14,"ITGB1, PI3K cat class IA, PAK, Lck, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, F-Actin cytoskeleton, ERK1/2, Fyn, AKT(PKB), SFK, PI3K reg class IB (p101)",9.81E-02,1.98E-01,11,"ITGB1, PI3K cat class IA, PAK, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, Fyn, AKT(PKB), SFK, PI3K reg class IB (p101)"
630,Stem cells_MMP-14-induced COX-2 expression in glioblastoma stem cells,23,1.42E-02,3.71E-02,1.67E-02,3.71E-02,6,"COX-2 (PTGS2), cPLA2, MMP-14, MMP-2, NF-kB, AKT(PKB)",1.42E-02,5.00E-02,6,"COX-2 (PTGS2), cPLA2, MMP-14, MMP-2, NF-kB, AKT(PKB)"
631,Signal transduction_NF-kB activation pathways,51,1.46E-02,4.01E-02,1.82E-02,4.01E-02,10,"IL-1 beta, c-IAP2, RelA (p65 NF-kB subunit), Pellino 1, Pellino 2, c-IAP1, TLR4, TIRAP (Mal), NF-kB, TLR2",1.46E-02,5.06E-02,10,"IL-1 beta, c-IAP2, RelA (p65 NF-kB subunit), Pellino 1, Pellino 2, c-IAP1, TLR4, TIRAP (Mal), NF-kB, TLR2"
632,Tinnitus-associated changes in auditory pathway ,82,1.46E-02,4.14E-02,1.92E-02,4.14E-02,14,"NMDA receptor, GRID1, GRIK4, GABA-A receptor, GRIK5, GluR6, NR1, GABA-A receptor delta subunit, mGluR4A, GRID2, GABA-A receptor gamma-3 subunit, GAD1, GABA-A receptor gamma-2 subunit, NR2A",1.46E-02,5.06E-02,14,"NMDA receptor, GRID1, GRIK4, GABA-A receptor, GRIK5, GluR6, NR1, GABA-A receptor delta subunit, mGluR4A, GRID2, GABA-A receptor gamma-3 subunit, GAD1, GABA-A receptor gamma-2 subunit, NR2A"
633,Skeletal muscle atrophy in COPD,57,1.53E-02,3.53E-02,1.53E-02,3.53E-02,11,"MYBPC1, Tuberin, RelA (p65 NF-kB subunit), iNOS, ERK1/2, PPARGC1 (PGC1-alpha), SMAD3, ERK2 (MAPK1), AKT(PKB), Vimentin, MyHC",4.12E-01,5.80E-01,6,"MYBPC1, RelA (p65 NF-kB subunit), iNOS, PPARGC1 (PGC1-alpha), AKT(PKB), Vimentin"
634,Lysophospholipid mediators-induced inflammatory signaling in normal and asthmatic airway epithelium,57,1.53E-02,3.53E-02,1.53E-02,3.53E-02,11,"COX-2 (PTGS2), CCL20, LPAR1, IL-8, Lyn, G-protein alpha-i family, ERK1/2, NF-kB, AKT(PKB), PDK (PDPK1), MMP-9",6.86E-02,1.53E-01,9,"COX-2 (PTGS2), CCL20, LPAR1, IL-8, Lyn, G-protein alpha-i family, NF-kB, AKT(PKB), MMP-9"
635,Neurophysiological process_Melatonin signaling,44,1.53E-02,4.11E-02,1.89E-02,4.11E-02,9,"MaxiK alpha subunit, ROR-alpha, G-protein alpha-i family, Adenylate cyclase, Melatonin receptor 1A, ALOX5, CYP19, Kir3.1, IP3 receptor",1.53E-02,5.25E-02,9,"MaxiK alpha subunit, ROR-alpha, G-protein alpha-i family, Adenylate cyclase, Melatonin receptor 1A, ALOX5, CYP19, Kir3.1, IP3 receptor"
636,Apoptosis and survival_nAChR in apoptosis inhibition and cell cycle progression,29,1.54E-02,3.53E-02,1.54E-02,3.53E-02,7,"nAChR alpha-7, Tuberin, PI3K cat class IA, nAChR alpha, Fyn, AKT(PKB), PDK (PDPK1)",1.16E-01,2.24E-01,5,"nAChR alpha-7, PI3K cat class IA, nAChR alpha, Fyn, AKT(PKB)"
637,Immune response_Delta-type opioid receptor signaling in T-cells,29,1.54E-02,3.53E-02,1.54E-02,3.53E-02,7,"Metenkefalin, G-protein alpha-i family, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), ERK1 (MAPK3)",2.65E-01,4.12E-01,4,"Metenkefalin, G-protein alpha-i family, AKT(PKB), PI3K reg class IB (p101)"
638,Stem cells_Notch signaling in medulloblastoma stem cells,29,1.54E-02,3.53E-02,1.54E-02,3.53E-02,7,"HES5, PTCH1, GLI-1, FKHL1, Jagged1, p27KIP1, GLI-2",4.21E-02,1.08E-01,6,"HES5, PTCH1, GLI-1, FKHL1, Jagged1, GLI-2"
639,Development_Auditory hair cell differentiation in embryogenesis,29,1.54E-02,3.53E-02,1.54E-02,3.53E-02,7,"NGFR(TNFRSF16), HES5, SOX2, BMP4, Jagged1, p27KIP1, GFI-1",4.21E-02,1.08E-01,6,"NGFR(TNFRSF16), HES5, SOX2, BMP4, Jagged1, GFI-1"
640,Reactive oxygen and nitrogen species production in eosinophils in asthma,59,1.55E-02,4.20E-02,1.96E-02,4.20E-02,11,"Histamine H1 receptor, ST2(L), ITGB1, PI3K cat class IA, iNOS, Eotaxin-2, ITGA4, ITGB2, ICAM1, IL-33, C3a",1.55E-02,5.26E-02,11,"Histamine H1 receptor, ST2(L), ITGB1, PI3K cat class IA, iNOS, Eotaxin-2, ITGA4, ITGB2, ICAM1, IL-33, C3a"
641,Role of SHH and Notch in SCLC,30,1.55E-02,4.04E-02,1.85E-02,4.04E-02,7,"PTCH1, BMP4, AL1A1, Nestin, GLI-1, Jagged1, GLI-2",1.55E-02,5.26E-02,7,"PTCH1, BMP4, AL1A1, Nestin, GLI-1, Jagged1, GLI-2"
642,A shift in alveolar macrophage phenotype in COPD,37,1.57E-02,4.11E-02,1.90E-02,4.11E-02,8,"MHC class II, iNOS, CD14, CD44, MMP-2, Matrilysin (MMP-7), AKT(PKB), MARCO",1.57E-02,5.27E-02,8,"MHC class II, iNOS, CD14, CD44, MMP-2, Matrilysin (MMP-7), AKT(PKB), MARCO"
643,Neurophysiological process_Leptin signaling in neurons,50,1.59E-02,3.65E-02,1.59E-02,3.65E-02,10,"STAT3, TY3H, POMC, MaxiK alpha subunit, PTEN, IRS-2, NPY, AKT(PKB), Kir6.2, PDK (PDPK1)",1.62E-01,2.85E-01,7,"TY3H, POMC, MaxiK alpha subunit, IRS-2, NPY, AKT(PKB), Kir6.2"
644,Modulation of tumor response to cytotoxic T cells by hypoxia in tumors,50,1.59E-02,3.65E-02,1.59E-02,3.65E-02,10,"STAT3, Bcl-2, ERK1/2, Beclin 1, 5'-NTD, CD137 ligand(TNFSF9), HOXA1, AKT(PKB), CD137(TNFRSF9), PD-L1",1.62E-01,2.85E-01,7,"Bcl-2, 5'-NTD, CD137 ligand(TNFSF9), HOXA1, AKT(PKB), CD137(TNFRSF9), PD-L1"
645,Immune response_Inhibitory action of lipoxins on superoxide production induced by IL-8 and Leukotriene B4 in neutrophils,50,1.59E-02,3.65E-02,1.59E-02,3.65E-02,10,"G-protein alpha-15, PKC-alpha, IL-8, G-protein alpha-i family, Rac2, IL8RA, PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor, PREX1",3.34E-02,9.29E-02,9,"G-protein alpha-15, PKC-alpha, IL-8, G-protein alpha-i family, Rac2, IL8RA, PI3K reg class IB (p101), IP3 receptor, PREX1"
646,Immune response_IL-6-induced acute-phase response in hepatocytes,36,1.62E-02,3.66E-02,1.62E-02,3.66E-02,8,"STAT3, GRO-1, SAA1, SAA2, A2M, C3, IL-6, Hemopexin",3.97E-02,1.05E-01,7,"GRO-1, SAA1, SAA2, A2M, C3, IL-6, Hemopexin"
647,Cigarette smoke components TCDD and Benzo[a]pyrene and receptor AHR signaling in lung epithelial cells,36,1.62E-02,3.66E-02,1.62E-02,3.66E-02,8,"COX-2 (PTGS2), IL-1 beta, CYP1A1, CCL2, TGF-beta receptor type II, Mucin 5AC, TGF-alpha, SMAD3",3.97E-02,1.05E-01,7,"COX-2 (PTGS2), IL-1 beta, CYP1A1, CCL2, TGF-beta receptor type II, Mucin 5AC, TGF-alpha"
648,Inhibition of apoptosis in multiple myeloma,36,1.62E-02,3.66E-02,1.62E-02,3.66E-02,8,"STAT3, c-IAP2, TLR4, Bcl-2, IL-6, NF-kB, p53, Jagged1",1.02E-01,2.02E-01,6,"c-IAP2, TLR4, Bcl-2, IL-6, NF-kB, Jagged1"
649,Development_SSTR2 in regulation of cell proliferation,36,1.62E-02,3.66E-02,1.62E-02,3.66E-02,8,"PI3K cat class IA, Cyclin E, G-protein alpha-i family, ERK1/2, SOS, AKT(PKB), PDK (PDPK1), p27KIP1",2.22E-01,3.60E-01,5,"PI3K cat class IA, Cyclin E, G-protein alpha-i family, SOS, AKT(PKB)"
650,Development_ACM2 and ACM4 activation of ERK,43,1.63E-02,3.66E-02,1.63E-02,3.66E-02,9,"PKC-alpha, EGFR, G-protein alpha-i family, ERK1/2, ACM4, Caldesmon, Fyn, SOS, IP3 receptor",3.66E-02,9.76E-02,8,"PKC-alpha, EGFR, G-protein alpha-i family, ACM4, Caldesmon, Fyn, SOS, IP3 receptor"
651,Apoptosis and survival_Anti-apoptotic action of Gastrin,43,1.63E-02,3.66E-02,1.63E-02,3.66E-02,9,"BAD, PI3K cat class IA, PKC-alpha, Bcl-2, ERK1/2, AKT(PKB), G-protein alpha-q/11, PDK (PDPK1), IP3 receptor",1.89E-01,3.20E-01,6,"PI3K cat class IA, PKC-alpha, Bcl-2, AKT(PKB), G-protein alpha-q/11, IP3 receptor"
652,Nicotine / nAChR alpha-7 signaling in NSCLC,43,1.63E-02,3.66E-02,1.63E-02,3.66E-02,9,"nAChR alpha-7, Tuberin, PI3K cat class IA, PKC-alpha, Cyclin E, ERK1/2, AKT(PKB), PDK (PDPK1), Fibronectin",1.89E-01,3.20E-01,6,"nAChR alpha-7, PI3K cat class IA, PKC-alpha, Cyclin E, AKT(PKB), Fibronectin"
653,Development_S1P3 receptor signaling pathway,43,1.63E-02,3.66E-02,1.63E-02,3.66E-02,9,"PI3K cat class IA, CD44, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), PDGF receptor, PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor",3.66E-02,9.76E-02,8,"PI3K cat class IA, CD44, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), PDGF receptor, PI3K reg class IB (p101), IP3 receptor"
654,Role of epigenetic alterations in survival and migration of SCLC cells,43,1.63E-02,3.66E-02,1.63E-02,3.66E-02,9,"Laminin 5, LAMC2, Connexin 26, Bcl-2, H-cadherin, LAMB3, Caspase-8, HGF receptor (Met), LAMA3 (Epiligrin)",3.66E-02,9.76E-02,8,"Laminin 5, LAMC2, Connexin 26, Bcl-2, H-cadherin, LAMB3, HGF receptor (Met), LAMA3 (Epiligrin)"
655,Environmental factors-induced inflammatory signaling in normal and asthmatic airway epithelium,43,1.63E-02,3.66E-02,1.63E-02,3.66E-02,9,"IL-1 beta, iNOS, PKC, ICAM1, IL-8, ERK1/2, sICAM1, IL-6, NF-kB",3.66E-02,9.76E-02,8,"IL-1 beta, iNOS, PKC, ICAM1, IL-8, sICAM1, IL-6, NF-kB"
656,Apoptosis and survival_Beta-2 adrenergic receptor anti-apoptotic action,23,1.67E-02,3.71E-02,1.67E-02,3.71E-02,6,"G-protein alpha-i family, Beta-2 adrenergic receptor, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), Adenylate cyclase type VII",5.11E-02,1.23E-01,5,"G-protein alpha-i family, Beta-2 adrenergic receptor, AKT(PKB), PI3K reg class IB (p101), Adenylate cyclase type VII"
657,Development_EGFR signaling via PIP3,23,1.67E-02,3.71E-02,1.67E-02,3.71E-02,6,"PI3K cat class IA, PTEN, IRS-2, EGFR, AKT(PKB), PDK (PDPK1)",1.49E-01,2.69E-01,4,"PI3K cat class IA, IRS-2, EGFR, AKT(PKB)"
658,Development_Delta- and kappa-type opioid receptors signaling via beta-arrestin,23,1.67E-02,3.71E-02,1.67E-02,3.71E-02,6,"Metenkefalin, PKC, G-protein alpha-i family, Leu-enkephalin, p27KIP1, Kappa-type opioid receptor",5.11E-02,1.23E-01,5,"Metenkefalin, PKC, G-protein alpha-i family, Leu-enkephalin, Kappa-type opioid receptor"
659,Development_Thrombopoietin signaling via JAK-STAT pathway,23,1.67E-02,3.71E-02,1.67E-02,3.71E-02,6,"STAT3, TAP1 (PSF1), CISH, ERG, Thrombopoietin, Pim-1",5.11E-02,1.23E-01,5,"TAP1 (PSF1), CISH, ERG, Thrombopoietin, Pim-1"
660,Involvement of VEGF signaling in the progression of lung cancer,17,1.69E-02,3.76E-02,1.69E-02,3.76E-02,5,"CNTN1 (F3), ERK1/2, Fyn, AKT(PKB), C/EBPalpha",6.11E-02,1.40E-01,4,"CNTN1 (F3), Fyn, AKT(PKB), C/EBPalpha"
661,Aberrant production of IL-2 and IL-17 in SLE T cells,58,1.73E-02,3.83E-02,1.73E-02,3.83E-02,11,"Syk, IL-1 beta, MHC class II, RelA (p65 NF-kB subunit), Lck, ETS1, ROR-gamma, ERK1/2, IL-6, SOS, AKT(PKB)",7.50E-02,1.63E-01,9,"Syk, IL-1 beta, MHC class II, RelA (p65 NF-kB subunit), ETS1, ROR-gamma, IL-6, SOS, AKT(PKB)"
662,"Immune response_TLR5, TLR7, TLR8 and TLR9 signaling pathways",58,1.73E-02,3.83E-02,1.73E-02,3.83E-02,11,"STAT3, IL-1 beta, PI3K cat class IA, IL-8, ERK1/2, IL-6, TLR7, NF-kB, AKT(PKB), PDK (PDPK1), IFN-beta",1.50E-01,2.70E-01,8,"IL-1 beta, PI3K cat class IA, IL-8, IL-6, TLR7, NF-kB, AKT(PKB), IFN-beta"
663,Hyaluronic acid/ CD44 signaling in cancer,58,1.73E-02,3.83E-02,1.73E-02,3.83E-02,11,"STAT3, Ankyrin 1, HOXD10, ESR1 (nuclear), CD44, PDCD4, Actin cytoskeletal, ERK2 (MAPK1), Collagen IV, MMP-9, MDR1",1.50E-01,2.70E-01,8,"Ankyrin 1, HOXD10, ESR1 (nuclear), CD44, PDCD4, Collagen IV, MMP-9, MDR1"
664,CHDI_DEGs from Replication data_Causal network,81,1.74E-02,3.84E-02,1.74E-02,3.84E-02,14,"PKC, PTEN, cPLA2, WNT, TCF7L2 (TCF4), ERK1/2, Beta-catenin, SOS, AKT(PKB), p53, Dsh, Frizzled, IP3 receptor, ACM3",3.09E-01,4.68E-01,9,"PKC, cPLA2, WNT, TCF7L2 (TCF4), SOS, AKT(PKB), Frizzled, IP3 receptor, ACM3"
665,Retinoic acid regulation of oligodendrocyte differentiation in multiple sclerosis,24,1.75E-02,4.39E-02,2.05E-02,4.39E-02,6,"Myelin basic protein, DHA2, BMP4, STRA6, PDGF-R-alpha, BMP2",1.75E-02,5.79E-02,6,"Myelin basic protein, DHA2, BMP4, STRA6, PDGF-R-alpha, BMP2"
666,Cell adhesion_Ephrin signaling,45,1.77E-02,4.60E-02,2.17E-02,4.60E-02,9,"HGK(MAP4K4), RHO6, G-protein alpha-i family, Ephrin-A receptor 8, Fyn, Ephrin-A receptors, Ephrin-B receptor 1, Ephrin-B receptors, Ephrin-A receptor 2",1.77E-02,5.79E-02,9,"HGK(MAP4K4), RHO6, G-protein alpha-i family, Ephrin-A receptor 8, Fyn, Ephrin-A receptors, Ephrin-B receptor 1, Ephrin-B receptors, Ephrin-A receptor 2"
667,Immune response_NF-AT in immune response,51,1.82E-02,4.01E-02,1.82E-02,4.01E-02,10,"Syk, MHC class II, PI3K cat class IA, Lck, PKC-theta, Lyn, BLNK, NF-kB, AKT(PKB), IP3 receptor",3.74E-02,9.94E-02,9,"Syk, MHC class II, PI3K cat class IA, PKC-theta, Lyn, BLNK, NF-kB, AKT(PKB), IP3 receptor"
668,Development_Schema: Embryonal myogenesis,12,1.82E-02,4.39E-02,2.05E-02,4.39E-02,4,"HGF, WNT7A, BMP4, HGF receptor (Met)",1.82E-02,5.95E-02,4,"HGF, WNT7A, BMP4, HGF receptor (Met)"
669,Cell adhesion_Cell-matrix glycoconjugates,38,1.84E-02,4.65E-02,2.22E-02,4.65E-02,8,"Galectin-3, NCAM1, CD44, Elastin, Versican, CEACAM5, A1M, MMP-9",1.84E-02,5.95E-02,8,"Galectin-3, NCAM1, CD44, Elastin, Versican, CEACAM5, A1M, MMP-9"
670,Development_G-CSF-induced myeloid differentiation,30,1.85E-02,4.04E-02,1.85E-02,4.04E-02,7,"STAT3, ITGB2, NGAL, ERK1/2, p27KIP1, C/EBPalpha, GFI-1",2.85E-01,4.37E-01,4,"ITGB2, NGAL, C/EBPalpha, GFI-1"
671,Role of CNTF and LIF in regulation of oligodendrocyte development in multiple sclerosis,30,1.85E-02,4.04E-02,1.85E-02,4.04E-02,7,"STAT3, c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), LIF, AKT(PKB), PDK (PDPK1)",1.29E-01,2.41E-01,5,"c-IAP2, PI3K cat class IA, RelA (p65 NF-kB subunit), LIF, AKT(PKB)"
672,Signal transduction_HTR2A signaling outside the nervous system,74,1.89E-02,4.11E-02,1.89E-02,4.11E-02,13,"STAT3, COX-2 (PTGS2), cPKC (conventional), PI3K cat class IA, PKC, EGFR, G-protein alpha-i family, Adenylate cyclase, ERK1/2, AKT(PKB), G-protein alpha-q/11, Caveolin-1, CaMK II delta",6.79E-02,1.52E-01,11,"COX-2 (PTGS2), cPKC (conventional), PI3K cat class IA, PKC, EGFR, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), G-protein alpha-q/11, Caveolin-1, CaMK II delta"
673,Cell adhesion_Role of tetraspanins in the integrin-mediated cell adhesion,37,1.90E-02,4.11E-02,1.90E-02,4.11E-02,8,"ITGB1, Laminin 5, alpha-4/beta-1 integrin, PKC-alpha, alpha-5/beta-1 integrin, Actin cytoskeletal, Fibronectin, Actin",4.53E-02,1.14E-01,7,"ITGB1, Laminin 5, alpha-4/beta-1 integrin, PKC-alpha, alpha-5/beta-1 integrin, Fibronectin, Actin"
674,Development_Negative feedback regulation of WNT/Beta-catenin signaling,37,1.90E-02,4.11E-02,1.90E-02,4.11E-02,8,"ZNF703, Tcf(Lef), WNT, G-protein alpha-i family, TCF7L2 (TCF4), Beta-catenin, Dsh, Frizzled",1.13E-01,2.19E-01,6,"ZNF703, Tcf(Lef), WNT, G-protein alpha-i family, TCF7L2 (TCF4), Frizzled"
675,Deregulation of PSD-95-dependent signaling in Huntington's disease,37,1.90E-02,4.11E-02,1.90E-02,4.11E-02,8,"NMDA receptor, RelA (p65 NF-kB subunit), NR2, NR1, ERK1/2, ERK2 (MAPK1), NR2A, ERK1 (MAPK3)",2.40E-01,3.83E-01,5,"NMDA receptor, RelA (p65 NF-kB subunit), NR2, NR1, NR2A"
676,Immune response_Oncostatin M signaling via MAPK,37,1.90E-02,4.11E-02,1.90E-02,4.11E-02,8,"MMP-13, CCL2, ERK1/2, LIFR, SOS, OSMR, ERK2 (MAPK1), ERK1 (MAPK3)",2.40E-01,3.83E-01,5,"MMP-13, CCL2, LIFR, SOS, OSMR"
677,Immune response_IL-7 signaling in T lymphocytes,37,1.90E-02,4.11E-02,1.90E-02,4.11E-02,8,"STAT3, Lck, IRS-2, Bcl-2, TCR gamma locus, Fyn, AKT(PKB), PDK (PDPK1)",2.40E-01,3.83E-01,5,"IRS-2, Bcl-2, TCR gamma locus, Fyn, AKT(PKB)"
678,Immune response_Regulation of T cell function by CTLA-4,37,1.90E-02,4.11E-02,1.90E-02,4.11E-02,8,"PI3K cat class IA, Lck, Lyn, Fyn, SOS, NF-kB, AKT(PKB), PDK (PDPK1)",1.13E-01,2.19E-01,6,"PI3K cat class IA, Lyn, Fyn, SOS, NF-kB, AKT(PKB)"
679,G-protein signaling_H-RAS regulation pathway,37,1.90E-02,4.11E-02,1.90E-02,4.11E-02,8,"TIE2, PI3K cat class IA, Lck, CalDAG-GEFIII, GFRalpha1, Angiopoietin 1, SOS, PDGF-R-beta",4.53E-02,1.14E-01,7,"TIE2, PI3K cat class IA, CalDAG-GEFIII, GFRalpha1, Angiopoietin 1, SOS, PDGF-R-beta"
680,Oxidative stress_Activation of NADPH oxidase,59,1.96E-02,4.20E-02,1.96E-02,4.20E-02,11,"cPKC (conventional), PI3K cat class IA, PKC, PKC-alpha, ERK1/2, Rac2, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor, PREX1",8.17E-02,1.73E-01,9,"cPKC (conventional), PI3K cat class IA, PKC, PKC-alpha, Rac2, AKT(PKB), PI3K reg class IB (p101), IP3 receptor, PREX1"
681,Proteolysis_Role of Parkin in the Ubiquitin-Proteasomal Pathway,24,2.05E-02,4.39E-02,2.05E-02,4.39E-02,6,"Tubulin beta, Alpha-synuclein, Cyclin E, Caspase-1, Caspase-8, Synphilin 1",5.99E-02,1.38E-01,5,"Tubulin beta, Alpha-synuclein, Cyclin E, Caspase-1, Synphilin 1"
682,Signal transduction_Activation of PKC via G-Protein coupled receptor,52,2.07E-02,4.42E-02,2.07E-02,4.42E-02,10,"PKC-theta, PKC-alpha, ERK1/2, MEF2, NF-kB, CPI-17, G-protein alpha-q/11, MELC, MLCK, IP3 receptor",4.18E-02,1.08E-01,9,"PKC-theta, PKC-alpha, MEF2, NF-kB, CPI-17, G-protein alpha-q/11, MELC, MLCK, IP3 receptor"
683,Signal transduction_Adenosine A2A receptor signaling pathway,52,2.07E-02,4.42E-02,2.07E-02,4.42E-02,10,"RelA (p65 NF-kB subunit), ENPP1, Adenylate cyclase, ERK1/2, SOS, AKT(PKB), Kir6.2, SFK, G-protein alpha-olf, Collagen III",4.18E-02,1.08E-01,9,"RelA (p65 NF-kB subunit), ENPP1, Adenylate cyclase, SOS, AKT(PKB), Kir6.2, SFK, G-protein alpha-olf, Collagen III"
684,"Development_NCAM1-mediated neurite outgrowth, synapse assembly and neuronal survival",75,2.10E-02,4.47E-02,2.10E-02,4.47E-02,13,"NMDA receptor, CACNA1H, NCAM1, PKC, GFRalpha1, NR1, ERK1/2, Fyn, Tau (MAPT), SOS, DNAI1, AKT(PKB), IP3 receptor",3.59E-02,9.75E-02,12,"NMDA receptor, CACNA1H, NCAM1, PKC, GFRalpha1, NR1, Fyn, Tau (MAPT), SOS, DNAI1, AKT(PKB), IP3 receptor"
685,Development_Cross-talk between VEGF and Angiopoietin 1 signaling pathways,25,2.14E-02,5.12E-02,2.49E-02,5.12E-02,6,"TIE2, ICAM1, PKC-alpha, Angiopoietin 1, NF-kB, IP3 receptor",2.14E-02,6.53E-02,6,"TIE2, ICAM1, PKC-alpha, Angiopoietin 1, NF-kB, IP3 receptor"
686,Immune response_LPS-induced platelet activation,25,2.14E-02,5.12E-02,2.49E-02,5.12E-02,6,"COX-2 (PTGS2), IL-1 beta, CD14, TLR4, MD-2, TLR2",2.14E-02,6.53E-02,6,"COX-2 (PTGS2), IL-1 beta, CD14, TLR4, MD-2, TLR2"
687,Zinc deficiency in Prostate Cancer,25,2.14E-02,5.12E-02,2.49E-02,5.12E-02,6,"c-IAP2, ICAM1, IL-8, IL-6, NF-kB, MMP-9",2.14E-02,6.53E-02,6,"c-IAP2, ICAM1, IL-8, IL-6, NF-kB, MMP-9"
688,Putative pathways of hormone action in neurofibromatosis type 1,25,2.14E-02,5.12E-02,2.49E-02,5.12E-02,6,"EGR2 (Krox20), PI3K cat class IA, ESR1 (nuclear), ESR1 (membrane), GHR, PR (nuclear)",2.14E-02,6.53E-02,6,"EGR2 (Krox20), PI3K cat class IA, ESR1 (nuclear), ESR1 (membrane), GHR, PR (nuclear)"
689,Immune response_PGE2 signaling in immune response,45,2.17E-02,4.60E-02,2.17E-02,4.60E-02,9,"HGF, COX-2 (PTGS2), PGE2R2, PGE2R4, IL-8, Adenylate cyclase, CCR5, ERK2 (MAPK1), ERK1 (MAPK3)",1.08E-01,2.12E-01,7,"HGF, COX-2 (PTGS2), PGE2R2, PGE2R4, IL-8, Adenylate cyclase, CCR5"
690,Development_Membrane-bound ESR1: interaction with growth factors signaling,45,2.17E-02,4.60E-02,2.17E-02,4.60E-02,9,"PI3K cat class IA, ESR1 (nuclear), ERK1/2, ErbB3, ESR1 (membrane), SOS, AKT(PKB), Caveolin-1, PDK (PDPK1)",2.18E-01,3.57E-01,6,"PI3K cat class IA, ESR1 (nuclear), ESR1 (membrane), SOS, AKT(PKB), Caveolin-1"
691,Protein folding and maturation_Bradykinin / Kallidin maturation,32,2.19E-02,5.29E-02,2.59E-02,5.29E-02,7,"Neprilysin, Tissue kallikreins, BDKRB1, BDKRB2, MMP-8, ACE2, CD13",2.19E-02,6.60E-02,7,"Neprilysin, Tissue kallikreins, BDKRB1, BDKRB2, MMP-8, ACE2, CD13"
692,NETosis in SLE,31,2.20E-02,4.63E-02,2.20E-02,4.63E-02,7,"IL-1 beta, PKC, ERK1/2, CAMP, TLR7, Fc gamma RII alpha, Histone H1",5.61E-02,1.31E-01,6,"IL-1 beta, PKC, CAMP, TLR7, Fc gamma RII alpha, Histone H1"
693,Neutrophil adhesion and transendothelial migration in asthma,31,2.20E-02,4.63E-02,2.20E-02,4.63E-02,7,"alpha-4/beta-1 integrin, ICAM1, alpha-9/beta-1 integrin, IL-8, cPLA2, ERK1/2, ERK1 (MAPK3)",1.43E-01,2.61E-01,5,"alpha-4/beta-1 integrin, ICAM1, alpha-9/beta-1 integrin, IL-8, cPLA2"
694,Development_FGF and BMP signaling in early embryonic hepatogenesis,31,2.20E-02,4.63E-02,2.20E-02,4.63E-02,7,"FGFR4, BMP4, ERK1/2, FGF2, SOS, HNF3-alpha, BMP2",5.61E-02,1.31E-01,6,"FGFR4, BMP4, FGF2, SOS, HNF3-alpha, BMP2"
695,Immune response_IL-23 signaling pathway,31,2.20E-02,4.63E-02,2.20E-02,4.63E-02,7,"STAT3, PI3K cat class IA, STAT4, ROR-gamma, NF-kB, AKT(PKB), PDK (PDPK1)",1.43E-01,2.61E-01,5,"PI3K cat class IA, STAT4, ROR-gamma, NF-kB, AKT(PKB)"
696,Apoptosis and survival_Anti-apoptotic action of membrane-bound ESR1,38,2.22E-02,4.65E-02,2.22E-02,4.65E-02,8,"BAD, PI3K cat class IA, PKC-alpha, Bcl-2, ERK1/2, ESR1 (membrane), AKT(PKB), PDK (PDPK1)",2.57E-01,4.03E-01,5,"PI3K cat class IA, PKC-alpha, Bcl-2, ESR1 (membrane), AKT(PKB)"
697,Development_Mu-type opioid receptor signaling,38,2.22E-02,4.65E-02,2.22E-02,4.65E-02,8,"Tuberin, beta-Endorphin extracellular region, G-protein alpha-i family, SOS, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor",1.24E-01,2.35E-01,6,"beta-Endorphin extracellular region, G-protein alpha-i family, SOS, AKT(PKB), PI3K reg class IB (p101), IP3 receptor"
698,TNF-alpha-induced inflammatory signaling in normal and asthmatic airway epithelium,38,2.22E-02,4.65E-02,2.22E-02,4.65E-02,8,"GRO-1, IP10, ICAM1, CCL2, IL-8, ERK1/2, IL-6, NF-kB",5.13E-02,1.23E-01,7,"GRO-1, IP10, ICAM1, CCL2, IL-8, IL-6, NF-kB"
699,Neurophysiological process_Dopamine D2 receptor signaling in CNS,47,2.31E-02,5.69E-02,2.82E-02,5.69E-02,9,"TY3H, Adenylate cyclase type V, Adenylate cyclase type II, Kir3.4, G-protein alpha-i family, Adenylate cyclase type IV, Kir3.1, IP3 receptor, Adenylate cyclase type VII",2.31E-02,6.90E-02,9,"TY3H, Adenylate cyclase type V, Adenylate cyclase type II, Kir3.4, G-protein alpha-i family, Adenylate cyclase type IV, Kir3.1, IP3 receptor, Adenylate cyclase type VII"
700,Development_Positive regulation of WNT/Beta-catenin signaling in the cytoplasm,76,2.32E-02,4.86E-02,2.32E-02,4.86E-02,13,"COX-2 (PTGS2), ITGB1, IRS-2, Tcf(Lef), WNT, RIPK4, Beta-catenin, SMAD3, ERK2 (MAPK1), AKT(PKB), Dsh, Frizzled, DACT1",2.47E-01,3.90E-01,9,"COX-2 (PTGS2), ITGB1, IRS-2, Tcf(Lef), WNT, RIPK4, AKT(PKB), Frizzled, DACT1"
701,"Development_The role of GDNF ligand family/ RET receptor in cell survival, growth and proliferation",92,2.32E-02,4.86E-02,2.32E-02,4.86E-02,15,"STAT3, ITGB1, PI3K cat class IA, GFRalpha2, N-Ras, Dopamine transporter, GFRalpha1, F-Actin cytoskeleton, Bcl-2, ERK1/2, SOS, NF-kB, AKT(PKB), PDK (PDPK1), IP3 receptor",3.19E-01,4.77E-01,10,"ITGB1, PI3K cat class IA, GFRalpha2, Dopamine transporter, GFRalpha1, Bcl-2, SOS, NF-kB, AKT(PKB), IP3 receptor"
702,Effect of H. pylori infection on apoptosis in gastric epithelial cells,53,2.35E-02,4.89E-02,2.35E-02,4.89E-02,10,"COX-2 (PTGS2), c-IAP2, MHC class II, c-IAP1, Bcl-2, NOXA, NF-kB, Caspase-1, Caspase-8, PTPR-zeta",4.65E-02,1.16E-01,9,"COX-2 (PTGS2), c-IAP2, MHC class II, c-IAP1, Bcl-2, NOXA, NF-kB, Caspase-1, PTPR-zeta"
703,Regulation of VEGF expression in lung cancer,53,2.35E-02,4.89E-02,2.35E-02,4.89E-02,10,"STAT3, COX-2 (PTGS2), IL-1 beta, PI3K cat class IA, ERK1/2, MMP-2, IL-6, NF-kB, AKT(PKB), PDK (PDPK1)",2.00E-01,3.35E-01,7,"COX-2 (PTGS2), IL-1 beta, PI3K cat class IA, MMP-2, IL-6, NF-kB, AKT(PKB)"
704,Immune response_Immunological synapse formation,55,2.41E-02,5.95E-02,2.97E-02,5.95E-02,10,"ITGB1, MHC class II, PI3K cat class IA, PKC-theta, ITGB2, alpha-4/beta-1 integrin, ICAM1, PKC-alpha, Fyn, GRAP2",2.41E-02,7.16E-02,10,"ITGB1, MHC class II, PI3K cat class IA, PKC-theta, ITGB2, alpha-4/beta-1 integrin, ICAM1, PKC-alpha, Fyn, GRAP2"
705,Immune response_Fc epsilon RI pathway: signaling through Fyn and PI3K,61,2.46E-02,5.12E-02,2.46E-02,5.12E-02,11,"Syk, SGK3, Lyn, N-Ras, SGK1, Fyn, NF-kB, AKT(PKB), PDK (PDPK1), LAMP3, PI3K cat class IA (p110-delta)",9.63E-02,1.96E-01,9,"Syk, SGK3, Lyn, SGK1, Fyn, NF-kB, AKT(PKB), LAMP3, PI3K cat class IA (p110-delta)"
706,Neurophysiological process_Delta-type opioid receptor in the nervous system,40,2.47E-02,5.94E-02,2.96E-02,5.94E-02,8,"PDE1C, Adenylate cyclase type II, Metenkefalin, G-protein alpha-i family, PDE1A, Leu-enkephalin, PDE1B, IP3 receptor",2.47E-02,7.23E-02,8,"PDE1C, Adenylate cyclase type II, Metenkefalin, G-protein alpha-i family, PDE1A, Leu-enkephalin, PDE1B, IP3 receptor"
707,CAR-mediated direct regulation of xenobiotic metabolizing enzymes / Human version,40,2.47E-02,5.94E-02,2.96E-02,5.94E-02,8,"GSTP1, UGT1A1, CYP24A1, AL1A1, CYP2A6, MDR1, CYP2B6, UGT1A6",2.47E-02,7.23E-02,8,"GSTP1, UGT1A1, CYP24A1, AL1A1, CYP2A6, MDR1, CYP2B6, UGT1A6"
708,High shear stress-induced platelet activation,46,2.48E-02,5.12E-02,2.48E-02,5.12E-02,9,"UFO, ITGB3, G-protein alpha-i family, Actin cytoskeletal, Ephrin-B receptor 1, AKT(PKB), Fibronectin, Collagen VI, Collagen III",5.20E-02,1.23E-01,8,"UFO, ITGB3, G-protein alpha-i family, Ephrin-B receptor 1, AKT(PKB), Fibronectin, Collagen VI, Collagen III"
709,Role of Nicotine-induced Leptin resistance in hypothalamus in development of obesity,25,2.49E-02,5.12E-02,2.49E-02,5.12E-02,6,"STAT3, POMC, Thyroliberin, ERK1/2, NPY, AKT(PKB)",1.85E-01,3.18E-01,4,"POMC, Thyroliberin, NPY, AKT(PKB)"
710,A proinflammatory phenotype of senescent alveolar epithelial cells in COPD,25,2.49E-02,5.12E-02,2.49E-02,5.12E-02,6,"RelA (p65 NF-kB subunit), IL-8, IL-6, p53, p16INK4, PI3K cat class IA (p110-delta)",6.95E-02,1.53E-01,5,"RelA (p65 NF-kB subunit), IL-8, IL-6, p16INK4, PI3K cat class IA (p110-delta)"
711,Cytoskeleton remodeling_Neurofilaments,25,2.49E-02,5.12E-02,2.49E-02,5.12E-02,6,"Tubulin beta, Nestin, Actin cytoskeletal, Alpha-internexin, Vimentin, Peripherin",6.95E-02,1.53E-01,5,"Tubulin beta, Nestin, Alpha-internexin, Vimentin, Peripherin"
712,"Development_ROBO2, ROBO3 and ROBO4 signaling pathways",25,2.49E-02,5.12E-02,2.49E-02,5.12E-02,6,"ROBO3, P-cadherin, Myosin II, alpha-5/beta-1 integrin, HIC5, ROBO4",6.95E-02,1.53E-01,5,"ROBO3, P-cadherin, alpha-5/beta-1 integrin, HIC5, ROBO4"
713,Development_BMP signaling,33,2.57E-02,5.99E-02,3.03E-02,5.99E-02,7,"BMP6, Gremlin, BMP4, Tob1, Follistatin, Chordin, BMP2",2.57E-02,7.45E-02,7,"BMP6, Gremlin, BMP4, Tob1, Follistatin, Chordin, BMP2"
714,Muscle contraction_Role of kappa-type opioid receptor in heart,33,2.57E-02,5.99E-02,3.03E-02,5.99E-02,7,"G-protein alpha-i family, Adenylate cyclase, Beta-2 adrenergic receptor, Kir6.2, Troponin I, cardiac, Kappa-type opioid receptor, IP3 receptor",2.57E-02,7.45E-02,7,"G-protein alpha-i family, Adenylate cyclase, Beta-2 adrenergic receptor, Kir6.2, Troponin I, cardiac, Kappa-type opioid receptor, IP3 receptor"
715,Resistance of melanoma cells to Apo-2L(TNFSF10)-induced apoptosis,39,2.57E-02,5.27E-02,2.57E-02,5.27E-02,8,"STAT3, TRUNDD(TNFRSF10D), PI3K cat class IA, RelA (p65 NF-kB subunit), Bcl-2, ERK1/2, Caspase-8, p53",4.75E-01,6.39E-01,4,"TRUNDD(TNFRSF10D), PI3K cat class IA, RelA (p65 NF-kB subunit), Bcl-2"
716,Signal transduction_Leptin signaling via JAK/STAT and MAPK cascade,39,2.57E-02,5.27E-02,2.57E-02,5.27E-02,8,"STAT3, POMC, Thyroliberin, cPLA2, ERK1/2, NT/NN, MMP-9, BMP2",1.36E-01,2.50E-01,6,"POMC, Thyroliberin, cPLA2, NT/NN, MMP-9, BMP2"
717,Pioglitazone and Rosiglitazone in treatment of type 2 diabetes and metabolic syndrome X,26,2.57E-02,5.95E-02,2.99E-02,5.95E-02,6,"Adiponectin, IRS-2, VLDLR, ABCG1, IL-6, SORBS1",2.57E-02,7.45E-02,6,"Adiponectin, IRS-2, VLDLR, ABCG1, IL-6, SORBS1"
718,Cytoskeleton remodeling_Fibronectin-binding integrins in cell motility,32,2.59E-02,5.29E-02,2.59E-02,5.29E-02,7,"PI3K cat class IA, alpha-5/beta-1 integrin, Actin cytoskeletal, Fyn, Caveolin-1, ITGA5, Fibronectin",6.39E-02,1.45E-01,6,"PI3K cat class IA, alpha-5/beta-1 integrin, Fyn, Caveolin-1, ITGA5, Fibronectin"
719,Role of IL-6 in obesity and type 2 diabetes in adipocytes,32,2.59E-02,5.29E-02,2.59E-02,5.29E-02,7,"STAT3, Adiponectin, CCL2, ERK1/2, IL-6, PPARGC1 (PGC1-alpha), Perilipin",1.58E-01,2.82E-01,5,"Adiponectin, CCL2, IL-6, PPARGC1 (PGC1-alpha), Perilipin"
720,Impaired inhibitory action of lipoxins on ROS production in neutrophils in CF,54,2.65E-02,5.40E-02,2.65E-02,5.40E-02,10,"G-protein alpha-15, PKC-alpha, IL-8, G-protein alpha-i family, Rac2, IL8RA, PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor, PREX1",5.15E-02,1.23E-01,9,"G-protein alpha-15, PKC-alpha, IL-8, G-protein alpha-i family, Rac2, IL8RA, PI3K reg class IB (p101), IP3 receptor, PREX1"
721,Development_Negative regulation of STK3/4 (Hippo) pathway and positive regulation of YAP/TAZ function,62,2.75E-02,5.60E-02,2.75E-02,5.60E-02,11,"Schwannomin (NF2), LPAR1, CD44, EGFR, ERK1/2, Actin cytoskeletal, TAZ, G-protein alpha-q/11, PDK (PDPK1), Angiomotin (AMOT), ERK1 (MAPK3)",4.94E-01,6.54E-01,6,"LPAR1, CD44, EGFR, TAZ, G-protein alpha-q/11, Angiomotin (AMOT)"
722,Immune response_IL-4 signaling pathway,94,2.77E-02,5.63E-02,2.77E-02,5.63E-02,15,"BAD, STAT3, Syk, Tuberin, PKC, IRS-2, Bcl-2, ERK1/2, c-Fes, ERK2 (MAPK1), AKT(PKB), PDE3A, PDK (PDPK1), PI3K cat class IA (p110-delta), IP3 receptor",4.80E-01,6.45E-01,9,"Syk, PKC, IRS-2, Bcl-2, c-Fes, AKT(PKB), PDE3A, PI3K cat class IA (p110-delta), IP3 receptor"
723,Development_Beta-adrenergic receptor-induced regulation of ERK,47,2.82E-02,5.69E-02,2.82E-02,5.69E-02,9,"CD44, G-protein alpha-i family, Adenylate cyclase, ERK1/2, SOS, Beta-2 adrenergic receptor, PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor",1.28E-01,2.40E-01,7,"CD44, G-protein alpha-i family, Adenylate cyclase, SOS, Beta-2 adrenergic receptor, PI3K reg class IB (p101), IP3 receptor"
724,Immune response_Fc gamma R-mediated phagocytosis in macrophages,47,2.82E-02,5.69E-02,2.82E-02,5.69E-02,9,"Syk, PI3K cat class IA, PKC-alpha, Lyn, F-Actin cytoskeleton, Myosin II, Actin cytoskeletal, Fc gamma RII alpha, IP3 receptor",2.49E-01,3.91E-01,6,"Syk, PI3K cat class IA, PKC-alpha, Lyn, Fc gamma RII alpha, IP3 receptor"
725,Canonical Notch signaling pathway in colorectal cancer,47,2.82E-02,5.69E-02,2.82E-02,5.69E-02,9,"HES5, CD44, Mucin 2, WNT, TCF7L2 (TCF4), Beta-catenin, AKT(PKB), Jagged1, p27KIP1",1.28E-01,2.40E-01,7,"HES5, CD44, Mucin 2, WNT, TCF7L2 (TCF4), AKT(PKB), Jagged1"
726,Chemotaxis_Lipoxin inhibitory action on Formyl-Met-Leu-Phe-induced neutrophil chemotaxis,47,2.82E-02,5.69E-02,2.82E-02,5.69E-02,9,"ICAM1, Lyn, G-protein alpha-i family, F-Actin cytoskeleton, Actin cytoskeletal, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), PREX1",2.49E-01,3.91E-01,6,"ICAM1, Lyn, G-protein alpha-i family, AKT(PKB), PI3K reg class IB (p101), PREX1"
727,Activation of Cortisol production in major depressive disorder,40,2.96E-02,5.94E-02,2.96E-02,5.94E-02,8,"CYP11B1, Adenylate cyclase type V, CYP11B2, ERK1/2, IL-6, ACTH, MDR1, CYP11A1",6.49E-02,1.46E-01,7,"CYP11B1, Adenylate cyclase type V, CYP11B2, IL-6, ACTH, MDR1, CYP11A1"
728,Immune response_IL-16 signaling pathway,55,2.97E-02,5.95E-02,2.97E-02,5.95E-02,10,"IL-15, IL-1 beta, cPKC (conventional), Lck, PKC, IL-6, CCR5, AKT(PKB), p27KIP1, IP3 receptor",1.20E-01,2.30E-01,8,"IL-15, IL-1 beta, cPKC (conventional), PKC, IL-6, CCR5, AKT(PKB), IP3 receptor"
729,Immune response_T regulatory cell-mediated modulation of effector T cell and NK cell functions,55,2.97E-02,5.95E-02,2.97E-02,5.95E-02,10,"COX-2 (PTGS2), PGE2R2, PGE2R4, STAT4, TGF-beta receptor type II, Galectin-1, 5'-NTD, SMAD3, Jagged1, Adenylate cyclase type VII",5.68E-02,1.32E-01,9,"COX-2 (PTGS2), PGE2R2, PGE2R4, STAT4, TGF-beta receptor type II, Galectin-1, 5'-NTD, Jagged1, Adenylate cyclase type VII"
730,Development_S1P2 and S1P3 receptors in cell proliferation and differentiation,26,2.99E-02,5.95E-02,2.99E-02,5.95E-02,6,"MYH11, ERK1/2, Transgelin, ACTA2, MKL1, Actin",2.04E-01,3.41E-01,4,"Transgelin, ACTA2, MKL1, Actin"
731,Cell adhesion_Endothelial cell contacts by junctional mechanisms,26,2.99E-02,5.95E-02,2.99E-02,5.95E-02,6,"N-cadherin, Beta-catenin, Actin cytoskeletal, Vimentin, Claudin-3, Claudin-1",2.04E-01,3.41E-01,4,"N-cadherin, Vimentin, Claudin-3, Claudin-1"
732,Signal transduction_HTR2A-dependent arachidonic acid production,26,2.99E-02,5.95E-02,2.99E-02,5.95E-02,6,"COX-2 (PTGS2), cPLA2, G-protein alpha-i family, ERK1/2, RhoA-related, G-protein alpha-q/11",8.00E-02,1.72E-01,5,"COX-2 (PTGS2), cPLA2, G-protein alpha-i family, RhoA-related, G-protein alpha-q/11"
733,Deficient alpha-MSH signaling in melanoma,33,3.03E-02,5.99E-02,3.03E-02,5.99E-02,7,"SOX10, PI3K cat class IA, N-Ras, ERK1/2, AKT(PKB), alpha-MSH, PDK (PDPK1)",3.49E-01,5.08E-01,4,"SOX10, PI3K cat class IA, AKT(PKB), alpha-MSH"
734,G-protein signaling_N-RAS regulation pathway,33,3.03E-02,5.99E-02,3.03E-02,5.99E-02,7,"MHC class II, Lck, EGFR, N-Ras, SOS, A-Raf-1, IP3 receptor",3.49E-01,5.08E-01,4,"MHC class II, EGFR, SOS, IP3 receptor"
735,Chemotaxis_CCL19- and CCL21-mediated chemotaxis,33,3.03E-02,5.99E-02,3.03E-02,5.99E-02,7,"PGE2R2, PGE2R4, G-protein alpha-i family, Adenylate cyclase, ERK1/2, MMP-9, IP3 receptor",7.24E-02,1.58E-01,6,"PGE2R2, PGE2R4, G-protein alpha-i family, Adenylate cyclase, MMP-9, IP3 receptor"
736,Th2-cytokines and IFN-mediated regulation of airway smooth muscle contraction,27,3.06E-02,6.85E-02,3.55E-02,6.85E-02,6,"Histamine H1 receptor, RelA (p65 NF-kB subunit), IRS-2, CD38, IFN-beta, PI3K cat class IA (p110-delta)",3.06E-02,8.61E-02,6,"Histamine H1 receptor, RelA (p65 NF-kB subunit), IRS-2, CD38, IFN-beta, PI3K cat class IA (p110-delta)"
737,Apoptosis and survival_Anti-apoptotic TNFs/NF-kB/IAP pathway,27,3.06E-02,6.85E-02,3.55E-02,6.85E-02,6,"TNF-R2, c-IAP2, RelA (p65 NF-kB subunit), c-IAP1, CD30(TNFRSF8), NF-kB",3.06E-02,8.61E-02,6,"TNF-R2, c-IAP2, RelA (p65 NF-kB subunit), c-IAP1, CD30(TNFRSF8), NF-kB"
738,Neuroprotective action of lithium,63,3.06E-02,6.04E-02,3.06E-02,6.04E-02,11,"NMDA receptor, P2X2, WNT, NR2, Bcl-2, Beta-catenin, Tau (MAPT), p53, NR2A, Dsh, Frizzled",2.07E-01,3.42E-01,8,"NMDA receptor, P2X2, WNT, NR2, Bcl-2, Tau (MAPT), NR2A, Frizzled"
739,Immune response_Fc epsilon RI pathway: Lyn-mediated cytokine production,87,3.07E-02,6.04E-02,3.07E-02,6.04E-02,14,"Syk, IL-1 beta, PKC, CCL2, PKC-alpha, Lyn, IL-33, ERK1/2, MEF2C, IL-6, SOS, NF-kB, GRAP2, IP3 receptor",4.84E-02,1.20E-01,13,"Syk, IL-1 beta, PKC, CCL2, PKC-alpha, Lyn, IL-33, MEF2C, IL-6, SOS, NF-kB, GRAP2, IP3 receptor"
740,Role of Langerin+ dermal dendritic cells in contact hypersensitivity,20,3.36E-02,6.59E-02,3.36E-02,6.59E-02,5,"STAT3, Langerin, ITGB2, CCL2, FLT3",1.01E-01,2.01E-01,4,"Langerin, ITGB2, CCL2, FLT3"
741,Stem cells_Putative pathways of telomerase regulation in glioblastoma stem cells,20,3.36E-02,6.59E-02,3.36E-02,6.59E-02,5,"PI3K cat class IA, PTEN, AKT(PKB), p53, PDK (PDPK1)",5.51E-01,7.03E-01,2,"PI3K cat class IA, AKT(PKB)"
742,Development_H3K36 demethylation in stem cell maintenance,20,3.36E-02,6.59E-02,3.36E-02,6.59E-02,5,"p14ARF, p15, p53, p16INK4, CDK6",1.01E-01,2.01E-01,4,"p14ARF, p15, p16INK4, CDK6"
743,Role of B cells in SLE,58,3.37E-02,7.78E-02,4.12E-02,7.78E-02,10,"Syk, MHC class II, PI3K cat class IA, ICAM1, Lyn, Bcl-2, IL-6, Fc gamma RII beta, NF-kB, AKT(PKB)",3.37E-02,9.32E-02,10,"Syk, MHC class II, PI3K cat class IA, ICAM1, Lyn, Bcl-2, IL-6, Fc gamma RII beta, NF-kB, AKT(PKB)"
744,Role of Bregs in attenuation of T and NK cells mediated anti-tumor immune responses,41,3.38E-02,6.60E-02,3.38E-02,6.60E-02,8,"STAT3, Lck, IP10, CD1d, TGF-beta receptor type II, 5'-NTD, SMAD3, PD-L1",3.11E-01,4.68E-01,5,"IP10, CD1d, TGF-beta receptor type II, 5'-NTD, PD-L1"
745,Development_Muscle progenitor cell migration in hypaxial myogenesis,41,3.38E-02,6.60E-02,3.38E-02,6.60E-02,8,"HGF, FGFR4, G-protein alpha-i family, ERK1/2, MEF2C, SNAIL1, SOS, HGF receptor (Met)",1.62E-01,2.85E-01,6,"HGF, FGFR4, G-protein alpha-i family, MEF2C, SOS, HGF receptor (Met)"
746,Stem cells_Inhibition of Hedgehog signaling in medulloblastoma stem cells,41,3.38E-02,6.60E-02,3.38E-02,6.60E-02,8,"PTCH1, FGFR4, PACAP, ERK1/2, FGF2, SOS, GLI-1, GLI-2",7.25E-02,1.58E-01,7,"PTCH1, FGFR4, PACAP, FGF2, SOS, GLI-1, GLI-2"
747,Development_Regulation of lung epithelial progenitor cell differentiation,41,3.38E-02,6.60E-02,3.38E-02,6.60E-02,8,"STAT3, Tcf(Lef), WNT, BMP4, Beta-catenin, Jagged1, Frizzled, ERM",1.62E-01,2.85E-01,6,"Tcf(Lef), WNT, BMP4, Jagged1, Frizzled, ERM"
748,Cytoskeleton remodeling_Role of PKA in cytoskeleton reorganisation,41,3.38E-02,6.60E-02,3.38E-02,6.60E-02,8,"alpha-4/beta-1 integrin, Adenylate cyclase, F-Actin cytoskeleton, Actin cytoskeletal, Beta adducin, MELC, MLCK, IP3 receptor",1.62E-01,2.85E-01,6,"alpha-4/beta-1 integrin, Adenylate cyclase, Beta adducin, MELC, MLCK, IP3 receptor"
749,Immune response_Inflammasome in inflammatory response,35,3.46E-02,7.72E-02,4.06E-02,7.72E-02,7,"CARD7, IL-1 beta, Caspase-5, Biglycan, TLR4, NF-kB, Caspase-1",3.46E-02,9.44E-02,7,"CARD7, IL-1 beta, Caspase-5, Biglycan, TLR4, NF-kB, Caspase-1"
750,Development_Transcriptional regulation of megakaryopoiesis,35,3.46E-02,7.72E-02,4.06E-02,7.72E-02,7,"NF-E2 (45 kDa), CD38, ETS, ETS1, LMO2, Fc gamma RII alpha, Jagged1",3.46E-02,9.44E-02,7,"NF-E2 (45 kDa), CD38, ETS, ETS1, LMO2, Fc gamma RII alpha, Jagged1"
751,Action of lithium on synaptic transmission and autophagy,35,3.46E-02,7.72E-02,4.06E-02,7.72E-02,7,"Adenylate cyclase type V, Adenylate cyclase type II, PKC-alpha, P2X2, Adenylate cyclase, PP2A regulatory, Adenylate cyclase type VII",3.46E-02,9.44E-02,7,"Adenylate cyclase type V, Adenylate cyclase type II, PKC-alpha, P2X2, Adenylate cyclase, PP2A regulatory, Adenylate cyclase type VII"
752,Development_CNTF receptor signaling,34,3.52E-02,6.85E-02,3.52E-02,6.85E-02,7,"STAT3, Tuberin, PI3K cat class IA, ERK1/2, LIFR, SOS, AKT(PKB)",3.70E-01,5.33E-01,4,"PI3K cat class IA, LIFR, SOS, AKT(PKB)"
753,HCV-dependent cytoplasmic signaling leading to HCC,27,3.55E-02,6.85E-02,3.55E-02,6.85E-02,6,"BAD, PKC, ERK1/2, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1)",7.15E-01,8.42E-01,2,"PKC, AKT(PKB)"
754,Desensitization of Beta-2 adrenergic receptor signaling and reduction of relaxation,27,3.55E-02,6.85E-02,3.55E-02,6.85E-02,6,"IL-1 beta, G-protein alpha-i family, ERK1/2, SOS, Beta-2 adrenergic receptor, PGE2R3",9.12E-02,1.87E-01,5,"IL-1 beta, G-protein alpha-i family, SOS, Beta-2 adrenergic receptor, PGE2R3"
755,Regulation of VEGF signaling in pancreatic cancer,27,3.55E-02,6.85E-02,3.55E-02,6.85E-02,6,"STAT3, Neuropilin-2, Neuropilin-1, ERK1/2, IL-6, SOS",2.24E-01,3.61E-01,4,"Neuropilin-2, Neuropilin-1, IL-6, SOS"
756,HCV-dependent regulation of membrane receptors signaling in HCC,27,3.55E-02,6.85E-02,3.55E-02,6.85E-02,6,"IL-1 beta, EGFR, ERK1/2, TGF-alpha, SOS, ERK2 (MAPK1)",2.24E-01,3.61E-01,4,"IL-1 beta, EGFR, TGF-alpha, SOS"
757,IL-6 signaling in tumor-associated monocytes/macrophages in breast cancer,14,3.56E-02,6.87E-02,3.56E-02,6.87E-02,4,"STAT3, Fra-1, IL-6, MMP-9",1.27E-01,2.40E-01,3,"Fra-1, IL-6, MMP-9"
758,Nicotine signaling (general schema),21,3.59E-02,7.73E-02,4.08E-02,7.73E-02,5,"NMDA receptor, nAChR alpha-7, HTR3, GABA-A receptor, nAChR alpha-4",3.59E-02,9.74E-02,5,"NMDA receptor, nAChR alpha-7, HTR3, GABA-A receptor, nAChR alpha-4"
759,Development_Schema: Osteogenic and adipogenic differentiation of mesenchymal stem cells,21,3.59E-02,7.73E-02,4.08E-02,7.73E-02,5,"RUNX2, BMP6, BMP4, Beta-adrenergic receptor, BMP2",3.59E-02,9.74E-02,5,"RUNX2, BMP6, BMP4, Beta-adrenergic receptor, BMP2"
760,Glucocorticoid- and LABA-mediated inhibition of pro-inflammatory signaling in airway fibroblasts/myofibroblasts,28,3.61E-02,7.83E-02,4.17E-02,7.83E-02,6,"IL-1 beta, ICAM1, IL-8, IL-6, Beta-2 adrenergic receptor, NF-kB",3.61E-02,9.75E-02,6,"IL-1 beta, ICAM1, IL-8, IL-6, Beta-2 adrenergic receptor, NF-kB"
761,Role of Insulin in regulation of eating behavior in obesity,43,3.66E-02,8.15E-02,4.36E-02,8.15E-02,8,"POMC, RelA (p65 NF-kB subunit), PKC-theta, IRS-2, TLR4, NPY, AKT(PKB), Acyl-CoA synthetase",3.66E-02,9.76E-02,8,"POMC, RelA (p65 NF-kB subunit), PKC-theta, IRS-2, TLR4, NPY, AKT(PKB), Acyl-CoA synthetase"
762,Role of nicotine in pathogenesis of SCLC,57,3.71E-02,7.14E-02,3.71E-02,7.14E-02,10,"PCNA, nAChR alpha-7, GRP-R, PKC-alpha, HTR1D, Bcl-2, ERK1/2, FGF2, AKT(PKB), IP3 receptor",1.40E-01,2.55E-01,8,"nAChR alpha-7, GRP-R, PKC-alpha, HTR1D, Bcl-2, FGF2, AKT(PKB), IP3 receptor"
763,Signal transduction_Angiotensin II signaling via Beta-arrestin,57,3.71E-02,7.14E-02,3.71E-02,7.14E-02,10,"BAD, TRPC3, EGFR, MRLC, ERK1/2, DGK, AKT(PKB), MYLK1, p27KIP1, MLCK",2.54E-01,3.99E-01,7,"TRPC3, EGFR, MRLC, DGK, AKT(PKB), MYLK1, MLCK"
764,Development_VEGF signaling and activation,42,3.85E-02,7.39E-02,3.85E-02,7.39E-02,8,"PI3K cat class IA, PKC, ESR1 (nuclear), ICAM1, PKC-alpha, ERK1/2, NF-kB, AKT(PKB)",8.05E-02,1.72E-01,7,"PI3K cat class IA, PKC, ESR1 (nuclear), ICAM1, PKC-alpha, NF-kB, AKT(PKB)"
765,"Oxidative stress_Activation of NOX1, NOX5, DUOX1 and DUOX2 NADPH Oxidases",42,3.85E-02,7.39E-02,3.85E-02,7.39E-02,8,"cPKC (conventional), PKC, PKC-alpha, DUOX2, Rac2, ERK2 (MAPK1), DUOX1, DUOXA1",8.05E-02,1.72E-01,7,"cPKC (conventional), PKC, PKC-alpha, DUOX2, Rac2, DUOX1, DUOXA1"
766,Gamma-secretase proteolytic targets,76,3.93E-02,8.92E-02,4.90E-02,8.92E-02,12,"NOTCH4 (ICD4), N-cadherin, NGFR (ICD), NGFR(TNFRSF16), NGFR (CTF), CD44, CD44 soluble, CD44 (EXT), NOTCH4, N-cadherin (CTF1), N-cadherin (CTF2), CD44 (ICD)",3.93E-02,1.04E-01,12,"NOTCH4 (ICD4), N-cadherin, NGFR (ICD), NGFR(TNFRSF16), NGFR (CTF), CD44, CD44 soluble, CD44 (EXT), NOTCH4, N-cadherin (CTF1), N-cadherin (CTF2), CD44 (ICD)"
767,Development_EDNRB signaling,50,4.04E-02,7.72E-02,4.04E-02,7.72E-02,9,"EDNRB, G-protein alpha-i family, ERK1/2, SOS, AKT(PKB), G-protein alpha-q/11, Caveolin-1, PI3K reg class IB (p101), IP3 receptor",7.81E-02,1.69E-01,8,"EDNRB, G-protein alpha-i family, SOS, AKT(PKB), G-protein alpha-q/11, Caveolin-1, PI3K reg class IB (p101), IP3 receptor"
768,Role of GITR in skin sensitization,15,4.04E-02,8.37E-02,4.51E-02,8.37E-02,4,"IL-1 beta, TNF-R2, IP10, GITRL",4.04E-02,1.06E-01,4,"IL-1 beta, TNF-R2, IP10, GITRL"
769,Immune response_Regulatory role of C1q in platelet activation,15,4.04E-02,8.37E-02,4.51E-02,8.37E-02,4,"PKC, C3b, Fc gamma RII alpha, Collagen III",4.04E-02,1.06E-01,4,"PKC, C3b, Fc gamma RII alpha, Collagen III"
770,Stem cells_Aberrant Hedgehog signaling in medulloblastoma stem cells,15,4.04E-02,8.37E-02,4.51E-02,8.37E-02,4,"PTCH1, GLI-1, SFRP1, GLI-2",4.04E-02,1.06E-01,4,"PTCH1, GLI-1, SFRP1, GLI-2"
771,Th2-cytokines induced expression of Mucin 5AC and maintenance of mucous cell phenotype in normal airway epithelium,35,4.06E-02,7.72E-02,4.06E-02,7.72E-02,7,"CLCA1, TGF-beta 2, TGF-beta receptor type II, Mucin 5AC, ERK1/2, HAG-2, PDEF",9.13E-02,1.87E-01,6,"CLCA1, TGF-beta 2, TGF-beta receptor type II, Mucin 5AC, HAG-2, PDEF"
772,Cell adhesion_Alpha-4 integrins in cell migration and adhesion,35,4.06E-02,7.72E-02,4.06E-02,7.72E-02,7,"ITGB1, PI3K cat class IA, ITGA4, alpha-4/beta-1 integrin, F-Actin cytoskeleton, Actin cytoskeletal, Fibronectin",2.06E-01,3.41E-01,5,"ITGB1, PI3K cat class IA, ITGA4, alpha-4/beta-1 integrin, Fibronectin"
773,TNF-alpha and IL-1 beta induce hyperglycemia in obesity and type 2 diabetes in adipocytes,35,4.06E-02,7.72E-02,4.06E-02,7.72E-02,7,"IL-1 beta, TNF-R2, RelA (p65 NF-kB subunit), GM3 synthase, NGAL, NF-kB, ERK2 (MAPK1)",9.13E-02,1.87E-01,6,"IL-1 beta, TNF-R2, RelA (p65 NF-kB subunit), GM3 synthase, NGAL, NF-kB"
774,Signal transduction_mTORC1 upstream signaling,74,4.11E-02,7.78E-02,4.11E-02,7.78E-02,12,"Tuberin, WNT, EGFR, TLR4, ERK1/2, ERK2 (MAPK1), AKT(PKB), PDGF receptor, PDK (PDPK1), Dsh, Frizzled, GHR",5.09E-01,6.72E-01,7,"WNT, EGFR, TLR4, AKT(PKB), PDGF receptor, Frizzled, GHR"
775,Immune response_IL-6 signaling pathway via MEK/ERK and PI3K/AKT cascades,74,4.11E-02,7.78E-02,4.11E-02,7.78E-02,12,"BAD, STAT3, Tuberin, PI3K cat class IA, N-Ras, ERK1/2, IL-6, SOS, AKT(PKB), PDK (PDPK1), p27KIP1, IP3 receptor",8.11E-01,9.12E-01,5,"PI3K cat class IA, IL-6, SOS, AKT(PKB), IP3 receptor"
776,Immune response_CCR5 signaling in macrophages and T lymphocytes,58,4.12E-02,7.78E-02,4.12E-02,7.78E-02,10,"STAT3, Lck, PKC-alpha, G-protein alpha-i family, ERK1/2, CCR5, AKT(PKB), PDK (PDPK1), PI3K reg class IB (p101), IP3 receptor",4.29E-01,5.99E-01,6,"PKC-alpha, G-protein alpha-i family, CCR5, AKT(PKB), PI3K reg class IB (p101), IP3 receptor"
777,Development_Regulation of endothelial progenitor cell differentiation from adult stem cells,60,4.14E-02,9.12E-02,5.04E-02,9.12E-02,10,"TIE2, PI3K cat class IA, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, Angiopoietin 1, AKT(PKB), CSF1, Thrombopoietin, MMP-9",4.14E-02,1.07E-01,10,"TIE2, PI3K cat class IA, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, Angiopoietin 1, AKT(PKB), CSF1, Thrombopoietin, MMP-9"
778,Development_Mu-type opioid receptor regulation of proliferation,28,4.17E-02,7.83E-02,4.17E-02,7.83E-02,6,"beta-Endorphin extracellular region, ADAM12, EGFR, G-protein alpha-i family, ERK1/2, SOS",1.03E-01,2.04E-01,5,"beta-Endorphin extracellular region, ADAM12, EGFR, G-protein alpha-i family, SOS"
779,Possible influence of low doses of Arsenite on glucose uptake in muscle,28,4.17E-02,7.83E-02,4.17E-02,7.83E-02,6,"PI3K cat class IA, PTGIS, IRS-2, MEF2C, AKT(PKB), PDK (PDPK1)",1.03E-01,2.04E-01,5,"PI3K cat class IA, PTGIS, IRS-2, MEF2C, AKT(PKB)"
780,Development_Delta-type opioid receptor signaling via G-protein alpha-14,28,4.17E-02,7.83E-02,4.17E-02,7.83E-02,6,"STAT3, Metenkefalin, PKC-alpha, SOS, ERK1 (MAPK3), IP3 receptor",2.44E-01,3.87E-01,4,"Metenkefalin, PKC-alpha, SOS, IP3 receptor"
781,Development_Generation of pancreatic beta-cells from embryonic stem cells (late stages),22,4.31E-02,8.92E-02,4.88E-02,8.92E-02,5,"HGF, BMP4, FGF2, Nkx2.2, PAX6",4.31E-02,1.09E-01,5,"HGF, BMP4, FGF2, Nkx2.2, PAX6"
782,Development_H3K9 demethylases in pluripotency maintenance of stem cells,22,4.31E-02,8.92E-02,4.88E-02,8.92E-02,5,"ZFP57, Oct-3/4, CDX2, AKT(PKB), LBP9",4.31E-02,1.09E-01,5,"ZFP57, Oct-3/4, CDX2, AKT(PKB), LBP9"
783,LRRK2 and immune function in Parkinson's disease,22,4.31E-02,8.92E-02,4.88E-02,8.92E-02,5,"MHC class II, CD14, LRRK2, NF-kB, IFN-beta",4.31E-02,1.09E-01,5,"MHC class II, CD14, LRRK2, NF-kB, IFN-beta"
784,HGF receptor (Met) and MSP receptor (RON) signaling pathways in SCLC,43,4.36E-02,8.15E-02,4.36E-02,8.15E-02,8,"STAT3, HGF, PI3K cat class IA, ERK1/2, FGF2, AKT(PKB), PDK (PDPK1), HGF receptor (Met)",3.48E-01,5.08E-01,5,"HGF, PI3K cat class IA, FGF2, AKT(PKB), HGF receptor (Met)"
785,Development_EPO-induced PI3K/AKT pathway and Ca(2+) influx,43,4.36E-02,8.15E-02,4.36E-02,8.15E-02,8,"Syk, PI3K cat class IA, TRPC3, IRS-2, Lyn, AKT(PKB), PDK (PDPK1), IP3 receptor",8.90E-02,1.85E-01,7,"Syk, PI3K cat class IA, TRPC3, IRS-2, Lyn, AKT(PKB), IP3 receptor"
786,Main chemotherapy drugs and their action in SCLC cells,100,4.49E-02,8.37E-02,4.49E-02,8.37E-02,15,"BAD, RelA (p65 NF-kB subunit), CCL2, PKC-alpha, IL-8, Cyclin E, EGFR, Bcl-2, ERK1/2, AKT(PKB), Caveolin-1, p53, p27KIP1, PLAU (UPA), MDR1",2.93E-01,4.46E-01,11,"RelA (p65 NF-kB subunit), CCL2, PKC-alpha, IL-8, Cyclin E, EGFR, Bcl-2, AKT(PKB), Caveolin-1, PLAU (UPA), MDR1"
787,Immune response_BAFF-induced signaling,51,4.51E-02,8.37E-02,4.51E-02,8.37E-02,9,"BAD, Tuberin, ERK1/2, ERK2 (MAPK1), AKT(PKB), TRIM2, PDK (PDPK1), ERK1 (MAPK3), PI3K cat class IA (p110-delta)",8.52E-01,9.47E-01,3,"AKT(PKB), TRIM2, PI3K cat class IA (p110-delta)"
788,Inhibition of Calcitriol/ VDR signaling in colorectal cancer,51,4.51E-02,8.37E-02,4.51E-02,8.37E-02,9,"G0/G1switch 2, CYP27A1, SLUG, CYP24A1, TCF7L2 (TCF4), Beta-catenin, Kallikrein 6 (Neurosin), SNAIL1, Kallikrein 10 (KLK10)",1.74E-01,3.02E-01,7,"G0/G1switch 2, CYP27A1, SLUG, CYP24A1, TCF7L2 (TCF4), Kallikrein 6 (Neurosin), Kallikrein 10 (KLK10)"
789,Immune response_Generation of memory CD4+ T cells,37,4.53E-02,9.54E-02,5.29E-02,9.54E-02,7,"IL-15, MHC class II, IL-15RA, IL7RA, CD44, Bcl-2, NF-kB",4.53E-02,1.14E-01,7,"IL-15, MHC class II, IL-15RA, IL7RA, CD44, Bcl-2, NF-kB"
790,Development_Negative regulation of WNT/Beta-catenin signaling at the receptor level,45,4.65E-02,9.89E-02,5.50E-02,9.89E-02,8,"LRP4, Tcf(Lef), WNT, TIKI, IBP4, SFRP, SOSTDC1, Frizzled",4.65E-02,1.16E-01,8,"LRP4, Tcf(Lef), WNT, TIKI, IBP4, SFRP, SOSTDC1, Frizzled"
791,Prolactin/ ERK signaling in breast cancer,36,4.65E-02,8.57E-02,4.65E-02,8.57E-02,7,"PI3K cat class IA, ERK1/2, MMP-2, SOS, AKT(PKB), PDK (PDPK1), Prolactin receptor",2.22E-01,3.60E-01,5,"PI3K cat class IA, MMP-2, SOS, AKT(PKB), Prolactin receptor"
792,Higher ESR1 / ESR2 ratio in breast cancer,36,4.65E-02,8.57E-02,4.65E-02,8.57E-02,7,"ITGA1, ESR1 (nuclear), PTEN, Cyclin E, ErbB3, AKT(PKB), p27KIP1",4.12E-01,5.80E-01,4,"ITGA1, ESR1 (nuclear), Cyclin E, AKT(PKB)"
793,Immune response_IL-22 signaling pathway,36,4.65E-02,8.57E-02,4.65E-02,8.57E-02,7,"STAT3, MHC class II, STAT4, Bcl-2, IL-22RA2, ERK1/2, IL22RA1",2.22E-01,3.60E-01,5,"MHC class II, STAT4, Bcl-2, IL-22RA2, IL22RA1"
794,Endothelial cell apoptosis in COPD,36,4.65E-02,8.57E-02,4.65E-02,8.57E-02,7,"BAD, PI3K cat class IA, Neuropilin-1, Bcl-2, NF-kB, AKT(PKB), PDK (PDPK1)",2.22E-01,3.60E-01,5,"PI3K cat class IA, Neuropilin-1, Bcl-2, NF-kB, AKT(PKB)"
795,Immune response_IL-12-induced IFN-gamma production,36,4.65E-02,8.57E-02,4.65E-02,8.57E-02,7,"STAT3, IL-18R1, GADD45 gamma, iNOS, STAT4, NF-kB, ERM",1.02E-01,2.02E-01,6,"IL-18R1, GADD45 gamma, iNOS, STAT4, NF-kB, ERM"
796,Immune response_CD137 signaling in immune cell,29,4.86E-02,8.92E-02,4.86E-02,8.92E-02,6,"Cyclin E, Bcl-2, ERK1/2, CD137 ligand(TNFSF9), NF-kB, CD137(TNFRSF9)",1.16E-01,2.24E-01,5,"Cyclin E, Bcl-2, CD137 ligand(TNFSF9), NF-kB, CD137(TNFRSF9)"
797,Retinol metabolism,70,4.86E-02,1.05E-01,5.96E-02,1.05E-01,11,"DHA6, LRAT, DHA2, CYP1A1, CRABP1, Xanthine oxidase, AL1A1, CYP2A6, UGT2B7, UGT1A8, CYP2B6",4.86E-02,1.20E-01,11,"DHA6, LRAT, DHA2, CYP1A1, CRABP1, Xanthine oxidase, AL1A1, CYP2A6, UGT2B7, UGT1A8, CYP2B6"
798,PDGF activation of prostacyclin synthesis ,30,4.88E-02,9.98E-02,5.61E-02,9.98E-02,6,"COX-2 (PTGS2), PTGIS, PKC-alpha, PA24A, IP3 receptor, PDGF-R-beta",4.88E-02,1.20E-01,6,"COX-2 (PTGS2), PTGIS, PKC-alpha, PA24A, IP3 receptor, PDGF-R-beta"
799,Inhibition of mast cell functions by Siglecs in asthma,30,4.88E-02,9.98E-02,5.61E-02,9.98E-02,6,"Syk, SIGLEC5, Lyn, Siglec-8, GRAP2, IP3 receptor",4.88E-02,1.20E-01,6,"Syk, SIGLEC5, Lyn, Siglec-8, GRAP2, IP3 receptor"
800,Inhibition of mast cell functions by Fc gamma RII beta in asthma,30,4.88E-02,9.98E-02,5.61E-02,9.98E-02,6,"Syk, Lyn, Fc gamma RII beta, SOS, AKT(PKB), IP3 receptor",4.88E-02,1.20E-01,6,"Syk, Lyn, Fc gamma RII beta, SOS, AKT(PKB), IP3 receptor"
801,Neurophysiological process_Mu-type opioid receptor-mediated analgesia,30,4.88E-02,9.98E-02,5.61E-02,9.98E-02,6,"beta-Endorphin extracellular region, Adenylate cyclase type V, Adenylate cyclase type II, G-protein alpha-i family, Adenylate cyclase type IV, Adenylate cyclase type VII",4.88E-02,1.20E-01,6,"beta-Endorphin extracellular region, Adenylate cyclase type V, Adenylate cyclase type II, G-protein alpha-i family, Adenylate cyclase type IV, Adenylate cyclase type VII"
802,Immune response_Oncostatin M signaling via JAK-Stat,22,4.88E-02,8.92E-02,4.88E-02,8.92E-02,5,"STAT3, CCL2, LIFR, ACTA2, OSMR",1.32E-01,2.45E-01,4,"CCL2, LIFR, ACTA2, OSMR"
803,Development_Mu-type opioid receptor signaling via Beta-arrestin,22,4.88E-02,8.92E-02,4.88E-02,8.92E-02,5,"STAT3, G-protein alpha-i family, ERK1/2, ERK2 (MAPK1), ERK1 (MAPK3)",8.76E-01,9.63E-01,1,G-protein alpha-i family
804,Immune response_IL-13 signaling via JAK-STAT,44,4.91E-02,8.92E-02,4.91E-02,8.92E-02,8,"STAT3, iNOS, SCCA-2, CCL2, IGHE, MMP-8, IGHG4, SCCA-1",9.81E-02,1.98E-01,7,"iNOS, SCCA-2, CCL2, IGHE, MMP-8, IGHG4, SCCA-1"
805,"Development_Activation of Erk by ACM1, ACM3 and ACM5",44,4.91E-02,8.92E-02,4.91E-02,8.92E-02,8,"PKC-alpha, cPLA2, EGFR, ERK1/2, TGF-alpha, SOS, IP3 receptor, ACM3",9.81E-02,1.98E-01,7,"PKC-alpha, cPLA2, EGFR, TGF-alpha, SOS, IP3 receptor, ACM3"
806,Development_Flt3 signaling,44,4.91E-02,8.92E-02,4.91E-02,8.92E-02,8,"BAD, PI3K cat class IA, ERK1/2, Fyn, SOS, FLT3, AKT(PKB), PDK (PDPK1)",3.67E-01,5.30E-01,5,"PI3K cat class IA, Fyn, SOS, FLT3, AKT(PKB)"
807,Development_S1P1 signaling pathway,44,4.91E-02,8.92E-02,4.91E-02,8.92E-02,8,"G-protein alpha-i1, S1P1 receptor, CD44, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), PDK (PDPK1), IP3 receptor",9.81E-02,1.98E-01,7,"G-protein alpha-i1, S1P1 receptor, CD44, G-protein alpha-i family, Adenylate cyclase, AKT(PKB), IP3 receptor"
808,Production of reactive oxygen species and arachidonic acid metabolites by neutrophils in asthma,68,4.99E-02,9.07E-02,4.99E-02,9.07E-02,11,"PI3K cat class IA, PKC, IL-8, G-protein alpha-i family, ALOX5, ERK1/2, PA24A, PRG2, IL8RA, PDK (PDPK1), IP3 receptor",1.58E-01,2.82E-01,9,"PI3K cat class IA, PKC, IL-8, G-protein alpha-i family, ALOX5, PA24A, PRG2, IL8RA, IP3 receptor"
809,Regulation of intrinsic membrane properties and excitability of striatonigral medium spiny neurons in Huntington's disease,62,5.03E-02,1.06E-01,6.08E-02,1.06E-01,10,"MaxiK alpha subunit, cPKC (conventional), Adenylate cyclase type V, PKC, SCN2A, G-protein alpha-q/11, PDE1B, G-protein alpha-olf, IP3 receptor, CACNA1D",5.03E-02,1.23E-01,10,"MaxiK alpha subunit, cPKC (conventional), Adenylate cyclase type V, PKC, SCN2A, G-protein alpha-q/11, PDE1B, G-protein alpha-olf, IP3 receptor, CACNA1D"
810,Development_Thyroliberin signaling,60,5.04E-02,9.12E-02,5.04E-02,9.12E-02,10,"RGS4, Thyroliberin, PKC-alpha, ETS1, CG alpha, Adenylate cyclase, ERK1/2, SOS, G-protein alpha-q/11, IP3 receptor",8.88E-02,1.85E-01,9,"RGS4, Thyroliberin, PKC-alpha, ETS1, CG alpha, Adenylate cyclase, SOS, G-protein alpha-q/11, IP3 receptor"
811,Oxidative stress_ROS-mediated MAPK activation via canonical pathways,60,5.04E-02,9.12E-02,5.04E-02,9.12E-02,10,"GSTP1, EGFR, ERK1/2, Fyn, SOS, ERK2 (MAPK1), SFK, IP3 receptor, CaMK II delta, PDGF-R-beta",1.72E-01,3.01E-01,8,"GSTP1, EGFR, Fyn, SOS, SFK, IP3 receptor, CaMK II delta, PDGF-R-beta"
812,Role of IL-17-producing T cells in allergic contact dermatitis,23,5.11E-02,1.02E-01,5.78E-02,1.02E-01,5,"MHC class II, GRO-1, ICAM1, IL-8, IL-6",5.11E-02,1.23E-01,5,"MHC class II, GRO-1, ICAM1, IL-8, IL-6"
813,Signal transduction_Cyclic AMP signaling,38,5.13E-02,1.05E-01,5.98E-02,1.05E-01,7,"Adenylate cyclase type V, Adenylate cyclase type II, PKC, PKC-alpha, G-protein alpha-i family, Adenylate cyclase type IV, Adenylate cyclase type VII",5.13E-02,1.23E-01,7,"Adenylate cyclase type V, Adenylate cyclase type II, PKC, PKC-alpha, G-protein alpha-i family, Adenylate cyclase type IV, Adenylate cyclase type VII"
814,Defective efferocytosis in COPD,38,5.13E-02,1.05E-01,5.98E-02,1.05E-01,7,"MBL2, MFGE8, CD14, SP-D, CX3CR1, ELMO1, Protein S",5.13E-02,1.23E-01,7,"MBL2, MFGE8, CD14, SP-D, CX3CR1, ELMO1, Protein S"
815,Impaired macrophage phagocytic function in asthma,38,5.13E-02,1.05E-01,5.98E-02,1.05E-01,7,"GSTP1, TNF-R2, CD14, SP-D, PA24A, iC3b, MMP-9",5.13E-02,1.23E-01,7,"GSTP1, TNF-R2, CD14, SP-D, PA24A, iC3b, MMP-9"
816,Role of type 2 innate lymphoid cells in asthma,38,5.13E-02,1.05E-01,5.98E-02,1.05E-01,7,"GATA-3, ST2(L), IL7RA, ROR-alpha, ETS1, IL-33, PI3K cat class IA (p110-delta)",5.13E-02,1.23E-01,7,"GATA-3, ST2(L), IL7RA, ROR-alpha, ETS1, IL-33, PI3K cat class IA (p110-delta)"
817,Down-regulation of mast cell functions through ITIM-containing inhibitory receptors in asthma,37,5.29E-02,9.54E-02,5.29E-02,9.54E-02,7,"Syk, SHPS-1, CCL2, Lyn, ERK1/2, Fyn, SOS1",1.13E-01,2.19E-01,6,"Syk, SHPS-1, CCL2, Lyn, Fyn, SOS1"
818,Immune response_CD16 signaling in NK cells,69,5.46E-02,9.84E-02,5.46E-02,9.84E-02,11,"Syk, PI3K cat class IA, Lck, PKC-theta, ERK1/2, Actin cytoskeletal, CD94, SOS, ERK2 (MAPK1), PLA2, IP3 receptor",4.34E-01,6.02E-01,7,"Syk, PI3K cat class IA, PKC-theta, CD94, SOS, PLA2, IP3 receptor"
819,Signal transduction_Angiotensin II/ AGTR1 signaling via JAK/STAT,45,5.50E-02,9.89E-02,5.50E-02,9.89E-02,8,"STAT3, IL-18R1, PKC, ERK1/2, IL-6, Fyn, RGS2, p53",3.85E-01,5.50E-01,5,"IL-18R1, PKC, IL-6, Fyn, RGS2"
820,Effect of H. pylori infection on inflammation in gastric epithelial cells,61,5.55E-02,9.96E-02,5.55E-02,9.96E-02,10,"COX-2 (PTGS2), iNOS, PKC-alpha, IL-8, TLR4, ERK1/2, IL-6, SOS, TLR2, IP3 receptor",9.63E-02,1.96E-01,9,"COX-2 (PTGS2), iNOS, PKC-alpha, IL-8, TLR4, IL-6, SOS, TLR2, IP3 receptor"
821,Sorafenib-induced inhibition of cell proliferation and angiogenesis in HCC,16,5.58E-02,9.98E-02,5.58E-02,9.98E-02,4,"ERK1/2, ERK2 (MAPK1), ERK1 (MAPK3), PDGF-R-beta",7.81E-01,8.94E-01,1,PDGF-R-beta
822,c-Myc in multiple myeloma,16,5.58E-02,9.98E-02,5.58E-02,9.98E-02,4,"STAT3, IL-6, YB-1, C/EBPalpha",4.32E-01,6.01E-01,2,"IL-6, C/EBPalpha"
823,Neurophysiological process_Kappa-type opioid receptor in transmission of nerve impulses,31,5.61E-02,1.12E-01,6.43E-02,1.12E-01,6,"Kir3.4, G-protein alpha-i family, EBP50, Kir3.1, DREAM, Kappa-type opioid receptor",5.61E-02,1.31E-01,6,"Kir3.4, G-protein alpha-i family, EBP50, Kir3.1, DREAM, Kappa-type opioid receptor"
824,Alternative complement cascade disruption in age-related macular degeneration,31,5.61E-02,1.12E-01,6.43E-02,1.12E-01,6,"C3, Factor I, C3b, Factor H, iC3b, C3a",5.61E-02,1.31E-01,6,"C3, Factor I, C3b, Factor H, iC3b, C3a"
825,Retinoic acid maintains mucocilliary differentiation and mucins expression in normal and asthmatic airway epithelium,30,5.61E-02,9.98E-02,5.61E-02,9.98E-02,6,"PKC-alpha, Mucin 2, Mucin 5AC, ERK1/2, Mucin 5B, Mucin 6",1.29E-01,2.41E-01,5,"PKC-alpha, Mucin 2, Mucin 5AC, Mucin 5B, Mucin 6"
826,"Immune response_Mast cell proliferation, differentiation and survival",30,5.61E-02,9.98E-02,5.61E-02,9.98E-02,6,"STAT3, Syk, Lyn, ERK1/2, Fyn, AKT(PKB)",2.85E-01,4.37E-01,4,"Syk, Lyn, Fyn, AKT(PKB)"
827,KLF6 and regulation of KLF6 alternative splicing in HCC,23,5.78E-02,1.02E-01,5.78E-02,1.02E-01,5,"PI3K cat class IA, EGFR, SOS, p53, PDK (PDPK1)",3.46E-01,5.08E-01,3,"PI3K cat class IA, EGFR, SOS"
828,Role of Leptin in regulation of eating behavior in obesity,23,5.78E-02,1.02E-01,5.78E-02,1.02E-01,5,"STAT3, POMC, ERK1/2, NPY, AKT(PKB)",3.46E-01,5.08E-01,3,"POMC, NPY, AKT(PKB)"
829,Signal transduction_Angiotensin II/ AGTR1 signaling via RhoA and JNK,78,5.79E-02,1.03E-01,5.79E-02,1.03E-01,12,"RECK, CCL2, TLR4, MRLC, ERK1/2, MMP-2, CTGF, G-protein alpha-q/11, MMP-9, MLCK, IP3 receptor, Collagen III",9.15E-02,1.87E-01,11,"RECK, CCL2, TLR4, MRLC, MMP-2, CTGF, G-protein alpha-q/11, MMP-9, MLCK, IP3 receptor, Collagen III"
830,Cell adhesion_Role of CDK5 in cell adhesion,10,5.95E-02,1.05E-01,5.95E-02,1.05E-01,3,"ITGB1, Tcf(Lef), Beta-catenin",2.27E-01,3.65E-01,2,"ITGB1, Tcf(Lef)"
831,Transcription_Role of AP-1 in regulation of cellular metabolism,38,5.98E-02,1.05E-01,5.98E-02,1.05E-01,7,"CGB3, CG alpha, ERK1/2, PLAUR (uPAR), ITGA5, TSG-6, IFN-beta",1.24E-01,2.35E-01,6,"CGB3, CG alpha, PLAUR (uPAR), ITGA5, TSG-6, IFN-beta"
832,"Dysregulation of Adiponectin secretion from adipocytes in obesity, type 2 diabetes and metabolic syndrome X",38,5.98E-02,1.05E-01,5.98E-02,1.05E-01,7,"IL-18R1, AP-2B, Adiponectin, IL18RAP, ERK1/2, AKT(PKB), C/EBPalpha",1.24E-01,2.35E-01,6,"IL-18R1, AP-2B, Adiponectin, IL18RAP, AKT(PKB), C/EBPalpha"
833,Development_WNT/Beta-catenin signaling in the nucleus,62,6.08E-02,1.06E-01,6.08E-02,1.06E-01,10,"Tcf(Lef), RUNX, WNT, TCF7L2 (TCF4), Beta-catenin, SNAIL1, MEF2, Dsh, TCF7 (TCF1), Frizzled",3.27E-01,4.85E-01,7,"Tcf(Lef), RUNX, WNT, TCF7L2 (TCF4), MEF2, TCF7 (TCF1), Frizzled"
834,Immune response_Antigen presentation by MHC class I: cross-presentation,99,6.13E-02,1.29E-01,7.68E-02,1.29E-01,14,"Syk, Dectin-1, UFO, MSR1, cPLA2, TLR4, LY75, Rac2, TLR7, Fc gamma RII alpha, TLR3, Cathepsin S, TAP, TLR2",6.13E-02,1.41E-01,14,"Syk, Dectin-1, UFO, MSR1, cPLA2, TLR4, LY75, Rac2, TLR7, Fc gamma RII alpha, TLR3, Cathepsin S, TAP, TLR2"
835,Immune response_IFN-gamma actions on extracellular matrix and cell differentiation,54,6.15E-02,1.07E-01,6.15E-02,1.07E-01,9,"iNOS, IP10, MYH11, ICAM1, CIITA, ACTA2, MYLPF, Collagen II, MMP-9",1.11E-01,2.17E-01,8,"iNOS, IP10, ICAM1, CIITA, ACTA2, MYLPF, Collagen II, MMP-9"
836,Translation_Regulation of EIF4F activity,54,6.15E-02,1.07E-01,6.15E-02,1.07E-01,9,"Tuberin, PI3K cat class IA, eIF4G2, TGF-beta receptor type II, EGFR, ERK1/2, SOS, AKT(PKB), PDK (PDPK1)",3.62E-01,5.26E-01,6,"PI3K cat class IA, eIF4G2, TGF-beta receptor type II, EGFR, SOS, AKT(PKB)"
837,Development_Differentiation of white adipocytes ,54,6.15E-02,1.07E-01,6.15E-02,1.07E-01,9,"BMP4, ERK1/2, FOXC2, PPARGC1 (PGC1-alpha), SOS, PSAT, BMP2, Perilipin, C/EBPalpha",1.11E-01,2.17E-01,8,"BMP4, FOXC2, PPARGC1 (PGC1-alpha), SOS, PSAT, BMP2, Perilipin, C/EBPalpha"
838,Th2 cytokine-induced alternative activation of alveolar macrophages in asthma,32,6.39E-02,1.25E-01,7.31E-02,1.25E-01,6,"CHI3L1, Galectin-3, ST2(L), Eotaxin-2, IL-33, MMP-12",6.39E-02,1.45E-01,6,"CHI3L1, Galectin-3, ST2(L), Eotaxin-2, IL-33, MMP-12"
839,Neurogenesis_NGF/ TrkA MAPK-mediated signaling,105,6.41E-02,1.12E-01,6.41E-02,1.12E-01,15,"TY3H, NGF, SHPS-1, Fra-1, N-Ras, ERK1/2, MEF2C, PLAUR (uPAR), PP2A regulatory, SGK1, SOS, SORBS1, RGS2, Ephrin-A receptor 2, IP3 receptor",1.52E-01,2.73E-01,13,"TY3H, NGF, SHPS-1, Fra-1, MEF2C, PLAUR (uPAR), PP2A regulatory, SGK1, SOS, SORBS1, RGS2, Ephrin-A receptor 2, IP3 receptor"
840,Blood coagulation_GPCRs in platelet aggregation,71,6.48E-02,1.12E-01,6.48E-02,1.12E-01,11,"PKC-alpha, ITGB3, G-protein alpha-i family, Adenylate cyclase, MRLC, Myosin II, Actin cytoskeletal, Alpha-2A adrenergic receptor, MELC, PI3K reg class IB (p101), IP3 receptor",1.90E-01,3.20E-01,9,"PKC-alpha, ITGB3, G-protein alpha-i family, Adenylate cyclase, MRLC, Alpha-2A adrenergic receptor, MELC, PI3K reg class IB (p101), IP3 receptor"
841,Signal transduction_Adenosine A2B receptor signaling pathway,71,6.48E-02,1.12E-01,6.48E-02,1.12E-01,11,"PDK1, PI3K cat class IA, PKC, Adenosine A2b receptor, Adenylate cyclase, ERK1/2, IL-6, AKT(PKB), G-protein alpha-q/11, PDK (PDPK1), IP3 receptor",3.11E-01,4.68E-01,8,"PI3K cat class IA, PKC, Adenosine A2b receptor, Adenylate cyclase, IL-6, AKT(PKB), G-protein alpha-q/11, IP3 receptor"
842,CAR-mediated direct regulation of xenobiotic metabolizing enzymes / Rodent version,40,6.49E-02,1.27E-01,7.53E-02,1.27E-01,7,"GSTP1, UGT1A1, CYP24A1, AL1A1, MDR1, CYP2B6, UGT1A6",6.49E-02,1.46E-01,7,"GSTP1, UGT1A1, CYP24A1, AL1A1, MDR1, CYP2B6, UGT1A6"
843,Immune response_Th1 and Th2 cell differentiation,40,6.49E-02,1.27E-01,7.53E-02,1.27E-01,7,"GATA-3, MHC class II, RUNX3, STAT4, CD137 ligand(TNFSF9), NF-kB, CD137(TNFRSF9)",6.49E-02,1.46E-01,7,"GATA-3, MHC class II, RUNX3, STAT4, CD137 ligand(TNFSF9), NF-kB, CD137(TNFRSF9)"
844,Development_PACAP signaling in neural cells,39,6.73E-02,1.16E-01,6.73E-02,1.16E-01,7,"TY3H, cPKC (conventional), PACAP, Bcl-2, ERK1/2, G-protein alpha-q/11, IP3 receptor",1.36E-01,2.50E-01,6,"TY3H, cPKC (conventional), PACAP, Bcl-2, G-protein alpha-q/11, IP3 receptor"
845,Role of neurotrophins in activation of p53 in major depressive disorder,39,6.73E-02,1.16E-01,6.73E-02,1.16E-01,7,"NGF, NGFR(TNFRSF16), PI3K cat class IA, PLAT (TPA), Bcl-2, SOS, p53",1.36E-01,2.50E-01,6,"NGF, NGFR(TNFRSF16), PI3K cat class IA, PLAT (TPA), Bcl-2, SOS"
846,Activation of Notch signaling in breast cancer,39,6.73E-02,1.16E-01,6.73E-02,1.16E-01,7,"STAT3, Neuregulin 1, NOTCH4, SNAIL1, MAML2, Jagged1, TCF8",2.75E-01,4.23E-01,5,"Neuregulin 1, NOTCH4, MAML2, Jagged1, TCF8"
847,Translation _Regulation of EIF2 activity,39,6.73E-02,1.16E-01,6.73E-02,1.16E-01,7,"PI3K cat class IA, IRS-2, EGFR, ERK1/2, SOS, AKT(PKB), PDK (PDPK1)",2.75E-01,4.23E-01,5,"PI3K cat class IA, IRS-2, EGFR, SOS, AKT(PKB)"
848,Autocrine Somatotropin signaling in breast cancer,39,6.73E-02,1.16E-01,6.73E-02,1.16E-01,7,"CISH, TFF3, Bcl-2, ERK1/2, HOXA1, SOS, GHR",1.36E-01,2.50E-01,6,"CISH, TFF3, Bcl-2, HOXA1, SOS, GHR"
849,Dual role of TGF-beta 1 in HCC ,24,6.76E-02,1.16E-01,6.76E-02,1.16E-01,5,"TGF-beta receptor type II, Bcl-2, p15, NF-kB, SMAD3",1.67E-01,2.92E-01,4,"TGF-beta receptor type II, Bcl-2, p15, NF-kB"
850,G-protein signaling_M-RAS regulation pathway,24,6.76E-02,1.16E-01,6.76E-02,1.16E-01,5,"Lck, CalDAG-GEFIII, ERK1/2, SOS, A-Raf-1",6.52E-01,7.89E-01,2,"CalDAG-GEFIII, SOS"
851,Immune response_CD28 signaling,55,6.77E-02,1.16E-01,6.77E-02,1.16E-01,9,"BAD, PI3K cat class IA, Lck, PKC-theta, Fyn, NF-kB, AKT(PKB), GRAP2, IP3 receptor",2.26E-01,3.64E-01,7,"PI3K cat class IA, PKC-theta, Fyn, NF-kB, AKT(PKB), GRAP2, IP3 receptor"
852,B cell signaling in hematological malignancies,80,6.78E-02,1.16E-01,6.78E-02,1.16E-01,12,"STAT3, Syk, CD38, Lyn, CD70(TNFSF7), Bcl-2, IL-6, NF-kB, AKT(PKB), PDK (PDPK1), PI3K cat class IA (p110-delta), IP3 receptor",1.84E-01,3.18E-01,10,"Syk, CD38, Lyn, CD70(TNFSF7), Bcl-2, IL-6, NF-kB, AKT(PKB), PI3K cat class IA (p110-delta), IP3 receptor"
853,Role of proinflammatory cytokines in activation of p53 in major depressive disorder,47,6.81E-02,1.16E-01,6.81E-02,1.16E-01,8,"NMDA receptor, 3HAO, IDO1, Bcl-2, NOXA, TGF-beta, NF-kB, p53",1.28E-01,2.40E-01,7,"NMDA receptor, 3HAO, IDO1, Bcl-2, NOXA, TGF-beta, NF-kB"
854,Transport_Alpha-2 adrenergic receptor regulation of ion channels,47,6.81E-02,1.16E-01,6.81E-02,1.16E-01,8,"G-protein alpha-i1, Adenylate cyclase type V, PKC, G-protein alpha-i family, Alpha-2A adrenergic receptor, AKT(PKB), PDK (PDPK1), IP3 receptor",1.28E-01,2.40E-01,7,"G-protein alpha-i1, Adenylate cyclase type V, PKC, G-protein alpha-i family, Alpha-2A adrenergic receptor, AKT(PKB), IP3 receptor"
855,Immune response_Role of DPP4 (CD26) in immune regulation,47,6.81E-02,1.16E-01,6.81E-02,1.16E-01,8,"MHC class II, Lck, ADA, IL-6, Fyn, DPP4, NF-kB, Caveolin-1",1.28E-01,2.40E-01,7,"MHC class II, ADA, IL-6, Fyn, DPP4, NF-kB, Caveolin-1"
856,Role of keratinocytes and Langerhans cells in skin sensitization,25,6.95E-02,1.31E-01,7.83E-02,1.31E-01,5,"IL-1 beta, TNF-R2, IL-18R1, MHC class II, Caspase-1",6.95E-02,1.53E-01,5,"IL-1 beta, TNF-R2, IL-18R1, MHC class II, Caspase-1"
857,Generation of cytotoxic CD8+ T cells in COPD,25,6.95E-02,1.31E-01,7.83E-02,1.31E-01,5,"MHC class II, ICAM1, CD137 ligand(TNFSF9), NF-kB, CD137(TNFRSF9)",6.95E-02,1.53E-01,5,"MHC class II, ICAM1, CD137 ligand(TNFSF9), NF-kB, CD137(TNFRSF9)"
858,Regulation of lipid metabolism_Regulation of lipid metabolism by niacin and isoprenaline,49,7.09E-02,1.38E-01,8.31E-02,1.38E-01,8,"Adenylate cyclase type V, Adenylate cyclase type II, PKC, PKC-alpha, G-protein alpha-i family, Adenylate cyclase type IV, Beta-2 adrenergic receptor, Adenylate cyclase type VII",7.09E-02,1.55E-01,8,"Adenylate cyclase type V, Adenylate cyclase type II, PKC, PKC-alpha, G-protein alpha-i family, Adenylate cyclase type IV, Beta-2 adrenergic receptor, Adenylate cyclase type VII"
859,Activation of ACTH production in pituitary gland in major depressive disorder,32,7.31E-02,1.25E-01,7.31E-02,1.25E-01,6,"STAT3, IL-1 beta, POMC, TNF-R2, IL-6, ACTH",1.58E-01,2.82E-01,5,"IL-1 beta, POMC, TNF-R2, IL-6, ACTH"
860,Development_Role of Activin A in cell differentiation and proliferation,40,7.53E-02,1.27E-01,7.53E-02,1.27E-01,7,"Activin A, Oct-3/4, Adenylate cyclase, p15, SMAD3, p27KIP1, CYP11A1",2.93E-01,4.46E-01,5,"Activin A, Oct-3/4, Adenylate cyclase, p15, CYP11A1"
861,Development_SLIT-ROBO1 signaling,40,7.53E-02,1.27E-01,7.53E-02,1.27E-01,7,"PI3K cat class IA, F-Actin cytoskeleton, Myosin II, Fyn, AKT(PKB), ACTB, PREX1",4.95E-01,6.54E-01,4,"PI3K cat class IA, Fyn, AKT(PKB), PREX1"
862,Role of glycosphingolipids in inhibition of Insulin signaling,40,7.53E-02,1.27E-01,7.53E-02,1.27E-01,7,"GM3 synthase, Actin cytoskeletal, SORBS1, B4G6, AKT(PKB), Caveolin-1, PDK (PDPK1)",2.93E-01,4.46E-01,5,"GM3 synthase, SORBS1, B4G6, AKT(PKB), Caveolin-1"
863,Reproduction_Progesterone-mediated oocyte maturation,40,7.53E-02,1.27E-01,7.53E-02,1.27E-01,7,"G-protein alpha-i family, Adenylate cyclase, Kinase MYT1, ESR1 (membrane), SOS, ERK2 (MAPK1), PR (membrane)",1.49E-01,2.69E-01,6,"G-protein alpha-i family, Adenylate cyclase, Kinase MYT1, ESR1 (membrane), SOS, PR (membrane)"
864,T follicular helper cell dysfunction in SLE,90,7.53E-02,1.27E-01,7.53E-02,1.27E-01,13,"STAT3, MHC class II, PI3K cat class IA, PKC-theta, IL-6, Fyn, KLF2, TLR7, NF-kB, AKT(PKB), A20, IFN-beta, BLIMP1 (PRDI-BF1)",1.11E-01,2.17E-01,12,"MHC class II, PI3K cat class IA, PKC-theta, IL-6, Fyn, KLF2, TLR7, NF-kB, AKT(PKB), A20, IFN-beta, BLIMP1 (PRDI-BF1)"
865,GLP-1 in beta cell apoptosis in type 2 diabetes,48,7.54E-02,1.27E-01,7.54E-02,1.27E-01,8,"BAD, IL-1 beta, c-IAP2, IRS-2, Bcl-2, ERK1/2, NF-kB, p53",4.41E-01,6.10E-01,5,"IL-1 beta, c-IAP2, IRS-2, Bcl-2, NF-kB"
866,Reproduction_Gonadotropin-releasing hormone (GnRH) signaling,73,7.62E-02,1.28E-01,7.62E-02,1.28E-01,11,"PACAP, CG alpha, Adenylate cyclase, ERK1/2, Follistatin, CaMK I, MKP-2, SOS, G-protein alpha-q/11, Secretogranin II, IP3 receptor",1.21E-01,2.30E-01,10,"PACAP, CG alpha, Adenylate cyclase, Follistatin, CaMK I, MKP-2, SOS, G-protein alpha-q/11, Secretogranin II, IP3 receptor"
867,G-protein signaling_K-RAS regulation pathway,25,7.83E-02,1.31E-01,7.83E-02,1.31E-01,5,"Lck, PKC-theta, EGFR, SOS, A-Raf-1",3.97E-01,5.60E-01,3,"PKC-theta, EGFR, SOS"
868,Neurophysiological process_NMDA-dependent postsynaptic long-term potentiation in CA1 hippocampal neurons,82,7.88E-02,1.32E-01,7.88E-02,1.32E-01,12,"NMDA receptor, PKC-alpha, NR2, NR1, ERK1/2, SOS, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1), NR2A, ERK1 (MAPK3), IP3 receptor",4.66E-01,6.34E-01,8,"NMDA receptor, PKC-alpha, NR2, NR1, SOS, AKT(PKB), NR2A, IP3 receptor"
869,Transport_ACM3 signaling in salivary glands,42,8.05E-02,1.51E-01,9.28E-02,1.51E-01,7,"G-protein alpha-i1, PKC, G-protein alpha-i family, G-protein alpha-q/11, MLCK, IP3 receptor, ACM3",8.05E-02,1.72E-01,7,"G-protein alpha-i1, PKC, G-protein alpha-i family, G-protein alpha-q/11, MLCK, IP3 receptor, ACM3"
870,Androgen signaling in HCC,18,8.09E-02,1.36E-01,8.09E-02,1.36E-01,4,"HGF, Androgen receptor, p53, HGF receptor (Met)",2.19E-01,3.57E-01,3,"HGF, Androgen receptor, HGF receptor (Met)"
871,Cytoskeleton remodeling_FAK signaling,57,8.13E-02,1.36E-01,8.13E-02,1.36E-01,9,"GRP-R, PI3K cat class IA, PTEN, ERK1/2, SOS, AKT(PKB), G-protein alpha-q/11, Fibronectin, IP3 receptor",2.54E-01,3.99E-01,7,"GRP-R, PI3K cat class IA, SOS, AKT(PKB), G-protein alpha-q/11, Fibronectin, IP3 receptor"
872,Proinflammatory mediators release and arachidonic acid metabolites production in basophils in asthma,57,8.13E-02,1.36E-01,8.13E-02,1.36E-01,9,"Syk, NGF, PI3K cat class IA, cPLA2, Lyn, G-protein alpha-i family, ERK1/2, SOS, IP3 receptor",1.40E-01,2.55E-01,8,"Syk, NGF, PI3K cat class IA, cPLA2, Lyn, G-protein alpha-i family, SOS, IP3 receptor"
873,Mechanism of action of CCR4 antagonists in asthma and atopic dermatitis (Variant 1),34,8.16E-02,1.51E-01,9.28E-02,1.51E-01,6,"ITGB1, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, IP3 receptor",8.16E-02,1.73E-01,6,"ITGB1, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, IP3 receptor"
874,CCR4-dependent immune cell chemotaxis in asthma and atopic dermatitis ,34,8.16E-02,1.51E-01,9.28E-02,1.51E-01,6,"ITGB1, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, IP3 receptor",8.16E-02,1.73E-01,6,"ITGB1, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, IP3 receptor"
875,Chemotaxis_CCR4-induced chemotaxis of immune cells,34,8.16E-02,1.51E-01,9.28E-02,1.51E-01,6,"ITGB1, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, IP3 receptor",8.16E-02,1.73E-01,6,"ITGB1, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family, IP3 receptor"
876,Signal transduction_Production and main functions of biologically active prostaglandins and Thromboxane A2,59,8.17E-02,1.56E-01,9.64E-02,1.56E-01,9,"COX-2 (PTGS2), PGE2R2, PGE2R4, PTGIS, AKR1C3, PGD2R, cPLA2, PGF2aR, PGE2R3",8.17E-02,1.73E-01,9,"COX-2 (PTGS2), PGE2R2, PGE2R4, PTGIS, AKR1C3, PGD2R, cPLA2, PGF2aR, PGE2R3"
877,Development_Activation of astroglial cells proliferation by ACM3,33,8.26E-02,1.38E-01,8.26E-02,1.38E-01,6,"PI3K cat class IA, ErbB3, AKT(PKB), PDK (PDPK1), IP3 receptor, ACM3",3.49E-01,5.08E-01,4,"PI3K cat class IA, AKT(PKB), IP3 receptor, ACM3"
878,Signal transduction_Activin A signaling regulation,33,8.26E-02,1.38E-01,8.26E-02,1.38E-01,6,"Activin A, DLX1, Follistatin, MECOM, SMAD3, FKHL1",1.73E-01,3.02E-01,5,"Activin A, DLX1, Follistatin, MECOM, FKHL1"
879,IgE- and MGF-induced Fyn-mediated activation of lung mast cells in asthma,49,8.31E-02,1.38E-01,8.31E-02,1.38E-01,8,"Syk, S1P1 receptor, Lyn, N-Ras, Fyn, SOS, AKT(PKB), PDK (PDPK1)",2.80E-01,4.31E-01,6,"Syk, S1P1 receptor, Lyn, Fyn, SOS, AKT(PKB)"
880,Development_Neurotrophin family signaling,41,8.38E-02,1.39E-01,8.38E-02,1.39E-01,7,"NGF, NGFR(TNFRSF16), PI3K cat class IA, ERK1/2, SOS, AKT(PKB), p53",3.11E-01,4.68E-01,5,"NGF, NGFR(TNFRSF16), PI3K cat class IA, SOS, AKT(PKB)"
881,Apoptosis and survival_Phosphorylation in TNF-alpha-induced NF-kB signaling,41,8.38E-02,1.39E-01,8.38E-02,1.39E-01,7,"PI3K cat class IA, RelA (p65 NF-kB subunit), Adenylate cyclase, PDK (PDPK1), Pim-1, NF-kB p65/p65, CDK6",1.62E-01,2.85E-01,6,"PI3K cat class IA, RelA (p65 NF-kB subunit), Adenylate cyclase, Pim-1, NF-kB p65/p65, CDK6"
882,Development_Beta-adrenergic receptors signaling via Cyclic AMP,51,8.57E-02,1.61E-01,9.98E-02,1.61E-01,8,"AKAP6, Troponin C, cardiac, Adenylate cyclase, PPARGC1 (PGC1-alpha), Beta-2 adrenergic receptor, PDE3A, Troponin I, cardiac, Perilipin",8.57E-02,1.80E-01,8,"AKAP6, Troponin C, cardiac, Adenylate cyclase, PPARGC1 (PGC1-alpha), Beta-2 adrenergic receptor, PDE3A, Troponin I, cardiac, Perilipin"
883,Protein folding_Membrane trafficking and signal transduction of G-alpha (i) heterotrimeric G-protein,19,8.63E-02,1.55E-01,9.53E-02,1.55E-01,4,"RGS4, Adenylate cyclase type II, G-protein gamma, G-protein alpha-i family",8.63E-02,1.80E-01,4,"RGS4, Adenylate cyclase type II, G-protein gamma, G-protein alpha-i family"
884,Schema: Initiation of T cell recruitment in allergic contact dermatitis,19,8.63E-02,1.55E-01,9.53E-02,1.55E-01,4,"IP10, alpha-4/beta-1 integrin, ICAM1, CD1d",8.63E-02,1.80E-01,4,"IP10, alpha-4/beta-1 integrin, ICAM1, CD1d"
885,Development_Prolactin receptor signaling,58,8.87E-02,1.47E-01,8.87E-02,1.47E-01,9,"STAT3, PI3K cat class IA, NMI, Bcl-2, ERK1/2, Fyn, SOS, AKT(PKB), Prolactin receptor",2.68E-01,4.16E-01,7,"PI3K cat class IA, NMI, Bcl-2, Fyn, SOS, AKT(PKB), Prolactin receptor"
886,Effect of H. pylori infection on gastric epithelial cell proliferation,58,8.87E-02,1.47E-01,8.87E-02,1.47E-01,9,"Lyn, EGFR, TLR4, ERK1/2, SOS1, p53, HGF receptor (Met), p27KIP1, IP3 receptor",4.29E-01,5.99E-01,6,"Lyn, EGFR, TLR4, SOS1, HGF receptor (Met), IP3 receptor"
887,Cell adhesion_Classical cadherin-mediated cell adhesion,26,8.98E-02,1.48E-01,8.98E-02,1.48E-01,5,"N-cadherin, F-Actin, F-Actin cytoskeleton, Beta-catenin, Actin cytoskeletal",9.15E-01,9.83E-01,1,N-cadherin
888,Notch signaling in oligodendrocyte precursor cell differentiation in multiple sclerosis,27,9.12E-02,1.64E-01,1.02E-01,1.64E-01,5,"CNTN1 (F3), SOX10, Myelin basic protein, HES5, Jagged1",9.12E-02,1.87E-01,5,"CNTN1 (F3), SOX10, Myelin basic protein, HES5, Jagged1"
889,Development_Generation of pancreatic beta-cells from induced pluripotent stem cells,27,9.12E-02,1.64E-01,1.02E-01,1.64E-01,5,"Activin A, Oct-3/4, SOX2, FGF2, Nkx2.2",9.12E-02,1.87E-01,5,"Activin A, Oct-3/4, SOX2, FGF2, Nkx2.2"
890,Regulatory T cells in murine model of contact hypersensitivity,27,9.12E-02,1.64E-01,1.02E-01,1.64E-01,5,"TNF-R2, MHC class II, ICAM1, 5'-NTD, NF-kB",9.12E-02,1.87E-01,5,"TNF-R2, MHC class II, ICAM1, 5'-NTD, NF-kB"
891,Development_IGF-1 receptor signaling,50,9.12E-02,1.50E-01,9.12E-02,1.50E-01,8,"BAD, PI3K cat class IA, IRS-2, ERK1/2, SOS, NF-kB, AKT(PKB), PDK (PDPK1)",4.77E-01,6.41E-01,5,"PI3K cat class IA, IRS-2, SOS, NF-kB, AKT(PKB)"
892,TGF-beta signaling via microRNA in breast cancer,50,9.12E-02,1.50E-01,9.12E-02,1.50E-01,8,"TGF-beta 2, TGF-beta 3, ETS1, SLUG, Bcl-2, SIP1 (ZFHX1B), SMAD3, TCF8",1.62E-01,2.85E-01,7,"TGF-beta 2, TGF-beta 3, ETS1, SLUG, Bcl-2, SIP1 (ZFHX1B), TCF8"
893,Immune response_IL-13 signaling via PI3K-ERK pathway,50,9.12E-02,1.50E-01,9.12E-02,1.50E-01,8,"IRS-2, Mucin 5AC, IGHE, ERK1/2, SOS, AKT(PKB), PI3K cat class IA (p110-delta), IP3 receptor",1.62E-01,2.85E-01,7,"IRS-2, Mucin 5AC, IGHE, SOS, AKT(PKB), PI3K cat class IA (p110-delta), IP3 receptor"
894,Development_HGF-dependent inhibition of TGF-beta-induced EMT,34,9.28E-02,1.51E-01,9.28E-02,1.51E-01,6,"HGF, COX-2 (PTGS2), TGF-beta receptor type II, ERK1/2, SOS, HGF receptor (Met)",1.89E-01,3.20E-01,5,"HGF, COX-2 (PTGS2), TGF-beta receptor type II, SOS, HGF receptor (Met)"
895,Proinflammatory cytokine release from eosinophils in asthma,34,9.28E-02,1.51E-01,9.28E-02,1.51E-01,6,"IL-1 beta, NGF, IL-8, ERK1/2, LIF, IL-6",1.89E-01,3.20E-01,5,"IL-1 beta, NGF, IL-8, LIF, IL-6"
896,Role of TNF-alpha in type 2 diabetes in skeletal muscle cells,42,9.28E-02,1.51E-01,9.28E-02,1.51E-01,7,"HGK(MAP4K4), RelA (p65 NF-kB subunit), PKC-theta, PKC-alpha, ACACB, PPARGC1 (PGC1-alpha), ERK2 (MAPK1)",1.75E-01,3.03E-01,6,"HGK(MAP4K4), RelA (p65 NF-kB subunit), PKC-theta, PKC-alpha, ACACB, PPARGC1 (PGC1-alpha)"
897,Serotonin modulation of dopamine release in nicotine addiction,42,9.28E-02,1.51E-01,9.28E-02,1.51E-01,7,"HTR3, PKC, GABA-A receptor, PTEN, G-protein alpha-i family, Adenylate cyclase, nAChR alpha-4",1.75E-01,3.03E-01,6,"HTR3, PKC, GABA-A receptor, G-protein alpha-i family, Adenylate cyclase, nAChR alpha-4"
898,Translation_Insulin regulation of translation,42,9.28E-02,1.51E-01,9.28E-02,1.51E-01,7,"Tuberin, PI3K cat class IA, IRS-2, ERK1/2, SOS, AKT(PKB), PDK (PDPK1)",5.34E-01,6.88E-01,4,"PI3K cat class IA, IRS-2, SOS, AKT(PKB)"
899,Immune response_T cell subsets: cell surface markers,52,9.36E-02,1.73E-01,1.09E-01,1.73E-01,8,"ST2(L), IL-15RA, IL7RA, TCR beta subunit, CD44, CCR8, CD94, CCR5",9.36E-02,1.91E-01,8,"ST2(L), IL-15RA, IL7RA, TCR beta subunit, CD44, CCR8, CD94, CCR5"
900,HCV-mediated liver damage and predisposition to HCC progression via p53,19,9.53E-02,1.55E-01,9.53E-02,1.55E-01,4,"ERK1/2, SOS, p53, Histone H1",5.23E-01,6.78E-01,2,"SOS, Histone H1"
901,Inhibition of WNT5A-dependent non-canonical pathway in colorectal cancer,19,9.53E-02,1.55E-01,9.53E-02,1.55E-01,4,"ROR-alpha, PKC-alpha, Beta-catenin, TCF7 (TCF1)",2.44E-01,3.87E-01,3,"ROR-alpha, PKC-alpha, TCF7 (TCF1)"
902,Role of TLR signaling in skin sensitization,44,9.81E-02,1.78E-01,1.13E-01,1.78E-01,7,"IL-1 beta, CD14, TLR4, IL-6, TIRAP (Mal), IFN-beta, TLR2",9.81E-02,1.98E-01,7,"IL-1 beta, CD14, TLR4, IL-6, TIRAP (Mal), IFN-beta, TLR2"
903,HIF-1 in gastric cancer,51,9.98E-02,1.61E-01,9.98E-02,1.61E-01,8,"COX-2 (PTGS2), PGE2R2, Bcl-2, ERK1/2, AKT(PKB), p53, PDK (PDPK1), MDR1",4.95E-01,6.54E-01,5,"COX-2 (PTGS2), PGE2R2, Bcl-2, AKT(PKB), MDR1"
904,Putative pathways of n-3 and n-6 fatty acids in obesity and type 2 diabetes,51,9.98E-02,1.61E-01,9.98E-02,1.61E-01,8,"COX-2 (PTGS2), PTGIS, Adiponectin, Adenylate cyclase, AKT(PKB), G-protein alpha-q/11, FASN, GPR120",1.74E-01,3.02E-01,7,"COX-2 (PTGS2), PTGIS, Adiponectin, Adenylate cyclase, AKT(PKB), G-protein alpha-q/11, GPR120"
905,Immune response_Fc epsilon RI pathway: calcium-dependent signaling,68,1.00E-01,1.61E-01,1.00E-01,1.61E-01,10,"Syk, PKC-alpha, ERM proteins, cPLA2, Lyn, ERK1/2, Myosin II, Fyn, AKT(PKB), IP3 receptor",2.71E-01,4.18E-01,8,"Syk, PKC-alpha, ERM proteins, cPLA2, Lyn, Fyn, AKT(PKB), IP3 receptor"
906,PR action in breast cancer: stimulation of metastasis,20,1.01E-01,1.76E-01,1.11E-01,1.76E-01,4,"IRS-2, Tissue factor, PR (membrane), PR (nuclear)",1.01E-01,2.01E-01,4,"IRS-2, Tissue factor, PR (membrane), PR (nuclear)"
907,Immune response_Antiviral actions of Interferons,53,1.02E-01,1.85E-01,1.18E-01,1.85E-01,8,"IDO1, MxA, MHC class II, iNOS, HLA-A, CIITA, HLA-DRA1, IFN-beta",1.02E-01,2.02E-01,8,"IDO1, MxA, MHC class II, iNOS, HLA-A, CIITA, HLA-DRA1, IFN-beta"
908,Activation of osteoclast differentiation in bone lesions formation in multiple myeloma,27,1.02E-01,1.64E-01,1.02E-01,1.64E-01,5,"RelA (p65 NF-kB subunit), alpha-4/beta-1 integrin, ERK1/2, CCR5, Osteoprotegerin",2.24E-01,3.61E-01,4,"RelA (p65 NF-kB subunit), alpha-4/beta-1 integrin, CCR5, Osteoprotegerin"
909,G-protein signaling_G-Protein alpha-i signaling cascades,27,1.02E-01,1.64E-01,1.02E-01,1.64E-01,5,"STAT3, G-protein alpha-i family, ERK1/2, SOS, Caveolin-1",4.47E-01,6.15E-01,3,"G-protein alpha-i family, SOS, Caveolin-1"
910,Development_Angiopoietin - Tie2 signaling,35,1.04E-01,1.66E-01,1.04E-01,1.66E-01,6,"STAT3, TIE2, PI3K cat class IA, Angiopoietin 1, NF-kB, AKT(PKB)",2.06E-01,3.41E-01,5,"TIE2, PI3K cat class IA, Angiopoietin 1, NF-kB, AKT(PKB)"
911,Anti-apoptotic action of Gastrin in pancreatic cancer,35,1.04E-01,1.66E-01,1.04E-01,1.66E-01,6,"BAD, PI3K cat class IA, RelA (p65 NF-kB subunit), Bcl-2, AKT(PKB), PDK (PDPK1)",3.91E-01,5.57E-01,4,"PI3K cat class IA, RelA (p65 NF-kB subunit), Bcl-2, AKT(PKB)"
912,Cell cycle_ESR1 regulation of G1/S transition,35,1.04E-01,1.66E-01,1.04E-01,1.66E-01,6,"ESR1 (nuclear), Cyclin E, ERK1/2, ERK2 (MAPK1), p27KIP1, CDK6",6.25E-01,7.64E-01,3,"ESR1 (nuclear), Cyclin E, CDK6"
913,Neurophysiological process_Ephrin-B receptors in dendritic spine morphogenesis and synaptogenesis,35,1.04E-01,1.66E-01,1.04E-01,1.66E-01,6,"NMDA receptor, GABA-A receptor, Ephrin-B receptor 2, Actin cytoskeletal, Fyn, Ephrin-B receptors",2.06E-01,3.41E-01,5,"NMDA receptor, GABA-A receptor, Ephrin-B receptor 2, Fyn, Ephrin-B receptors"
914,Regulation of CFTR activity (normal and CF),62,1.04E-01,1.90E-01,1.22E-01,1.90E-01,9,"Syk, PGE2R4, Adenosine A2b receptor, G-protein alpha-i family, Adenylate cyclase, PDZK1, EBP50, PP2A regulatory, Beta-2 adrenergic receptor",1.04E-01,2.05E-01,9,"Syk, PGE2R4, Adenosine A2b receptor, G-protein alpha-i family, Adenylate cyclase, PDZK1, EBP50, PP2A regulatory, Beta-2 adrenergic receptor"
915,Development_TGF-beta receptor signaling,52,1.09E-01,1.73E-01,1.09E-01,1.73E-01,8,"TGF-beta receptor type II, ERK1/2, p15, SOS, NF-kB, SMAD3, Caveolin-1, ER81",3.29E-01,4.86E-01,6,"TGF-beta receptor type II, p15, SOS, NF-kB, Caveolin-1, ER81"
916,Neurophysiological process_Synaptic vesicle fusion and recycling in nerve terminals,52,1.09E-01,1.73E-01,1.09E-01,1.73E-01,8,"Alpha-synuclein, SV2A, AP180, F-Actin, CaMK I, Synapsin II, Endophilin A1, Complexin",1.87E-01,3.20E-01,7,"Alpha-synuclein, SV2A, AP180, CaMK I, Synapsin II, Endophilin A1, Complexin"
917,DNA damage_Inhibition of telomerase activity and cellular senescence,20,1.11E-01,1.76E-01,1.11E-01,1.76E-01,4,"AKT(PKB), p53, p16INK4, CDK6",2.69E-01,4.16E-01,3,"AKT(PKB), p16INK4, CDK6"
918,wtCFTR and deltaF508-CFTR traffic / Clathrin coated vesicles formation (normal and CF),20,1.11E-01,1.76E-01,1.11E-01,1.76E-01,4,"AP180, Myosin I, Actin cytoskeletal, Actin",2.69E-01,4.16E-01,3,"AP180, Myosin I, Actin"
919,Cytoskeleton remodeling_Role of Activin A in cytoskeleton remodeling,20,1.11E-01,1.76E-01,1.11E-01,1.76E-01,4,"Activin A, ACTA2, SMAD3, Fibronectin",2.69E-01,4.16E-01,3,"Activin A, ACTA2, Fibronectin"
920,Proliferative action of Gastrin in pancreatic cancer,44,1.13E-01,1.78E-01,1.13E-01,1.78E-01,7,"STAT3, PI3K cat class IA, PKC-alpha, ERK1/2, SOS, PDK (PDPK1), IP3 receptor",5.72E-01,7.22E-01,4,"PI3K cat class IA, PKC-alpha, SOS, IP3 receptor"
921,Chemotaxis_C5a-induced chemotaxis,44,1.13E-01,1.78E-01,1.13E-01,1.78E-01,7,"G-protein alpha-15, G-protein alpha-i family, F-Actin cytoskeleton, ERK1/2, Actin cytoskeletal, IP3 receptor, PREX1",5.72E-01,7.22E-01,4,"G-protein alpha-15, G-protein alpha-i family, IP3 receptor, PREX1"
922,Immune response_iC3b-induced phagocytosis via alpha-M/beta-2 integrin,61,1.13E-01,1.79E-01,1.13E-01,1.79E-01,9,"Syk, PI3K cat class IA, PKC, ITGB2, Myosin II, Actin cytoskeletal, Rac2, iC3b, IP3 receptor",3.12E-01,4.68E-01,7,"Syk, PI3K cat class IA, PKC, ITGB2, Rac2, iC3b, IP3 receptor"
923,Development_Beta adrenergic receptors in brown adipocyte differentiation,36,1.15E-01,1.81E-01,1.15E-01,1.81E-01,6,"EGR2 (Krox20), Adenylate cyclase, FOXC2, PPARGC1 (PGC1-alpha), Beta-2 adrenergic receptor, FASN",2.22E-01,3.60E-01,5,"EGR2 (Krox20), Adenylate cyclase, FOXC2, PPARGC1 (PGC1-alpha), Beta-2 adrenergic receptor"
924,Microsatellite instability in colorectal cancer,36,1.15E-01,1.81E-01,1.15E-01,1.81E-01,6,"PCNA, TGF-beta receptor type II, EGFR, Ephrin-B receptor 2, HLA-DRA1, p53",4.12E-01,5.80E-01,4,"TGF-beta receptor type II, EGFR, Ephrin-B receptor 2, HLA-DRA1"
925,Cell cycle_Regulation of G1/S transition (part 2),28,1.15E-01,1.81E-01,1.15E-01,1.81E-01,5,"RelA (p65 NF-kB subunit), Cyclin E, ERK1/2, AKT(PKB), CDK6",2.44E-01,3.87E-01,4,"RelA (p65 NF-kB subunit), Cyclin E, AKT(PKB), CDK6"
926,Gamma-secretase regulation of mammary cell development,21,1.16E-01,1.97E-01,1.27E-01,1.97E-01,4,"NOTCH4 (ICD4), Neuregulin 1, NOTCH4, MTG16 (CBFA2T3)",1.16E-01,2.24E-01,4,"NOTCH4 (ICD4), Neuregulin 1, NOTCH4, MTG16 (CBFA2T3)"
927,Role of ZNF202 in regulation of expression of genes involved in atherosclerosis,21,1.16E-01,1.97E-01,1.27E-01,1.97E-01,4,"ABCG1, IA-1, HDL proteins, PEMT",1.16E-01,2.24E-01,4,"ABCG1, IA-1, HDL proteins, PEMT"
928,Role of IFN-beta in activation of T cell apoptosis in multiple sclerosis,29,1.16E-01,1.99E-01,1.29E-01,1.99E-01,5,"c-IAP2, c-IAP1, 5'-NTD, AKT(PKB), IFN-beta",1.16E-01,2.24E-01,5,"c-IAP2, c-IAP1, 5'-NTD, AKT(PKB), IFN-beta"
929,Signal transduction_Calcium signaling,46,1.18E-01,2.07E-01,1.34E-01,2.07E-01,7,"cPKC (conventional), AKAP6, CD44, NCX1, CaMK I, MEF2, IP3 receptor",1.18E-01,2.26E-01,7,"cPKC (conventional), AKAP6, CD44, NCX1, CaMK I, MEF2, IP3 receptor"
930,Apoptosis and survival_Role of PKR in stress-induced apoptosis,53,1.18E-01,1.85E-01,1.18E-01,1.85E-01,8,"TLR4, ERK1/2, PP2A regulatory, NF-kB, Caspase-8, p53, TLR3, IFN-beta",5.30E-01,6.85E-01,5,"TLR4, PP2A regulatory, NF-kB, TLR3, IFN-beta"
931,ENaC regulation in normal and CF airways ,53,1.18E-01,1.85E-01,1.18E-01,1.85E-01,8,"cPKC (conventional), PI3K cat class IA, EDNRB, SERPINE2, Adenylate cyclase, ERK1/2, Beta-2 adrenergic receptor, G-protein alpha-q/11",2.00E-01,3.35E-01,7,"cPKC (conventional), PI3K cat class IA, EDNRB, SERPINE2, Adenylate cyclase, Beta-2 adrenergic receptor, G-protein alpha-q/11"
932,TLRs-mediated IFN-alpha production by plasmacytoid dendritic cells in SLE,53,1.18E-01,1.85E-01,1.18E-01,1.85E-01,8,"CAMP, TLR7, AKT(PKB), Fc gamma RII alpha, PDK (PDPK1), A20, Pim-1, PI3K cat class IA (p110-delta)",2.00E-01,3.35E-01,7,"CAMP, TLR7, AKT(PKB), Fc gamma RII alpha, A20, Pim-1, PI3K cat class IA (p110-delta)"
933,Oxidative stress in adipocyte dysfunction in type 2 diabetes and metabolic syndrome X,64,1.21E-01,2.16E-01,1.41E-01,2.16E-01,9,"PI3K cat class IA, RelA (p65 NF-kB subunit), Adiponectin, IRS-2, CCL2, Xanthine oxidase, IL-6, AKT(PKB), PLA2",1.21E-01,2.31E-01,9,"PI3K cat class IA, RelA (p65 NF-kB subunit), Adiponectin, IRS-2, CCL2, Xanthine oxidase, IL-6, AKT(PKB), PLA2"
934,Renin-Angiotensin-Aldosterone System,62,1.22E-01,1.90E-01,1.22E-01,1.90E-01,9,"CYP11B2, PKC-alpha, cPLA2, ERK1/2, CaMK I, G-protein alpha-q/11, RGS2, MDR1, IP3 receptor",1.95E-01,3.28E-01,8,"CYP11B2, PKC-alpha, cPLA2, CaMK I, G-protein alpha-q/11, RGS2, MDR1, IP3 receptor"
935,Regulation of microRNAs in colorectal cancer,62,1.22E-01,1.90E-01,1.22E-01,1.90E-01,9,"STAT3, RelA (p65 NF-kB subunit), LIN-28B, EGFR, TCF7L2 (TCF4), MECOM, AKT(PKB), p53, HGF receptor (Met)",3.27E-01,4.85E-01,7,"RelA (p65 NF-kB subunit), LIN-28B, EGFR, TCF7L2 (TCF4), MECOM, AKT(PKB), HGF receptor (Met)"
936,Nicotine signaling in chromaffin cells,45,1.23E-01,1.92E-01,1.23E-01,1.92E-01,7,"Chapsyn-110, TY3H, N-cadherin, Chromogranin A, PKC-alpha, ERK1/2, Beta-catenin",3.85E-01,5.50E-01,5,"Chapsyn-110, TY3H, N-cadherin, Chromogranin A, PKC-alpha"
937,Apo-2L(TNFSF10)-induced apoptosis in melanoma,45,1.23E-01,1.92E-01,1.23E-01,1.92E-01,7,"RelA (p65 NF-kB subunit), IL-8, XBP1, NF-kB, Caspase-8, IFN-beta, XAF1",2.18E-01,3.57E-01,6,"RelA (p65 NF-kB subunit), IL-8, XBP1, NF-kB, IFN-beta, XAF1"
938,Development_Activation of ERK by Alpha-1 adrenergic receptors,45,1.23E-01,1.92E-01,1.23E-01,1.92E-01,7,"G-protein alpha-15, PKC-alpha, ERK1/2, SOS1, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor, IP3 receptor",2.18E-01,3.57E-01,6,"G-protein alpha-15, PKC-alpha, SOS1, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor, IP3 receptor"
939,Development_EPO-induced MAPK pathway,45,1.23E-01,1.92E-01,1.23E-01,1.92E-01,7,"Syk, PKC-alpha, Lyn, N-Ras, ERK1/2, SOS, IP3 receptor",3.85E-01,5.50E-01,5,"Syk, PKC-alpha, Lyn, SOS, IP3 receptor"
940,Cytoskeleton remodeling_ACM3 and ACM4 in keratinocyte migration,38,1.24E-01,2.14E-01,1.40E-01,2.14E-01,6,"iNOS, G-protein alpha-i family, ACM4, G-protein alpha-q/11, IP3 receptor, ACM3",1.24E-01,2.35E-01,6,"iNOS, G-protein alpha-i family, ACM4, G-protein alpha-q/11, IP3 receptor, ACM3"
941,Development_Positive regulation of STK3/4 (Hippo) pathway and negative regulation of YAP/TAZ function,71,1.24E-01,1.93E-01,1.24E-01,1.93E-01,10,"Schwannomin (NF2), Adenylate cyclase, LIF, AMPK gamma subunit, Beta-catenin, EBP50, Actin cytoskeletal, TAZ, Beta-2 adrenergic receptor, Angiomotin (AMOT)",4.64E-01,6.32E-01,7,"Adenylate cyclase, LIF, AMPK gamma subunit, EBP50, TAZ, Beta-2 adrenergic receptor, Angiomotin (AMOT)"
942,Development_Beta-catenin destruction complex signaling,21,1.27E-01,1.97E-01,1.27E-01,1.97E-01,4,"Tcf(Lef), TCF7L2 (TCF4), Beta-catenin, TCF7 (TCF1)",2.94E-01,4.48E-01,3,"Tcf(Lef), TCF7L2 (TCF4), TCF7 (TCF1)"
943,Neurophysiological process_PGE2-induced pain processing,47,1.28E-01,2.21E-01,1.46E-01,2.21E-01,7,"NMDA receptor, COX-2 (PTGS2), PGE2R2, PGE2R4, cPLA2, Adenylate cyclase, PGE2R3",1.28E-01,2.40E-01,7,"NMDA receptor, COX-2 (PTGS2), PGE2R2, PGE2R4, cPLA2, Adenylate cyclase, PGE2R3"
944,Dysregulation of indirect glucose-induced inhibition of Glucagon secretion from alpha-cells in type 2 diabetes ,54,1.28E-01,1.98E-01,1.28E-01,1.98E-01,8,"PI3K cat class IA, SUR1, GABA-A receptor, IRS-2, Kir6.2, PC2, PDK (PDPK1), PAX6",2.13E-01,3.50E-01,7,"PI3K cat class IA, SUR1, GABA-A receptor, IRS-2, Kir6.2, PC2, PAX6"
945,Neurophysiological process_Dynein-dynactin motor complex in axonal transport in neurons,54,1.28E-01,1.98E-01,1.28E-01,1.98E-01,8,"NGF, ERK1/2, PRNP, AKT(PKB), Carboxypeptidase H, Dynein 1, cytoplasmic, intermediate chains, DYNC1I1, Vimentin",2.13E-01,3.50E-01,7,"NGF, PRNP, AKT(PKB), Carboxypeptidase H, Dynein 1, cytoplasmic, intermediate chains, DYNC1I1, Vimentin"
946,Muscle contraction_S1P2 receptor-mediated smooth muscle contraction,30,1.29E-01,2.19E-01,1.44E-01,2.19E-01,5,"PKC-alpha, MRLC, CPI-17, MLCK, IP3 receptor",1.29E-01,2.41E-01,5,"PKC-alpha, MRLC, CPI-17, MLCK, IP3 receptor"
947,Gamma-secretase regulation of angiogenesis,30,1.29E-01,2.19E-01,1.44E-01,2.19E-01,5,"NOTCH4 (ICD4), TIE2, Ephrin-B receptor 2, Angiopoietin 1, NOTCH4",1.29E-01,2.41E-01,5,"NOTCH4 (ICD4), TIE2, Ephrin-B receptor 2, Angiopoietin 1, NOTCH4"
948,Transcription_Ligand-dependent activation of the ESR1/SP pathway,30,1.29E-01,2.19E-01,1.44E-01,2.19E-01,5,"ESR1 (nuclear), Cyclin E, EGFR, ADA, Prolactin receptor",1.29E-01,2.41E-01,5,"ESR1 (nuclear), Cyclin E, EGFR, ADA, Prolactin receptor"
949,Muscle contraction_Regulation of eNOS activity in endothelial cells,65,1.30E-01,2.28E-01,1.51E-01,2.28E-01,9,"PI3K cat class IA, EDNRB, ETS1, G-protein alpha-i family, KLF2, BDKRB2, AKT(PKB), Caveolin-1, IP3 receptor",1.30E-01,2.42E-01,9,"PI3K cat class IA, EDNRB, ETS1, G-protein alpha-i family, KLF2, BDKRB2, AKT(PKB), Caveolin-1, IP3 receptor"
950,Amitraz-induced inhibition of Insulin secretion,22,1.32E-01,2.20E-01,1.45E-01,2.20E-01,4,"G-protein alpha-i1, Adenylate cyclase type V, G-protein alpha-i family, Alpha-2A adrenergic receptor",1.32E-01,2.45E-01,4,"G-protein alpha-i1, Adenylate cyclase type V, G-protein alpha-i family, Alpha-2A adrenergic receptor"
951,Apoptosis and survival_IL-17-induced CIKS-independent signaling pathways,46,1.34E-01,2.07E-01,1.34E-01,2.07E-01,7,"STAT3, PI3K cat class IA, Fra-1, STAT4, ERK1/2, NF-kB, PDK (PDPK1)",6.08E-01,7.53E-01,4,"PI3K cat class IA, Fra-1, STAT4, NF-kB"
952,Nociception_Pro-nociceptive action of Nociceptin in spinal cord at low doses,39,1.36E-01,2.31E-01,1.53E-01,2.31E-01,6,"NMDA receptor, Histamine H1 receptor, PGE2R4, GABA-A receptor, NR2, NR2A",1.36E-01,2.50E-01,6,"NMDA receptor, Histamine H1 receptor, PGE2R4, GABA-A receptor, NR2, NR2A"
953,Development_BMP7 in brown adipocyte differentiation,39,1.36E-01,2.31E-01,1.53E-01,2.31E-01,6,"OTOP1, PPARGC1 (PGC1-alpha), COL5A1, Annexin I, PSAT, EDNRA",1.36E-01,2.50E-01,6,"OTOP1, PPARGC1 (PGC1-alpha), COL5A1, Annexin I, PSAT, EDNRA"
954,Tau pathology in Alzheimer disease,55,1.38E-01,2.13E-01,1.38E-01,2.13E-01,8,"NMDA receptor, PKC, NR2, MAP2, ERK1/2, Tau (MAPT), ERK2 (MAPK1), Caspase-8",5.63E-01,7.13E-01,5,"NMDA receptor, PKC, NR2, MAP2, Tau (MAPT)"
955,Development_WNT/Beta-catenin signaling in the cytoplasm,55,1.38E-01,2.13E-01,1.38E-01,2.13E-01,8,"Tcf(Lef), WNT, Beta-catenin, SNAIL1, AKT(PKB), Nucleoredoxin, Dsh, Frizzled",5.63E-01,7.13E-01,5,"Tcf(Lef), WNT, AKT(PKB), Nucleoredoxin, Frizzled"
956,Regulation of intrinsic membrane properties and excitability of striatopallidal medium spiny neurons in Huntington's disease,57,1.40E-01,2.40E-01,1.60E-01,2.40E-01,8,"MaxiK alpha subunit, cPKC (conventional), PKC, G-protein alpha-i family, SCN2A, G-protein alpha-q/11, IP3 receptor, CACNA1D",1.40E-01,2.55E-01,8,"MaxiK alpha subunit, cPKC (conventional), PKC, G-protein alpha-i family, SCN2A, G-protein alpha-q/11, IP3 receptor, CACNA1D"
957,Development_SDF-1 signaling in hematopoietic stem cell homing,38,1.40E-01,2.14E-01,1.40E-01,2.14E-01,6,"PI3K cat class IA, alpha-4/beta-1 integrin, Lyn, ERK1/2, PDK (PDPK1), MMP-9",4.54E-01,6.24E-01,4,"PI3K cat class IA, alpha-4/beta-1 integrin, Lyn, MMP-9"
958,Role of histone modificators in progression of multiple myeloma,30,1.44E-01,2.19E-01,1.44E-01,2.19E-01,5,"N-Ras, IL-6, Dynein 1, cytoplasmic, intermediate chains, p27KIP1, CDK6",5.18E-01,6.76E-01,3,"IL-6, Dynein 1, cytoplasmic, intermediate chains, CDK6"
959,Development_Dopamine-induced expression of CNTF in adult neurogenesis,22,1.45E-01,2.20E-01,1.45E-01,2.20E-01,4,"STAT3, Adenylate cyclase type V, G-protein alpha-i family, LIFR",3.20E-01,4.77E-01,3,"Adenylate cyclase type V, G-protein alpha-i family, LIFR"
960,Role of Huntingtin in regulation of BDNF in Huntington's disease,22,1.45E-01,2.20E-01,1.45E-01,2.20E-01,4,"PI3K cat class IA, RelA (p65 NF-kB subunit), AKT(PKB), PDK (PDPK1)",3.20E-01,4.77E-01,3,"PI3K cat class IA, RelA (p65 NF-kB subunit), AKT(PKB)"
961,Regulation of lipid metabolism_Insulin signaling: generic cascades,47,1.46E-01,2.21E-01,1.46E-01,2.21E-01,7,"Tuberin, PI3K cat class IA, IRS-2, ERK1/2, SOS, AKT(PKB), PDK (PDPK1)",6.25E-01,7.64E-01,4,"PI3K cat class IA, IRS-2, SOS, AKT(PKB)"
962,Immune response_KLRK1 (NKG2D) signaling pathway,47,1.46E-01,2.21E-01,1.46E-01,2.21E-01,7,"Syk, PI3K cat class IA, Lck, ERK1/2, Fyn, AKT(PKB), IP3 receptor",4.22E-01,5.91E-01,5,"Syk, PI3K cat class IA, Fyn, AKT(PKB), IP3 receptor"
963,Metabolic syndrome X (general schema),15,1.48E-01,2.40E-01,1.60E-01,2.40E-01,3,"IL-1 beta, Adiponectin, IL-6",1.48E-01,2.69E-01,3,"IL-1 beta, Adiponectin, IL-6"
964,Memory CD8+ T cells in allergic contact dermatitis,40,1.49E-01,2.49E-01,1.67E-01,2.49E-01,6,"IL-15, IL-1 beta, IL7RA, alpha-4/beta-1 integrin, ICAM1, NF-kB",1.49E-01,2.69E-01,6,"IL-15, IL-1 beta, IL7RA, alpha-4/beta-1 integrin, ICAM1, NF-kB"
965,Role of Ghrelin in activation eating behavior in obesity,40,1.49E-01,2.49E-01,1.67E-01,2.49E-01,6,"Adenylate cyclase type II, Ghrelin, NPY, G-protein alpha-q/11, IP3 receptor, Adenylate cyclase type VII",1.49E-01,2.69E-01,6,"Adenylate cyclase type II, Ghrelin, NPY, G-protein alpha-q/11, IP3 receptor, Adenylate cyclase type VII"
966,Neurophysiological process_ACM1 and ACM2 in neuronal membrane polarization,40,1.49E-01,2.49E-01,1.67E-01,2.49E-01,6,"G-protein alpha-i1, PKC-alpha, Kir2.1, Kir3.1, Kir2.2, IP3 receptor",1.49E-01,2.69E-01,6,"G-protein alpha-i1, PKC-alpha, Kir2.1, Kir3.1, Kir2.2, IP3 receptor"
967,Muscle contraction_ACM regulation of smooth muscle contraction,56,1.49E-01,2.26E-01,1.49E-01,2.26E-01,8,"TRPC4, PKC, MRLC, CPI-17, PDK (PDPK1), MLCK, IP3 receptor, ACM3",2.40E-01,3.83E-01,7,"TRPC4, PKC, MRLC, CPI-17, MLCK, IP3 receptor, ACM3"
968,Transcription_p53 signaling pathway,39,1.53E-01,2.31E-01,1.53E-01,2.31E-01,6,"p14ARF, Bcl-2, MMP-2, Beta-catenin, NF-kB, p53",4.75E-01,6.39E-01,4,"p14ARF, Bcl-2, MMP-2, NF-kB"
969,Immune response_NF-AT signaling and leukocyte interactions,48,1.58E-01,2.38E-01,1.58E-01,2.38E-01,7,"COX-2 (PTGS2), MHC class II, Lck, cPLA2, IGHE, NF-kB, IP3 receptor",2.64E-01,4.12E-01,6,"COX-2 (PTGS2), MHC class II, cPLA2, IGHE, NF-kB, IP3 receptor"
970,Development_Schema: Embryonal cardiomyogenesis,8,1.59E-01,2.51E-01,1.68E-01,2.51E-01,2,"Jagged1, BMP2",1.59E-01,2.83E-01,2,"Jagged1, BMP2"
971,Influence of low doses of Arsenite on glucose uptake in adipocytes,31,1.59E-01,2.40E-01,1.59E-01,2.40E-01,5,"PI3K cat class IA, IRS-2, AKT(PKB), PDK (PDPK1), C/EBPalpha",3.06E-01,4.64E-01,4,"PI3K cat class IA, IRS-2, AKT(PKB), C/EBPalpha"
972,SLE genetic marker-specific pathways in antigen-presenting cells (APC),84,1.60E-01,2.40E-01,1.60E-01,2.40E-01,11,"IL-1 beta, ICAM1, STAT4, TLR4, Beclin 1, TLR7, iC3b, NF-kB, Fc gamma RII alpha, A20, IFN-beta",2.26E-01,3.64E-01,10,"IL-1 beta, ICAM1, STAT4, TLR4, TLR7, iC3b, NF-kB, Fc gamma RII alpha, A20, IFN-beta"
973,Transport_ACM3 signaling in lacrimal glands,75,1.61E-01,2.41E-01,1.61E-01,2.41E-01,10,"MaxiK alpha subunit, CD14, PKC-alpha, SP-D, ERK1/2, Mucin 5B, G-protein alpha-q/11, Mucin 7, IP3 receptor, ACM3",2.35E-01,3.77E-01,9,"MaxiK alpha subunit, CD14, PKC-alpha, SP-D, Mucin 5B, G-protein alpha-q/11, Mucin 7, IP3 receptor, ACM3"
974,Apoptosis and survival_Ceramides signaling pathway,40,1.67E-01,2.49E-01,1.67E-01,2.49E-01,6,"BAD, PI3K cat class IA, Bcl-2, ERK1/2, AKT(PKB), Caspase-8",7.14E-01,8.42E-01,3,"PI3K cat class IA, Bcl-2, AKT(PKB)"
975,Huntingtin-depended transcription deregulation in Huntington's Disease,24,1.67E-01,2.69E-01,1.82E-01,2.69E-01,4,"NGFR(TNFRSF16), Enkephalin A, NR1, C/EBPalpha",1.67E-01,2.92E-01,4,"NGFR(TNFRSF16), Enkephalin A, NR1, C/EBPalpha"
976,Breakdown of CD4+ T cell peripheral tolerance in type 1 diabetes mellitus,49,1.70E-01,2.54E-01,1.70E-01,2.54E-01,7,"HLA-DRB1, MHC class II, Lck, STAT4, PTPN22, NF-kB, PD-L1",2.80E-01,4.31E-01,6,"HLA-DRB1, MHC class II, STAT4, PTPN22, NF-kB, PD-L1"
977,Nicotine signaling in glutamatergic neurons,33,1.73E-01,2.80E-01,1.92E-01,2.80E-01,5,"NMDA receptor, Adenylate cyclase type V, PKC-alpha, G-protein alpha-i family, nAChR alpha-4",1.73E-01,3.02E-01,5,"NMDA receptor, Adenylate cyclase type V, PKC-alpha, G-protein alpha-i family, nAChR alpha-4"
978,Cytoskeleton remodeling_Thyroliberin in cytoskeleton remodeling,33,1.73E-01,2.80E-01,1.92E-01,2.80E-01,5,"Thyroliberin, PKC-alpha, Adenylate cyclase, Tau (MAPT), IP3 receptor",1.73E-01,3.02E-01,5,"Thyroliberin, PKC-alpha, Adenylate cyclase, Tau (MAPT), IP3 receptor"
979,Neurophysiological process_GABAergic neurotransmission,51,1.74E-01,2.83E-01,1.96E-01,2.83E-01,7,"GABA-A receptor, G-protein alpha-i family, ALDR, GABT, GAD1, GAT1, SLC7A7",1.74E-01,3.02E-01,7,"GABA-A receptor, G-protein alpha-i family, ALDR, GABT, GAD1, GAT1, SLC7A7"
980,Development_Transcription regulation of granulocyte development,32,1.75E-01,2.60E-01,1.75E-01,2.60E-01,5,"STAT3, PKC, c-Fes, CD13, C/EBPalpha",3.28E-01,4.85E-01,4,"PKC, c-Fes, CD13, C/EBPalpha"
981,Selective Insulin resistance in type 2 diabetes in liver,32,1.75E-01,2.60E-01,1.75E-01,2.60E-01,5,"PKC-theta, IRS-2, PPARGC1 (PGC1-alpha), AKT(PKB), PDK (PDPK1)",3.28E-01,4.85E-01,4,"PKC-theta, IRS-2, PPARGC1 (PGC1-alpha), AKT(PKB)"
982,Epithelial cell apoptosis in COPD,32,1.75E-01,2.60E-01,1.75E-01,2.60E-01,5,"BAD, Bcl-2, NF-kB, AKT(PKB), p53",5.63E-01,7.13E-01,3,"Bcl-2, NF-kB, AKT(PKB)"
983,Apoptosis and survival_Anti-apoptotic TNFs/NF-kB/Bcl-2 pathway,42,1.75E-01,2.83E-01,1.95E-01,2.83E-01,6,"NGF, TNF-R2, NGFR(TNFRSF16), RelA (p65 NF-kB subunit), Bcl-2, NF-kB",1.75E-01,3.03E-01,6,"NGF, TNF-R2, NGFR(TNFRSF16), RelA (p65 NF-kB subunit), Bcl-2, NF-kB"
984,Blood coagulation_GPIb-IX-V-dependent platelet activation,77,1.81E-01,2.68E-01,1.81E-01,2.68E-01,10,"Syk, PKC-alpha, ITGB3, cPLA2, Lyn, Fyn, ERK2 (MAPK1), Fc gamma RII alpha, Actin, IP3 receptor",2.59E-01,4.06E-01,9,"Syk, PKC-alpha, ITGB3, cPLA2, Lyn, Fyn, Fc gamma RII alpha, Actin, IP3 receptor"
985,Regulation of metabolism_Bile acids regulation of glucose and lipid metabolism via FXR,41,1.81E-01,2.68E-01,1.81E-01,2.68E-01,6,"ACACB, AKT(PKB), FASN, HNF3-alpha, HNF3, F16P",3.11E-01,4.68E-01,5,"ACACB, AKT(PKB), HNF3-alpha, HNF3, F16P"
986,Signaling Transduction_Role of MIF as an intracellular mediator,41,1.81E-01,2.68E-01,1.81E-01,2.68E-01,6,"IL-1 beta, RelA (p65 NF-kB subunit), p53, PRSS11 (HtrA1), Vimentin, p27KIP1",5.15E-01,6.76E-01,4,"IL-1 beta, RelA (p65 NF-kB subunit), PRSS11 (HtrA1), Vimentin"
987,Apoptosis and survival_NO signaling in survival,24,1.82E-01,2.69E-01,1.82E-01,2.69E-01,4,"BAD, AKT(PKB), PDK (PDPK1), PI3K cat class IA (p110-delta)",6.52E-01,7.89E-01,2,"AKT(PKB), PI3K cat class IA (p110-delta)"
988,Immune response_IL-27 signaling pathway,24,1.82E-01,2.69E-01,1.82E-01,2.69E-01,4,"STAT3, ICAM1, NF-kB, Pim-1",3.71E-01,5.33E-01,3,"ICAM1, NF-kB, Pim-1"
989,Neurophysiological process_Corticoliberin signaling via CRHR1 ,50,1.83E-01,2.70E-01,1.83E-01,2.70E-01,7,"POMC, cPKC (conventional), PKC-alpha, Adenylate cyclase, ERK2 (MAPK1), G-protein alpha-q/11, IP3 receptor",2.96E-01,4.50E-01,6,"POMC, cPKC (conventional), PKC-alpha, Adenylate cyclase, G-protein alpha-q/11, IP3 receptor"
990,Transport_The role of AVP in regulation of Aquaporin 2 and renal water reabsorption,50,1.83E-01,2.70E-01,1.83E-01,2.70E-01,7,"MRLC, ERK1/2, Myosin II, Actin cytoskeletal, MyHC, MLCK, ACTB",9.48E-01,1.00E+00,2,"MRLC, MLCK"
991,Suppression of p53 signaling in multiple myeloma,50,1.83E-01,2.70E-01,1.83E-01,2.70E-01,7,"p14ARF, p53 (mitochondrial), Bcl-2, IL-6, NOXA, Caspase-8, p53",6.74E-01,8.10E-01,4,"p14ARF, Bcl-2, IL-6, NOXA"
992,Regulation of lipid metabolism_G-alpha(q) regulation of lipid metabolism,59,1.83E-01,2.70E-01,1.83E-01,2.70E-01,8,"COX-2 (PTGS2), APOC1, PKC, ABCG1, cPLA2, ERK1/2, G-protein alpha-q/11, IP3 receptor",2.83E-01,4.34E-01,7,"COX-2 (PTGS2), APOC1, PKC, ABCG1, cPLA2, G-protein alpha-q/11, IP3 receptor"
993,Cytoskeleton remodeling_Substance P mediated membrane blebbing,16,1.84E-01,2.70E-01,1.84E-01,2.70E-01,3,"MRLC, Myosin II, MLCK",4.32E-01,6.01E-01,2,"MRLC, MLCK"
994,Putative pathways of activation of monoclonal protein secretion in multiple myeloma,25,1.85E-01,2.90E-01,2.02E-01,2.90E-01,4,"XBP1, BOB1, BLIMP1 (PRDI-BF1), ERP5",1.85E-01,3.18E-01,4,"XBP1, BOB1, BLIMP1 (PRDI-BF1), ERP5"
995,Immune response_T cell subsets: secreted signals,25,1.85E-01,2.90E-01,2.02E-01,2.90E-01,4,"CCL20, Amphiregulin, IL-6, TGF-beta",1.85E-01,3.18E-01,4,"CCL20, Amphiregulin, IL-6, TGF-beta"
996,Regulation of proinflammatory cytokine production by Th2 cells in asthma,43,1.89E-01,2.98E-01,2.11E-01,2.98E-01,6,"IL-15, IL-19, GATA-3, ST2(L), MHC class II, IL-33",1.89E-01,3.20E-01,6,"IL-15, IL-19, GATA-3, ST2(L), MHC class II, IL-33"
997,Immune response_Antimicrobial actions of IFN-gamma,43,1.89E-01,2.98E-01,2.11E-01,2.98E-01,6,"IDO1, NGAL, Staf-50, MD-2, SLC26A3 (DRA), TLR3",1.89E-01,3.20E-01,6,"IDO1, NGAL, Staf-50, MD-2, SLC26A3 (DRA), TLR3"
998,Role of platelets in the initiation of in-stent restenosis,43,1.89E-01,2.98E-01,2.11E-01,2.98E-01,6,"ICAM1, CCL2, IL-8, Tissue factor, ICAM2, Collagen III",1.89E-01,3.20E-01,6,"ICAM1, CCL2, IL-8, Tissue factor, ICAM2, Collagen III"
999,Role of platelets in allograft rejection,43,1.89E-01,2.98E-01,2.11E-01,2.98E-01,6,"IL-1 beta, ICAM1, TGF-beta, Tissue factor, Kainate receptor, Collagen III",1.89E-01,3.20E-01,6,"IL-1 beta, ICAM1, TGF-beta, Tissue factor, Kainate receptor, Collagen III"
1000,G-protein signaling_RhoA regulation pathway,34,1.89E-01,2.98E-01,2.09E-01,2.98E-01,5,"BMX, Rhophilin 1, Fyn, Ephrin-A receptors, G-protein alpha-q/11",1.89E-01,3.20E-01,5,"BMX, Rhophilin 1, Fyn, Ephrin-A receptors, G-protein alpha-q/11"
1001,Cannabinoid receptor signaling in nicotine addiction,34,1.89E-01,2.98E-01,2.09E-01,2.98E-01,5,"NMDA receptor, nAChR alpha-7, G-protein alpha-i1, G-protein alpha-i family, nAChR alpha-4",1.89E-01,3.20E-01,5,"NMDA receptor, nAChR alpha-7, G-protein alpha-i1, G-protein alpha-i family, nAChR alpha-4"
1002,Development_EGFR signaling via small GTPases,33,1.92E-01,2.80E-01,1.92E-01,2.80E-01,5,"PI3K cat class IA, EGFR, N-Ras, ERK1/2, SOS",5.84E-01,7.32E-01,3,"PI3K cat class IA, EGFR, SOS"
1003,Apoptosis and survival_Regulation of Apoptosis by Mitochondrial Proteins,33,1.92E-01,2.80E-01,1.92E-01,2.80E-01,5,"BAD, Bcl-2, NOXA, Caspase-8, Bcl-B",5.84E-01,7.32E-01,3,"Bcl-2, NOXA, Bcl-B"
1004,Resistance of pancreatic cancer cells to death receptor signaling,33,1.92E-01,2.80E-01,1.92E-01,2.80E-01,5,"TRUNDD(TNFRSF10D), c-IAP2, RelA (p65 NF-kB subunit), c-IAP1, Caspase-8",3.49E-01,5.08E-01,4,"TRUNDD(TNFRSF10D), c-IAP2, RelA (p65 NF-kB subunit), c-IAP1"
1005,Transcription_Negative regulation of HIF1A function,69,1.94E-01,2.83E-01,1.94E-01,2.83E-01,9,"FHL3, p14ARF, FHL1 (SLIM1), RUNX3, PTEN, MTG16 (CBFA2T3), KLF2, PSMA7, p53",4.34E-01,6.02E-01,7,"FHL3, p14ARF, FHL1 (SLIM1), RUNX3, MTG16 (CBFA2T3), KLF2, PSMA7"
1006,Development_Positive regulation of WNT/Beta-catenin signaling in the nucleus,69,1.94E-01,2.83E-01,1.94E-01,2.83E-01,9,"Tcf(Lef), RUNX, WNT, TCF7L2 (TCF4), Beta-catenin, ERK2 (MAPK1), Dsh, TCF7 (TCF1), Frizzled",6.02E-01,7.51E-01,6,"Tcf(Lef), RUNX, WNT, TCF7L2 (TCF4), TCF7 (TCF1), Frizzled"
1007,Immune response_TCR alpha/beta signaling pathway,97,1.94E-01,2.83E-01,1.94E-01,2.83E-01,12,"NMDA receptor, MHC class II, Lck, PKC-theta, TRPC3, PKC-alpha, ERK1/2, Fyn, AKT(PKB), Caspase-8, GRAP2, IP3 receptor",5.19E-01,6.77E-01,9,"NMDA receptor, MHC class II, PKC-theta, TRPC3, PKC-alpha, Fyn, AKT(PKB), GRAP2, IP3 receptor"
1008,GLP-1 in inhibition of beta cell proliferation and function in type 2 diabetes,42,1.95E-01,2.83E-01,1.95E-01,2.83E-01,6,"IRS-2, EGFR, TCF7L2 (TCF4), ERK1/2, Beta-catenin, PDK (PDPK1)",7.45E-01,8.69E-01,3,"IRS-2, EGFR, TCF7L2 (TCF4)"
1009,Development_Growth hormone signaling via PI3K/AKT and MAPK cascades,42,1.95E-01,2.83E-01,1.95E-01,2.83E-01,6,"Tuberin, IRS-2, SOS, ERK2 (MAPK1), AKT(PKB), GHR",5.34E-01,6.88E-01,4,"IRS-2, SOS, AKT(PKB), GHR"
1010,A shift from oxidative to glycolytic muscle fiber phenotype in quadriceps muscles in COPD,60,1.96E-01,2.83E-01,1.96E-01,2.83E-01,8,"Troponin C, cardiac, Fatty acid-binding protein, PPARGC1 (PGC1-alpha), MEF2, NF-kB, MKL1, ERK2 (MAPK1), Myoglobin",2.98E-01,4.51E-01,7,"Troponin C, cardiac, Fatty acid-binding protein, PPARGC1 (PGC1-alpha), MEF2, NF-kB, MKL1, Myoglobin"
1011,Neutrophil resistance to apoptosis in COPD and proresolving impact of lipid mediators,60,1.96E-01,2.83E-01,1.96E-01,2.83E-01,8,"BAD, PI3K cat class IA, SAA1, TNF-R2 soluble, c-IAP1, ERK1/2, AKT(PKB), Caspase-8",6.42E-01,7.83E-01,5,"PI3K cat class IA, SAA1, TNF-R2 soluble, c-IAP1, AKT(PKB)"
1012,Signal transduction_mTORC1 downstream signaling,60,1.96E-01,2.83E-01,1.96E-01,2.83E-01,8,"BAD, STAT3, PDK1, PDCD4, SGK1, HMGCS2, p53, p27KIP1",9.18E-01,9.83E-01,3,"PDCD4, SGK1, HMGCS2"
1013,Stimulation of gastric acid secretion in gastric cancer,60,1.96E-01,2.83E-01,1.96E-01,2.83E-01,8,"Chromogranin A, PKC-alpha, Kir2.1, Adenylate cyclase, ERK1/2, G-protein alpha-q/11, IP3 receptor, ACM3",2.98E-01,4.51E-01,7,"Chromogranin A, PKC-alpha, Kir2.1, Adenylate cyclase, G-protein alpha-q/11, IP3 receptor, ACM3"
1014,Immune response_IFN-gamma signaling via MAPK,51,1.96E-01,2.83E-01,1.96E-01,2.83E-01,7,"iNOS, IP10, IFI16, IFI6, ERK1/2, TIRAP (Mal), ERK2 (MAPK1)",4.95E-01,6.54E-01,5,"iNOS, IP10, IFI16, IFI6, TIRAP (Mal)"
1015,microRNA in Prostate Cancer,51,1.96E-01,2.83E-01,1.96E-01,2.83E-01,7,"CD44, microRNA 221, PDCD4, Bcl-2, p53, p27KIP1, CDK6",4.95E-01,6.54E-01,5,"CD44, microRNA 221, PDCD4, Bcl-2, CDK6"
1016,Immune response_IL-2 signaling via JAK/ STAT,25,2.02E-01,2.90E-01,2.02E-01,2.90E-01,4,"STAT3, Syk, STAT4, Bcl-2",3.97E-01,5.60E-01,3,"Syk, STAT4, Bcl-2"
1017,Apoptosis and survival_Role of nuclear PI3K in NGF/ TrkA signaling,25,2.02E-01,2.90E-01,2.02E-01,2.90E-01,4,"NGF, PI3K cat class IA, AKT(PKB), PDK (PDPK1)",3.97E-01,5.60E-01,3,"NGF, PI3K cat class IA, AKT(PKB)"
1018,Neurophysiological process_GABA-B receptor signaling at postsynaptic sides of synapses,26,2.04E-01,3.13E-01,2.22E-01,3.13E-01,4,"NMDA receptor, Kir3.4, G-protein alpha-i family, Kir3.1",2.04E-01,3.41E-01,4,"NMDA receptor, Kir3.4, G-protein alpha-i family, Kir3.1"
1019,CD8+ Tc1 cells in allergic contact dermatitis,26,2.04E-01,3.13E-01,2.22E-01,3.13E-01,4,"IL-1 beta, TNF-R2, MHC class II, Caspase-1",2.04E-01,3.41E-01,4,"IL-1 beta, TNF-R2, MHC class II, Caspase-1"
1020,Altered Ca2+ handling in heart failure,35,2.06E-01,3.17E-01,2.26E-01,3.17E-01,5,"NCX1, G-protein alpha-i family, Adenylate cyclase, Beta-2 adrenergic receptor, CaMK II delta",2.06E-01,3.41E-01,5,"NCX1, G-protein alpha-i family, Adenylate cyclase, Beta-2 adrenergic receptor, CaMK II delta"
1021,NF-kB pathway in multiple myeloma,35,2.06E-01,3.17E-01,2.26E-01,3.17E-01,5,"c-IAP2, c-IAP1, Bcl-2, IL-6, NF-kB",2.06E-01,3.41E-01,5,"c-IAP2, c-IAP1, Bcl-2, IL-6, NF-kB"
1022,O-glycan biosynthesis,63,2.07E-01,3.26E-01,2.34E-01,3.26E-01,8,"GALNT15, GALNTL2, GALNTL1, GALNTL3, GALNTL4, B3GT2, GALNT6, GALNT14",2.07E-01,3.42E-01,8,"GALNT15, GALNTL2, GALNTL1, GALNTL3, GALNTL4, B3GT2, GALNT6, GALNT14"
1023,Induction of mucin secretion in  airway goblet cells by purinergic receptors,61,2.08E-01,2.98E-01,2.08E-01,2.98E-01,8,"iNOS, PKC-alpha, PP2A regulatory, Actin cytoskeletal, NF-kB, G-protein alpha-q/11, MUNC13, IP3 receptor",3.12E-01,4.68E-01,7,"iNOS, PKC-alpha, PP2A regulatory, NF-kB, G-protein alpha-q/11, MUNC13, IP3 receptor"
1024,Immune response_IL-11 signaling via JAK/STAT,34,2.09E-01,2.98E-01,2.09E-01,2.98E-01,5,"STAT3, A2M, Bcl-2, CYP19, Pim-1",3.70E-01,5.33E-01,4,"A2M, Bcl-2, CYP19, Pim-1"
1025,Development_Histone acetylation in embryonic stem cells,34,2.09E-01,2.98E-01,2.09E-01,2.98E-01,5,"Oct-3/4, SOX2, SNAIL1, p53, p27KIP1",8.26E-01,9.25E-01,2,"Oct-3/4, SOX2"
1026,"Apoptosis and survival_Cytoplasmic/mitochondrial transport of proapoptotic proteins Bid, Bmf and Bim",34,2.09E-01,2.98E-01,2.09E-01,2.98E-01,5,"HGK(MAP4K4), Caspase-10, Bcl-2, GCKR(MAP4K5), Caspase-8",3.70E-01,5.33E-01,4,"HGK(MAP4K4), Caspase-10, Bcl-2, GCKR(MAP4K5)"
1027,Development_FGF10 in development of subcutaneous white adipose tissue in embryogenesis,17,2.09E-01,2.98E-01,2.09E-01,2.98E-01,3,"ERK1/2, SOS, C/EBPalpha",4.63E-01,6.31E-01,2,"SOS, C/EBPalpha"
1028,DNA damage_Role of SUMO in p53 regulation,17,2.09E-01,2.98E-01,2.09E-01,2.98E-01,3,"SAE2, AKT(PKB), p53",4.63E-01,6.31E-01,2,"SAE2, AKT(PKB)"
1029,Cell adhesion_Integrin inside-out signaling in T cells,52,2.10E-01,2.98E-01,2.10E-01,2.98E-01,7,"ITGB1, CCL20, Lck, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family",3.29E-01,4.86E-01,6,"ITGB1, CCL20, ITGB2, alpha-4/beta-1 integrin, ICAM1, G-protein alpha-i family"
1030,Development_WNT/Beta-catenin signaling pathway. Signalosome,43,2.11E-01,2.98E-01,2.11E-01,2.98E-01,6,"Schwannomin (NF2), WNT, G-protein alpha-i family, DAAM2, Dsh, Frizzled",5.53E-01,7.04E-01,4,"WNT, G-protein alpha-i family, DAAM2, Frizzled"
1031,Impaired inhibitory action of lipoxins and Resolvin E1 on neutrophil functions in CF,43,2.11E-01,2.98E-01,2.11E-01,2.98E-01,6,"IL-1 beta, IL-8, G-protein alpha-i family, ERK1/2, NF-kB, PI3K reg class IB (p101)",3.48E-01,5.08E-01,5,"IL-1 beta, IL-8, G-protein alpha-i family, NF-kB, PI3K reg class IB (p101)"
1032,Apoptosis and survival_TNFR1 signaling pathway,43,2.11E-01,2.98E-01,2.11E-01,2.98E-01,6,"c-IAP2, Caspase-10, c-IAP1, Bcl-2, NF-kB, Caspase-8",3.48E-01,5.08E-01,5,"c-IAP2, Caspase-10, c-IAP1, Bcl-2, NF-kB"
1033,Blood coagulation_GPVI-dependent platelet activation,54,2.13E-01,3.31E-01,2.38E-01,3.31E-01,7,"Syk, PKC-alpha, ITGB3, Lyn, Fyn, GRAP2, IP3 receptor",2.13E-01,3.50E-01,7,"Syk, PKC-alpha, ITGB3, Lyn, Fyn, GRAP2, IP3 receptor"
1034,"Immune response_Antigen presentation by MHC class I, classical pathway",54,2.13E-01,3.31E-01,2.38E-01,3.31E-01,7,"MHC Class I alpha chain, TAP1 (PSF1), PSMB8(LMP7), TAP2 (PSF2), PSMB9, ERAP2, TAP",2.13E-01,3.50E-01,7,"MHC Class I alpha chain, TAP1 (PSF1), PSMB8(LMP7), TAP2 (PSF2), PSMB9, ERAP2, TAP"
1035,Regulation of lipid metabolism_Alpha-1 adrenergic receptors signaling via arachidonic acid,71,2.17E-01,3.07E-01,2.17E-01,3.07E-01,9,"COX-2 (PTGS2), PTGIS, PKC-alpha, cPLA2, ERK1/2, SOS1, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor, IP3 receptor",3.11E-01,4.68E-01,8,"COX-2 (PTGS2), PTGIS, PKC-alpha, cPLA2, SOS1, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor, IP3 receptor"
1036,Stem cells_Excitotoxicity of Glutamate in glioblastoma,45,2.18E-01,3.35E-01,2.42E-01,3.35E-01,6,"NMDA receptor, SLC1A2/EAAT2, G-protein alpha-i family, SLC7A11, CDO1, GLAST1/EAAT1",2.18E-01,3.57E-01,6,"NMDA receptor, SLC1A2/EAAT2, G-protein alpha-i family, SLC7A11, CDO1, GLAST1/EAAT1"
1037,"Role of inflammasome in macrophages, adipocytes and pancreatic beta cells in type 2 diabetes",18,2.19E-01,3.26E-01,2.34E-01,3.26E-01,3,"IL-1 beta, NF-kB, Caspase-1",2.19E-01,3.57E-01,3,"IL-1 beta, NF-kB, Caspase-1"
1038,Stem cells_CD30 signaling in transformed embryonic stem cells,18,2.19E-01,3.26E-01,2.34E-01,3.26E-01,3,"Oct-3/4, SOX2, CD30(TNFRSF8)",2.19E-01,3.57E-01,3,"Oct-3/4, SOX2, CD30(TNFRSF8)"
1039,Heme metabolism,103,2.19E-01,3.51E-01,2.55E-01,3.51E-01,12,"UGT2B28, Ceruloplasmin, Apotransferrin, UGT1A1, UGT1A10, Holotransferrin, Neuroglobin, Myoglobin, UGT2B17, UGT1A4, CYP2B6, UGT1A6",2.19E-01,3.57E-01,12,"UGT2B28, Ceruloplasmin, Apotransferrin, UGT1A1, UGT1A10, Holotransferrin, Neuroglobin, Myoglobin, UGT2B17, UGT1A4, CYP2B6, UGT1A6"
1040,Nicotine / nAChR alpha-3/nAChR beta-2 signaling in NSCLC,26,2.22E-01,3.13E-01,2.22E-01,3.13E-01,4,"PKC-alpha, AKT(PKB), PDK (PDPK1), PI3K cat class IA (p110-delta)",4.22E-01,5.91E-01,3,"PKC-alpha, AKT(PKB), PI3K cat class IA (p110-delta)"
1041,"Development_Lipoxin inhibitory action on PDGF, EGF and LTD4 signaling",36,2.22E-01,3.37E-01,2.44E-01,3.37E-01,5,"EGFR, G-protein alpha-i family, Adenylate cyclase, G-protein alpha-q/11, PDGF-R-beta",2.22E-01,3.60E-01,5,"EGFR, G-protein alpha-i family, Adenylate cyclase, G-protein alpha-q/11, PDGF-R-beta"
1042,Development_Role of HDAC and calcium/calmodulin-dependent kinase (CaMK) in control of skeletal myogenesis,53,2.24E-01,3.15E-01,2.24E-01,3.15E-01,7,"HDAC9, Tuberin, PI3K cat class IA, MEF2C, MEF2, AKT(PKB), PDK (PDPK1)",5.30E-01,6.85E-01,5,"HDAC9, PI3K cat class IA, MEF2C, MEF2, AKT(PKB)"
1043,Neurophysiological process_GABA-A receptor life cycle,27,2.24E-01,3.36E-01,2.43E-01,3.36E-01,4,"GABA-A receptor, PLCL2, GABA-A receptor gamma-2 subunit, Dynein 1, cytoplasmic, intermediate chains",2.24E-01,3.61E-01,4,"GABA-A receptor, PLCL2, GABA-A receptor gamma-2 subunit, Dynein 1, cytoplasmic, intermediate chains"
1044,Immune response_Differentiation of natural regulatory T cells,35,2.26E-01,3.17E-01,2.26E-01,3.17E-01,5,"STAT3, MHC class II, TGF-beta receptor type II, GITRL, SMAD3",6.25E-01,7.64E-01,3,"MHC class II, TGF-beta receptor type II, GITRL"
1045,Anti-apoptotic action of Gastrin in gastric cancer,35,2.26E-01,3.17E-01,2.26E-01,3.17E-01,5,"BAD, PKC-alpha, Bcl-2, ERK1/2, IP3 receptor",6.25E-01,7.64E-01,3,"PKC-alpha, Bcl-2, IP3 receptor"
1046,Immune response_Lipoxins and Resolvin E1 inhibitory action on neutrophil functions,35,2.26E-01,3.17E-01,2.26E-01,3.17E-01,5,"IL-8, G-protein alpha-i family, ERK1/2, NF-kB, PI3K reg class IB (p101)",3.91E-01,5.57E-01,4,"IL-8, G-protein alpha-i family, NF-kB, PI3K reg class IB (p101)"
1047,Angiotensin II Signaling in Cardiac Hypertrophy,72,2.29E-01,3.20E-01,2.29E-01,3.20E-01,9,"TRPC3, PKC-alpha, NCX1, ERK1/2, Kv4.3 channel, NF-kB, TRPC6, G-protein alpha-q/11, IP3 receptor",3.25E-01,4.84E-01,8,"TRPC3, PKC-alpha, NCX1, Kv4.3 channel, NF-kB, TRPC6, G-protein alpha-q/11, IP3 receptor"
1048,Transcription_Assembly of RNA Polymerase II preinitiation complex on TATA-less promoters ,18,2.34E-01,3.26E-01,2.34E-01,3.26E-01,3,"PCNA, p15, MDR1",4.94E-01,6.54E-01,2,"p15, MDR1"
1049,Multiple myeloma (general schema),18,2.34E-01,3.26E-01,2.34E-01,3.26E-01,3,"N-Ras, IL-6, FGF2",4.94E-01,6.54E-01,2,"IL-6, FGF2"
1050,Development_FGFR signaling pathway,54,2.38E-01,3.31E-01,2.38E-01,3.31E-01,7,"PI3K cat class IA, ERK1/2, FGF2, SOS, AKT(PKB), PDK (PDPK1), IP3 receptor",5.47E-01,6.99E-01,5,"PI3K cat class IA, FGF2, SOS, AKT(PKB), IP3 receptor"
1051,Immune response_IFN-gamma signaling via JAK/STAT and PLC-gamma,54,2.38E-01,3.31E-01,2.38E-01,3.31E-01,7,"STAT3, PKC-alpha, NOXA, Fyn, XAF1, Aquaporin 1, IP3 receptor",3.62E-01,5.26E-01,6,"PKC-alpha, NOXA, Fyn, XAF1, Aquaporin 1, IP3 receptor"
1052,Brca1 in ovarian cancer,27,2.43E-01,3.36E-01,2.43E-01,3.36E-01,4,"Maspin, c-IAP1, AKT(PKB), p53",4.47E-01,6.15E-01,3,"Maspin, c-IAP1, AKT(PKB)"
1053,Immune response_ETV3 affect on CSF1-promoted macrophage differentiation,19,2.44E-01,3.57E-01,2.60E-01,3.57E-01,3,"MSR1, CSF1, PLAU (UPA)",2.44E-01,3.87E-01,3,"MSR1, CSF1, PLAU (UPA)"
1054,iNKT cell-keratinocyte interactions in allergic contact dermatitis,36,2.44E-01,3.37E-01,2.44E-01,3.37E-01,5,"TCR beta subunit, IP10, ICAM1, CD1d, ERK1/2",4.12E-01,5.80E-01,4,"TCR beta subunit, IP10, ICAM1, CD1d"
1055,Immune response_IFN-gamma actions on blood cells,28,2.44E-01,3.60E-01,2.64E-01,3.60E-01,4,"IL-15, PD-L2, IL-6, PD-L1",2.44E-01,3.87E-01,4,"IL-15, PD-L2, IL-6, PD-L1"
1056,Platelet activation during ADAM-TS13-deficient thrombotic microangiopathy development,28,2.44E-01,3.60E-01,2.64E-01,3.60E-01,4,"Fc gamma RII alpha, Fibronectin, Collagen VI, Collagen III",2.44E-01,3.87E-01,4,"Fc gamma RII alpha, Fibronectin, Collagen VI, Collagen III"
1057,Immune response_Reactive oxygen species (ROS) in IL-4 signaling,66,2.44E-01,3.73E-01,2.74E-01,3.73E-01,8,"cPKC (conventional), iNOS, PKC, PKC-alpha, DUOX2, PDE3A, DUOX1, DUOXA1",2.44E-01,3.87E-01,8,"cPKC (conventional), iNOS, PKC, PKC-alpha, DUOX2, PDE3A, DUOX1, DUOXA1"
1058,Neurophysiological process_Activity-dependent synaptic AMPA receptor removal,64,2.47E-01,3.41E-01,2.47E-01,3.41E-01,8,"NMDA receptor, cPKC (conventional), MAP-1B, PKC, PKC-alpha, NPTX2, Actin cytoskeletal, IP3 receptor",3.58E-01,5.21E-01,7,"NMDA receptor, cPKC (conventional), MAP-1B, PKC, PKC-alpha, NPTX2, IP3 receptor"
1059,Aminoglycoside- and cisplatin-induced hair cell death,112,2.47E-01,3.41E-01,2.47E-01,3.41E-01,13,"COX-2 (PTGS2), IL-1 beta, RelA (p65 NF-kB subunit), iNOS, PKC, Bcl-2, ERK1/2, IL-6, Beta-catenin, NF-kB, Caspase-1, Caspase-8, p53",6.94E-01,8.29E-01,9,"COX-2 (PTGS2), IL-1 beta, RelA (p65 NF-kB subunit), iNOS, PKC, Bcl-2, IL-6, NF-kB, Caspase-1"
1060,Huntington's disease (general schema),3,2.48E-01,3.51E-01,2.55E-01,3.51E-01,1,NMDA receptor,2.48E-01,3.91E-01,1,NMDA receptor
1061,Development_G-protein-mediated regulation of MAPK-ERK signaling,46,2.58E-01,3.55E-01,2.58E-01,3.55E-01,6,"G-protein alpha-i family, SOS, ERK2 (MAPK1), G-protein alpha-q/11, ERK1 (MAPK3), IP3 receptor",6.08E-01,7.53E-01,4,"G-protein alpha-i family, SOS, G-protein alpha-q/11, IP3 receptor"
1062,Development_Alpha-1 adrenergic receptors signaling via Cyclic AMP,19,2.60E-01,3.57E-01,2.60E-01,3.57E-01,3,"Adenylate cyclase, Alpha-1B adrenergic receptor, p27KIP1",5.23E-01,6.78E-01,2,"Adenylate cyclase, Alpha-1B adrenergic receptor"
1063,Signal transduction_mTORC2 upstream signaling,65,2.61E-01,3.57E-01,2.61E-01,3.57E-01,8,"Tuberin, Sestrin 3, PI3K cat class IA, Protor-2, EGFR, AKT(PKB), PDK (PDPK1), Frizzled",5.42E-01,6.94E-01,6,"Sestrin 3, PI3K cat class IA, Protor-2, EGFR, AKT(PKB), Frizzled"
1064,"Mechanism of Pioglitazone/Glimepiride and Rosiglitazone/Glimepiride cooperative action in Diabetes mellitus, Type 2",11,2.62E-01,3.74E-01,2.75E-01,3.74E-01,2,"SUR1, Kir6.2",2.62E-01,4.10E-01,2,"SUR1, Kir6.2"
1065,Transcription_CoREST complex-mediated epigenetic gene silencing,37,2.62E-01,3.59E-01,2.62E-01,3.59E-01,5,"NMDA receptor, NR1, SCN2A, SNAIL1, GFI-1",4.33E-01,6.02E-01,4,"NMDA receptor, NR1, SCN2A, GFI-1"
1066,Development_Regulation of CDK5 in CNS,28,2.64E-01,3.60E-01,2.64E-01,3.60E-01,4,"NGF, Adenylate cyclase type V, ERK1/2, SOS",4.71E-01,6.37E-01,3,"NGF, Adenylate cyclase type V, SOS"
1067,GLP-1 in inhibition of insulin secretion in type 2 diabetes,28,2.64E-01,3.60E-01,2.64E-01,3.60E-01,4,"EGFR, Kir6.2, PDK (PDPK1), CACNA1D",4.71E-01,6.37E-01,3,"EGFR, Kir6.2, CACNA1D"
1068,Protein folding and maturation_Angiotensin system maturation,48,2.64E-01,3.92E-01,2.91E-01,3.92E-01,6,"MC-CPA, Neprilysin, MMP-8, Kallikrein 1, ACE2, CD13",2.64E-01,4.12E-01,6,"MC-CPA, Neprilysin, MMP-8, Kallikrein 1, ACE2, CD13"
1069,"Nicotine signaling in dopaminergic neurons, Pt. 1 - cell body",48,2.64E-01,3.92E-01,2.91E-01,3.92E-01,6,"NMDA receptor, nAChR alpha-7, GABA-A receptor, G-protein alpha-i family, nAChR alpha-4, IP3 receptor",2.64E-01,4.12E-01,6,"NMDA receptor, nAChR alpha-7, GABA-A receptor, G-protein alpha-i family, nAChR alpha-4, IP3 receptor"
1070,Platelet activation as a result of endothelial dysfunction after stenting,56,2.68E-01,3.64E-01,2.68E-01,3.64E-01,7,"PKC, PLAT (TPA), G-protein alpha-i family, Adenylate cyclase, Actin cytoskeletal, PDE3A, IP3 receptor",3.96E-01,5.60E-01,6,"PKC, PLAT (TPA), G-protein alpha-i family, Adenylate cyclase, PDE3A, IP3 receptor"
1071,Development_Keratinocyte differentiation,56,2.68E-01,3.64E-01,2.68E-01,3.64E-01,7,"Fra-1, PKC-alpha, ERK1/2, SMAD3, G-protein alpha-q/11, IP3 receptor, C/EBPalpha",5.80E-01,7.30E-01,5,"Fra-1, PKC-alpha, G-protein alpha-q/11, IP3 receptor, C/EBPalpha"
1072,Neurophysiological process_Olfactory transduction,20,2.69E-01,3.86E-01,2.87E-01,3.86E-01,3,"Olfactory receptor, ANO2, G-protein alpha-olf",2.69E-01,4.16E-01,3,"Olfactory receptor, ANO2, G-protein alpha-olf"
1073,Protein folding and maturation_Insulin processing,20,2.69E-01,3.86E-01,2.87E-01,3.86E-01,3,"PC1, PC2, Carboxypeptidase H",2.69E-01,4.16E-01,3,"PC1, PC2, Carboxypeptidase H"
1074,Role of iNKT and B cells in T cell recruitment in allergic contact dermatitis,39,2.75E-01,4.02E-01,2.99E-01,4.02E-01,5,"IP10, alpha-4/beta-1 integrin, ICAM1, CD1d, NF-kB",2.75E-01,4.23E-01,5,"IP10, alpha-4/beta-1 integrin, ICAM1, CD1d, NF-kB"
1075,HIV-1 signaling via CCR5 in macrophages and T lymphocytes,39,2.75E-01,4.02E-01,2.99E-01,4.02E-01,5,"CCL2, PKC-alpha, CCR5, SOS, IP3 receptor",2.75E-01,4.23E-01,5,"CCL2, PKC-alpha, CCR5, SOS, IP3 receptor"
1076,G-protein signaling_Rap1B regulation pathway,11,2.75E-01,3.74E-01,2.75E-01,3.74E-01,2,"Tuberin, Ca-ATPase3",6.48E-01,7.87E-01,1,Ca-ATPase3
1077,Development_Noncanonical WNT signaling in cardiac myogenesis,38,2.81E-01,3.80E-01,2.81E-01,3.80E-01,5,"PKC, SMAD3, FZD7, Dsh, Troponin I, cardiac",6.81E-01,8.16E-01,3,"PKC, FZD7, Troponin I, cardiac"
1078,IgE-dependent production of pro-inflammatory mediators by neutrophils in asthma,38,2.81E-01,3.80E-01,2.81E-01,3.80E-01,5,"COX-2 (PTGS2), Galectin-3, IL-8, ERK1/2, NF-kB",4.54E-01,6.24E-01,4,"COX-2 (PTGS2), Galectin-3, IL-8, NF-kB"
1079,Adiponectin in pathogenesis of type 2 diabetes,29,2.86E-01,3.86E-01,2.86E-01,3.86E-01,4,"Adiponectin, ACACB, PPARGC1 (PGC1-alpha), FASN",4.95E-01,6.54E-01,3,"Adiponectin, ACACB, PPARGC1 (PGC1-alpha)"
1080,Histone deacetylases in Prostate Cancer,29,2.86E-01,3.86E-01,2.86E-01,3.86E-01,4,"Androgen receptor, HDAC9, p53, Kallikrein 3 (PSA)",4.95E-01,6.54E-01,3,"Androgen receptor, HDAC9, Kallikrein 3 (PSA)"
1081,Apoptosis and survival_p53-dependent apoptosis,29,2.86E-01,3.86E-01,2.86E-01,3.86E-01,4,"BAD, p14ARF, Bcl-2, p53",7.52E-01,8.74E-01,2,"p14ARF, Bcl-2"
1082,HBV mediates angiogenesis in HCC,20,2.87E-01,3.86E-01,2.87E-01,3.86E-01,3,"STAT3, ERK1/2, SOS",8.50E-01,9.46E-01,1,SOS
1083,Role of IGH translocations in multiple myeloma,40,2.93E-01,4.21E-01,3.18E-01,4.21E-01,5,"N-cadherin, NCAM1, ITGA5, BLIMP1 (PRDI-BF1), CDK6",2.93E-01,4.46E-01,5,"N-cadherin, NCAM1, ITGA5, BLIMP1 (PRDI-BF1), CDK6"
1084,Recurrent gene fusions in Prostate Cancer,40,2.93E-01,4.21E-01,3.18E-01,4.21E-01,5,"Androgen receptor, ERG, SLTM, ER81, ERM",2.93E-01,4.46E-01,5,"Androgen receptor, ERG, SLTM, ER81, ERM"
1085,Development_Generation of pancreatic beta-cells from embryonic stem cells (early stages),21,2.94E-01,4.16E-01,3.13E-01,4.16E-01,3,"Activin A, Oct-3/4, SOX2",2.94E-01,4.48E-01,3,"Activin A, Oct-3/4, SOX2"
1086,Deregulation of Ca2+-dependent neuronal cell survival in Huntington's disease,39,2.99E-01,4.02E-01,2.99E-01,4.02E-01,5,"NMDA receptor, PI3K cat class IA, Beta-catenin, AKT(PKB), PDK (PDPK1)",6.98E-01,8.29E-01,3,"NMDA receptor, PI3K cat class IA, AKT(PKB)"
1087,Development_Osteopontin signaling in osteoclasts,30,3.07E-01,4.10E-01,3.07E-01,4.10E-01,4,"Syk, CD44, MSN (moesin), Actin cytoskeletal",5.18E-01,6.76E-01,3,"Syk, CD44, MSN (moesin)"
1088,T regulatory cells in asthma,30,3.07E-01,4.10E-01,3.07E-01,4.10E-01,4,"STAT3, MHC class II, TGF-beta receptor type II, SMAD3",7.69E-01,8.87E-01,2,"MHC class II, TGF-beta receptor type II"
1089,DNA damage_Brca1 as a transcription regulator,30,3.07E-01,4.10E-01,3.07E-01,4.10E-01,4,"PCNA, ESR1 (nuclear), p53, p27KIP1",9.42E-01,9.96E-01,1,ESR1 (nuclear)
1090,Transport_Aldosterone-mediated regulation of ENaC sodium transport,30,3.07E-01,4.10E-01,3.07E-01,4.10E-01,4,"SGK1, ERK2 (MAPK1), AKT(PKB), PDK (PDPK1)",7.69E-01,8.87E-01,2,"SGK1, AKT(PKB)"
1091,Putative role of Tregs in COPD,30,3.07E-01,4.10E-01,3.07E-01,4.10E-01,4,"STAT3, IL7RA, ROR-gamma, ERK1/2",7.69E-01,8.87E-01,2,"IL7RA, ROR-gamma"
1092,Production of arachidonic acid derivatives by mast cells in asthma,30,3.07E-01,4.10E-01,3.07E-01,4.10E-01,4,"COX-2 (PTGS2), PLA2(hGIIA), cPLA2, ERK1/2",5.18E-01,6.76E-01,3,"COX-2 (PTGS2), PLA2(hGIIA), cPLA2"
1093,Signal transduction_Additional pathways of NF-kB activation (in the nucleus),30,3.07E-01,4.10E-01,3.07E-01,4.10E-01,4,"RelA (p65 NF-kB subunit), Adenylate cyclase, ERK1/2, CDK6",5.18E-01,6.76E-01,3,"RelA (p65 NF-kB subunit), Adenylate cyclase, CDK6"
1094,Demyelination in multiple sclerosis,49,3.08E-01,4.10E-01,3.08E-01,4.10E-01,6,"Myelin basic protein, iNOS, AKT(PKB), Caspase-8, p53, MMP-9",6.58E-01,7.95E-01,4,"Myelin basic protein, iNOS, AKT(PKB), MMP-9"
1095,Development_Oxytocin receptor signaling,41,3.11E-01,4.43E-01,3.38E-01,4.43E-01,5,"cPKC (conventional), iNOS, MEF2C, G-protein alpha-q/11, IP3 receptor",3.11E-01,4.68E-01,5,"cPKC (conventional), iNOS, MEF2C, G-protein alpha-q/11, IP3 receptor"
1096,Neurophysiological process_Constitutive and activity-dependent synaptic AMPA receptor delivery,59,3.13E-01,4.16E-01,3.13E-01,4.16E-01,7,"NMDA receptor, Chapsyn-110, PKC, PKC-alpha, Actin cytoskeletal, Complexin, NEEP21",4.45E-01,6.15E-01,6,"NMDA receptor, Chapsyn-110, PKC, PKC-alpha, Complexin, NEEP21"
1097,Possible regulation of HSF-1/ chaperone pathway in Huntington's disease,21,3.13E-01,4.16E-01,3.13E-01,4.16E-01,3,"PKC-alpha, PLA2, ERK1 (MAPK3)",5.78E-01,7.28E-01,2,"PKC-alpha, PLA2"
1098,HCV-dependent transcription regulation leading to HCC,21,3.13E-01,4.16E-01,3.13E-01,4.16E-01,3,"STAT3, Cyclin E, p53",8.64E-01,9.56E-01,1,Cyclin E
1099,Mechanism of Maraviroc action in HIV Infections,4,3.16E-01,4.29E-01,3.25E-01,4.29E-01,1,CCR5,3.16E-01,4.72E-01,1,CCR5
1100,Role of microRNAs in cell proliferation in colorectal cancer,69,3.17E-01,4.20E-01,3.17E-01,4.20E-01,8,"PGE2R4, PTEN, miR-221-3p, Beta-catenin, p53, HGF receptor (Met), RhoB, CDK6",7.60E-01,8.81E-01,5,"PGE2R4, miR-221-3p, HGF receptor (Met), RhoB, CDK6"
1101,Neurophysiological process_Glucose-excited neurons of arcuate nucleus (rodent model),40,3.18E-01,4.21E-01,3.18E-01,4.21E-01,5,"POMC, Tuberin, SUR1, SLC5A1, Kir6.2",4.95E-01,6.54E-01,4,"POMC, SUR1, SLC5A1, Kir6.2"
1102,Stem cells_Response to hypoxia in glioblastoma stem cells,40,3.18E-01,4.21E-01,3.18E-01,4.21E-01,5,"HES5, BMP4, p53, Jagged1, BMP2",4.95E-01,6.54E-01,4,"HES5, BMP4, Jagged1, BMP2"
1103,Immune response_Function of MEF2 in T lymphocytes,50,3.25E-01,4.29E-01,3.25E-01,4.29E-01,6,"HDAC9, Lck, MEF2C, CaMK I, MEF2, IP3 receptor",4.77E-01,6.41E-01,5,"HDAC9, MEF2C, CaMK I, MEF2, IP3 receptor"
1104,Neurophysiological process_Glucose-excited neurons of ventromedial nucleus (rodent model),32,3.28E-01,4.58E-01,3.51E-01,4.58E-01,4,"SUR1, SLC5A1, GABA-A receptor, Kir6.2",3.28E-01,4.85E-01,4,"SUR1, SLC5A1, GABA-A receptor, Kir6.2"
1105,Oxidative stress_Role of Sirtuin1 and PGC1-alpha in activation of antioxidant defense system,60,3.29E-01,4.33E-01,3.29E-01,4.33E-01,7,"GSTP1, Sestrin 3, GSTM5, SLC7A11, AMPK gamma subunit, PPARGC1 (PGC1-alpha), p53",4.62E-01,6.31E-01,6,"GSTP1, Sestrin 3, GSTM5, SLC7A11, AMPK gamma subunit, PPARGC1 (PGC1-alpha)"
1106,Glucagon-induced glucose upregulation in type 2 diabetes in liver ,52,3.29E-01,4.67E-01,3.59E-01,4.67E-01,6,"iNOS, G-protein alpha-i family, Adenylate cyclase, PPARGC1 (PGC1-alpha), G-protein alpha-q/11, IP3 receptor",3.29E-01,4.86E-01,6,"iNOS, G-protein alpha-i family, Adenylate cyclase, PPARGC1 (PGC1-alpha), G-protein alpha-q/11, IP3 receptor"
1107,Apoptosis and survival_Role of IAP-proteins in apoptosis,31,3.29E-01,4.33E-01,3.29E-01,4.33E-01,4,"c-IAP2, c-IAP1, Caspase-8, NAIP",5.41E-01,6.93E-01,3,"c-IAP2, c-IAP1, NAIP"
1108,Role of IL-2 in the enhancement of NK cell cytotoxicity in multiple sclerosis,31,3.29E-01,4.33E-01,3.29E-01,4.33E-01,4,"PI3K cat class IA, CX3CR1, NF-kB, PDK (PDPK1)",5.41E-01,6.93E-01,3,"PI3K cat class IA, CX3CR1, NF-kB"
1109,Apoptosis and survival_Phosphorylation and acetylation in TNF-alpha-induced NF-kB signaling,41,3.38E-01,4.43E-01,3.38E-01,4.43E-01,5,"PI3K cat class IA, RelA (p65 NF-kB subunit), PKC-alpha, ERK1/2, IP3 receptor",5.15E-01,6.76E-01,4,"PI3K cat class IA, RelA (p65 NF-kB subunit), PKC-alpha, IP3 receptor"
1110,Development_S1P4 receptor signaling pathway,22,3.40E-01,4.44E-01,3.40E-01,4.44E-01,3,"G-protein alpha-i family, ERK1/2, IP3 receptor",6.04E-01,7.51E-01,2,"G-protein alpha-i family, IP3 receptor"
1111,Inhibition of GSK3 beta by lithium in major depressive disorder,22,3.40E-01,4.44E-01,3.40E-01,4.44E-01,3,"Bcl-2, SMAD3, AKT(PKB)",6.04E-01,7.51E-01,2,"Bcl-2, AKT(PKB)"
1112,Translation_Role of Retinoic acid signaling in the initiation of translation,22,3.40E-01,4.44E-01,3.40E-01,4.44E-01,3,"NMDA receptor, MAP2, ERK1/2",6.04E-01,7.51E-01,2,"NMDA receptor, MAP2"
1113,Microsatellite instability in gastric cancer,22,3.40E-01,4.44E-01,3.40E-01,4.44E-01,3,"PCNA, TGF-beta receptor type II, p16INK4",6.04E-01,7.51E-01,2,"TGF-beta receptor type II, p16INK4"
1114,Transcription_ChREBP regulation pathway,23,3.46E-01,4.75E-01,3.66E-01,4.75E-01,3,"G-protein alpha-i family, AMPK gamma subunit, Acyl-CoA synthetase",3.46E-01,5.08E-01,3,"G-protein alpha-i family, AMPK gamma subunit, Acyl-CoA synthetase"
1115,Development_NODAL signaling in early mesendoderm formation,23,3.46E-01,4.75E-01,3.66E-01,4.75E-01,3,"BMP4, Mixl1, WNT3",3.46E-01,5.08E-01,3,"BMP4, Mixl1, WNT3"
1116,"Nicotine signaling in dopaminergic neurons, Pt. 2 - axon terminal",43,3.48E-01,4.86E-01,3.76E-01,4.86E-01,5,"NMDA receptor, Adenylate cyclase type V, PLAT (TPA), G-protein alpha-i family, IP3 receptor",3.48E-01,5.08E-01,5,"NMDA receptor, Adenylate cyclase type V, PLAT (TPA), G-protein alpha-i family, IP3 receptor"
1117,Cell cycle_Role of Nek in cell cycle regulation,32,3.51E-01,4.58E-01,3.51E-01,4.58E-01,4,"Tubulin beta, PI3K cat class IA, PDK (PDPK1), Histone H1",5.63E-01,7.13E-01,3,"Tubulin beta, PI3K cat class IA, Histone H1"
1118,DNA damage_ATM/ATR regulation of G1/S checkpoint,32,3.51E-01,4.58E-01,3.51E-01,4.58E-01,4,"PCNA, Cyclin E, NF-kB, p53",7.99E-01,9.03E-01,2,"Cyclin E, NF-kB"
1119,CFTR-dependent regulation of ion channels in CF,42,3.57E-01,4.64E-01,3.57E-01,4.64E-01,5,"EBP50, Actin cytoskeletal, G-protein alpha-q/11, IP3 receptor, CLCA2",5.34E-01,6.88E-01,4,"EBP50, G-protein alpha-q/11, IP3 receptor, CLCA2"
1120,Role of epigenetic alterations in proliferation and differentiation of SCLC cells,72,3.60E-01,4.68E-01,3.60E-01,4.68E-01,8,"LIN-28, Beta-catenin, Caveolin-1, p53, p27KIP1, DMRTA2, C/EBPalpha, CDK6",7.92E-01,9.02E-01,5,"LIN-28, Caveolin-1, DMRTA2, C/EBPalpha, CDK6"
1121,GTP metabolism,54,3.62E-01,5.04E-01,3.94E-01,5.04E-01,6,"PDE1C, PDE1A, GUCY1B2, PDE3A, Guanylate cyclase beta, PDE1B",3.62E-01,5.26E-01,6,"PDE1C, PDE1A, GUCY1B2, PDE3A, Guanylate cyclase beta, PDE1B"
1122,Asthma-specific pathways of airway smooth muscle cell proliferation,14,3.66E-01,4.92E-01,3.82E-01,4.92E-01,2,"PPARGC1 (PGC1-alpha), C/EBPalpha",3.66E-01,5.30E-01,2,"PPARGC1 (PGC1-alpha), C/EBPalpha"
1123,G-protein signaling_Cross-talk between Ras-family GTPases,23,3.66E-01,4.75E-01,3.66E-01,4.75E-01,3,"PI3K cat class IA, AKT(PKB), PDK (PDPK1)",6.29E-01,7.67E-01,2,"PI3K cat class IA, AKT(PKB)"
1124,Development_ERK5 in cell proliferation and neuronal survival,23,3.66E-01,4.75E-01,3.66E-01,4.75E-01,3,"NGF, Lck, MEF2C",6.29E-01,7.67E-01,2,"NGF, MEF2C"
1125,Impaired Lipoxin A4 signaling in CF,44,3.67E-01,5.04E-01,3.95E-01,5.04E-01,5,"EGFR, G-protein alpha-i family, Adenylate cyclase, G-protein alpha-q/11, PDGF-R-beta",3.67E-01,5.30E-01,5,"EGFR, G-protein alpha-i family, Adenylate cyclase, G-protein alpha-q/11, PDGF-R-beta"
1126,Transport_cAMP/ Ca(2+)-dependent Insulin secretion,44,3.67E-01,5.04E-01,3.95E-01,5.04E-01,5,"SUR1, PKC-alpha, Kir6.2, IP3 receptor, CACNA1D",3.67E-01,5.30E-01,5,"SUR1, PKC-alpha, Kir6.2, IP3 receptor, CACNA1D"
1127,Development_BMP signaling in cardiac myogenesis,34,3.70E-01,5.04E-01,3.95E-01,5.04E-01,4,"BMP6, BMP4, MEF2C, BMP2",3.70E-01,5.33E-01,4,"BMP6, BMP4, MEF2C, BMP2"
1128,Development_MicroRNA-dependent regulation of EMT,24,3.71E-01,5.04E-01,3.93E-01,5.04E-01,3,"TGF-beta 2, SIP1 (ZFHX1B), TCF8",3.71E-01,5.33E-01,3,"TGF-beta 2, SIP1 (ZFHX1B), TCF8"
1129,ATP metabolism,107,3.74E-01,5.28E-01,4.19E-01,5.28E-01,11,"BPNT1, PDE7B, PDE1C, Adenylate cyclase type V, Adenylate cyclase type II, AK5, CD38, ENPP1, Adenylate cyclase type IV, PDE3A, Adenylate cyclase type VII",3.74E-01,5.36E-01,11,"BPNT1, PDE7B, PDE1C, Adenylate cyclase type V, Adenylate cyclase type II, AK5, CD38, ENPP1, Adenylate cyclase type IV, PDE3A, Adenylate cyclase type VII"
1130,Transcription_PPAR Pathway,63,3.76E-01,4.86E-01,3.76E-01,4.86E-01,7,"COX-2 (PTGS2), PI3K cat class IA, PTGIS, ERK1/2, SOS, AKT(PKB), PDGF receptor",5.10E-01,6.72E-01,6,"COX-2 (PTGS2), PI3K cat class IA, PTGIS, SOS, AKT(PKB), PDGF receptor"
1131,Neurophysiological process_Long-term depression in cerebellum,53,3.77E-01,4.86E-01,3.77E-01,4.86E-01,6,"PKC-alpha, cPLA2, ERK1/2, PA24A, GRID2, IP3 receptor",5.30E-01,6.85E-01,5,"PKC-alpha, cPLA2, PA24A, GRID2, IP3 receptor"
1132,Translation_Translation regulation by Alpha-1 adrenergic receptors,53,3.77E-01,4.86E-01,3.77E-01,4.86E-01,6,"Tuberin, ERK2 (MAPK1), SOS1, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor, IP3 receptor",7.18E-01,8.45E-01,4,"SOS1, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor, IP3 receptor"
1133,Possible role of neonatal nicotine exposure in development of postnatal obesity,5,3.78E-01,5.00E-01,3.88E-01,5.00E-01,1,nAChR alpha-4,3.78E-01,5.41E-01,1,nAChR alpha-4
1134,Cell cycle_Nucleocytoplasmic transport of CDK/Cyclins,14,3.82E-01,4.92E-01,3.82E-01,4.92E-01,2,"Cyclin E, ERK1 (MAPK3)",7.35E-01,8.59E-01,1,Cyclin E
1135,Immune response_Distinct metabolic pathways in naive and effector CD8+ T cells,74,3.89E-01,5.01E-01,3.89E-01,5.01E-01,8,"Tuberin, PI3K cat class IA, Lck, DHE4, ERK1/2, Fyn, AKT(PKB), PDK (PDPK1)",9.12E-01,9.83E-01,4,"PI3K cat class IA, DHE4, Fyn, AKT(PKB)"
1136,Oxidative stress_NOX and DUOX families of NADPH oxidases ,35,3.91E-01,5.28E-01,4.17E-01,5.28E-01,4,"DUOX2, Rac2, DUOX1, DUOXA1",3.91E-01,5.57E-01,4,"DUOX2, Rac2, DUOX1, DUOXA1"
1137,Beta-alanine metabolism,35,3.91E-01,5.28E-01,4.17E-01,5.28E-01,4,"DPYD, GABT, GAD1, ABP1",3.91E-01,5.57E-01,4,"DPYD, GABT, GAD1, ABP1"
1138,Development_Signaling of Beta-adrenergic receptors via Beta-arrestins,24,3.93E-01,5.04E-01,3.93E-01,5.04E-01,3,"ERK1/2, SOS, Beta-2 adrenergic receptor",6.52E-01,7.89E-01,2,"SOS, Beta-2 adrenergic receptor"
1139,Prolactin/ JAK2 signaling in breast cancer,24,3.93E-01,5.04E-01,3.93E-01,5.04E-01,3,"STAT3, CISH, Prolactin receptor",6.52E-01,7.89E-01,2,"CISH, Prolactin receptor"
1140,Role of ER stress in obesity and type 2 diabetes,54,3.94E-01,5.04E-01,3.94E-01,5.04E-01,6,"PI3K cat class IA, Adiponectin, IRS-2, XBP1, FASN, C/EBPalpha",5.47E-01,6.99E-01,5,"PI3K cat class IA, Adiponectin, IRS-2, XBP1, C/EBPalpha"
1141,Regulation of metabolism_Triiodothyronine and Thyroxine signaling,44,3.95E-01,5.04E-01,3.95E-01,5.04E-01,5,"DIO1, S14 protein, Calcipressin 2, Beta-2 adrenergic receptor, FASN",5.72E-01,7.22E-01,4,"DIO1, S14 protein, Calcipressin 2, Beta-2 adrenergic receptor"
1142,Oxidative stress_ROS-mediated activation of MAPK via inhibition of phosphatases,34,3.95E-01,5.04E-01,3.95E-01,5.04E-01,4,"EGFR, ERK1/2, PP2A regulatory, PDGF-R-beta",6.05E-01,7.51E-01,3,"EGFR, PP2A regulatory, PDGF-R-beta"
1143,Nicotine metabolism in liver,56,3.96E-01,5.39E-01,4.28E-01,5.39E-01,6,"FMO3, CYP2A6, UGT2B7, UGT1A4, CYP2B6, INMT",3.96E-01,5.60E-01,6,"FMO3, CYP2A6, UGT2B7, UGT1A4, CYP2B6, INMT"
1144,Muscle contraction_Regulation of eNOS activity in cardiomyocytes,56,3.96E-01,5.39E-01,4.28E-01,5.39E-01,6,"Adenylate cyclase type V, AKAP6, G-protein alpha-i family, PDE3A, Troponin I, cardiac, IP3 receptor",3.96E-01,5.60E-01,6,"Adenylate cyclase type V, AKAP6, G-protein alpha-i family, PDE3A, Troponin I, cardiac, IP3 receptor"
1145,Fenofibrate in treatment of type 2 diabetes and metabolic syndrome X,25,3.97E-01,5.28E-01,4.19E-01,5.28E-01,3,"Adiponectin, ABCG1, Acyl-CoA synthetase",3.97E-01,5.60E-01,3,"Adiponectin, ABCG1, Acyl-CoA synthetase"
1146,"Role of TNF-alpha, IL-1beta and IL-6 in development of obesity and type 2 diabetes in liver",45,4.14E-01,5.28E-01,4.14E-01,5.28E-01,5,"STAT3, IL-1 beta, TNF-R2, RelA (p65 NF-kB subunit), IL-6",5.90E-01,7.38E-01,4,"IL-1 beta, TNF-R2, RelA (p65 NF-kB subunit), IL-6"
1147,HSP22 and BAG-3-dependend macroautophagy in Huntington's disease,15,4.16E-01,5.28E-01,4.16E-01,5.28E-01,2,"HSP22, Beclin 1",7.59E-01,8.81E-01,1,HSP22
1148,Development_Regulation of telomere length and cellular immortalization,35,4.17E-01,5.28E-01,4.17E-01,5.28E-01,4,"PI3K cat class IA, PKC-alpha, AKT(PKB), PDK (PDPK1)",6.25E-01,7.64E-01,3,"PI3K cat class IA, PKC-alpha, AKT(PKB)"
1149,Glucose-excited neurons of arcuate nucleus in obesity (rodent model),35,4.17E-01,5.28E-01,4.17E-01,5.28E-01,4,"POMC, Tuberin, SUR1, Kir6.2",6.25E-01,7.64E-01,3,"POMC, SUR1, Kir6.2"
1150,Development_Glucocorticoid receptor signaling,25,4.19E-01,5.28E-01,4.19E-01,5.28E-01,3,"MMP-13, NF-kB, SMAD3",6.74E-01,8.10E-01,2,"MMP-13, NF-kB"
1151,Transcription_Transcription regulation of aminoacid metabolism,25,4.19E-01,5.28E-01,4.19E-01,5.28E-01,3,"NF-E2 (45 kDa), PKC, ERK1/2",6.74E-01,8.10E-01,2,"NF-E2 (45 kDa), PKC"
1152,Gamma-secretase regulation of gastrointestinal epithelial cell development,25,4.19E-01,5.28E-01,4.19E-01,5.28E-01,3,"Jagged1, p27KIP1, PAX6",6.74E-01,8.10E-01,2,"Jagged1, PAX6"
1153,G-protein signaling_TC21 regulation pathway,25,4.19E-01,5.28E-01,4.19E-01,5.28E-01,3,"Lck, CalDAG-GEFIII, ERK1/2",9.07E-01,9.83E-01,1,CalDAG-GEFIII
1154,Cell cycle_Initiation of mitosis,26,4.22E-01,5.58E-01,4.45E-01,5.58E-01,3,"Kinase MYT1, AKT(PKB), Histone H1",4.22E-01,5.91E-01,3,"Kinase MYT1, AKT(PKB), Histone H1"
1155,Glyoxylate metabolism,26,4.22E-01,5.58E-01,4.45E-01,5.58E-01,3,"AGXT, MCT1 (SLC16A1), AGT2",4.22E-01,5.91E-01,3,"AGXT, MCT1 (SLC16A1), AGT2"
1156,CAR signaling via cross-talk / Human Version,26,4.22E-01,5.58E-01,4.45E-01,5.58E-01,3,"ESR1 (nuclear), PPARGC1 (PGC1-alpha), CYP2B6",4.22E-01,5.91E-01,3,"ESR1 (nuclear), PPARGC1 (PGC1-alpha), CYP2B6"
1157,"Mechanism of Pioglitazone/ Metformin and Rosiglitazone/ Metformin  cooperative action in Diabetes mellitus, Type 2",16,4.32E-01,5.63E-01,4.50E-01,5.63E-01,2,"Adiponectin, AMPK gamma subunit",4.32E-01,6.01E-01,2,"Adiponectin, AMPK gamma subunit"
1158,G-protein signaling_Regulation of p38 and JNK signaling mediated by G-proteins,37,4.33E-01,5.75E-01,4.60E-01,5.75E-01,4,"G-protein alpha-i family, MEF2C, G-protein alpha-q/11, PI3K reg class IB (p101)",4.33E-01,6.02E-01,4,"G-protein alpha-i family, MEF2C, G-protein alpha-q/11, PI3K reg class IB (p101)"
1159,Development_Non-genomic action of Retinoic acid in cell differentiation,57,4.45E-01,5.58E-01,4.45E-01,5.58E-01,6,"COX-2 (PTGS2), PKC-alpha, ERK1/2, AKT(PKB), PDK (PDPK1), IP3 receptor",7.70E-01,8.87E-01,4,"COX-2 (PTGS2), PKC-alpha, AKT(PKB), IP3 receptor"
1160,Regulation of lipid metabolism_Insulin regulation of glycogen metabolism ,57,4.45E-01,5.58E-01,4.45E-01,5.58E-01,6,"PI3K cat class IA, IRS-2, ERK1/2, SOS, AKT(PKB), PDK (PDPK1)",7.70E-01,8.87E-01,4,"PI3K cat class IA, IRS-2, SOS, AKT(PKB)"
1161,CAR signaling via cross-talk / Rodent version,27,4.47E-01,5.84E-01,4.70E-01,5.84E-01,3,"ESR1 (nuclear), PPARGC1 (PGC1-alpha), CYP2B6",4.47E-01,6.15E-01,3,"ESR1 (nuclear), PPARGC1 (PGC1-alpha), CYP2B6"
1162,Glomerular filtration and renal reabsorption of bile acids / Rodent version,27,4.47E-01,5.84E-01,4.70E-01,5.84E-01,3,"ABCC11, OATP-A, AKR1C1",4.47E-01,6.15E-01,3,"ABCC11, OATP-A, AKR1C1"
1163,Neurophysiological process_Sweet taste signaling,27,4.47E-01,5.84E-01,4.70E-01,5.84E-01,3,"P2X2, TRPM5, IP3R3",4.47E-01,6.15E-01,3,"P2X2, TRPM5, IP3R3"
1164,Development_Hedgehog signaling,47,4.52E-01,5.66E-01,4.52E-01,5.66E-01,5,"GAS1, PTCH1, Beta-catenin, GLI-1, GLI-2",6.25E-01,7.64E-01,4,"GAS1, PTCH1, GLI-1, GLI-2"
1165,Neurophysiological process_Circadian rhythm,47,4.52E-01,5.66E-01,4.52E-01,5.66E-01,5,"NMDA receptor, ROR-alpha, PACAP, ERK1/2, Dexras1",6.25E-01,7.64E-01,4,"NMDA receptor, ROR-alpha, PACAP, Dexras1"
1166,Aldosterone biosynthesis and metabolism,38,4.54E-01,5.97E-01,4.81E-01,5.97E-01,4,"AKR1C4, CYP11B2, UGT2B4, UGT2B7",4.54E-01,6.24E-01,4,"AKR1C4, CYP11B2, UGT2B4, UGT2B7"
1167,Axonal degeneration in multiple sclerosis,49,4.59E-01,6.06E-01,4.90E-01,6.06E-01,5,"iNOS, GluR6, NCX1, SCN2A, CACNA1D",4.59E-01,6.29E-01,5,"iNOS, GluR6, NCX1, SCN2A, CACNA1D"
1168,Immune response_ICOS signaling pathway in T-helper cell,60,4.62E-01,6.11E-01,4.96E-01,6.11E-01,6,"MHC class II, PI3K cat class IA, ROR-gamma, KLF2, AKT(PKB), IP3 receptor",4.62E-01,6.31E-01,6,"MHC class II, PI3K cat class IA, ROR-gamma, KLF2, AKT(PKB), IP3 receptor"
1169,Triacylglycerol metabolism p.1,60,4.62E-01,6.11E-01,4.96E-01,6.11E-01,6,"ACSL4, AKR1C4, ALDR, AKR1C1, AK1BA, PLCD",4.62E-01,6.31E-01,6,"ACSL4, AKR1C4, ALDR, AKR1C1, AK1BA, PLCD"
1170,NMDA-independent presynaptic long-term potentiation in Huntington's disease,58,4.62E-01,5.77E-01,4.62E-01,5.77E-01,6,"GABA-A receptor, PKC-alpha, GluR7, GluR6, Actin cytoskeletal, IP3 receptor",6.12E-01,7.57E-01,5,"GABA-A receptor, PKC-alpha, GluR7, GluR6, IP3 receptor"
1171,Transcription_Transcription factor Tubby signaling pathways,17,4.63E-01,5.97E-01,4.82E-01,5.97E-01,2,"PKC, G-protein alpha-q/11",4.63E-01,6.31E-01,2,"PKC, G-protein alpha-q/11"
1172,Insulin-dependent stimulation of SREBP-1 in type 2 diabetes in liver,27,4.70E-01,5.84E-01,4.70E-01,5.84E-01,3,"IRS-2, PDK (PDPK1), FASN",9.23E-01,9.86E-01,1,IRS-2
1173,Immune response_OX40L/ OX40 signaling pathway,69,4.70E-01,5.85E-01,4.70E-01,5.85E-01,7,"PI3K cat class IA, PKC-theta, Bcl-2, NF-kB, AKT(PKB), PDK (PDPK1), IP3 receptor",6.02E-01,7.51E-01,6,"PI3K cat class IA, PKC-theta, Bcl-2, NF-kB, AKT(PKB), IP3 receptor"
1174,Role of Diethylhexyl Phthalate and Tributyltin in fat cell differentiation ,28,4.71E-01,6.10E-01,4.94E-01,6.10E-01,3,"Adiponectin, PPARGC1 (PGC1-alpha), C/EBPalpha",4.71E-01,6.37E-01,3,"Adiponectin, PPARGC1 (PGC1-alpha), C/EBPalpha"
1175,Neurophysiological process_Bitter taste signaling,28,4.71E-01,6.10E-01,4.94E-01,6.10E-01,3,"P2X2, TRPM5, IP3R3",4.71E-01,6.37E-01,3,"P2X2, TRPM5, IP3R3"
1176,Pro-oncogenic action of Androgen receptor in ovarian cancer,28,4.71E-01,6.10E-01,4.94E-01,6.10E-01,3,"GSTP1, Androgen receptor, TGF-beta receptor type II",4.71E-01,6.37E-01,3,"GSTP1, Androgen receptor, TGF-beta receptor type II"
1177,NRSF-dependent transcription deregulation in Huntington's Disease,39,4.75E-01,6.17E-01,5.02E-01,6.17E-01,4,"ITGB1, Enkephalin A, NR1, ACM4",4.75E-01,6.39E-01,4,"ITGB1, Enkephalin A, NR1, ACM4"
1178,"VLDL, LDL dyslipidemia in type 2 diabetes and metabolic syndrome X",39,4.75E-01,6.17E-01,5.02E-01,6.17E-01,4,"Biglycan proteoglycan, APOB48 receptor, Versican proteoglycan, MSR1",4.75E-01,6.39E-01,4,"Biglycan proteoglycan, APOB48 receptor, Versican proteoglycan, MSR1"
1179,Nicotine signaling in GABAergic neurons,39,4.75E-01,6.17E-01,5.02E-01,6.17E-01,4,"GABA-A receptor, G-protein alpha-i family, nAChR alpha-4, GAT1",4.75E-01,6.39E-01,4,"GABA-A receptor, G-protein alpha-i family, nAChR alpha-4, GAT1"
1180,Neolacto-series GSL Metabolism p.2,61,4.78E-01,6.28E-01,5.13E-01,6.28E-01,6,"B3GNT5, SIA10, GALGT2, CHST4, SIA7E, CHST1",4.78E-01,6.42E-01,6,"B3GNT5, SIA10, GALGT2, CHST4, SIA7E, CHST1"
1181,LRRK2 in neuronal apoptosis in Parkinson's disease,17,4.82E-01,5.97E-01,4.82E-01,5.97E-01,2,"LRRK2, Caspase-8",8.01E-01,9.03E-01,1,LRRK2
1182,G-protein signaling_Rac3 regulation pathway,17,4.82E-01,5.97E-01,4.82E-01,5.97E-01,2,"Androgen receptor, F-Actin",8.01E-01,9.03E-01,1,Androgen receptor
1183,Regulatory T cells in human allergic contact dermatitis,7,4.85E-01,6.13E-01,4.97E-01,6.13E-01,1,MHC class II,4.85E-01,6.50E-01,1,MHC class II
1184,Regulation of lipid metabolism_Regulation of acetyl-CoA carboxylase 1 activity,18,4.94E-01,6.28E-01,5.13E-01,6.28E-01,2,"ACACB, AMPK gamma subunit",4.94E-01,6.54E-01,2,"ACACB, AMPK gamma subunit"
1185,Beta-adrenergic-dependent CFTR expression,18,4.94E-01,6.28E-01,5.13E-01,6.28E-01,2,"Adenylate cyclase, Beta-2 adrenergic receptor",4.94E-01,6.54E-01,2,"Adenylate cyclase, Beta-2 adrenergic receptor"
1186,Heparan sulfate/heparin metabolism,62,4.94E-01,6.45E-01,5.29E-01,6.45E-01,6,"Exostosin-1, 3-OST5, HSST4, 3-OST-3A, 3-OST1, HS6ST3",4.94E-01,6.54E-01,6,"Exostosin-1, 3-OST5, HSST4, 3-OST-3A, 3-OST1, HS6ST3"
1187,Cortisone biosynthesis and metabolism,51,4.95E-01,6.42E-01,5.26E-01,6.42E-01,5,"CYP11B1, AKR1C3, AKR1C4, CYP11B2, AKR1C2",4.95E-01,6.54E-01,5,"CYP11B1, AKR1C3, AKR1C4, CYP11B2, AKR1C2"
1188,Cholesterol and Sphingolipid transport / Recycling to plasma membrane in lung (normal and CF),29,4.95E-01,6.34E-01,5.19E-01,6.34E-01,3,"ABCG1, PA24A, Caveolin-1",4.95E-01,6.54E-01,3,"ABCG1, PA24A, Caveolin-1"
1189,Lacto-series GSL Metabolism,63,5.10E-01,6.56E-01,5.45E-01,6.56E-01,6,"B3GNT5, G3ST2, ABO system transferase, SIA7E, G3ST3, B3GT2",5.10E-01,6.72E-01,6,"B3GNT5, G3ST2, ABO system transferase, SIA7E, G3ST3, B3GT2"
1190,"Regulation of lipid metabolism_RXR-dependent regulation of lipid metabolism via PPAR, RAR and VDR",30,5.18E-01,6.56E-01,5.42E-01,6.56E-01,3,"CYP24A1, CYP19, HMGCS2",5.18E-01,6.76E-01,3,"CYP24A1, CYP19, HMGCS2"
1191,Role of prenatal nicotine exposure in apoptosis and proliferation of pancreatic beta cells,30,5.18E-01,6.56E-01,5.42E-01,6.56E-01,3,"nAChR alpha-7, Bcl-2, nAChR alpha-4",5.18E-01,6.76E-01,3,"nAChR alpha-7, Bcl-2, nAChR alpha-4"
1192,Neurophysiological process_nNOS signaling in neuronal synapses,30,5.18E-01,6.56E-01,5.42E-01,6.56E-01,3,"NMDA receptor, NR2, Dexras1",5.18E-01,6.76E-01,3,"NMDA receptor, NR2, Dexras1"
1193,Putative pathways of Oleic acid sensing in ventromedial hypothalamus in obesity (rodent model),30,5.18E-01,6.56E-01,5.42E-01,6.56E-01,3,"ACSL4, SUR1, Kir6.2",5.18E-01,6.76E-01,3,"ACSL4, SUR1, Kir6.2"
1194,Cell cycle_Role of SCF complex in cell cycle regulation,29,5.19E-01,6.34E-01,5.19E-01,6.34E-01,3,"Cyclin E, SMAD3, p27KIP1",9.36E-01,9.92E-01,1,Cyclin E
1195,Proteolysis_Putative SUMO-1 pathway,29,5.19E-01,6.34E-01,5.19E-01,6.34E-01,3,"NF-kB, SAE2, p53",7.52E-01,8.74E-01,2,"NF-kB, SAE2"
1196,Anti-apoptotic pathways in endoplasmic reticulum stress response in multiple myeloma,19,5.23E-01,6.56E-01,5.42E-01,6.56E-01,2,"XBP1, Bcl-2",5.23E-01,6.78E-01,2,"XBP1, Bcl-2"
1197,Regulation of lipid metabolism_Regulation of acetyl-CoA carboxylase 2 activity in muscle,19,5.23E-01,6.56E-01,5.42E-01,6.56E-01,2,"ACACB, AMPK gamma subunit",5.23E-01,6.78E-01,2,"ACACB, AMPK gamma subunit"
1198,Brca1 and Brca2 in breast cancer,19,5.23E-01,6.56E-01,5.42E-01,6.56E-01,2,"ESR1 (nuclear), ESR1 (membrane)",5.23E-01,6.78E-01,2,"ESR1 (nuclear), ESR1 (membrane)"
1199,Ethanol/Acetaldehyde-dependent stimulation of MMP-9 expression in HCC,19,5.23E-01,6.56E-01,5.42E-01,6.56E-01,2,"NF-kB, MMP-9",5.23E-01,6.78E-01,2,"NF-kB, MMP-9"
1200,Immune responses in asthma (schema),8,5.32E-01,6.56E-01,5.45E-01,6.56E-01,1,IL-1 beta,5.32E-01,6.87E-01,1,IL-1 beta
1201,Apoptosis and survival_Lymphotoxin-beta receptor signaling,42,5.34E-01,6.76E-01,5.62E-01,6.76E-01,4,"RelA (p65 NF-kB subunit), c-IAP1, IL-8, LIGHT(TNFSF14)",5.34E-01,6.88E-01,4,"RelA (p65 NF-kB subunit), c-IAP1, IL-8, LIGHT(TNFSF14)"
1202,Linoleic acid metabolism,31,5.41E-01,6.76E-01,5.65E-01,6.76E-01,3,"PLA2(hGIIA), ALOX15B, PA24A",5.41E-01,6.93E-01,3,"PLA2(hGIIA), ALOX15B, PA24A"
1203,IL-1 beta-dependent CFTR expression,31,5.41E-01,6.76E-01,5.65E-01,6.76E-01,3,"IL-1 beta, Pellino 1, Pellino 2",5.41E-01,6.93E-01,3,"IL-1 beta, Pellino 1, Pellino 2"
1204,Regulation of lipid metabolism_FXR-dependent negative-feedback regulation of bile acids concentration,31,5.41E-01,6.76E-01,5.65E-01,6.76E-01,3,"UGT2B4, HNF3-alpha, CYP2B6",5.41E-01,6.93E-01,3,"UGT2B4, HNF3-alpha, CYP2B6"
1205,Apoptosis and survival_Granzyme A signaling,30,5.42E-01,6.56E-01,5.42E-01,6.56E-01,3,"MUNC13-4, p53, Histone H1",7.69E-01,8.87E-01,2,"MUNC13-4, Histone H1"
1206,Development_Growth hormone-releasing hormone (GH-RH) signaling,41,5.43E-01,6.56E-01,5.43E-01,6.56E-01,4,"cPKC (conventional), Adenylate cyclase, ERK1/2, IP3 receptor",7.30E-01,8.58E-01,3,"cPKC (conventional), Adenylate cyclase, IP3 receptor"
1207,Mechanism of gemcitabine action in pancreatic cancer,52,5.44E-01,6.56E-01,5.44E-01,6.56E-01,5,"CDD, CNT3 (SLC28A3), p53, 5'-NT1A, CNT1",7.04E-01,8.34E-01,4,"CDD, CNT3 (SLC28A3), 5'-NT1A, CNT1"
1208,Nicotine signaling in cholinergic neurons,52,5.44E-01,6.56E-01,5.44E-01,6.56E-01,5,"NGF, PI3K cat class IA, nAChR alpha-4, Tau (MAPT), ERK2 (MAPK1)",7.04E-01,8.34E-01,4,"NGF, PI3K cat class IA, nAChR alpha-4, Tau (MAPT)"
1209,Transcription_Sirtuin6 regulation and functions ,63,5.45E-01,6.56E-01,5.45E-01,6.56E-01,6,"c-IAP2, RelA (p65 NF-kB subunit), ICAM1, AMPK gamma subunit, PPARGC1 (PGC1-alpha), FASN",6.85E-01,8.20E-01,5,"c-IAP2, RelA (p65 NF-kB subunit), ICAM1, AMPK gamma subunit, PPARGC1 (PGC1-alpha)"
1210,Tumor metabolic pathways promoting development of Treg cells,96,5.49E-01,6.61E-01,5.49E-01,6.61E-01,9,"STAT3, PDK1, MHC class II, RelA (p65 NF-kB subunit), TGF-beta receptor type II, 5'-NTD, CCR5, FASN, PD-L1",8.76E-01,9.63E-01,6,"MHC class II, RelA (p65 NF-kB subunit), TGF-beta receptor type II, 5'-NTD, CCR5, PD-L1"
1211,Development_TGF-beta-induction of EMT via ROS,20,5.51E-01,6.82E-01,5.71E-01,6.82E-01,2,"TGF-beta receptor type II, SOS",5.51E-01,7.03E-01,2,"TGF-beta receptor type II, SOS"
1212,Regulation of caspase activity in Huntington's disease,20,5.51E-01,6.82E-01,5.71E-01,6.82E-01,2,"NMDA receptor, Caspase-1",5.51E-01,7.03E-01,2,"NMDA receptor, Caspase-1"
1213,Immune response_T regulatory cell-mediated modulation of antigen-presenting cell functions,66,5.57E-01,7.06E-01,5.92E-01,7.06E-01,6,"3HAO, IDO1, MHC class II, ICAM1, 5'-NTD, NF-kB",5.57E-01,7.08E-01,6,"3HAO, IDO1, MHC class II, ICAM1, 5'-NTD, NF-kB"
1214,Development_Inhibition of angiogenesis by PEDF,31,5.65E-01,6.76E-01,5.65E-01,6.76E-01,3,"PA24A, Caspase-8, p53",9.47E-01,1.00E+00,1,PA24A
1215,Inhibition of TGF-beta signaling in lung cancer,31,5.65E-01,6.76E-01,5.65E-01,6.76E-01,3,"TGF-beta receptor type II, p15, SMAD3",7.84E-01,8.96E-01,2,"TGF-beta receptor type II, p15"
1216,Role of prenatal nicotine exposure in inhibition of pancreatic beta cells differentiation and function,21,5.78E-01,7.12E-01,5.98E-01,7.12E-01,2,"Kir6.2, PAX6",5.78E-01,7.28E-01,2,"Kir6.2, PAX6"
1217,Cell cycle_Cell cycle (generic schema),21,5.78E-01,7.12E-01,5.98E-01,7.12E-01,2,"Cyclin E, CDK6",5.78E-01,7.28E-01,2,"Cyclin E, CDK6"
1218,G-protein signaling_Regulation of CDC42 activity,33,5.84E-01,7.21E-01,6.08E-01,7.21E-01,3,"CDGAP, Fyn, Caspase-1",5.84E-01,7.32E-01,3,"CDGAP, Fyn, Caspase-1"
1219,Prolactin signaling in Prostate Cancer,33,5.84E-01,7.21E-01,6.08E-01,7.21E-01,3,"Androgen receptor, PIP, Prolactin receptor",5.84E-01,7.32E-01,3,"Androgen receptor, PIP, Prolactin receptor"
1220,Interconnectivity between Folic acid and Fluorouracil pathways in gastric cancer,91,5.87E-01,7.36E-01,6.27E-01,7.39E-01,8,"ABCC11, FR-alpha, CES1, UDP, DPYD, CDD, CYP2A6, Aquaporin 9",5.87E-01,7.36E-01,8,"ABCC11, FR-alpha, CES1, UDP, DPYD, CDD, CYP2A6, Aquaporin 9"
1221,Neurophysiological process_Glutamic acid regulation of Dopamine D1A receptor signaling,45,5.90E-01,7.32E-01,6.18E-01,7.32E-01,4,"NMDA receptor, Adenylate cyclase type V, PP2A regulatory, IP3 receptor",5.90E-01,7.38E-01,4,"NMDA receptor, Adenylate cyclase type V, PP2A regulatory, IP3 receptor"
1222,Apoptosis and survival_FAS signaling cascades,44,6.00E-01,7.13E-01,6.00E-01,7.13E-01,4,"Caspase-10, c-IAP1, Bcl-2, Caspase-8",7.73E-01,8.89E-01,3,"Caspase-10, c-IAP1, Bcl-2"
1223,Role of mevalonate pathway in multiple myeloma,44,6.00E-01,7.13E-01,6.00E-01,7.13E-01,4,"PI3K cat class IA, N-Ras, ERK1/2, RhoB",9.17E-01,9.83E-01,2,"PI3K cat class IA, RhoB"
1224,Regulation of lipid metabolism_Insulin regulation of fatty acid metabolism,89,6.01E-01,7.14E-01,6.01E-01,7.14E-01,8,"PI3K cat class IA, IRS-2, ERK1/2, SOS, AKT(PKB), PDK (PDPK1), FASN, Perilipin",9.14E-01,9.83E-01,5,"PI3K cat class IA, IRS-2, SOS, AKT(PKB), Perilipin"
1225,Differences between Langerhans cells and dermal dendritic cells in allergic contact dermatitis,22,6.04E-01,7.37E-01,6.24E-01,7.37E-01,2,"MHC class II, PD-L1",6.04E-01,7.51E-01,2,"MHC class II, PD-L1"
1226,Serotonin - melatonin biosynthesis and metabolism,46,6.08E-01,7.48E-01,6.36E-01,7.48E-01,4,"IDO1, CYP1A1, ALDR, INMT",6.08E-01,7.53E-01,4,"IDO1, CYP1A1, ALDR, INMT"
1227,Apoptosis and survival_Granzyme B signaling,33,6.08E-01,7.21E-01,6.08E-01,7.21E-01,3,"Caspase-10, MUNC13-4, Caspase-8",8.13E-01,9.13E-01,2,"Caspase-10, MUNC13-4"
1228,Sitagliptin in treatment of type 2 diabetes and metabolic syndrome X,10,6.13E-01,7.39E-01,6.26E-01,7.39E-01,1,DPP4,6.13E-01,7.58E-01,1,DPP4
1229,Androgen biosynthetic pathways,82,6.20E-01,7.64E-01,6.57E-01,7.67E-01,7,"CYP11B1, AKR1C3, AKR1C4, CYP11B2, AKR1C1, AKR1C2, CYP11A1",6.20E-01,7.64E-01,7,"CYP11B1, AKR1C3, AKR1C4, CYP11B2, AKR1C1, AKR1C2, CYP11A1"
1230,Cell cycle_Sister chromatid cohesion,22,6.24E-01,7.37E-01,6.24E-01,7.37E-01,2,"PCNA, Histone H1",8.76E-01,9.63E-01,1,Histone H1
1231,Cell cycle_Role of 14-3-3 proteins in cell cycle regulation,22,6.24E-01,7.37E-01,6.24E-01,7.37E-01,2,"AKT(PKB), p53",8.76E-01,9.63E-01,1,AKT(PKB)
1232,Keratan sulfate metabolism p.1,35,6.25E-01,7.61E-01,6.49E-01,7.61E-01,3,"CHST3, CHST6, CHST1",6.25E-01,7.64E-01,3,"CHST3, CHST6, CHST1"
1233,"Development_TNF-alpha, IL-1 alpha and WNT5A-dependent regulation of osteogenesis and adipogenesis in mesenchymal stem cells",47,6.25E-01,7.62E-01,6.53E-01,7.62E-01,4,"RUNX2, ALPL, TAZ, IP3 receptor",6.25E-01,7.64E-01,4,"RUNX2, ALPL, TAZ, IP3 receptor"
1234,Transport_GPR40 signaling pathway in beta cells,47,6.25E-01,7.62E-01,6.53E-01,7.62E-01,4,"Kv2.2, G-protein alpha-q/11, IP3 receptor, CACNA1D",6.25E-01,7.64E-01,4,"Kv2.2, G-protein alpha-q/11, IP3 receptor, CACNA1D"
1235,wtCFTR and deltaF508 traffic / Membrane expression (normal and CF),47,6.25E-01,7.62E-01,6.53E-01,7.62E-01,4,"HGF, EBP50, Beta-2 adrenergic receptor, HGF receptor (Met)",6.25E-01,7.64E-01,4,"HGF, EBP50, Beta-2 adrenergic receptor, HGF receptor (Met)"
1236,Renal secretion of inorganic electrolytes,59,6.27E-01,7.66E-01,6.58E-01,7.67E-01,5,"SLC12A1, NCX1, SLC4A4, Aquaporin 1, CALB1",6.27E-01,7.66E-01,5,"SLC12A1, NCX1, SLC4A4, Aquaporin 1, CALB1"
1237,Apoptosis and survival_Caspase cascade,34,6.29E-01,7.41E-01,6.29E-01,7.41E-01,3,"Caspase-10, AKT(PKB), Caspase-8",8.26E-01,9.25E-01,2,"Caspase-10, AKT(PKB)"
1238,Role of GIP in pathogenesis of type 2 diabetes,46,6.36E-01,7.48E-01,6.36E-01,7.48E-01,4,"BAD, Bcl-2, ERK1/2, AKT(PKB)",9.29E-01,9.92E-01,2,"Bcl-2, AKT(PKB)"
1239,G-protein signaling_Rac2 regulation pathway,36,6.44E-01,7.76E-01,6.68E-01,7.76E-01,3,"iNOS, Rac2, PREX1",6.44E-01,7.84E-01,3,"iNOS, Rac2, PREX1"
1240,Nitrogen metabolism,36,6.44E-01,7.76E-01,6.68E-01,7.76E-01,3,"Carbonic anhydrase XII, DHE4, Carbonic anhydrase IX",6.44E-01,7.84E-01,3,"Carbonic anhydrase XII, DHE4, Carbonic anhydrase IX"
1241,Autophagy_Autophagy,35,6.49E-01,7.61E-01,6.49E-01,7.61E-01,3,"BAD, Bcl-2, Beclin 1",9.64E-01,1.00E+00,1,Bcl-2
1242,Development_Growth hormone signaling via STATs and PLC/IP3,35,6.49E-01,7.61E-01,6.49E-01,7.61E-01,3,"STAT3, Fyn, GHR",8.38E-01,9.38E-01,2,"Fyn, GHR"
1243,"Triacylglycerol biosynthesis in obesity and diabetes mellitus, type II",24,6.52E-01,7.79E-01,6.71E-01,7.79E-01,2,"MOGAT3, PLCD",6.52E-01,7.89E-01,2,"MOGAT3, PLCD"
1244,"Mechanism of action of DGAT1 inhibitors in obesity and diabetes mellitus, type II (Variant 1)",24,6.52E-01,7.79E-01,6.71E-01,7.79E-01,2,"MOGAT3, PLCD",6.52E-01,7.89E-01,2,"MOGAT3, PLCD"
1245,Signal transduction_JNK pathway,47,6.53E-01,7.62E-01,6.53E-01,7.62E-01,4,"HGK(MAP4K4), SOS, GCKR(MAP4K5), p53",8.10E-01,9.12E-01,3,"HGK(MAP4K4), SOS, GCKR(MAP4K5)"
1246,Development_WNT5A signaling,47,6.53E-01,7.62E-01,6.53E-01,7.62E-01,4,"PKC-alpha, Tcf(Lef), Beta-catenin, Dsh",9.34E-01,9.92E-01,2,"PKC-alpha, Tcf(Lef)"
1247,Transcription_N-CoR/ SMRT complex-mediated epigenetic gene silencing,49,6.58E-01,7.93E-01,6.85E-01,7.93E-01,4,"PBX1a/HOXB1, NF-kB, PBX1, HOXB1",6.58E-01,7.95E-01,4,"PBX1a/HOXB1, NF-kB, PBX1, HOXB1"
1248,Cholehepatic circulation of bile acids / Rodent version,37,6.63E-01,7.93E-01,6.86E-01,7.93E-01,3,"ABCC11, OATP-A, AKR1C1",6.63E-01,7.99E-01,3,"ABCC11, OATP-A, AKR1C1"
1249,Statin action on the PI3K/ Akt pathway in COPD,36,6.68E-01,7.76E-01,6.68E-01,7.76E-01,3,"PI3K cat class IA, AKT(PKB), p27KIP1",8.49E-01,9.46E-01,2,"PI3K cat class IA, AKT(PKB)"
1250,G-protein signaling_G-Protein alpha-s signaling cascades,36,6.68E-01,7.76E-01,6.68E-01,7.76E-01,3,"AK5, ERK1/2, RGS2",8.49E-01,9.46E-01,2,"AK5, RGS2"
1251,Regulation of lipid metabolism_Stimulation of Arachidonic acid production by ACM receptors,72,6.77E-01,7.85E-01,6.77E-01,7.85E-01,6,"PKC, PKC-alpha, cPLA2, ERK1/2, IP3 receptor, ACM3",7.92E-01,9.02E-01,5,"PKC, PKC-alpha, cPLA2, IP3 receptor, ACM3"
1252,Cortisol biosynthesis from Cholesterol,38,6.81E-01,8.10E-01,7.04E-01,8.10E-01,3,"CYP11B1, CYP11B2, CYP11A1",6.81E-01,8.16E-01,3,"CYP11B1, CYP11B2, CYP11A1"
1253,HDL dyslipidemia in type 2 diabetes and metabolic syndrome X,38,6.81E-01,8.10E-01,7.04E-01,8.10E-01,3,"S1P1 receptor, LIPE, ABCG1",6.81E-01,8.16E-01,3,"S1P1 receptor, LIPE, ABCG1"
1254,G-protein signaling_RAC1 in cellular process,37,6.86E-01,7.93E-01,6.86E-01,7.93E-01,3,"F-Actin cytoskeleton, Actin cytoskeletal, POR1",9.70E-01,1.00E+00,1,POR1
1255,Apoptosis and survival_Anti-apoptotic action of nuclear ESR1 and ESR2,37,6.86E-01,7.93E-01,6.86E-01,7.93E-01,3,"ESR1 (nuclear), Bcl-2, ERK1/2",8.60E-01,9.55E-01,2,"ESR1 (nuclear), Bcl-2"
1256,Transport_RAB5A regulation pathway,25,6.93E-01,7.99E-01,6.93E-01,7.99E-01,2,"Tuberin, EGFR",9.07E-01,9.83E-01,1,EGFR
1257,CREB1-dependent transcription deregulation in Huntington's Disease,26,6.95E-01,8.19E-01,7.14E-01,8.19E-01,2,"Bcl-2, PPARGC1 (PGC1-alpha)",6.95E-01,8.29E-01,2,"Bcl-2, PPARGC1 (PGC1-alpha)"
1258,Development_NOTCH1-mediated pathway for NF-KB activity modulation,26,6.95E-01,8.19E-01,7.14E-01,8.19E-01,2,"NF-kB, Jagged1",6.95E-01,8.29E-01,2,"NF-kB, Jagged1"
1259,"SREBP1 cross-talk with PXR, CAR and LXR",26,6.95E-01,8.19E-01,7.14E-01,8.19E-01,2,"PPARGC1 (PGC1-alpha), CYP2B6",6.95E-01,8.29E-01,2,"PPARGC1 (PGC1-alpha), CYP2B6"
1260,Keratan sulfate metabolism p.2,39,6.98E-01,8.23E-01,7.20E-01,8.23E-01,3,"CHST3, CHST4, CHST1",6.98E-01,8.29E-01,3,"CHST3, CHST4, CHST1"
1261,Regulation of degradation of deltaF508-CFTR in CF,39,6.98E-01,8.23E-01,7.20E-01,8.23E-01,3,"UCHL1, BAG-2, Dynein 1, cytoplasmic, intermediate chains",6.98E-01,8.29E-01,3,"UCHL1, BAG-2, Dynein 1, cytoplasmic, intermediate chains"
1262,Apoptosis and survival_APRIL and BAFF signaling,39,6.98E-01,8.23E-01,7.20E-01,8.23E-01,3,"COX-2 (PTGS2), RelA (p65 NF-kB subunit), Bcl-2",6.98E-01,8.29E-01,3,"COX-2 (PTGS2), RelA (p65 NF-kB subunit), Bcl-2"
1263,Apoptosis and survival_Ubiquitination and phosphorylation in TNF-alpha-induced NF-kB signaling,39,6.98E-01,8.23E-01,7.20E-01,8.23E-01,3,"c-IAP2, RelA (p65 NF-kB subunit), c-IAP1",6.98E-01,8.29E-01,3,"c-IAP2, RelA (p65 NF-kB subunit), c-IAP1"
1264,"Regulation of lipid metabolism_Regulation of lipid metabolism via LXR, NF-Y and SREBP",38,7.04E-01,8.10E-01,7.04E-01,8.10E-01,3,"AMPK gamma subunit, Caveolin-1, FASN",8.70E-01,9.62E-01,2,"AMPK gamma subunit, Caveolin-1"
1265,Gamma-aminobutyrate (GABA) biosynthesis and metabolism,52,7.04E-01,8.32E-01,7.30E-01,8.32E-01,4,"DHE4, GABT, GAD1, ABP1",7.04E-01,8.34E-01,4,"DHE4, GABT, GAD1, ABP1"
1266,Vitamin B3 and NAD+ metabolism,125,7.04E-01,8.34E-01,7.44E-01,8.45E-01,10,"PAM, SLC5A8, CD38, ENPP1, Xanthine oxidase, NNMT, ALPL, 5'-NTD, ALPP, MCT1 (SLC16A1)",7.04E-01,8.34E-01,10,"PAM, SLC5A8, CD38, ENPP1, Xanthine oxidase, NNMT, ALPL, 5'-NTD, ALPP, MCT1 (SLC16A1)"
1267,Development_Role of nicotinamide in G-CSF-induced granulopoiesis,13,7.09E-01,8.23E-01,7.21E-01,8.23E-01,1,C/EBPalpha,7.09E-01,8.39E-01,1,C/EBPalpha
1268,Transcription_Role of heterochromatin protein 1 (HP1) family in transcriptional silencing,40,7.14E-01,8.37E-01,7.36E-01,8.37E-01,3,"HDAC9, Cyclin E, MEF2",7.14E-01,8.42E-01,3,"HDAC9, Cyclin E, MEF2"
1269,Enterohepatic circulation of bile acids / Rodent version,40,7.14E-01,8.37E-01,7.36E-01,8.37E-01,3,"ABCC11, OATP-A, AKR1C1",7.14E-01,8.42E-01,3,"ABCC11, OATP-A, AKR1C1"
1270,Neurophysiological process_GABA-B receptor-mediated regulation of glutamate signaling in Purkinje cells,27,7.15E-01,8.35E-01,7.34E-01,8.35E-01,2,"G-protein alpha-i family, IP3 receptor",7.15E-01,8.42E-01,2,"G-protein alpha-i family, IP3 receptor"
1271,Triacylglycerol metabolism p.2,27,7.15E-01,8.35E-01,7.34E-01,8.35E-01,2,"LIPE, CEL",7.15E-01,8.42E-01,2,"LIPE, CEL"
1272,Atorvastatin in treatment of type 2 diabetes and metabolic syndrome X,39,7.20E-01,8.23E-01,7.20E-01,8.23E-01,3,"OATP-B, ERK2 (MAPK1), ERK1 (MAPK3)",9.75E-01,1.00E+00,1,OATP-B
1273,Neurophysiological process_GABA-B receptor signaling in presynaptic nerve terminals,28,7.34E-01,8.48E-01,7.52E-01,8.48E-01,2,"Adenylate cyclase type V, G-protein alpha-i family",7.34E-01,8.59E-01,2,"Adenylate cyclase type V, G-protein alpha-i family"
1274,Mitogenic action of Estradiol / ESR1 (nuclear) in breast cancer,28,7.34E-01,8.48E-01,7.52E-01,8.48E-01,2,"ESR1 (nuclear), Cyclin E",7.34E-01,8.59E-01,2,"ESR1 (nuclear), Cyclin E"
1275,Neurophysiological process_Role of CDK5 in presynaptic signaling,28,7.34E-01,8.48E-01,7.52E-01,8.48E-01,2,"TY3H, Endophilin A1",7.34E-01,8.59E-01,2,"TY3H, Endophilin A1"
1276,Muscle contraction_nNOS signaling in skeletal muscle ,28,7.34E-01,8.48E-01,7.52E-01,8.48E-01,2,"Dystrophin, Actin",7.34E-01,8.59E-01,2,"Dystrophin, Actin"
1277,Riboflavin metabolism,14,7.35E-01,8.47E-01,7.48E-01,8.47E-01,1,ENPP1,7.35E-01,8.59E-01,1,ENPP1
1278,Immune response  _Sialic-acid receptors (Siglecs) signaling,14,7.35E-01,8.47E-01,7.48E-01,8.47E-01,1,Lyn,7.35E-01,8.59E-01,1,Lyn
1279,G-protein signaling_Rap1A regulation pathway,40,7.36E-01,8.37E-01,7.36E-01,8.37E-01,3,"Tuberin, CalDAG-GEFIII, G-protein alpha-i family",8.88E-01,9.69E-01,2,"CalDAG-GEFIII, G-protein alpha-i family"
1280,L-Tryptophan metabolism (part 1),80,7.42E-01,8.65E-01,7.71E-01,8.65E-01,6,"SLC7A8, IDO1, IDO2, AL1A1, ALDR, INMT",7.42E-01,8.66E-01,6,"SLC7A8, IDO1, IDO2, AL1A1, ALDR, INMT"
1281,Transport_HDL-mediated reverse cholesterol transport,42,7.45E-01,8.63E-01,7.66E-01,8.63E-01,3,"CES1, LIPE, ABCG1",7.45E-01,8.69E-01,3,"CES1, LIPE, ABCG1"
1282,Possible pathway of TGF-beta 1-dependent inhibition of CFTR expression,41,7.52E-01,8.48E-01,7.52E-01,8.48E-01,3,"TGF-beta receptor type II, Beta-2 adrenergic receptor, SMAD3",8.96E-01,9.76E-01,2,"TGF-beta receptor type II, Beta-2 adrenergic receptor"
1283,Cholesterol and Sphingolipid transport / Influx to the early endosome in lung (normal and CF),29,7.52E-01,8.64E-01,7.69E-01,8.64E-01,2,"Caveolin-2, Caveolin-1",7.52E-01,8.74E-01,2,"Caveolin-2, Caveolin-1"
1284,Vitamin D2 (ergocalciferol) metabolism,29,7.52E-01,8.64E-01,7.69E-01,8.64E-01,2,"CYP27A1, CYP24A1",7.52E-01,8.74E-01,2,"CYP27A1, CYP24A1"
1285,DNA damage_ATM / ATR regulation of G2 / M checkpoint,28,7.52E-01,8.48E-01,7.52E-01,8.48E-01,2,"Kinase MYT1, p53",9.30E-01,9.92E-01,1,Kinase MYT1
1286,Development_Ligand-dependent activation of the ESR1/AP-1 pathway,15,7.59E-01,8.65E-01,7.71E-01,8.65E-01,1,ESR1 (nuclear),7.59E-01,8.81E-01,1,ESR1 (nuclear)
1287,Stem cells_Neovascularization of glioblastoma in response to hypoxia,30,7.69E-01,8.79E-01,7.85E-01,8.79E-01,2,"PKC-alpha, IP3 receptor",7.69E-01,8.87E-01,2,"PKC-alpha, IP3 receptor"
1288,Development_SSTR1 in regulation of cell proliferation and migration,29,7.69E-01,8.64E-01,7.69E-01,8.64E-01,2,"ERK1/2, PI3K reg class IB (p101)",9.36E-01,9.92E-01,1,PI3K reg class IB (p101)
1289,Prostaglandin 1 biosynthesis and metabolism,57,7.70E-01,8.84E-01,7.93E-01,8.84E-01,4,"COX-2 (PTGS2), PTGIS, ALOX15B, Acyl-CoA synthetase",7.70E-01,8.87E-01,4,"COX-2 (PTGS2), PTGIS, ALOX15B, Acyl-CoA synthetase"
1290,Tyrosine metabolism p.1 (dopamine) ,70,7.71E-01,8.87E-01,7.96E-01,8.87E-01,5,"TY3H, AL1A1, PNMT, PAH, ABP1",7.71E-01,8.87E-01,5,"TY3H, AL1A1, PNMT, PAH, ABP1"
1291,Ganglioside Metabolism p2,44,7.73E-01,8.84E-01,7.93E-01,8.84E-01,3,"SIA7C, SIA7E, SIAT8A",7.73E-01,8.89E-01,3,"SIA7C, SIA7E, SIAT8A"
1292,Regulation of metabolism_Role of Adiponectin in regulation of metabolism,43,7.80E-01,8.73E-01,7.80E-01,8.73E-01,3,"Tuberin, Adiponectin, PPARGC1 (PGC1-alpha)",9.11E-01,9.83E-01,2,"Adiponectin, PPARGC1 (PGC1-alpha)"
1293,Apoptosis and survival_TNF-alpha-induced Caspase-8 signaling,43,7.80E-01,8.73E-01,7.80E-01,8.73E-01,3,"PP2A regulatory, AKT(PKB), Caspase-8",9.11E-01,9.83E-01,2,"PP2A regulatory, AKT(PKB)"
1294,wtCFTR and deltaF508 traffic / Late endosome and lysosome (normal and CF),16,7.81E-01,8.84E-01,7.93E-01,8.84E-01,1,MUNC13-4,7.81E-01,8.94E-01,1,MUNC13-4
1295,G-protein signaling_RhoB regulation pathway,16,7.81E-01,8.84E-01,7.93E-01,8.84E-01,1,RhoB,7.81E-01,8.94E-01,1,RhoB
1296,Intercellular relations in asthma (general schema),16,7.81E-01,8.84E-01,7.93E-01,8.84E-01,1,ICAM1,7.81E-01,8.94E-01,1,ICAM1
1297,Glutathione metabolism,71,7.81E-01,8.94E-01,8.07E-01,8.97E-01,5,"GSTP1, GSTM5, GPX7, GSTA3, CD13",7.81E-01,8.94E-01,5,"GSTP1, GSTM5, GPX7, GSTA3, CD13"
1298,"SREBP1 cross-talk with PXR, CAR and LXR/ Rodent version",31,7.84E-01,8.91E-01,8.01E-01,8.91E-01,2,"PPARGC1 (PGC1-alpha), CYP2B6",7.84E-01,8.96E-01,2,"PPARGC1 (PGC1-alpha), CYP2B6"
1299,Neolacto-series GSL Metabolism p.1,72,7.92E-01,9.01E-01,8.16E-01,9.01E-01,5,"B3GNT5, SIA10, G3ST2, ABO system transferase, G3ST3",7.92E-01,9.02E-01,5,"B3GNT5, SIA10, G3ST2, ABO system transferase, G3ST3"
1300,Niacin-HDL metabolism,46,7.99E-01,9.01E-01,8.18E-01,9.01E-01,3,"PAM, NNMT, HDL proteins",7.99E-01,9.03E-01,3,"PAM, NNMT, HDL proteins"
1301,L-Alanine and L-cysteine metabolism,46,7.99E-01,9.01E-01,8.18E-01,9.01E-01,3,"AGXT, CDO1, AGT2",7.99E-01,9.03E-01,3,"AGXT, CDO1, AGT2"
1302,Anandamide biosynthesis and metabolism,46,7.99E-01,9.01E-01,8.18E-01,9.01E-01,3,"PLA2(hGIIA), PA24A, PTPN22",7.99E-01,9.03E-01,3,"PLA2(hGIIA), PA24A, PTPN22"
1303,Acetylcholine biosynthesis and metabolism,32,7.99E-01,9.00E-01,8.15E-01,9.00E-01,2,"PEMT, PA24A",7.99E-01,9.03E-01,2,"PEMT, PA24A"
1304,Immune response_BAFF-induced non-canonical NF-kB signaling,32,7.99E-01,9.00E-01,8.15E-01,9.00E-01,2,"c-IAP2, c-IAP1",7.99E-01,9.03E-01,2,"c-IAP2, c-IAP1"
1305,Cell cycle_Start of DNA replication in early S phase,32,7.99E-01,9.00E-01,8.15E-01,9.00E-01,2,"Cyclin E, Histone H1",7.99E-01,9.03E-01,2,"Cyclin E, Histone H1"
1306,Putative mechanism of drug action for CCR5 antagonists,17,8.01E-01,9.00E-01,8.12E-01,9.00E-01,1,CCR5,8.01E-01,9.03E-01,1,CCR5
1307,DeltaF508-CFTR traffic / ER-to-Golgi in CF,17,8.01E-01,9.00E-01,8.12E-01,9.00E-01,1,EBP50,8.01E-01,9.03E-01,1,EBP50
1308,G-protein signaling_Rap2A regulation pathway,17,8.01E-01,9.00E-01,8.12E-01,9.00E-01,1,G-protein alpha-i family,8.01E-01,9.03E-01,1,G-protein alpha-i family
1309,wtCFTR traffic / ER-to-Golgi (normal),17,8.01E-01,9.00E-01,8.12E-01,9.00E-01,1,EBP50,8.01E-01,9.03E-01,1,EBP50
1310,Chondroitin sulfate and dermatan sulfate metabolism,60,8.04E-01,9.06E-01,8.25E-01,9.09E-01,4,"CHST3, SART2, CGAT1, CHSTD",8.04E-01,9.06E-01,4,"CHST3, SART2, CGAT1, CHSTD"
1311,Mechanisms of deltaF508 CFTR activation by S-nitrosoglutathione,47,8.10E-01,9.11E-01,8.29E-01,9.11E-01,3,"Ceruloplasmin, iNOS, IL-8",8.10E-01,9.12E-01,3,"Ceruloplasmin, iNOS, IL-8"
1312,Phospholipid metabolism p.3,33,8.13E-01,9.10E-01,8.28E-01,9.10E-01,2,"LRAT, PA24A",8.13E-01,9.13E-01,2,"LRAT, PA24A"
1313,Globo-(isoglobo) series GSL Metabolism,48,8.22E-01,9.22E-01,8.40E-01,9.22E-01,3,"ABO system transferase, SIA7E, G3ST1",8.22E-01,9.22E-01,3,"ABO system transferase, SIA7E, G3ST1"
1314,Immune response_Production and main functions of biologically active leukotrienes and Lipoxin A4,50,8.42E-01,9.38E-01,8.59E-01,9.38E-01,3,"ABCC11, cPLA2, ALOX5",8.42E-01,9.42E-01,3,"ABCC11, cPLA2, ALOX5"
1315,L-Threonine metabolism,50,8.42E-01,9.38E-01,8.59E-01,9.38E-01,3,"SLC7A8, SDSL, SDHL",8.42E-01,9.42E-01,3,"SLC7A8, SDSL, SDHL"
1316,Development_Direct reprogramming of cardiac fibroblasts into cardiomyocytes,20,8.50E-01,9.38E-01,8.60E-01,9.38E-01,1,MEF2C,8.50E-01,9.46E-01,1,MEF2C
1317,Regulation of degradation of wtCFTR,20,8.50E-01,9.38E-01,8.60E-01,9.38E-01,1,BAG-2,8.50E-01,9.46E-01,1,BAG-2
1318,Mechanisms of hapten presentation to T cells in allergic contact dermatitis,20,8.50E-01,9.38E-01,8.60E-01,9.38E-01,1,MHC class II,8.50E-01,9.46E-01,1,MHC class II
1319,Transcription_Role of the non-genomic action of Retinoic acid and phosphorylation of Retinoic acid receptors in the initiation of transcription,35,8.52E-01,9.33E-01,8.52E-01,9.33E-01,2,"STRA6, PDK (PDPK1)",9.64E-01,1.00E+00,1,STRA6
1320,HCV-mediated liver damage and predisposition to HCC via cell stress,63,8.53E-01,9.33E-01,8.53E-01,9.33E-01,4,"STAT3, XBP1, IL-6, NF-kB",9.33E-01,9.92E-01,3,"XBP1, IL-6, NF-kB"
1321,Cholesterol and Sphingolipid transport / Transport from Golgi and ER to the apical membrane (normal and CF),37,8.60E-01,9.50E-01,8.73E-01,9.50E-01,2,"CES1, Caveolin-1",8.60E-01,9.55E-01,2,"CES1, Caveolin-1"
1322,CoA biosynthesis,52,8.61E-01,9.53E-01,8.77E-01,9.53E-01,3,"VNN1, ACSL4, ENPP1",8.61E-01,9.55E-01,3,"VNN1, ACSL4, ENPP1"
1323,Cell cycle_Chromosome condensation in prometaphase,21,8.64E-01,9.50E-01,8.73E-01,9.50E-01,1,Histone H1,8.64E-01,9.56E-01,1,Histone H1
1324,Fructose metabolism,81,8.68E-01,9.59E-01,8.87E-01,9.59E-01,5,"DHSO, ALDR, AK1BA, F16Q, F16P",8.68E-01,9.60E-01,5,"DHSO, ALDR, AK1BA, F16Q, F16P"
1325,Transcription_CREM signaling in testis,22,8.76E-01,9.58E-01,8.85E-01,9.58E-01,1,KIF17,8.76E-01,9.63E-01,1,KIF17
1326,PXR signaling via cross-talk / Rodent version,22,8.76E-01,9.58E-01,8.85E-01,9.58E-01,1,PPARGC1 (PGC1-alpha),8.76E-01,9.63E-01,1,PPARGC1 (PGC1-alpha)
1327,Taurine and hypotaurine metabolism,22,8.76E-01,9.58E-01,8.85E-01,9.58E-01,1,CDO1,8.76E-01,9.63E-01,1,CDO1
1328,PXR signaling via cross-talk / Human Version,22,8.76E-01,9.58E-01,8.85E-01,9.58E-01,1,PPARGC1 (PGC1-alpha),8.76E-01,9.63E-01,1,PPARGC1 (PGC1-alpha)
1329,Ganglioside Metabolism p1,54,8.78E-01,9.63E-01,8.92E-01,9.63E-01,3,"GM3 synthase, NEU4, SIAT8A",8.78E-01,9.64E-01,3,"GM3 synthase, NEU4, SIAT8A"
1330,Transport_Regulation of ATP-binding transporters by Retinoic acid and orphan nuclear receptor PXR,39,8.79E-01,9.63E-01,8.92E-01,9.63E-01,2,"ABCG1, MDR1",8.79E-01,9.64E-01,2,"ABCG1, MDR1"
1331,Butanoic acid metabolism,39,8.79E-01,9.63E-01,8.92E-01,9.63E-01,2,"SLC5A8, MCT1 (SLC16A1)",8.79E-01,9.64E-01,2,"SLC5A8, MCT1 (SLC16A1)"
1332,Transport_Intracellular cholesterol transport,83,8.81E-01,9.65E-01,8.99E-01,9.67E-01,5,"CES1, Caveolin-2, VLDLR, ABCG1, Caveolin-1",8.81E-01,9.65E-01,5,"CES1, Caveolin-2, VLDLR, ABCG1, Caveolin-1"
1333,G-protein signaling_G-Protein alpha-12 signaling pathway,38,8.83E-01,9.58E-01,8.83E-01,9.58E-01,2,"PI3K cat class IA, ERK1/2",9.73E-01,1.00E+00,1,PI3K cat class IA
1334,Proteolysis_Putative ubiquitin pathway,23,8.87E-01,9.65E-01,8.96E-01,9.65E-01,1,Synphilin 1,8.87E-01,9.69E-01,1,Synphilin 1
1335,Ascorbate metabolism,23,8.87E-01,9.65E-01,8.96E-01,9.65E-01,1,PAM,8.87E-01,9.69E-01,1,PAM
1336,Apoptosis and survival_NO signaling in apoptosis,23,8.87E-01,9.65E-01,8.96E-01,9.65E-01,1,iNOS,8.87E-01,9.69E-01,1,iNOS
1337,Neurophysiological process_Netrin-1 in regulation of axon guidance,40,8.88E-01,9.68E-01,9.00E-01,9.68E-01,2,"Fyn, IP3 receptor",8.88E-01,9.69E-01,2,"Fyn, IP3 receptor"
1338,Apoptosis and survival_Endoplasmic reticulum stress response pathway,56,8.93E-01,9.73E-01,9.06E-01,9.73E-01,3,"XBP1, Bcl-2, ERP5",8.93E-01,9.74E-01,3,"XBP1, Bcl-2, ERP5"
1339,Translation_(L)-selenoaminoacids incorporation in proteins during translation,41,8.96E-01,9.74E-01,9.07E-01,9.74E-01,2,"DIO1, Selenoprotein P",8.96E-01,9.76E-01,2,"DIO1, Selenoprotein P"
1340,Mitochondrial ketone bodies biosynthesis and metabolism,24,8.97E-01,9.73E-01,9.06E-01,9.73E-01,1,HMGCS2,8.97E-01,9.77E-01,1,HMGCS2
1341,Disruption of methionine metabolism in induction and progression of HCC,42,9.04E-01,9.79E-01,9.14E-01,9.79E-01,2,"GNMT, BHMT",9.04E-01,9.82E-01,2,"GNMT, BHMT"
1342,Estrogen biosynthesis,42,9.04E-01,9.79E-01,9.14E-01,9.79E-01,2,"CYP11B1, CYP19",9.04E-01,9.82E-01,2,"CYP11B1, CYP19"
1343,HSP70 and HSP40-dependent folding in Huntington's disease,25,9.07E-01,9.79E-01,9.15E-01,9.79E-01,1,HSP22,9.07E-01,9.83E-01,1,HSP22
1344,Transport_Clathrin-coated vesicle cycle,71,9.09E-01,9.75E-01,9.09E-01,9.75E-01,4,"AP180, Myosin I, Actin cytoskeletal, Actin",9.61E-01,1.00E+00,3,"AP180, Myosin I, Actin"
1345,Vitamin D3 metabolic C-23 and C-24 pathways,43,9.11E-01,9.83E-01,9.21E-01,9.85E-01,2,"CYP27A1, CYP24A1",9.11E-01,9.83E-01,2,"CYP27A1, CYP24A1"
1346,Arachidonic acid production,74,9.12E-01,9.83E-01,9.25E-01,9.85E-01,4,"PLA2(hGIIA), ACSL4, PLC-eta 2, PA24A",9.12E-01,9.83E-01,4,"PLA2(hGIIA), ACSL4, PLC-eta 2, PA24A"
1347,L-Phenylalanine metabolism,74,9.12E-01,9.83E-01,9.25E-01,9.85E-01,4,"SLC7A8, GLYATL1, AL1A1, PAH",9.12E-01,9.83E-01,4,"SLC7A8, GLYATL1, AL1A1, PAH"
1348,L-Methionine metabolism,59,9.12E-01,9.83E-01,9.24E-01,9.85E-01,3,"BHMT2, BHMT, SLC7A7",9.12E-01,9.83E-01,3,"BHMT2, BHMT, SLC7A7"
1349,Catecholamine metabolism,75,9.17E-01,9.83E-01,9.30E-01,9.85E-01,4,"TY3H, AL1A1, PNMT, SULT1A1",9.17E-01,9.83E-01,4,"TY3H, AL1A1, PNMT, SULT1A1"
1350,Apoptosis and survival_Inhibition of ROS-induced apoptosis by 17beta-estradiol,44,9.17E-01,9.83E-01,9.27E-01,9.85E-01,2,"ESR1 (mitochondrial), Bcl-2",9.17E-01,9.83E-01,2,"ESR1 (mitochondrial), Bcl-2"
1351,Aberrant lipid trafficking and metabolism in age-related macular degeneration pathogenesis,60,9.18E-01,9.83E-01,9.29E-01,9.85E-01,3,"CYP27A1, Clusterin, TLR2",9.18E-01,9.83E-01,3,"CYP27A1, Clusterin, TLR2"
1352,Apoptosis and survival_TNF-alpha-induced ROS-dependent Caspase-3 signaling,60,9.18E-01,9.83E-01,9.29E-01,9.85E-01,3,"Bcl-2, Rac2, PI3K cat class IA (p110-delta)",9.18E-01,9.83E-01,3,"Bcl-2, Rac2, PI3K cat class IA (p110-delta)"
1353,Antioxidant effects of statins in COPD,60,9.18E-01,9.83E-01,9.29E-01,9.85E-01,3,"Rac2, Caveolin-1, RhoB",9.18E-01,9.83E-01,3,"Rac2, Caveolin-1, RhoB"
1354,Histamine metabolism,27,9.23E-01,9.85E-01,9.30E-01,9.85E-01,1,ABP1,9.23E-01,9.86E-01,1,ABP1
1355,n-6 Polyunsaturated fatty acid biosynthesis,61,9.23E-01,9.86E-01,9.34E-01,9.88E-01,3,"ACSL4, ELOVL2, ACOX2",9.23E-01,9.86E-01,3,"ACSL4, ELOVL2, ACOX2"
1356,SCAP/SREBP Transcriptional Control of Cholesterol and FA Biosynthesis,45,9.33E-01,9.88E-01,9.33E-01,9.88E-01,2,"HMGCS2, FASN",9.86E-01,1.00E+00,1,HMGCS2
1357,n-3 Polyunsaturated fatty acid biosynthesis,63,9.33E-01,9.92E-01,9.42E-01,9.95E-01,3,"ACSL4, ELOVL2, ACOX2",9.33E-01,9.92E-01,3,"ACSL4, ELOVL2, ACOX2"
1358,Renal secretion of drugs / Rodent version ,47,9.34E-01,9.92E-01,9.43E-01,9.95E-01,2,"SLC22A3, MDR1",9.34E-01,9.92E-01,2,"SLC22A3, MDR1"
1359,L-Arginine metabolism,79,9.35E-01,9.92E-01,9.46E-01,9.97E-01,4,"iNOS, AL1A1, ADC, ABP1",9.35E-01,9.92E-01,4,"iNOS, AL1A1, ADC, ABP1"
1360,Cigarette smoke-mediated regulation of NRF2-antioxidant pathway in airway epithelial cells,29,9.36E-01,9.92E-01,9.42E-01,9.95E-01,1,UGT1A4,9.36E-01,9.92E-01,1,UGT1A4
1361,Plasmalogen biosynthesis,64,9.37E-01,9.92E-01,9.46E-01,9.97E-01,3,"PEMT, PLA2, PLCD",9.37E-01,9.92E-01,3,"PEMT, PLA2, PLCD"
1362,Polyamine metabolism,64,9.37E-01,9.92E-01,9.46E-01,9.97E-01,3,"ADC, Spermine oxidase, ABP1",9.37E-01,9.92E-01,3,"ADC, Spermine oxidase, ABP1"
1363,Folic acid metabolism,64,9.37E-01,9.92E-01,9.46E-01,9.97E-01,3,"FR-alpha, ALDH1L2, FOLH1 (GCP2)",9.37E-01,9.92E-01,3,"FR-alpha, ALDH1L2, FOLH1 (GCP2)"
1364,HETE and HPETE biosynthesis and metabolism,82,9.46E-01,1.00E+00,9.55E-01,1.00E+00,4,"COX-2 (PTGS2), PTGIS, ALOX5, ALOX15B",9.46E-01,1.00E+00,4,"COX-2 (PTGS2), PTGIS, ALOX5, ALOX15B"
1365,Tyrosine metabolism p.2 (melanin),83,9.50E-01,1.00E+00,9.58E-01,1.00E+00,4,"Xanthine oxidase, TAT, PERT, ABP1",9.50E-01,1.00E+00,4,"Xanthine oxidase, TAT, PERT, ABP1"
1366,Stem cells_Role of ion channels in glioblastoma cell invasion,32,9.52E-01,1.00E+00,9.57E-01,1.00E+00,1,MaxiK alpha subunit,9.52E-01,1.00E+00,1,MaxiK alpha subunit
1367,Neolacto-series GSL Metabolism p.3,68,9.52E-01,1.00E+00,9.60E-01,1.00E+00,3,"B3GNT5, SIA10, ABO system transferase",9.52E-01,1.00E+00,3,"B3GNT5, SIA10, ABO system transferase"
1368,Cell cycle_Spindle assembly and chromosome separation,33,9.56E-01,1.00E+00,9.61E-01,1.00E+00,1,"Dynein 1, cytoplasmic, intermediate chains",9.56E-01,1.00E+00,1,"Dynein 1, cytoplasmic, intermediate chains"
1369,Prostaglandin 2 biosynthesis and metabolism,86,9.58E-01,1.00E+00,9.66E-01,1.00E+00,4,"COX-2 (PTGS2), PTGIS, AKR1C3, LOXE3",9.58E-01,1.00E+00,4,"COX-2 (PTGS2), PTGIS, AKR1C3, LOXE3"
1370,Regulation of CFTR gating (normal and CF),34,9.60E-01,1.00E+00,9.65E-01,1.00E+00,1,Adenylate cyclase,9.60E-01,1.00E+00,1,Adenylate cyclase
1371,Vitamin B6 metabolism,34,9.60E-01,1.00E+00,9.65E-01,1.00E+00,1,ALPL,9.60E-01,1.00E+00,1,ALPL
1372,Cholesterol metabolism,87,9.61E-01,1.00E+00,9.68E-01,1.00E+00,4,"CYP27A1, AKR1C4, CYP7B1, ACOX2",9.61E-01,1.00E+00,4,"CYP27A1, AKR1C4, CYP7B1, ACOX2"
1373,Glycine and L-Serine metabolism,133,9.62E-01,1.00E+00,9.71E-01,1.00E+00,7,"SLC7A8, SDSL, SDHL, GNMT, AGXT, BHMT, PSAT",9.62E-01,1.00E+00,7,"SLC7A8, SDSL, SDHL, GNMT, AGXT, BHMT, PSAT"
1374,"Metabolism of L-cysteine, D-cysteine and L-cystine",119,9.64E-01,1.00E+00,9.72E-01,1.00E+00,6,"SLC7A8, Ceruloplasmin, SLC1A2/EAAT2, SLC7A11, CDO1, GLAST1/EAAT1",9.64E-01,1.00E+00,6,"SLC7A8, Ceruloplasmin, SLC1A2/EAAT2, SLC7A11, CDO1, GLAST1/EAAT1"
1375,Urea cycle,36,9.67E-01,1.00E+00,9.71E-01,1.00E+00,1,Aquaporin 9,9.67E-01,1.00E+00,1,Aquaporin 9
1376,Influence of low doses of Arsenite on Glucose stimulated Insulin secretion in pancreatic cells,36,9.67E-01,1.00E+00,9.71E-01,1.00E+00,1,Calpain 10,9.67E-01,1.00E+00,1,Calpain 10
1377,G-protein signaling_Regulation of RAC1 activity,36,9.67E-01,1.00E+00,9.71E-01,1.00E+00,1,Caspase-1,9.67E-01,1.00E+00,1,Caspase-1
1378,Sphingolipid metabolism,107,9.70E-01,1.00E+00,9.77E-01,1.00E+00,5,"ACER1, GM3 synthase, G3ST1, B4G6, DEGS2",9.70E-01,1.00E+00,5,"ACER1, GM3 synthase, G3ST1, B4G6, DEGS2"
1379,ATP/ITP metabolism,123,9.71E-01,1.00E+00,9.78E-01,1.00E+00,6,"AK5, ADA, 5'-NTD, ALPP, ADAR3, 5'-NT1A",9.71E-01,1.00E+00,6,"AK5, ADA, 5'-NTD, ALPP, ADAR3, 5'-NT1A"
1380,Activation of Ca2+-dependent neuronal cell death in Huntington's disease,38,9.73E-01,1.00E+00,9.76E-01,1.00E+00,1,NMDA receptor,9.73E-01,1.00E+00,1,NMDA receptor
1381,Cholesterol and Sphingolipid transport / Distribution to the intracellular membrane compartments (normal and CF),38,9.73E-01,1.00E+00,9.76E-01,1.00E+00,1,OSBPL5,9.73E-01,1.00E+00,1,OSBPL5
1382,wtCFTR and deltaF508-CFTR traffic / Generic schema (normal and CF),38,9.73E-01,1.00E+00,9.76E-01,1.00E+00,1,EBP50,9.73E-01,1.00E+00,1,EBP50
1383,L-Lysine metabolism,93,9.74E-01,1.00E+00,9.79E-01,1.00E+00,4,"CRYM, CAT-3, CAT-2, SLC7A7",9.74E-01,1.00E+00,4,"CRYM, CAT-3, CAT-2, SLC7A7"
1384,Mitochondrial dysfunction in neurodegenerative diseases,59,9.75E-01,1.00E+00,9.79E-01,1.00E+00,2,"NMDA receptor, IP3 receptor",9.75E-01,1.00E+00,2,"NMDA receptor, IP3 receptor"
1385,Aminosugar metabolism,60,9.77E-01,1.00E+00,9.80E-01,1.00E+00,2,"GFPT2, UDP-GlcNAc- 2-epimerase",9.77E-01,1.00E+00,2,"GFPT2, UDP-GlcNAc- 2-epimerase"
1386,Histidine-glutamate-glutamine metabolism,95,9.77E-01,1.00E+00,9.82E-01,1.00E+00,4,"GFPT2, DHE4, GABT, GAD1",9.77E-01,1.00E+00,4,"GFPT2, DHE4, GABT, GAD1"
1387,Leukotriene 4 biosynthesis and metabolism,40,9.78E-01,1.00E+00,9.81E-01,1.00E+00,1,ALOX5,9.78E-01,1.00E+00,1,ALOX5
1388,"N-Acylethanolamines, Phospholipase A2 pathway",40,9.78E-01,1.00E+00,9.81E-01,1.00E+00,1,PLA2(hGIIA),9.78E-01,1.00E+00,1,PLA2(hGIIA)
1389,Neurophysiological process_Glucose-inhibited neurons of ventromedial and arcuate nuclei (rodent model),41,9.80E-01,1.00E+00,9.82E-01,1.00E+00,1,NPY,9.80E-01,1.00E+00,1,NPY
1390,Cigarette smoke-induced oxidative stress and apoptosis in airway epithelial cells,60,9.80E-01,1.00E+00,9.80E-01,1.00E+00,2,"Bcl-2, p53",9.97E-01,1.00E+00,1,Bcl-2
1391,Sulfur metabolism,42,9.82E-01,1.00E+00,9.84E-01,1.00E+00,1,CDO1,9.82E-01,1.00E+00,1,CDO1
1392,Transcription_FXR-regulated cholesterol and bile acids cellular transport,42,9.82E-01,1.00E+00,9.84E-01,1.00E+00,1,MDR1,9.82E-01,1.00E+00,1,MDR1
1393,Chylomicron dyslipidemia in type 2 diabetes and metabolic syndrome X,42,9.82E-01,1.00E+00,9.84E-01,1.00E+00,1,APOB48 receptor,9.82E-01,1.00E+00,1,APOB48 receptor
1394,Propionate metabolism p.2,63,9.82E-01,1.00E+00,9.85E-01,1.00E+00,2,"ACACB, GABT",9.82E-01,1.00E+00,2,"ACACB, GABT"
1395,Immune response_BAFF-induced canonical NF-kB signaling,43,9.83E-01,1.00E+00,9.86E-01,1.00E+00,1,IP3 receptor,9.83E-01,1.00E+00,1,IP3 receptor
1396,N-Glycan biosynthesis p2,43,9.83E-01,1.00E+00,9.86E-01,1.00E+00,1,GNT-III,9.83E-01,1.00E+00,1,GNT-III
1397,"Leucine, isoleucine and valine metabolism",43,9.83E-01,1.00E+00,9.86E-01,1.00E+00,1,BCAT1,9.83E-01,1.00E+00,1,BCAT1
1398,Development_Notch Signaling Pathway,43,9.83E-01,1.00E+00,9.86E-01,1.00E+00,1,Jagged1,9.83E-01,1.00E+00,1,Jagged1
1399,Unsaturated fatty acid biosynthesis,65,9.84E-01,1.00E+00,9.87E-01,1.00E+00,2,"ACSL4, ELOVL2",9.84E-01,1.00E+00,2,"ACSL4, ELOVL2"
1400,Thiamine metabolism,44,9.85E-01,1.00E+00,9.87E-01,1.00E+00,1,SLC44A4,9.85E-01,1.00E+00,1,SLC44A4
1401,Pyruvate metabolism,66,9.86E-01,1.00E+00,9.88E-01,1.00E+00,2,"LDHD, MCT1 (SLC16A1)",9.86E-01,1.00E+00,2,"LDHD, MCT1 (SLC16A1)"
1402,Metabolism in pancreatic cancer cells,66,9.86E-01,1.00E+00,9.88E-01,1.00E+00,2,"DHE4, SLC7A11",9.86E-01,1.00E+00,2,"DHE4, SLC7A11"
1403,Mitochondrial unsaturated fatty acid beta-oxidation,45,9.86E-01,1.00E+00,9.88E-01,1.00E+00,1,ACSL4,9.86E-01,1.00E+00,1,ACSL4
1404,TTP metabolism,68,9.88E-01,1.00E+00,9.90E-01,1.00E+00,2,"UDP, DPYD",9.88E-01,1.00E+00,2,"UDP, DPYD"
1405,Lipoprotein metabolism,68,9.88E-01,1.00E+00,9.90E-01,1.00E+00,2,"VLDLR, ABCG1",9.88E-01,1.00E+00,2,"VLDLR, ABCG1"
1406,Phospholipid metabolism p.2,47,9.89E-01,1.00E+00,9.90E-01,1.00E+00,1,PEMT,9.89E-01,1.00E+00,1,PEMT
1407,Regulation of lipid metabolism_PPAR regulation of lipid metabolism,47,9.89E-01,1.00E+00,9.90E-01,1.00E+00,1,Fatty acid-binding protein,9.89E-01,1.00E+00,1,Fatty acid-binding protein
1408,Phosphatidylinositol metabolism,85,9.89E-01,1.00E+00,9.89E-01,1.00E+00,3,"INPP, PTEN, INPP4B",1.00E+00,1.00E+00,1,INPP
1409,CTP/UTP metabolism,107,9.90E-01,1.00E+00,9.92E-01,1.00E+00,4,"UDP, DPYD, AK5, CDD",9.90E-01,1.00E+00,4,"UDP, DPYD, AK5, CDD"
1410,GTP-XTP metabolism,90,9.90E-01,1.00E+00,9.93E-01,1.00E+00,3,"Xanthine oxidase, Guanine deaminase, 5'-NTD",9.90E-01,1.00E+00,3,"Xanthine oxidase, Guanine deaminase, 5'-NTD"
1411,Immune response_The effect of IDO1 on T cell metabolism,89,9.92E-01,1.00E+00,9.92E-01,1.00E+00,3,"IDO1, DHE4, p53",9.98E-01,1.00E+00,2,"IDO1, DHE4"
1412,Aspartate and asparagine metabolism,73,9.92E-01,1.00E+00,9.94E-01,1.00E+00,2,"GABT, GAD1",9.92E-01,1.00E+00,2,"GABT, GAD1"
1413,dCTP/dUTP metabolism,74,9.93E-01,1.00E+00,9.94E-01,1.00E+00,2,"AK5, CDD",9.93E-01,1.00E+00,2,"AK5, CDD"
1414,Metabolism of L-Proline and derivatives,74,9.93E-01,1.00E+00,9.94E-01,1.00E+00,2,"CRYM, DHDPSL",9.93E-01,1.00E+00,2,"CRYM, DHDPSL"
1415,Peroxysomal straight-chain fatty acid beta-oxidation,74,9.93E-01,1.00E+00,9.94E-01,1.00E+00,2,"ACSL4, ACOX2",9.93E-01,1.00E+00,2,"ACSL4, ACOX2"
1416,Ubiquinone metabolism,74,9.93E-01,1.00E+00,9.94E-01,1.00E+00,2,"TAT, NDUFA2",9.93E-01,1.00E+00,2,"TAT, NDUFA2"
1417,Impaired NO signaling in CF airways,52,9.93E-01,1.00E+00,9.94E-01,1.00E+00,1,iNOS,9.93E-01,1.00E+00,1,iNOS
1418,dATP/dITP metabolism,94,9.93E-01,1.00E+00,9.95E-01,1.00E+00,3,"AK5, ADA, 5'-NTD",9.93E-01,1.00E+00,3,"AK5, ADA, 5'-NTD"
1419,Bile Acid Biosynthesis,94,9.93E-01,1.00E+00,9.95E-01,1.00E+00,3,"CYP27A1, AKR1C4, ACOX2",9.93E-01,1.00E+00,3,"CYP27A1, AKR1C4, ACOX2"
1420,Renal secretion of organic electrolytes / Rodent version ,75,9.93E-01,1.00E+00,9.95E-01,1.00E+00,2,"PEPT1, SLC5A8",9.93E-01,1.00E+00,2,"PEPT1, SLC5A8"
1421,Androstenedione and testosterone biosynthesis and metabolism p.1,54,9.94E-01,1.00E+00,9.95E-01,1.00E+00,1,CYP1A1,9.94E-01,1.00E+00,1,CYP1A1
1422,Arsenite metabolism and transport,54,9.94E-01,1.00E+00,9.95E-01,1.00E+00,1,Aquaporin 9,9.94E-01,1.00E+00,1,Aquaporin 9
1423,"Leucine, isoleucine and valine metabolism.p.2",79,9.95E-01,1.00E+00,9.96E-01,1.00E+00,2,"GABT, HMGCS2",9.95E-01,1.00E+00,2,"GABT, HMGCS2"
1424,Signal transduction_Amino acid-dependent mTORC1 activation,96,9.95E-01,1.00E+00,9.95E-01,1.00E+00,3,"Tuberin, CAT-3, NPRL3",9.99E-01,1.00E+00,2,"CAT-3, NPRL3"
1425,Transcription_Epigenetic regulation of gene expression,57,9.96E-01,1.00E+00,9.96E-01,1.00E+00,1,HDAC9,9.96E-01,1.00E+00,1,HDAC9
1426,Vitamin E (alfa-tocopherol) metabolism,81,9.96E-01,1.00E+00,9.97E-01,1.00E+00,2,"ACSL4, ACOX2",9.96E-01,1.00E+00,2,"ACSL4, ACOX2"
1427,Transcription_Effect of Folic acid on genome stability,60,9.97E-01,1.00E+00,9.97E-01,1.00E+00,1,FR-alpha,9.97E-01,1.00E+00,1,FR-alpha
1428,Peroxisomal branched chain fatty acid oxidation,84,9.97E-01,1.00E+00,9.98E-01,1.00E+00,2,"ACADL, ACOX2",9.97E-01,1.00E+00,2,"ACADL, ACOX2"
1429,Galactose metabolism,63,9.98E-01,1.00E+00,9.98E-01,1.00E+00,1,ALD2,9.98E-01,1.00E+00,1,ALD2
1430,Glycolysis and gluconeogenesis,94,9.99E-01,1.00E+00,9.99E-01,1.00E+00,2,"F16Q, F16P",9.99E-01,1.00E+00,2,"F16Q, F16P"
1431,L-Tryptophan metabolism (part 2),97,9.99E-01,1.00E+00,9.99E-01,1.00E+00,2,"3HAO, SULT1B1",9.99E-01,1.00E+00,2,"3HAO, SULT1B1"
1432,Mitochondrial beta-oxidation of long-chain saturated fatty acids,125,9.99E-01,1.00E+00,1.00E+00,1.00E+00,3,"ACSL4, B-FABP, ACADL",9.99E-01,1.00E+00,3,"ACSL4, B-FABP, ACADL"
